Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Carcinoma in situ of breast,A1BG,Alpha-1B-glycoprotein,19630,119,1.35 [0.50-3.64],0.5590037430339732
Chapter II Neoplasms,Carcinoma in situ of breast,AAMDC,Mth938 domain-containing protein,19106,119,0.83 [0.59-1.15],0.2614169305509911
Chapter II Neoplasms,Carcinoma in situ of breast,AARSD1,Alanyl-tRNA editing protein Aarsd1,22413,140,0.88 [0.67-1.15],0.3511515740080551
Chapter II Neoplasms,Carcinoma in situ of breast,ABCA2,ATP-binding cassette sub-family A member 2,19003,118,0.89 [0.54-1.46],0.6391737958298276
Chapter II Neoplasms,Carcinoma in situ of breast,ABHD14B,Protein ABHD14B,22289,138,0.84 [0.65-1.10],0.2035510394941605
Chapter II Neoplasms,Carcinoma in situ of breast,ABL1,Tyrosine-protein kinase ABL1,22413,140,0.70 [0.55-0.88],0.0031221513587005
Chapter II Neoplasms,Carcinoma in situ of breast,ABO,Histo-blood group ABO system transferase,19605,119,0.94 [0.84-1.06],0.3459353448576927
Chapter II Neoplasms,Carcinoma in situ of breast,ABRAXAS2,BRISC complex subunit Abraxas 2,19003,118,0.74 [0.56-0.97],0.0323254146749549
Chapter II Neoplasms,Carcinoma in situ of breast,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22008,134,0.89 [0.74-1.09],0.2608770022239701
Chapter II Neoplasms,Carcinoma in situ of breast,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19223,122,0.83 [0.62-1.11],0.2062475172953374
Chapter II Neoplasms,Carcinoma in situ of breast,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19600,119,0.85 [0.69-1.04],0.1176491313230111
Chapter II Neoplasms,Carcinoma in situ of breast,ACAN,Aggrecan core protein,22314,139,1.19 [0.70-2.03],0.5204015242863047
Chapter II Neoplasms,Carcinoma in situ of breast,ACE,Angiotensin-converting enzyme,19605,119,0.80 [0.41-1.57],0.52009869465067
Chapter II Neoplasms,Carcinoma in situ of breast,ACE2,Angiotensin-converting enzyme 2,22115,137,0.79 [0.56-1.12],0.1903212725427783
Chapter II Neoplasms,Carcinoma in situ of breast,ACHE,Acetylcholinesterase,19191,120,0.95 [0.54-1.65],0.8462325053862967
Chapter II Neoplasms,Carcinoma in situ of breast,ACOT13,Acyl-coenzyme A thioesterase 13,19501,122,0.87 [0.75-1.02],0.0843097664136963
Chapter II Neoplasms,Carcinoma in situ of breast,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22518,139,0.91 [0.66-1.23],0.5312982712944219
Chapter II Neoplasms,Carcinoma in situ of breast,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19054,117,0.78 [0.51-1.19],0.2429120647824433
Chapter II Neoplasms,Carcinoma in situ of breast,ACP5,Tartrate-resistant acid phosphatase type 5,22624,135,1.01 [0.63-1.63],0.9535875105264308
Chapter II Neoplasms,Carcinoma in situ of breast,ACP6,Lysophosphatidic acid phosphatase type 6,22677,137,0.96 [0.77-1.19],0.6797324550993799
Chapter II Neoplasms,Carcinoma in situ of breast,ACRBP,Acrosin-binding protein,19495,120,0.84 [0.52-1.36],0.4845973565883935
Chapter II Neoplasms,Carcinoma in situ of breast,ACRV1,Acrosomal protein SP-10,19054,117,1.04 [0.64-1.71],0.869115915541605
Chapter II Neoplasms,Carcinoma in situ of breast,ACSL1,Long-chain-fatty-acid--CoA ligase 1,19003,118,0.90 [0.55-1.49],0.6920869071371105
Chapter II Neoplasms,Carcinoma in situ of breast,ACTA2,"Actin, aortic smooth muscle",22115,137,1.18 [0.86-1.63],0.2956904332165669
Chapter II Neoplasms,Carcinoma in situ of breast,ACTN2,Alpha-actinin-2,19003,118,0.82 [0.58-1.16],0.2690798796789743
Chapter II Neoplasms,Carcinoma in situ of breast,ACTN4,Alpha-actinin-4,22090,138,1.03 [0.65-1.64],0.8991472960471956
Chapter II Neoplasms,Carcinoma in situ of breast,ACVRL1,Serine/threonine-protein kinase receptor R3,22333,139,1.30 [0.69-2.48],0.4192673431346088
Chapter II Neoplasms,Carcinoma in situ of breast,ACY1,Aminoacylase-1,22518,139,0.85 [0.65-1.10],0.2064334972317834
Chapter II Neoplasms,Carcinoma in situ of breast,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19003,118,0.90 [0.65-1.24],0.5195770194929304
Chapter II Neoplasms,Carcinoma in situ of breast,ACYP1,Acylphosphatase-1,19108,120,0.77 [0.58-1.00],0.0521207058436553
Chapter II Neoplasms,Carcinoma in situ of breast,ADA,Adenosine deaminase,22764,139,0.71 [0.45-1.12],0.1372267278886352
Chapter II Neoplasms,Carcinoma in situ of breast,ADA2,Adenosine deaminase 2,22360,136,0.99 [0.69-1.43],0.9751643618064224
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19054,117,1.07 [0.67-1.72],0.769612073784471
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22115,137,0.78 [0.47-1.30],0.3440583156509625
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22368,139,0.91 [0.58-1.40],0.6554241215094462
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22764,139,1.02 [0.66-1.57],0.9291023741395844
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22675,138,1.18 [0.69-2.03],0.5450639006001963
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19501,122,1.14 [0.64-2.04],0.6464842564027244
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19054,117,0.75 [0.41-1.37],0.3563934373282054
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22786,138,1.12 [0.58-2.17],0.741825260010216
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22413,140,0.90 [0.66-1.23],0.5078023520465044
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22115,137,0.78 [0.45-1.36],0.3896554220328291
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19054,117,1.12 [0.69-1.82],0.6404733931686738
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22586,140,1.23 [0.88-1.72],0.2167670045243316
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTSL2,ADAMTS-like protein 2,19597,123,0.83 [0.47-1.47],0.5300623018480133
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTSL4,ADAMTS-like protein 4,19106,119,1.16 [0.55-2.48],0.6943854233428834
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTSL5,ADAMTS-like protein 5,19600,119,0.71 [0.45-1.10],0.1230609956708943
Chapter II Neoplasms,Carcinoma in situ of breast,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22008,134,1.00 [0.66-1.52],0.9982044778558528
Chapter II Neoplasms,Carcinoma in situ of breast,ADD1,Alpha-adducin,19191,120,0.76 [0.59-0.98],0.0333788185619926
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRB3,Adhesion G protein-coupled receptor B3,22333,139,1.50 [0.96-2.33],0.0740377708445291
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRD1,Adhesion G-protein coupled receptor D1,19191,120,1.06 [0.65-1.72],0.8064095252168864
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRE1,Adhesion G protein-coupled receptor E1,19501,122,1.16 [0.85-1.58],0.3455291964495967
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRE2,Adhesion G protein-coupled receptor E2,22619,141,1.13 [0.66-1.92],0.6622266007648174
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRE5,Adhesion G protein-coupled receptor E5,22679,136,0.86 [0.51-1.45],0.5686964969952285
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRF5,Adhesion G protein-coupled receptor F5,19600,119,0.67 [0.38-1.20],0.1771236226851798
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRG1,Adhesion G-protein coupled receptor G1,22413,140,0.65 [0.45-0.93],0.0198585053327463
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRG2,Adhesion G-protein coupled receptor G2,22518,139,1.24 [0.71-2.17],0.4426995235969222
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRV1,Adhesion G-protein coupled receptor V1,18997,118,0.73 [0.54-0.99],0.0459021032420539
Chapter II Neoplasms,Carcinoma in situ of breast,ADH1B,All-trans-retinol dehydrogenase,19191,120,0.98 [0.77-1.24],0.8361088718815326
Chapter II Neoplasms,Carcinoma in situ of breast,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22115,137,0.89 [0.74-1.07],0.2265082956217166
Chapter II Neoplasms,Carcinoma in situ of breast,ADIPOQ,Adiponectin,19630,119,1.25 [0.96-1.62],0.0992102204280599
Chapter II Neoplasms,Carcinoma in situ of breast,ADM,Pro-adrenomedullin,22716,137,0.92 [0.53-1.61],0.7677414529451949
Chapter II Neoplasms,Carcinoma in situ of breast,ADRA2A,Alpha-2A adrenergic receptor,19003,118,0.98 [0.77-1.26],0.8822695051428042
Chapter II Neoplasms,Carcinoma in situ of breast,AFAP1,Actin filament-associated protein 1,19191,120,0.82 [0.66-1.02],0.0736430812753939
Chapter II Neoplasms,Carcinoma in situ of breast,AFM,Afamin,19630,119,0.76 [0.30-1.92],0.5672080342160453
Chapter II Neoplasms,Carcinoma in situ of breast,AFP,Alpha-fetoprotein,22305,137,1.22 [0.99-1.51],0.0646513062925017
Chapter II Neoplasms,Carcinoma in situ of breast,AGBL2,Cytosolic carboxypeptidase 2,18997,118,0.98 [0.81-1.19],0.849555839346661
Chapter II Neoplasms,Carcinoma in situ of breast,AGER,Advanced glycosylation end product-specific receptor,22467,140,1.13 [0.78-1.64],0.5118622924343477
Chapter II Neoplasms,Carcinoma in situ of breast,AGR2,Anterior gradient protein 2 homolog,21760,131,0.95 [0.81-1.11],0.5077092534399228
Chapter II Neoplasms,Carcinoma in situ of breast,AGR3,Anterior gradient protein 3,21969,134,0.90 [0.69-1.17],0.4272542430953047
Chapter II Neoplasms,Carcinoma in situ of breast,AGRN,Agrin,22619,141,0.85 [0.53-1.36],0.5018196473941111
Chapter II Neoplasms,Carcinoma in situ of breast,AGRP,Agouti-related protein,22764,139,1.05 [0.80-1.39],0.7220093104947869
Chapter II Neoplasms,Carcinoma in situ of breast,AGT,Angiotensinogen,19605,119,0.80 [0.42-1.52],0.4897859938468724
Chapter II Neoplasms,Carcinoma in situ of breast,AGXT,Serine--pyruvate aminotransferase,22518,139,1.05 [0.87-1.27],0.5889035166776755
Chapter II Neoplasms,Carcinoma in situ of breast,AHCY,Adenosylhomocysteinase,22518,139,0.82 [0.65-1.02],0.0736559276177083
Chapter II Neoplasms,Carcinoma in situ of breast,AHNAK,Neuroblast differentiation-associated protein AHNAK,19106,119,1.17 [0.68-2.02],0.5697622615907225
Chapter II Neoplasms,Carcinoma in situ of breast,AHNAK2,Protein AHNAK2,19106,119,1.26 [0.70-2.26],0.4391066321610217
Chapter II Neoplasms,Carcinoma in situ of breast,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19495,120,0.59 [0.42-0.83],0.0023324996038916
Chapter II Neoplasms,Carcinoma in situ of breast,AHSG,Alpha-2-HS-glycoprotein,19605,119,0.79 [0.43-1.45],0.4442445638278122
Chapter II Neoplasms,Carcinoma in situ of breast,AHSP,Alpha-hemoglobin-stabilizing protein,22489,137,1.03 [0.87-1.22],0.7182901767420353
Chapter II Neoplasms,Carcinoma in situ of breast,AIDA,"Axin interactor, dorsalization-associated protein",19054,119,0.98 [0.80-1.21],0.8573661442712962
Chapter II Neoplasms,Carcinoma in situ of breast,AIF1,Allograft inflammatory factor 1,22008,134,0.97 [0.72-1.30],0.8362038611293561
Chapter II Neoplasms,Carcinoma in situ of breast,AIF1L,Allograft inflammatory factor 1-like,19106,119,1.01 [0.75-1.36],0.9599169364452944
Chapter II Neoplasms,Carcinoma in situ of breast,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22368,140,0.83 [0.72-0.96],0.0146896931837128
Chapter II Neoplasms,Carcinoma in situ of breast,AK1,Adenylate kinase isoenzyme 1,22518,139,0.88 [0.69-1.11],0.2720582090452624
Chapter II Neoplasms,Carcinoma in situ of breast,AK2,"Adenylate kinase 2, mitochondrial",19562,122,0.90 [0.76-1.05],0.1842695565551796
Chapter II Neoplasms,Carcinoma in situ of breast,AKAP12,A-kinase anchor protein 12,19191,120,1.32 [0.64-2.72],0.4545357590234374
Chapter II Neoplasms,Carcinoma in situ of breast,AKR1B1,Aldo-keto reductase family 1 member B1,22008,134,0.90 [0.73-1.10],0.2903788358529006
Chapter II Neoplasms,Carcinoma in situ of breast,AKR1B10,Aldo-keto reductase family 1 member B10,19054,119,0.87 [0.63-1.18],0.3669656879510775
Chapter II Neoplasms,Carcinoma in situ of breast,AKR1C4,Aldo-keto reductase family 1 member C4,22115,137,1.02 [0.78-1.34],0.8773722729930019
Chapter II Neoplasms,Carcinoma in situ of breast,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19054,117,1.05 [0.83-1.34],0.6700725279917923
Chapter II Neoplasms,Carcinoma in situ of breast,AKT1S1,Proline-rich AKT1 substrate 1,21957,134,0.71 [0.57-0.90],0.0042359796542783
Chapter II Neoplasms,Carcinoma in situ of breast,AKT2,RAC-beta serine/threonine-protein kinase,19571,121,0.87 [0.76-1.00],0.0429285821655431
Chapter II Neoplasms,Carcinoma in situ of breast,AKT3,RAC-gamma serine/threonine-protein kinase,21900,134,0.78 [0.59-1.03],0.0758963745305835
Chapter II Neoplasms,Carcinoma in situ of breast,ALCAM,CD166 antigen,22786,138,1.59 [0.73-3.46],0.2403820875954244
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH1A1,Retinal dehydrogenase 1,22524,138,0.90 [0.68-1.20],0.4682895310735817
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH2,"Aldehyde dehydrogenase, mitochondrial",19495,120,0.99 [0.71-1.38],0.9497298532237828
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22444,136,1.09 [0.88-1.36],0.4243419183827961
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19571,121,1.07 [0.75-1.53],0.7165591306156637
Chapter II Neoplasms,Carcinoma in situ of breast,ALMS1,Alstrom syndrome protein 1,19223,122,1.00 [0.69-1.46],0.987466474653725
Chapter II Neoplasms,Carcinoma in situ of breast,ALPI,Intestinal-type alkaline phosphatase,19054,117,0.96 [0.83-1.11],0.55552680137901
Chapter II Neoplasms,Carcinoma in situ of breast,ALPP,"Alkaline phosphatase, placental type",22413,140,0.93 [0.80-1.08],0.3285938465559856
Chapter II Neoplasms,Carcinoma in situ of breast,AMBN,Ameloblastin,22090,138,0.82 [0.45-1.49],0.5202660765195302
Chapter II Neoplasms,Carcinoma in situ of breast,AMBP,Protein AMBP,22683,136,1.64 [0.76-3.53],0.2078045739230802
Chapter II Neoplasms,Carcinoma in situ of breast,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19597,123,0.90 [0.46-1.76],0.7693238589752183
Chapter II Neoplasms,Carcinoma in situ of breast,AMFR,E3 ubiquitin-protein ligase AMFR,21957,134,1.07 [0.85-1.34],0.5584323067627834
Chapter II Neoplasms,Carcinoma in situ of breast,AMIGO1,Amphoterin-induced protein 1,19054,119,0.94 [0.65-1.34],0.7227737193718773
Chapter II Neoplasms,Carcinoma in situ of breast,AMIGO2,Amphoterin-induced protein 2,22413,140,0.73 [0.37-1.41],0.3418660135732387
Chapter II Neoplasms,Carcinoma in situ of breast,AMN,Protein amnionless,22090,138,1.17 [0.86-1.59],0.3074284234076509
Chapter II Neoplasms,Carcinoma in situ of breast,AMOT,Angiomotin,19191,120,0.79 [0.51-1.22],0.2928314136883637
Chapter II Neoplasms,Carcinoma in situ of breast,AMOTL2,Angiomotin-like protein 2,19438,120,0.60 [0.38-0.95],0.0288642014908108
Chapter II Neoplasms,Carcinoma in situ of breast,AMPD3,AMP deaminase 3,19562,122,0.97 [0.77-1.22],0.7807377757008439
Chapter II Neoplasms,Carcinoma in situ of breast,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18344,107,0.69 [0.46-1.04],0.0737873366608858
Chapter II Neoplasms,Carcinoma in situ of breast,AMY2A,Pancreatic alpha-amylase,21624,133,0.82 [0.59-1.15],0.2497575214497069
Chapter II Neoplasms,Carcinoma in situ of breast,AMY2B,Alpha-amylase 2B,20972,128,0.82 [0.58-1.15],0.2413363987949832
Chapter II Neoplasms,Carcinoma in situ of breast,ANG,Angiogenin,22434,137,1.36 [0.90-2.05],0.1478536935063961
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPT1,Angiopoietin-1,22436,140,0.88 [0.74-1.05],0.1521552140558046
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPT2,Angiopoietin-2,22716,137,0.94 [0.64-1.40],0.7753823131064124
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL1,Angiopoietin-related protein 1,22215,139,0.83 [0.50-1.40],0.4897847504871537
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL2,Angiopoietin-related protein 2,22552,141,1.17 [0.80-1.69],0.415280242457929
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL3,Angiopoietin-related protein 3,22502,139,1.33 [0.88-2.02],0.1785281035511498
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL4,Angiopoietin-related protein 4,22580,141,0.96 [0.69-1.33],0.8007071106170693
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL7,Angiopoietin-related protein 7,22716,137,0.78 [0.52-1.18],0.2365042746350101
Chapter II Neoplasms,Carcinoma in situ of breast,ANK2,Ankyrin-2,19003,118,1.11 [0.89-1.38],0.3534273408385115
Chapter II Neoplasms,Carcinoma in situ of breast,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19054,117,0.73 [0.58-0.92],0.0070056754961926
Chapter II Neoplasms,Carcinoma in situ of breast,ANKRA2,Ankyrin repeat family A protein 2,18908,119,1.17 [0.88-1.55],0.276060367494849
Chapter II Neoplasms,Carcinoma in situ of breast,ANKRD54,Ankyrin repeat domain-containing protein 54,22008,134,0.94 [0.71-1.23],0.6409054095683446
Chapter II Neoplasms,Carcinoma in situ of breast,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19106,119,0.83 [0.51-1.34],0.4416654092061377
Chapter II Neoplasms,Carcinoma in situ of breast,ANPEP,Aminopeptidase N,22538,139,1.69 [1.04-2.75],0.0344132565144772
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA1,Annexin A1,19066,120,1.24 [0.88-1.75],0.2197089789549233
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA10,Annexin A10,21957,134,0.82 [0.67-1.01],0.0633094816367891
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA11,Annexin A11,22448,136,0.90 [0.72-1.12],0.3254827993777347
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA2,Annexin A2,18816,119,0.92 [0.71-1.19],0.5127994841919559
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA3,Annexin A3,22675,138,0.90 [0.73-1.12],0.3401535600664667
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA4,Annexin A4,22401,138,0.83 [0.67-1.03],0.0976771709329362
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA5,Annexin A5,21897,134,0.88 [0.53-1.47],0.6319541964312647
Chapter II Neoplasms,Carcinoma in situ of breast,AOC1,Amiloride-sensitive amine oxidase [copper-containing],22090,138,1.02 [0.79-1.32],0.8690757154817937
Chapter II Neoplasms,Carcinoma in situ of breast,AOC3,Membrane primary amine oxidase,22579,139,1.91 [1.17-3.12],0.0098521530777414
Chapter II Neoplasms,Carcinoma in situ of breast,AP1G2,AP-1 complex subunit gamma-like 2,19495,120,0.74 [0.59-0.93],0.011111549402912
Chapter II Neoplasms,Carcinoma in situ of breast,AP2B1,AP-2 complex subunit beta,19054,119,0.67 [0.45-1.01],0.0555565984328762
Chapter II Neoplasms,Carcinoma in situ of breast,AP3B1,AP-3 complex subunit beta-1,19501,122,0.82 [0.65-1.04],0.1012919969830059
Chapter II Neoplasms,Carcinoma in situ of breast,AP3S2,AP-3 complex subunit sigma-2,19562,122,0.74 [0.50-1.10],0.1422359757862013
Chapter II Neoplasms,Carcinoma in situ of breast,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22413,140,1.03 [0.75-1.43],0.8493095667584256
Chapter II Neoplasms,Carcinoma in situ of breast,APCS,Serum amyloid P-component,19450,117,1.38 [0.84-2.27],0.203649496959722
Chapter II Neoplasms,Carcinoma in situ of breast,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22643,137,1.03 [0.80-1.32],0.8411983748149349
Chapter II Neoplasms,Carcinoma in situ of breast,APLP1,Amyloid-like protein 1,22518,139,1.15 [0.87-1.53],0.332961934547573
Chapter II Neoplasms,Carcinoma in situ of breast,APOA1,Apolipoprotein A-I,19630,119,1.24 [0.69-2.20],0.4718588151897899
Chapter II Neoplasms,Carcinoma in situ of breast,APOA2,Apolipoprotein A-II,19605,119,1.22 [0.85-1.75],0.2890579048650419
Chapter II Neoplasms,Carcinoma in situ of breast,APOA4,Apolipoprotein A-IV,19630,119,1.27 [0.84-1.92],0.2599868807925147
Chapter II Neoplasms,Carcinoma in situ of breast,APOB,Apolipoprotein B-100,19605,119,0.74 [0.35-1.55],0.4223674015704119
Chapter II Neoplasms,Carcinoma in situ of breast,APOBR,Apolipoprotein B receptor,19106,119,1.06 [0.69-1.60],0.8014777828475501
Chapter II Neoplasms,Carcinoma in situ of breast,APOC1,Apolipoprotein C-I,19587,118,1.13 [0.71-1.80],0.6142448478371432
Chapter II Neoplasms,Carcinoma in situ of breast,APOD,Apolipoprotein D,18721,111,1.18 [0.83-1.67],0.3471452259699044
Chapter II Neoplasms,Carcinoma in situ of breast,APOE,Apolipoprotein E,19630,119,0.87 [0.66-1.16],0.3458748547949557
Chapter II Neoplasms,Carcinoma in situ of breast,APOF,Apolipoprotein F,19605,119,1.19 [0.60-2.36],0.6098938377675902
Chapter II Neoplasms,Carcinoma in situ of breast,APOH,Beta-2-glycoprotein 1,22524,138,1.19 [0.79-1.79],0.4143264172333393
Chapter II Neoplasms,Carcinoma in situ of breast,APOL1,Apolipoprotein L1,19605,119,1.07 [0.83-1.37],0.6073346560414572
Chapter II Neoplasms,Carcinoma in situ of breast,APOM,Apolipoprotein M,22542,139,2.03 [1.16-3.53],0.0126613336371213
Chapter II Neoplasms,Carcinoma in situ of breast,APP,Amyloid-beta precursor protein,22490,138,0.83 [0.66-1.04],0.0991776849173316
Chapter II Neoplasms,Carcinoma in situ of breast,APPL2,DCC-interacting protein 13-beta,19191,120,0.85 [0.73-0.99],0.034250469495055
Chapter II Neoplasms,Carcinoma in situ of breast,APRT,Adenine phosphoribosyltransferase,22338,139,0.78 [0.58-1.05],0.1047316095174139
Chapter II Neoplasms,Carcinoma in situ of breast,ARAF,Serine/threonine-protein kinase A-Raf,19223,122,0.76 [0.57-1.01],0.0557081231534508
Chapter II Neoplasms,Carcinoma in situ of breast,AREG,Amphiregulin,22413,140,1.26 [0.95-1.67],0.1029959278417465
Chapter II Neoplasms,Carcinoma in situ of breast,ARF6,ADP-ribosylation factor 6,19501,122,0.95 [0.81-1.12],0.5461582193403601
Chapter II Neoplasms,Carcinoma in situ of breast,ARFIP1,Arfaptin-1,19571,121,0.84 [0.65-1.09],0.1944843697409954
Chapter II Neoplasms,Carcinoma in situ of breast,ARG1,Arginase-1,22422,135,1.06 [0.80-1.40],0.6905161047601982
Chapter II Neoplasms,Carcinoma in situ of breast,ARG2,"Arginase-2, mitochondrial",19495,120,1.21 [0.86-1.69],0.2715973152117766
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP1,Rho GTPase-activating protein 1,22008,134,0.76 [0.54-1.05],0.097805628903207
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP25,Rho GTPase-activating protein 25,22008,134,0.94 [0.72-1.22],0.6349426567451089
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP30,Rho GTPase-activating protein 30,19223,122,0.70 [0.40-1.22],0.2124600773306519
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP45,Rho GTPase-activating protein 45,19191,120,0.83 [0.67-1.03],0.0977924986429509
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP5,Rho GTPase-activating protein 5,18908,119,0.81 [0.62-1.05],0.1166747711871193
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF1,Rho guanine nucleotide exchange factor 1,19562,122,0.81 [0.67-0.99],0.0347476041369231
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF10,Rho guanine nucleotide exchange factor 10,19571,121,0.80 [0.66-0.97],0.0236717936624022
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF12,Rho guanine nucleotide exchange factor 12,22477,136,0.84 [0.73-0.98],0.0217732858537491
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF5,Rho guanine nucleotide exchange factor 5,18997,118,1.06 [0.84-1.34],0.605210692786686
Chapter II Neoplasms,Carcinoma in situ of breast,ARID3A,AT-rich interactive domain-containing protein 3A,18997,118,1.03 [0.67-1.60],0.8784527006150731
Chapter II Neoplasms,Carcinoma in situ of breast,ARID4B,AT-rich interactive domain-containing protein 4B,21957,134,1.09 [0.78-1.52],0.6147814658133803
Chapter II Neoplasms,Carcinoma in situ of breast,ARL13B,ADP-ribosylation factor-like protein 13B,19003,118,0.73 [0.55-0.97],0.0302503460604421
Chapter II Neoplasms,Carcinoma in situ of breast,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19003,118,0.72 [0.46-1.14],0.1607060208344093
Chapter II Neoplasms,Carcinoma in situ of breast,ARMCX2,Armadillo repeat-containing X-linked protein 2,18997,118,1.03 [0.79-1.34],0.8393879111248481
Chapter II Neoplasms,Carcinoma in situ of breast,ARNT,Aryl hydrocarbon receptor nuclear translocator,22090,138,0.54 [0.33-0.87],0.0121135350024656
Chapter II Neoplasms,Carcinoma in situ of breast,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19003,118,0.98 [0.70-1.37],0.9119730109631476
Chapter II Neoplasms,Carcinoma in situ of breast,ARSA,Arylsulfatase A,22524,138,0.74 [0.52-1.05],0.0924107607373528
Chapter II Neoplasms,Carcinoma in situ of breast,ARSB,Arylsulfatase B,22413,140,0.79 [0.60-1.05],0.1040562666082696
Chapter II Neoplasms,Carcinoma in situ of breast,ART3,Ecto-ADP-ribosyltransferase 3,22579,139,1.14 [0.72-1.81],0.5779445923282358
Chapter II Neoplasms,Carcinoma in situ of breast,ART5,Ecto-ADP-ribosyltransferase 5,18997,118,0.96 [0.72-1.27],0.7747613803130786
Chapter II Neoplasms,Carcinoma in situ of breast,ARTN,Artemin,22090,138,0.98 [0.70-1.38],0.912534791009847
Chapter II Neoplasms,Carcinoma in situ of breast,ASAH1,Acid ceramidase,19414,123,0.85 [0.58-1.25],0.4061488826840782
Chapter II Neoplasms,Carcinoma in situ of breast,ASAH2,Neutral ceramidase,22368,139,1.07 [0.80-1.44],0.637877155533926
Chapter II Neoplasms,Carcinoma in situ of breast,ASGR1,Asialoglycoprotein receptor 1,22368,139,0.78 [0.46-1.33],0.3650536378073267
Chapter II Neoplasms,Carcinoma in situ of breast,ASGR2,Asialoglycoprotein receptor 2,19605,119,1.32 [0.68-2.57],0.40818526106812
Chapter II Neoplasms,Carcinoma in situ of breast,ASPN,Asporin,19600,119,1.27 [0.69-2.35],0.4421859735355955
Chapter II Neoplasms,Carcinoma in situ of breast,ASPSCR1,Tether containing UBX domain for GLUT4,19571,121,0.72 [0.56-0.94],0.0154269293715926
Chapter II Neoplasms,Carcinoma in situ of breast,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19106,119,0.91 [0.76-1.08],0.2895577037402924
Chapter II Neoplasms,Carcinoma in situ of breast,ASS1,Argininosuccinate synthase,19003,118,0.96 [0.77-1.20],0.7130769571163447
Chapter II Neoplasms,Carcinoma in situ of breast,ATF2,Cyclic AMP-dependent transcription factor ATF-2,21957,134,0.87 [0.67-1.13],0.3115441041244007
Chapter II Neoplasms,Carcinoma in situ of breast,ATF4,Cyclic AMP-dependent transcription factor ATF-4,18908,119,0.56 [0.31-0.99],0.0451569220579301
Chapter II Neoplasms,Carcinoma in situ of breast,ATG16L1,Autophagy-related protein 16-1,19501,122,0.82 [0.66-1.00],0.0551144115030559
Chapter II Neoplasms,Carcinoma in situ of breast,ATG4A,Cysteine protease ATG4A,22008,134,0.70 [0.53-0.92],0.0103817975269822
Chapter II Neoplasms,Carcinoma in situ of breast,ATOX1,Copper transport protein ATOX1,22586,140,0.82 [0.67-1.00],0.0553486682076878
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19003,118,0.97 [0.67-1.40],0.8793719354411969
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19003,118,0.83 [0.46-1.48],0.5272462360416442
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19003,118,1.06 [0.70-1.61],0.7876287120918184
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B4,Protein ATP1B4,18908,119,0.47 [0.29-0.78],0.0035767478009331
Chapter II Neoplasms,Carcinoma in situ of breast,ATP2B4,Plasma membrane calcium-transporting ATPase 4,19003,118,1.03 [0.78-1.35],0.8431150421842275
Chapter II Neoplasms,Carcinoma in situ of breast,ATP5F1D,"ATP synthase subunit delta, mitochondrial",19003,118,1.05 [0.78-1.43],0.7420913282686051
Chapter II Neoplasms,Carcinoma in situ of breast,ATP5IF1,"ATPase inhibitor, mitochondrial",22619,141,0.86 [0.75-0.98],0.023451694984141
Chapter II Neoplasms,Carcinoma in situ of breast,ATP5PO,"ATP synthase subunit O, mitochondrial",21957,134,0.73 [0.49-1.08],0.1101172731678003
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6AP2,Renin receptor,22008,134,1.10 [0.79-1.54],0.577045250658565
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1D,V-type proton ATPase subunit D,22413,140,0.33 [0.18-0.62],0.0004815165516703
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1F,V-type proton ATPase subunit F,21909,134,0.94 [0.74-1.19],0.623251901128728
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1G1,V-type proton ATPase subunit G 1,19106,119,0.81 [0.63-1.05],0.1094565712566903
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1G2,V-type proton ATPase subunit G 2,19003,118,0.99 [0.83-1.18],0.9193623321346722
Chapter II Neoplasms,Carcinoma in situ of breast,ATRAID,All-trans retinoic acid-induced differentiation factor,19501,122,1.27 [0.82-1.98],0.2866093969090905
Chapter II Neoplasms,Carcinoma in situ of breast,ATRN,"Attractin, Isoform 2",19630,119,2.07 [0.72-5.99],0.1788570671955055
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN10,Ataxin-10,21957,134,0.84 [0.68-1.04],0.1074216166913138
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN2,Ataxin-2,18997,118,0.99 [0.84-1.15],0.8687630072140278
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN2L,Ataxin-2-like protein,19571,121,0.71 [0.47-1.07],0.1019741392377814
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN3,Ataxin-3,19562,122,0.81 [0.61-1.07],0.1357236631770415
Chapter II Neoplasms,Carcinoma in situ of breast,AXIN1,Axin-1,22477,136,0.81 [0.69-0.95],0.0101284014838928
Chapter II Neoplasms,Carcinoma in situ of breast,AXL,Tyrosine-protein kinase receptor UFO,22579,139,1.85 [1.10-3.13],0.0209500192072911
Chapter II Neoplasms,Carcinoma in situ of breast,AZI2,5-azacytidine-induced protein 2,19571,121,0.77 [0.56-1.08],0.1267629175771996
Chapter II Neoplasms,Carcinoma in situ of breast,AZU1,Azurocidin,21800,131,1.19 [1.01-1.42],0.0425200630442654
Chapter II Neoplasms,Carcinoma in situ of breast,B2M,Beta-2-microglobulin,19630,119,1.05 [0.62-1.78],0.8437410660354869
Chapter II Neoplasms,Carcinoma in situ of breast,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19003,118,0.96 [0.41-2.27],0.9282507999451262
Chapter II Neoplasms,Carcinoma in situ of breast,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19106,119,0.76 [0.47-1.22],0.2524509307950872
Chapter II Neoplasms,Carcinoma in situ of breast,B4GALT1,"Beta-1,4-galactosyltransferase 1",22619,141,1.07 [0.62-1.87],0.7993879180563319
Chapter II Neoplasms,Carcinoma in situ of breast,B4GAT1,"Beta-1,4-glucuronyltransferase 1",22524,138,0.93 [0.50-1.73],0.8117996095049358
Chapter II Neoplasms,Carcinoma in situ of breast,BABAM1,BRISC and BRCA1-A complex member 1,19054,117,0.73 [0.38-1.42],0.3549813956163588
Chapter II Neoplasms,Carcinoma in situ of breast,BACH1,Transcription regulator protein BACH1,22477,136,0.81 [0.65-1.01],0.0588857388986777
Chapter II Neoplasms,Carcinoma in situ of breast,BAG3,BAG family molecular chaperone regulator 3,22333,139,1.05 [0.72-1.54],0.7978655987697119
Chapter II Neoplasms,Carcinoma in situ of breast,BAG4,BAG family molecular chaperone regulator 4,19054,117,0.92 [0.63-1.33],0.6396082340961238
Chapter II Neoplasms,Carcinoma in situ of breast,BAG6,Large proline-rich protein BAG6,22115,137,0.73 [0.48-1.13],0.1622503599249166
Chapter II Neoplasms,Carcinoma in situ of breast,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22008,134,0.85 [0.65-1.10],0.209751048528787
Chapter II Neoplasms,Carcinoma in situ of breast,BAMBI,BMP and activin membrane-bound inhibitor homolog,22008,134,0.62 [0.36-1.07],0.0838421403924705
Chapter II Neoplasms,Carcinoma in situ of breast,BANK1,B-cell scaffold protein with ankyrin repeats,22477,136,0.89 [0.77-1.03],0.1144079432725579
Chapter II Neoplasms,Carcinoma in situ of breast,BAP18,Chromatin complexes subunit BAP18,19562,122,1.16 [0.93-1.45],0.1949065528128765
Chapter II Neoplasms,Carcinoma in situ of breast,BATF,Basic leucine zipper transcriptional factor ATF-like,19054,119,0.92 [0.73-1.15],0.4699974123552604
Chapter II Neoplasms,Carcinoma in situ of breast,BAX,Apoptosis regulator BAX,21927,134,0.86 [0.72-1.03],0.0919792565386724
Chapter II Neoplasms,Carcinoma in situ of breast,BCAM,Basal cell adhesion molecule,22524,138,0.80 [0.42-1.53],0.5048234818868136
Chapter II Neoplasms,Carcinoma in situ of breast,BCAN,Brevican core protein,22368,139,1.13 [0.72-1.78],0.5867493579230727
Chapter II Neoplasms,Carcinoma in situ of breast,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19600,119,0.66 [0.36-1.24],0.1972265629954302
Chapter II Neoplasms,Carcinoma in situ of breast,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",18997,118,1.11 [0.83-1.48],0.4873713850961606
Chapter II Neoplasms,Carcinoma in situ of breast,BCHE,Cholinesterase,19233,117,2.16 [1.13-4.13],0.0196692723863442
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2,Apoptosis regulator Bcl-2,19501,122,1.32 [1.04-1.68],0.0240810625817937
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2L1,Bcl-2-like protein 1,19562,122,0.82 [0.69-0.97],0.0209043785565364
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22477,136,0.87 [0.64-1.20],0.4043575394411309
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2L15,Bcl-2-like protein 15,19054,117,1.10 [0.83-1.46],0.5167356548824837
Chapter II Neoplasms,Carcinoma in situ of breast,BCL7A,B-cell CLL/lymphoma 7 protein family member A,18908,119,0.80 [0.58-1.09],0.1609641678918745
Chapter II Neoplasms,Carcinoma in situ of breast,BCL7B,B-cell CLL/lymphoma 7 protein family member B,19495,120,0.95 [0.64-1.41],0.8023173578928452
Chapter II Neoplasms,Carcinoma in situ of breast,BCR,Breakpoint cluster region protein,22477,136,0.85 [0.72-1.00],0.0535213492711096
Chapter II Neoplasms,Carcinoma in situ of breast,BDNF,Brain-derived neurotrophic factor,19597,123,0.82 [0.67-1.00],0.0453284577432443
Chapter II Neoplasms,Carcinoma in situ of breast,BECN1,Beclin-1,19106,119,0.78 [0.58-1.06],0.1131825881623142
Chapter II Neoplasms,Carcinoma in situ of breast,BEX3,Protein BEX3,18908,119,0.70 [0.44-1.09],0.1118263182194426
Chapter II Neoplasms,Carcinoma in situ of breast,BGLAP,Osteocalcin,19597,123,0.90 [0.75-1.09],0.2871605619375301
Chapter II Neoplasms,Carcinoma in situ of breast,BGN,Biglycan,21969,133,1.07 [0.95-1.22],0.2613631834121619
Chapter II Neoplasms,Carcinoma in situ of breast,BHLHE40,Class E basic helix-loop-helix protein 40,18997,118,1.06 [0.84-1.34],0.6075597129334085
Chapter II Neoplasms,Carcinoma in situ of breast,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19003,118,0.73 [0.37-1.44],0.3648815237891102
Chapter II Neoplasms,Carcinoma in situ of breast,BID,BH3-interacting domain death agonist,22477,136,0.82 [0.65-1.03],0.0867626314553506
Chapter II Neoplasms,Carcinoma in situ of breast,BIN2,Bridging integrator 2,22524,138,0.81 [0.68-0.96],0.0151568355034189
Chapter II Neoplasms,Carcinoma in situ of breast,BIRC2,Baculoviral IAP repeat-containing protein 2,22008,134,0.77 [0.60-0.99],0.0454881566110033
Chapter II Neoplasms,Carcinoma in situ of breast,BLMH,Bleomycin hydrolase,22786,138,0.69 [0.45-1.07],0.0952236761592972
Chapter II Neoplasms,Carcinoma in situ of breast,BLNK,B-cell linker protein,19054,117,0.89 [0.54-1.47],0.6572270715163757
Chapter II Neoplasms,Carcinoma in situ of breast,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,18997,118,0.81 [0.62-1.07],0.1459103171075811
Chapter II Neoplasms,Carcinoma in situ of breast,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19562,122,0.62 [0.39-1.00],0.0496546995679748
Chapter II Neoplasms,Carcinoma in situ of breast,BLVRB,Flavin reductase,22524,138,1.07 [0.86-1.32],0.5399337419094135
Chapter II Neoplasms,Carcinoma in situ of breast,BMP10,Bone morphogenetic protein 10,19191,120,1.38 [0.74-2.59],0.3086503811396754
Chapter II Neoplasms,Carcinoma in situ of breast,BMP4,Bone morphogenetic protein 4,22333,139,1.01 [0.73-1.40],0.9510497319546292
Chapter II Neoplasms,Carcinoma in situ of breast,BMP6,Bone morphogenetic protein 6,22079,135,0.80 [0.57-1.12],0.1876072585450865
Chapter II Neoplasms,Carcinoma in situ of breast,BMPER,BMP-binding endothelial regulator protein,19191,120,1.63 [0.80-3.34],0.1783971310696797
Chapter II Neoplasms,Carcinoma in situ of breast,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19600,119,0.74 [0.43-1.28],0.2819111205803799
Chapter II Neoplasms,Carcinoma in situ of breast,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19054,117,0.77 [0.51-1.18],0.236961962753813
Chapter II Neoplasms,Carcinoma in situ of breast,BOC,Brother of CDO,22115,137,1.47 [0.78-2.79],0.2357364039646022
Chapter II Neoplasms,Carcinoma in situ of breast,BOLA1,BolA-like protein 1,18997,118,0.75 [0.52-1.07],0.1085949594276335
Chapter II Neoplasms,Carcinoma in situ of breast,BOLA2_BOLA2B,BolA-like protein 2,19106,119,0.81 [0.59-1.10],0.1790635527390446
Chapter II Neoplasms,Carcinoma in situ of breast,BPIFA2,BPI fold-containing family A member 2,18427,114,1.09 [0.93-1.28],0.2965827569415296
Chapter II Neoplasms,Carcinoma in situ of breast,BPIFB1,BPI fold-containing family B member 1,22459,135,0.93 [0.73-1.19],0.5809981001492012
Chapter II Neoplasms,Carcinoma in situ of breast,BPIFB2,BPI fold-containing family B member 2,19566,119,0.83 [0.64-1.10],0.1948317041891544
Chapter II Neoplasms,Carcinoma in situ of breast,BRAP,BRCA1-associated protein,19331,120,0.86 [0.74-1.01],0.069436492786266
Chapter II Neoplasms,Carcinoma in situ of breast,BRD1,Bromodomain-containing protein 1,19223,122,0.88 [0.49-1.59],0.6780681179706021
Chapter II Neoplasms,Carcinoma in situ of breast,BRD2,Bromodomain-containing protein 2,18997,118,0.99 [0.59-1.66],0.959306246246312
Chapter II Neoplasms,Carcinoma in situ of breast,BRD3,Bromodomain-containing protein 3,19003,118,0.94 [0.64-1.37],0.7397064380206765
Chapter II Neoplasms,Carcinoma in situ of breast,BRDT,Bromodomain testis-specific protein,19003,118,0.75 [0.46-1.23],0.2575512274927002
Chapter II Neoplasms,Carcinoma in situ of breast,BRK1,Protein BRICK1,21957,134,0.87 [0.61-1.24],0.44926808853349
Chapter II Neoplasms,Carcinoma in situ of breast,BRME1,Break repair meiotic recombinase recruitment factor 1,18997,118,0.96 [0.63-1.47],0.8475337792980854
Chapter II Neoplasms,Carcinoma in situ of breast,BRSK2,Serine/threonine-protein kinase BRSK2,19571,121,0.57 [0.35-0.94],0.0290027873538105
Chapter II Neoplasms,Carcinoma in situ of breast,BSG,Basigin,22724,138,1.34 [0.61-2.97],0.4655974532190478
Chapter II Neoplasms,Carcinoma in situ of breast,BSND,Barttin,18908,119,0.63 [0.34-1.15],0.1350006042493873
Chapter II Neoplasms,Carcinoma in situ of breast,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22715,138,0.86 [0.65-1.14],0.2944391978056471
Chapter II Neoplasms,Carcinoma in situ of breast,BST2,Bone marrow stromal antigen 2,22715,138,0.84 [0.62-1.15],0.2825761857740828
Chapter II Neoplasms,Carcinoma in situ of breast,BTC,Probetacellulin,22008,134,0.88 [0.71-1.10],0.2636882459907075
Chapter II Neoplasms,Carcinoma in situ of breast,BTD,Biotinidase,19630,119,2.51 [1.05-5.98],0.0376447710538663
Chapter II Neoplasms,Carcinoma in situ of breast,BTLA,B- and T-lymphocyte attenuator,18908,119,0.83 [0.64-1.07],0.1519433433286493
Chapter II Neoplasms,Carcinoma in situ of breast,BTN1A1,Butyrophilin subfamily 1 member A1,19460,120,0.98 [0.65-1.49],0.9300101142145152
Chapter II Neoplasms,Carcinoma in situ of breast,BTN2A1,Butyrophilin subfamily 2 member A1,22619,141,1.27 [0.71-2.30],0.4224161215026345
Chapter II Neoplasms,Carcinoma in situ of breast,BTN3A2,Butyrophilin subfamily 3 member A2,22477,136,0.76 [0.51-1.15],0.191220639103982
Chapter II Neoplasms,Carcinoma in situ of breast,BTNL10,Butyrophilin-like protein 10,18908,119,0.80 [0.48-1.33],0.3892035422767604
Chapter II Neoplasms,Carcinoma in situ of breast,C19orf12,Protein C19orf12,21957,134,0.86 [0.66-1.13],0.2815764843255102
Chapter II Neoplasms,Carcinoma in situ of breast,C1GALT1C1,C1GALT1-specific chaperone 1,19003,118,0.67 [0.37-1.21],0.1849879454251445
Chapter II Neoplasms,Carcinoma in situ of breast,C1QA,Complement C1q subcomponent subunit A,22647,138,0.69 [0.36-1.32],0.2622983647385922
Chapter II Neoplasms,Carcinoma in situ of breast,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19571,121,0.97 [0.75-1.26],0.8332861597139217
Chapter II Neoplasms,Carcinoma in situ of breast,C1QL2,Complement C1q-like protein 2,19054,117,1.03 [0.69-1.54],0.8859262225798428
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22579,139,1.37 [0.98-1.92],0.0692316141387633
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19191,120,1.38 [0.86-2.20],0.1838055842060437
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19571,121,0.98 [0.57-1.67],0.9301904584810616
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19149,120,1.15 [0.79-1.67],0.4668250239827018
Chapter II Neoplasms,Carcinoma in situ of breast,C1R,Complement C1r subcomponent,19630,119,1.13 [0.48-2.65],0.7835618953116024
Chapter II Neoplasms,Carcinoma in situ of breast,C1RL,Complement C1r subcomponent-like protein,19598,119,0.83 [0.34-2.02],0.6837785701026426
Chapter II Neoplasms,Carcinoma in situ of breast,C1S,Complement C1s subcomponent,19630,119,1.20 [0.52-2.75],0.666011044238191
Chapter II Neoplasms,Carcinoma in situ of breast,C2,Complement C2,22542,139,2.17 [1.05-4.48],0.035754229417997
Chapter II Neoplasms,Carcinoma in situ of breast,C2CD2L,Phospholipid transfer protein C2CD2L,21909,134,0.89 [0.62-1.28],0.5414797573509147
Chapter II Neoplasms,Carcinoma in situ of breast,C2orf69,UPF0565 protein C2orf69,19054,119,0.81 [0.57-1.15],0.2428575880922644
Chapter II Neoplasms,Carcinoma in situ of breast,C3,Complement C3,18629,112,0.89 [0.59-1.36],0.5983428363794879
Chapter II Neoplasms,Carcinoma in situ of breast,C4BPB,C4b-binding protein beta chain,22586,140,0.98 [0.68-1.41],0.8993678642569944
Chapter II Neoplasms,Carcinoma in situ of breast,C5,Complement C5,19630,119,0.80 [0.25-2.57],0.7116396375576518
Chapter II Neoplasms,Carcinoma in situ of breast,C7,Complement component C7,19154,115,0.87 [0.49-1.53],0.6265191277735283
Chapter II Neoplasms,Carcinoma in situ of breast,C7orf50,Uncharacterized protein C7orf50,19562,122,1.03 [0.50-2.12],0.9376967787597408
Chapter II Neoplasms,Carcinoma in situ of breast,C8B,Complement component C8 beta chain,19630,119,0.87 [0.50-1.53],0.6368205189808703
Chapter II Neoplasms,Carcinoma in situ of breast,C9,Complement component C9,19605,119,1.00 [0.70-1.44],0.9880891707862012
Chapter II Neoplasms,Carcinoma in situ of breast,C9orf40,Uncharacterized protein C9orf40,19501,122,0.98 [0.80-1.20],0.8165772301303389
Chapter II Neoplasms,Carcinoma in situ of breast,CA1,Carbonic anhydrase 1,21985,132,1.12 [0.88-1.43],0.3454009202745297
Chapter II Neoplasms,Carcinoma in situ of breast,CA11,Carbonic anhydrase-related protein 11,22008,134,0.87 [0.52-1.46],0.6069556176831554
Chapter II Neoplasms,Carcinoma in situ of breast,CA12,Carbonic anhydrase 12,22413,140,1.40 [0.91-2.15],0.1289296504214
Chapter II Neoplasms,Carcinoma in situ of breast,CA13,Carbonic anhydrase 13,22280,136,0.85 [0.74-0.97],0.0196276311764261
Chapter II Neoplasms,Carcinoma in situ of breast,CA14,Carbonic anhydrase 14,22716,137,1.65 [1.06-2.54],0.0248771336546152
Chapter II Neoplasms,Carcinoma in situ of breast,CA2,Carbonic anhydrase 2,22448,137,0.99 [0.80-1.22],0.925834108002668
Chapter II Neoplasms,Carcinoma in situ of breast,CA3,Carbonic anhydrase 3,22747,137,1.04 [0.82-1.33],0.7179322459438178
Chapter II Neoplasms,Carcinoma in situ of breast,CA4,Carbonic anhydrase 4,22786,138,0.87 [0.46-1.67],0.6778827225306227
Chapter II Neoplasms,Carcinoma in situ of breast,CA5A,"Carbonic anhydrase 5A, mitochondrial",22115,137,1.04 [0.88-1.22],0.6680523161003443
Chapter II Neoplasms,Carcinoma in situ of breast,CA6,Carbonic anhydrase 6,22453,137,1.39 [1.10-1.77],0.0066071578620713
Chapter II Neoplasms,Carcinoma in situ of breast,CA7,Carbonic anhydrase 7,19223,122,0.94 [0.56-1.56],0.7960807641061576
Chapter II Neoplasms,Carcinoma in situ of breast,CA8,Carbonic anhydrase-related protein,19054,117,1.06 [0.56-1.99],0.8645070903838622
Chapter II Neoplasms,Carcinoma in situ of breast,CA9,Carbonic anhydrase 9,22716,137,1.08 [0.77-1.51],0.6516243985084152
Chapter II Neoplasms,Carcinoma in situ of breast,CABP2,Calcium-binding protein 2,19054,119,0.90 [0.68-1.20],0.4874432766335492
Chapter II Neoplasms,Carcinoma in situ of breast,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,18997,118,0.82 [0.46-1.46],0.4979002724773038
Chapter II Neoplasms,Carcinoma in situ of breast,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19003,118,1.07 [0.82-1.40],0.6264016232265315
Chapter II Neoplasms,Carcinoma in situ of breast,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,18997,118,1.05 [0.79-1.40],0.7444556751100438
Chapter II Neoplasms,Carcinoma in situ of breast,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19571,121,0.80 [0.65-0.98],0.0322613593279775
Chapter II Neoplasms,Carcinoma in situ of breast,CACYBP,Calcyclin-binding protein,19148,120,0.87 [0.73-1.03],0.0966792962958425
Chapter II Neoplasms,Carcinoma in situ of breast,CADPS,Calcium-dependent secretion activator 1,19054,119,0.56 [0.33-0.96],0.0349815839294084
Chapter II Neoplasms,Carcinoma in situ of breast,CALB1,Calbindin,22413,140,1.09 [0.76-1.57],0.6395284482231303
Chapter II Neoplasms,Carcinoma in situ of breast,CALB2,Calretinin,21957,134,0.81 [0.48-1.37],0.4311180750763475
Chapter II Neoplasms,Carcinoma in situ of breast,CALCA,Calcitonin,22320,139,1.09 [0.83-1.42],0.5460152240458399
Chapter II Neoplasms,Carcinoma in situ of breast,CALCB,Calcitonin gene-related peptide 2,19562,122,1.23 [0.84-1.81],0.2904066010414854
Chapter II Neoplasms,Carcinoma in situ of breast,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22643,137,0.83 [0.71-0.96],0.0118235245213355
Chapter II Neoplasms,Carcinoma in situ of breast,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19106,119,0.85 [0.67-1.07],0.1701366219961896
Chapter II Neoplasms,Carcinoma in situ of breast,CALY,Neuron-specific vesicular protein calcyon,19003,118,0.79 [0.46-1.34],0.3810349911622788
Chapter II Neoplasms,Carcinoma in situ of breast,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22008,134,0.56 [0.38-0.82],0.0032076736072598
Chapter II Neoplasms,Carcinoma in situ of breast,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19054,119,0.60 [0.40-0.88],0.0087081709336261
Chapter II Neoplasms,Carcinoma in situ of breast,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19571,121,0.83 [0.70-0.98],0.0258383367598067
Chapter II Neoplasms,Carcinoma in situ of breast,CANT1,Soluble calcium-activated nucleotidase 1,22452,139,1.13 [0.54-2.38],0.7462746943110212
Chapter II Neoplasms,Carcinoma in situ of breast,CAPG,Macrophage-capping protein,22363,135,1.23 [0.96-1.58],0.1010400731588403
Chapter II Neoplasms,Carcinoma in situ of breast,CAPN3,Calpain-3,19495,120,0.78 [0.46-1.33],0.3615246440337343
Chapter II Neoplasms,Carcinoma in situ of breast,CAPS,Calcyphosin,19562,122,0.98 [0.81-1.18],0.8283143935383027
Chapter II Neoplasms,Carcinoma in situ of breast,CARHSP1,Calcium-regulated heat-stable protein 1,21957,134,0.91 [0.68-1.22],0.5191627024329587
Chapter II Neoplasms,Carcinoma in situ of breast,CASC3,Protein CASC3,19054,119,0.71 [0.45-1.12],0.1401763923336256
Chapter II Neoplasms,Carcinoma in situ of breast,CASP1,Caspase-1,21957,134,1.09 [0.88-1.35],0.4363342614732346
Chapter II Neoplasms,Carcinoma in situ of breast,CASP10,Caspase-10,21957,134,0.91 [0.73-1.12],0.3576752596133296
Chapter II Neoplasms,Carcinoma in situ of breast,CASP2,Caspase-2,22477,136,0.97 [0.78-1.22],0.8233963045472263
Chapter II Neoplasms,Carcinoma in situ of breast,CASP3,Caspase-3,22786,138,0.81 [0.68-0.95],0.0121926779348163
Chapter II Neoplasms,Carcinoma in situ of breast,CASP4,Caspase-4,19223,122,1.02 [0.92-1.12],0.6939854423720693
Chapter II Neoplasms,Carcinoma in situ of breast,CASP7,Caspase-7,19562,122,0.82 [0.67-1.02],0.0692286289832652
Chapter II Neoplasms,Carcinoma in situ of breast,CASP8,Caspase-8,22644,136,0.94 [0.74-1.20],0.6287188827026992
Chapter II Neoplasms,Carcinoma in situ of breast,CASP9,Caspase-9,19054,117,0.76 [0.56-1.03],0.0778864898832265
Chapter II Neoplasms,Carcinoma in situ of breast,CASQ2,Calsequestrin-2,19003,118,1.17 [0.87-1.58],0.3033165149179083
Chapter II Neoplasms,Carcinoma in situ of breast,CAT,Catalase,19304,118,0.93 [0.68-1.28],0.6586268115494501
Chapter II Neoplasms,Carcinoma in situ of breast,CBLIF,Cobalamin binding intrinsic factor,22484,139,1.11 [0.90-1.37],0.3230794961320722
Chapter II Neoplasms,Carcinoma in situ of breast,CBLN1,Cerebellin-1,18997,118,0.84 [0.67-1.05],0.1260569064717172
Chapter II Neoplasms,Carcinoma in situ of breast,CBLN4,Cerebellin-4,22716,137,1.15 [0.72-1.85],0.5532734495914464
Chapter II Neoplasms,Carcinoma in situ of breast,CBS,Cystathionine beta-synthase,19106,119,1.09 [0.78-1.53],0.6027519615579434
Chapter II Neoplasms,Carcinoma in situ of breast,CBX2,Chromobox protein homolog 2,19003,118,0.85 [0.52-1.38],0.5056421203941661
Chapter II Neoplasms,Carcinoma in situ of breast,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22368,139,0.81 [0.66-1.00],0.054648623989885
Chapter II Neoplasms,Carcinoma in situ of breast,CCAR2,Cell cycle and apoptosis regulator protein 2,19562,122,1.19 [0.94-1.51],0.1521236072551851
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC134,Coiled-coil domain-containing protein 134,19495,120,0.66 [0.45-0.97],0.0342563256755337
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC28A,Coiled-coil domain-containing protein 28A,19054,119,0.78 [0.43-1.43],0.425356876757611
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC50,Coiled-coil domain-containing protein 50,19571,121,0.93 [0.74-1.17],0.542429319020056
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC80,Coiled-coil domain-containing protein 80,22518,139,0.89 [0.57-1.38],0.604881142728239
Chapter II Neoplasms,Carcinoma in situ of breast,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19106,119,0.79 [0.58-1.06],0.1155497277192712
Chapter II Neoplasms,Carcinoma in situ of breast,CCL11,Eotaxin,22764,139,0.80 [0.54-1.18],0.2548873764705656
Chapter II Neoplasms,Carcinoma in situ of breast,CCL13,C-C motif chemokine 13,22724,139,0.85 [0.69-1.06],0.1526865287171677
Chapter II Neoplasms,Carcinoma in situ of breast,CCL14,C-C motif chemokine 14,22434,137,0.99 [0.67-1.46],0.9698547380535488
Chapter II Neoplasms,Carcinoma in situ of breast,CCL15,C-C motif chemokine 15,22786,138,0.94 [0.66-1.33],0.7082210991055724
Chapter II Neoplasms,Carcinoma in situ of breast,CCL16,C-C motif chemokine 16,22786,138,0.99 [0.75-1.31],0.939073329777143
Chapter II Neoplasms,Carcinoma in situ of breast,CCL17,C-C motif chemokine 17,22484,138,0.87 [0.74-1.03],0.1181515180513253
Chapter II Neoplasms,Carcinoma in situ of breast,CCL18,C-C motif chemokine 18,22169,134,0.90 [0.71-1.13],0.3521883077144225
Chapter II Neoplasms,Carcinoma in situ of breast,CCL19,C-C motif chemokine 19,22715,138,0.98 [0.87-1.10],0.7030505241485567
Chapter II Neoplasms,Carcinoma in situ of breast,CCL2,C-C motif chemokine 2,22333,139,0.97 [0.73-1.29],0.8610589482542639
Chapter II Neoplasms,Carcinoma in situ of breast,CCL20,C-C motif chemokine 20,22764,139,1.06 [0.90-1.24],0.4809151087914209
Chapter II Neoplasms,Carcinoma in situ of breast,CCL21,C-C motif chemokine 21,22619,141,1.16 [0.84-1.61],0.3575160422940635
Chapter II Neoplasms,Carcinoma in situ of breast,CCL22,C-C motif chemokine 22,22293,138,0.84 [0.62-1.14],0.2706597769559064
Chapter II Neoplasms,Carcinoma in situ of breast,CCL23,C-C motif chemokine 23,22619,141,0.87 [0.60-1.25],0.4393487362020463
Chapter II Neoplasms,Carcinoma in situ of breast,CCL24,C-C motif chemokine 24,22580,141,1.07 [0.90-1.28],0.4580323142560433
Chapter II Neoplasms,Carcinoma in situ of breast,CCL25,C-C motif chemokine 25,22764,139,0.97 [0.71-1.31],0.840769360497073
Chapter II Neoplasms,Carcinoma in situ of breast,CCL26,C-C motif chemokine 26,22477,136,0.91 [0.76-1.09],0.3210902430537149
Chapter II Neoplasms,Carcinoma in situ of breast,CCL27,C-C motif chemokine 27,22518,139,0.91 [0.71-1.16],0.4446790195439528
Chapter II Neoplasms,Carcinoma in situ of breast,CCL28,C-C motif chemokine 28,22402,136,0.79 [0.60-1.04],0.0881613872663895
Chapter II Neoplasms,Carcinoma in situ of breast,CCL3,C-C motif chemokine 3,22477,136,1.00 [0.78-1.28],0.9926224689499096
Chapter II Neoplasms,Carcinoma in situ of breast,CCL4,C-C motif chemokine 4,22551,139,0.80 [0.62-1.04],0.1026742973765019
Chapter II Neoplasms,Carcinoma in situ of breast,CCL5,C-C motif chemokine 5,22579,139,0.84 [0.72-0.97],0.0214369875463125
Chapter II Neoplasms,Carcinoma in situ of breast,CCL7,C-C motif chemokine 7,22477,136,0.90 [0.68-1.17],0.4283659279608977
Chapter II Neoplasms,Carcinoma in situ of breast,CCL8,C-C motif chemokine 8,22683,136,0.97 [0.76-1.23],0.7861704816583346
Chapter II Neoplasms,Carcinoma in situ of breast,CCN1,CCN family member 1,22373,139,0.91 [0.75-1.10],0.3120293437376507
Chapter II Neoplasms,Carcinoma in situ of breast,CCN2,CCN family member 2,22506,140,0.76 [0.58-0.98],0.0359977989191811
Chapter II Neoplasms,Carcinoma in situ of breast,CCN3,CCN family member 3,22753,138,1.32 [0.85-2.04],0.2217298929727291
Chapter II Neoplasms,Carcinoma in situ of breast,CCN4,CCN family member 4,22716,137,1.04 [0.72-1.49],0.8321661592522078
Chapter II Neoplasms,Carcinoma in situ of breast,CCN5,CCN family member 5,22524,138,1.13 [0.77-1.66],0.5188744450080243
Chapter II Neoplasms,Carcinoma in situ of breast,CCND2,G1/S-specific cyclin-D2,19223,122,1.38 [0.86-2.22],0.1852530282908691
Chapter II Neoplasms,Carcinoma in situ of breast,CCNE1,G1/S-specific cyclin-E1,19054,117,0.96 [0.79-1.17],0.6878355477932867
Chapter II Neoplasms,Carcinoma in situ of breast,CCS,Copper chaperone for superoxide dismutase,22368,139,0.85 [0.62-1.17],0.3251307723188942
Chapter II Neoplasms,Carcinoma in situ of breast,CCT5,T-complex protein 1 subunit epsilon,22008,134,0.57 [0.39-0.85],0.0052188681296569
Chapter II Neoplasms,Carcinoma in situ of breast,CD101,Immunoglobulin superfamily member 2,19501,122,0.97 [0.64-1.45],0.8715354012101388
Chapter II Neoplasms,Carcinoma in situ of breast,CD109,CD109 antigen,22524,138,0.67 [0.44-1.04],0.0743839939103748
Chapter II Neoplasms,Carcinoma in situ of breast,CD14,Monocyte differentiation antigen CD14,22017,135,1.21 [0.84-1.74],0.3169693075016244
Chapter II Neoplasms,Carcinoma in situ of breast,CD160,CD160 antigen,22764,139,0.83 [0.59-1.16],0.2669574206961986
Chapter II Neoplasms,Carcinoma in situ of breast,CD163,Scavenger receptor cysteine-rich type 1 protein M130,22579,139,1.01 [0.71-1.44],0.9510534740547346
Chapter II Neoplasms,Carcinoma in situ of breast,CD164,Sialomucin core protein 24,22524,138,1.27 [0.78-2.07],0.3355349179230494
Chapter II Neoplasms,Carcinoma in situ of breast,CD164L2,CD164 sialomucin-like 2 protein,19054,119,0.89 [0.55-1.45],0.6386497621202905
Chapter II Neoplasms,Carcinoma in situ of breast,CD177,CD177 antigen,22495,138,1.04 [0.92-1.18],0.5126081565750452
Chapter II Neoplasms,Carcinoma in situ of breast,CD1C,T-cell surface glycoprotein CD1c,22586,140,1.58 [0.82-3.02],0.1688029046539622
Chapter II Neoplasms,Carcinoma in situ of breast,CD2,T-cell surface antigen CD2,19003,118,0.75 [0.44-1.28],0.2975391531917312
Chapter II Neoplasms,Carcinoma in situ of breast,CD200,OX-2 membrane glycoprotein,22477,136,1.30 [0.72-2.36],0.3811996392516835
Chapter II Neoplasms,Carcinoma in situ of breast,CD200R1,Cell surface glycoprotein CD200 receptor 1,22409,135,0.89 [0.57-1.40],0.6270118482673206
Chapter II Neoplasms,Carcinoma in situ of breast,CD207,C-type lectin domain family 4 member K,22021,139,0.87 [0.58-1.30],0.4964204329724524
Chapter II Neoplasms,Carcinoma in situ of breast,CD209,CD209 antigen,22563,134,1.24 [0.84-1.83],0.2720785985935025
Chapter II Neoplasms,Carcinoma in situ of breast,CD22,B-cell receptor CD22,22764,139,0.73 [0.50-1.06],0.0996160094056278
Chapter II Neoplasms,Carcinoma in situ of breast,CD226,CD226 antigen,19054,117,0.62 [0.40-0.97],0.0343248138772513
Chapter II Neoplasms,Carcinoma in situ of breast,CD244,Natural killer cell receptor 2B4,22764,139,0.77 [0.44-1.35],0.3630004873375857
Chapter II Neoplasms,Carcinoma in situ of breast,CD248,Endosialin,19597,123,1.15 [0.75-1.77],0.5137078145751464
Chapter II Neoplasms,Carcinoma in situ of breast,CD27,CD27 antigen,22586,140,1.15 [0.79-1.68],0.4701986181546266
Chapter II Neoplasms,Carcinoma in situ of breast,CD274,Programmed cell death 1 ligand 1,22368,139,1.29 [0.86-1.94],0.2244924871331589
Chapter II Neoplasms,Carcinoma in situ of breast,CD276,CD276 antigen,22510,140,1.33 [0.87-2.03],0.1905907623721053
Chapter II Neoplasms,Carcinoma in situ of breast,CD28,T-cell-specific surface glycoprotein CD28,22008,134,0.94 [0.61-1.46],0.7825445506403089
Chapter II Neoplasms,Carcinoma in situ of breast,CD2AP,CD2-associated protein,22518,139,0.70 [0.55-0.90],0.0044746857416086
Chapter II Neoplasms,Carcinoma in situ of breast,CD300A,CMRF35-like molecule 8,19191,120,0.78 [0.43-1.42],0.4101851841828827
Chapter II Neoplasms,Carcinoma in situ of breast,CD300C,CMRF35-like molecule 6,22715,138,1.04 [0.67-1.61],0.8699362816807962
Chapter II Neoplasms,Carcinoma in situ of breast,CD300E,CMRF35-like molecule 2,22637,137,1.08 [0.73-1.58],0.701605902123695
Chapter II Neoplasms,Carcinoma in situ of breast,CD300LF,CMRF35-like molecule 1,22716,137,1.05 [0.82-1.35],0.701512744153534
Chapter II Neoplasms,Carcinoma in situ of breast,CD300LG,CMRF35-like molecule 9,22524,138,1.31 [0.88-1.97],0.184043017138291
Chapter II Neoplasms,Carcinoma in situ of breast,CD302,CD302 antigen,22413,140,1.06 [0.63-1.76],0.8355488575842182
Chapter II Neoplasms,Carcinoma in situ of breast,CD33,Myeloid cell surface antigen CD33,22586,140,0.93 [0.78-1.12],0.4342141704482004
Chapter II Neoplasms,Carcinoma in situ of breast,CD34,Hematopoietic progenitor cell antigen CD34,22633,138,1.01 [0.54-1.88],0.982787454505684
Chapter II Neoplasms,Carcinoma in situ of breast,CD36,Platelet glycoprotein 4,19054,117,0.74 [0.49-1.11],0.1473082535361783
Chapter II Neoplasms,Carcinoma in situ of breast,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22413,140,0.83 [0.51-1.37],0.4671032351670272
Chapter II Neoplasms,Carcinoma in situ of breast,CD3D,T-cell surface glycoprotein CD3 delta chain,18997,118,1.10 [0.69-1.78],0.6821552407116004
Chapter II Neoplasms,Carcinoma in situ of breast,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19223,122,1.21 [0.81-1.80],0.3452773230826068
Chapter II Neoplasms,Carcinoma in situ of breast,CD3G,T-cell surface glycoprotein CD3 gamma chain,19054,117,1.02 [0.85-1.23],0.8218301195056696
Chapter II Neoplasms,Carcinoma in situ of breast,CD4,T-cell surface glycoprotein CD4,22435,136,0.83 [0.49-1.42],0.5016191635466929
Chapter II Neoplasms,Carcinoma in situ of breast,CD40,Tumor necrosis factor receptor superfamily member 5,22512,139,0.79 [0.58-1.08],0.1463072198032389
Chapter II Neoplasms,Carcinoma in situ of breast,CD40LG,CD40 ligand,22764,139,0.82 [0.67-0.99],0.0357803508173082
Chapter II Neoplasms,Carcinoma in situ of breast,CD46,Membrane cofactor protein,22354,136,1.45 [0.88-2.39],0.1498353082018084
Chapter II Neoplasms,Carcinoma in situ of breast,CD48,CD48 antigen,22580,141,0.93 [0.55-1.55],0.7678634773953161
Chapter II Neoplasms,Carcinoma in situ of breast,CD5,T-cell surface glycoprotein CD5,22683,136,0.89 [0.55-1.42],0.6235092123654706
Chapter II Neoplasms,Carcinoma in situ of breast,CD55,Complement decay-accelerating factor,21711,130,1.61 [0.99-2.62],0.0566051531980192
Chapter II Neoplasms,Carcinoma in situ of breast,CD58,Lymphocyte function-associated antigen 3,22476,140,1.14 [0.49-2.65],0.7669960216173413
Chapter II Neoplasms,Carcinoma in situ of breast,CD59,CD59 glycoprotein,21683,130,0.97 [0.46-2.06],0.945187306887656
Chapter II Neoplasms,Carcinoma in situ of breast,CD5L,CD5 antigen-like,19514,118,0.82 [0.56-1.21],0.3255709253064606
Chapter II Neoplasms,Carcinoma in situ of breast,CD6,T-cell differentiation antigen CD6,22724,138,0.89 [0.67-1.17],0.4048395416072282
Chapter II Neoplasms,Carcinoma in situ of breast,CD63,CD63 antigen,22333,139,0.91 [0.68-1.21],0.5056237998598498
Chapter II Neoplasms,Carcinoma in situ of breast,CD69,Early activation antigen CD69,22421,137,0.84 [0.71-0.99],0.0384544197654872
Chapter II Neoplasms,Carcinoma in situ of breast,CD7,T-cell antigen CD7,19015,117,1.26 [0.85-1.87],0.2504614532697917
Chapter II Neoplasms,Carcinoma in situ of breast,CD70,CD70 antigen,22477,136,1.30 [0.90-1.87],0.1581970905559407
Chapter II Neoplasms,Carcinoma in situ of breast,CD72,B-cell differentiation antigen CD72,19191,120,0.88 [0.57-1.36],0.5785053612102793
Chapter II Neoplasms,Carcinoma in situ of breast,CD74,HLA class II histocompatibility antigen gamma chain,22715,138,1.09 [0.71-1.69],0.6960370693090965
Chapter II Neoplasms,Carcinoma in situ of breast,CD79B,B-cell antigen receptor complex-associated protein beta chain,22764,139,0.89 [0.62-1.27],0.5100276068814443
Chapter II Neoplasms,Carcinoma in situ of breast,CD80,T-lymphocyte activation antigen CD80,19600,119,0.97 [0.57-1.64],0.8960328400058815
Chapter II Neoplasms,Carcinoma in situ of breast,CD82,CD82 antigen,19223,122,0.91 [0.59-1.41],0.6805935232179248
Chapter II Neoplasms,Carcinoma in situ of breast,CD83,CD83 antigen,22477,136,0.91 [0.57-1.46],0.6908588625197079
Chapter II Neoplasms,Carcinoma in situ of breast,CD84,SLAM family member 5,22477,136,0.70 [0.43-1.14],0.151910444837019
Chapter II Neoplasms,Carcinoma in situ of breast,CD86,T-lymphocyte activation antigen CD86,19501,122,1.21 [0.67-2.19],0.530429786067752
Chapter II Neoplasms,Carcinoma in situ of breast,CD8A,T-cell surface glycoprotein CD8 alpha chain,22715,138,1.04 [0.77-1.42],0.7848214957407132
Chapter II Neoplasms,Carcinoma in situ of breast,CD93,Complement component C1q receptor,21634,127,1.75 [1.08-2.85],0.023370967398691
Chapter II Neoplasms,Carcinoma in situ of breast,CD99,CD99 antigen,22524,138,1.14 [0.52-2.51],0.7446721120496458
Chapter II Neoplasms,Carcinoma in situ of breast,CD99L2,CD99 antigen-like protein 2,22524,138,0.80 [0.42-1.51],0.4860794229949944
Chapter II Neoplasms,Carcinoma in situ of breast,CDA,Cytidine deaminase,19559,119,1.47 [1.06-2.03],0.0200854300610493
Chapter II Neoplasms,Carcinoma in situ of breast,CDAN1,Codanin-1,19562,122,0.90 [0.42-1.91],0.7803851781304623
Chapter II Neoplasms,Carcinoma in situ of breast,CDC123,Cell division cycle protein 123 homolog,18908,119,1.06 [0.82-1.37],0.6702889283361742
Chapter II Neoplasms,Carcinoma in situ of breast,CDC25A,M-phase inducer phosphatase 1,18908,119,0.51 [0.31-0.86],0.0109342044965946
Chapter II Neoplasms,Carcinoma in situ of breast,CDC26,Anaphase-promoting complex subunit CDC26,19473,122,0.80 [0.62-1.03],0.0867249749158405
Chapter II Neoplasms,Carcinoma in situ of breast,CDC27,Cell division cycle protein 27 homolog,22008,134,0.68 [0.52-0.91],0.008281028220857
Chapter II Neoplasms,Carcinoma in situ of breast,CDC37,Hsp90 co-chaperone Cdc37,22586,140,0.81 [0.68-0.97],0.0229169456576777
Chapter II Neoplasms,Carcinoma in situ of breast,CDC42BPB,Serine/threonine-protein kinase MRCK beta,19501,122,0.77 [0.64-0.92],0.0038554788455588
Chapter II Neoplasms,Carcinoma in situ of breast,CDCP1,CUB domain-containing protein 1,22368,139,0.86 [0.62-1.18],0.3484916324913927
Chapter II Neoplasms,Carcinoma in situ of breast,CDH1,Cadherin-1,21734,131,1.08 [0.74-1.58],0.7011244029476955
Chapter II Neoplasms,Carcinoma in situ of breast,CDH15,Cadherin-15,22667,138,0.83 [0.58-1.20],0.3213013576287274
Chapter II Neoplasms,Carcinoma in situ of breast,CDH17,Cadherin-17,22518,139,0.79 [0.62-1.00],0.0481910262957808
Chapter II Neoplasms,Carcinoma in situ of breast,CDH2,Cadherin-2,22518,139,1.08 [0.71-1.65],0.7159483195009156
Chapter II Neoplasms,Carcinoma in situ of breast,CDH22,Cadherin-22,19223,122,0.87 [0.47-1.63],0.669497884295417
Chapter II Neoplasms,Carcinoma in situ of breast,CDH23,Cadherin-23,19562,122,1.06 [0.56-2.02],0.8517738647758637
Chapter II Neoplasms,Carcinoma in situ of breast,CDH3,Cadherin-3,22715,138,1.59 [1.06-2.37],0.0234002916306464
Chapter II Neoplasms,Carcinoma in situ of breast,CDH4,Cadherin-4,18997,118,1.03 [0.72-1.48],0.8731901003767601
Chapter II Neoplasms,Carcinoma in situ of breast,CDH5,Cadherin-5,22786,138,0.76 [0.46-1.27],0.29849578403091
Chapter II Neoplasms,Carcinoma in situ of breast,CDH6,Cadherin-6,22518,139,1.28 [0.86-1.89],0.2229270481957044
Chapter II Neoplasms,Carcinoma in situ of breast,CDHR1,Cadherin-related family member 1,21957,134,1.22 [0.88-1.68],0.2285211997265715
Chapter II Neoplasms,Carcinoma in situ of breast,CDHR2,Cadherin-related family member 2,22413,140,0.85 [0.70-1.03],0.0986297065700596
Chapter II Neoplasms,Carcinoma in situ of breast,CDHR5,Cadherin-related family member 5,22518,139,0.96 [0.65-1.40],0.8148413820272506
Chapter II Neoplasms,Carcinoma in situ of breast,CDK1,Cyclin-dependent kinase 1,18908,119,0.78 [0.48-1.25],0.300592155405312
Chapter II Neoplasms,Carcinoma in situ of breast,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19571,121,0.86 [0.63-1.18],0.3478085879140403
Chapter II Neoplasms,Carcinoma in situ of breast,CDKL5,Cyclin-dependent kinase-like 5,18997,118,1.27 [0.98-1.65],0.0726650273206591
Chapter II Neoplasms,Carcinoma in situ of breast,CDKN1A,Cyclin-dependent kinase inhibitor 1,22413,140,0.83 [0.72-0.95],0.0085661811589539
Chapter II Neoplasms,Carcinoma in situ of breast,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22413,140,0.86 [0.74-1.00],0.0563046050937834
Chapter II Neoplasms,Carcinoma in situ of breast,CDNF,Cerebral dopamine neurotrophic factor,22413,140,0.73 [0.45-1.19],0.204090638630376
Chapter II Neoplasms,Carcinoma in situ of breast,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22552,140,1.61 [0.91-2.82],0.0995133726421601
Chapter II Neoplasms,Carcinoma in situ of breast,CDSN,Corneodesmosin,22684,139,1.44 [1.02-2.03],0.0397817640001001
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22548,140,1.05 [0.56-1.98],0.8763863615698778
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19501,122,1.30 [1.04-1.62],0.0223980638802326
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19223,122,0.96 [0.74-1.25],0.7644311222673744
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19501,122,1.09 [0.71-1.68],0.6972303153540897
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19223,122,0.85 [0.56-1.30],0.4510626996189966
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22477,136,1.03 [0.87-1.23],0.6998956646681324
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22008,134,0.84 [0.60-1.17],0.2972503122280207
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21706,134,0.80 [0.62-1.03],0.0863554199980312
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19597,123,1.06 [0.67-1.69],0.8003074013473018
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22115,137,1.04 [0.77-1.41],0.7775898764332064
Chapter II Neoplasms,Carcinoma in situ of breast,CEBPA,CCAAT/enhancer-binding protein alpha,19054,117,1.05 [0.69-1.60],0.8156692163633772
Chapter II Neoplasms,Carcinoma in situ of breast,CEBPB,CCAAT/enhancer-binding protein beta,22115,137,0.96 [0.64-1.43],0.8373342020037239
Chapter II Neoplasms,Carcinoma in situ of breast,CELA2A,Chymotrypsin-like elastase family member 2A,19597,123,0.89 [0.66-1.19],0.4161069349788435
Chapter II Neoplasms,Carcinoma in situ of breast,CELA3A,Chymotrypsin-like elastase family member 3A,22749,138,0.87 [0.66-1.14],0.3115437869602522
Chapter II Neoplasms,Carcinoma in situ of breast,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19191,120,0.55 [0.29-1.02],0.0594565953527783
Chapter II Neoplasms,Carcinoma in situ of breast,CEMIP2,Cell surface hyaluronidase,19054,117,0.72 [0.38-1.35],0.3057089203866191
Chapter II Neoplasms,Carcinoma in situ of breast,CEND1,Cell cycle exit and neuronal differentiation protein 1,18997,118,0.90 [0.64-1.25],0.5183724387849888
Chapter II Neoplasms,Carcinoma in situ of breast,CENPF,Centromere protein F,19223,122,0.80 [0.57-1.12],0.1915526702943498
Chapter II Neoplasms,Carcinoma in situ of breast,CENPJ,Centromere protein J,19223,122,1.21 [0.99-1.47],0.0608238576943172
Chapter II Neoplasms,Carcinoma in situ of breast,CEP112,Centrosomal protein of 112 kDa,19003,118,0.81 [0.51-1.28],0.3703271962281792
Chapter II Neoplasms,Carcinoma in situ of breast,CEP152,Centrosomal protein of 152 kDa,18908,119,0.74 [0.46-1.17],0.1985435207121371
Chapter II Neoplasms,Carcinoma in situ of breast,CEP164,Centrosomal protein of 164 kDa,22090,138,1.14 [0.94-1.39],0.1928210226035765
Chapter II Neoplasms,Carcinoma in situ of breast,CEP170,Centrosomal protein of 170 kDa,19106,119,0.76 [0.59-0.97],0.0266630588840364
Chapter II Neoplasms,Carcinoma in situ of breast,CEP20,Centrosomal protein 20,22008,134,0.83 [0.67-1.03],0.0968961918065348
Chapter II Neoplasms,Carcinoma in situ of breast,CEP290,Centrosomal protein of 290 kDa,19223,122,0.88 [0.62-1.26],0.4925117455137521
Chapter II Neoplasms,Carcinoma in situ of breast,CEP350,Centrosome-associated protein 350,18908,119,0.78 [0.48-1.28],0.3231197972688514
Chapter II Neoplasms,Carcinoma in situ of breast,CEP43,Centrosomal protein 43,21940,135,0.79 [0.62-0.99],0.0411241624688255
Chapter II Neoplasms,Carcinoma in situ of breast,CEP85,Centrosomal protein of 85 kDa,22008,134,0.67 [0.51-0.87],0.0024636709477426
Chapter II Neoplasms,Carcinoma in situ of breast,CERT,Ceramide transfer protein,21957,134,0.92 [0.72-1.19],0.5381733781964304
Chapter II Neoplasms,Carcinoma in situ of breast,CES1,Liver carboxylesterase 1,22563,138,0.89 [0.73-1.09],0.2546782368230783
Chapter II Neoplasms,Carcinoma in situ of breast,CES2,Cocaine esterase,22413,140,1.16 [0.89-1.51],0.2736460663736503
Chapter II Neoplasms,Carcinoma in situ of breast,CES3,Carboxylesterase 3,22413,140,0.94 [0.75-1.17],0.5795991329711893
Chapter II Neoplasms,Carcinoma in situ of breast,CETN2,Centrin-2,21957,134,0.88 [0.69-1.11],0.2669540845447371
Chapter II Neoplasms,Carcinoma in situ of breast,CETN3,Centrin-3,19501,122,0.85 [0.68-1.07],0.1760805607977342
Chapter II Neoplasms,Carcinoma in situ of breast,CFB,Complement factor B,19257,117,1.51 [0.88-2.58],0.1323839507348826
Chapter II Neoplasms,Carcinoma in situ of breast,CFC1,Cryptic protein,22008,134,0.88 [0.62-1.25],0.4654565657065986
Chapter II Neoplasms,Carcinoma in situ of breast,CFD,Complement factor D,19630,119,1.29 [0.52-3.16],0.5813122064875227
Chapter II Neoplasms,Carcinoma in situ of breast,CFH,Complement factor H,18470,111,1.54 [0.71-3.34],0.2796344090692185
Chapter II Neoplasms,Carcinoma in situ of breast,CFHR2,Complement factor H-related protein 2,19488,119,0.77 [0.58-1.01],0.0611812999695869
Chapter II Neoplasms,Carcinoma in situ of breast,CFHR4,Complement factor H-related protein 4,19599,119,1.06 [0.83-1.35],0.64994265575336
Chapter II Neoplasms,Carcinoma in situ of breast,CFHR5,Complement factor H-related protein 5,19339,115,1.12 [0.72-1.73],0.6119097337026231
Chapter II Neoplasms,Carcinoma in situ of breast,CFI,Complement factor I,19630,119,1.31 [0.55-3.11],0.5414775430360534
Chapter II Neoplasms,Carcinoma in situ of breast,CFP,Properdin,19630,119,1.35 [0.74-2.48],0.3284074710020661
Chapter II Neoplasms,Carcinoma in situ of breast,CGA,Glycoprotein hormones alpha chain,22524,138,1.10 [0.93-1.30],0.2627690776549507
Chapter II Neoplasms,Carcinoma in situ of breast,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19605,119,1.15 [0.89-1.49],0.2850000387766042
Chapter II Neoplasms,Carcinoma in situ of breast,CGN,Cingulin,19054,119,0.70 [0.42-1.16],0.1690034260260722
Chapter II Neoplasms,Carcinoma in situ of breast,CGREF1,Cell growth regulator with EF hand domain protein 1,22518,139,0.86 [0.60-1.24],0.4191617645917751
Chapter II Neoplasms,Carcinoma in situ of breast,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22008,134,0.75 [0.57-0.98],0.0372514588219176
Chapter II Neoplasms,Carcinoma in situ of breast,CHAD,Chondroadherin,19191,120,0.84 [0.61-1.16],0.2971395966654923
Chapter II Neoplasms,Carcinoma in situ of breast,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19562,122,0.84 [0.52-1.34],0.4593823482745035
Chapter II Neoplasms,Carcinoma in situ of breast,CHCHD6,MICOS complex subunit MIC25,19495,120,1.13 [0.64-1.99],0.6630798975753094
Chapter II Neoplasms,Carcinoma in situ of breast,CHEK2,Serine/threonine-protein kinase Chk2,22115,137,1.29 [0.86-1.93],0.2215833023177776
Chapter II Neoplasms,Carcinoma in situ of breast,CHGA,Chromogranin-A,19597,123,0.95 [0.77-1.16],0.613676563366644
Chapter II Neoplasms,Carcinoma in situ of breast,CHGB,Secretogranin-1,22624,137,0.97 [0.66-1.43],0.8676758111702385
Chapter II Neoplasms,Carcinoma in situ of breast,CHI3L1,Chitinase-3-like protein 1,21994,131,1.00 [0.81-1.24],0.9909882972077456
Chapter II Neoplasms,Carcinoma in situ of breast,CHIT1,Chitotriosidase-1,22607,135,1.07 [0.95-1.20],0.2820260949788781
Chapter II Neoplasms,Carcinoma in situ of breast,CHL1,Neural cell adhesion molecule L1-like protein,22542,137,1.54 [0.99-2.39],0.0567244857249806
Chapter II Neoplasms,Carcinoma in situ of breast,CHM,Rab proteins geranylgeranyltransferase component A 1,19054,119,0.73 [0.54-0.99],0.0409199989187911
Chapter II Neoplasms,Carcinoma in situ of breast,CHMP1A,Charged multivesicular body protein 1a,22368,139,0.83 [0.69-1.00],0.0472407721053995
Chapter II Neoplasms,Carcinoma in situ of breast,CHMP6,Charged multivesicular body protein 6,19600,119,0.74 [0.54-1.01],0.0583289699628675
Chapter II Neoplasms,Carcinoma in situ of breast,CHP1,Calcineurin B homologous protein 1,18997,118,0.98 [0.77-1.25],0.9012821015953852
Chapter II Neoplasms,Carcinoma in situ of breast,CHRDL1,Chordin-like protein 1,22580,141,1.39 [0.85-2.27],0.193052106625501
Chapter II Neoplasms,Carcinoma in situ of breast,CHRDL2,Chordin-like protein 2,22518,139,1.02 [0.79-1.32],0.8738148689502018
Chapter II Neoplasms,Carcinoma in situ of breast,CHRM1,Muscarinic acetylcholine receptor M1,19054,119,0.70 [0.41-1.21],0.2049547608913705
Chapter II Neoplasms,Carcinoma in situ of breast,CIAPIN1,Anamorsin,22586,140,0.78 [0.62-0.99],0.0401430463456177
Chapter II Neoplasms,Carcinoma in situ of breast,CILP,Cartilage intermediate layer protein 1,19597,123,1.08 [0.78-1.49],0.6608624227904466
Chapter II Neoplasms,Carcinoma in situ of breast,CINP,Cyclin-dependent kinase 2-interacting protein,19223,122,0.74 [0.47-1.17],0.2011487051452803
Chapter II Neoplasms,Carcinoma in situ of breast,CIRBP,Cold-inducible RNA-binding protein,19501,122,0.86 [0.72-1.03],0.0932997526056412
Chapter II Neoplasms,Carcinoma in situ of breast,CIT,Citron Rho-interacting kinase,19054,119,0.71 [0.46-1.08],0.1080640146550923
Chapter II Neoplasms,Carcinoma in situ of breast,CKAP4,Cytoskeleton-associated protein 4,22656,136,1.24 [0.70-2.20],0.4657554078609136
Chapter II Neoplasms,Carcinoma in situ of breast,CKB,Creatine kinase B-type,19597,123,1.03 [0.77-1.37],0.8491002193311373
Chapter II Neoplasms,Carcinoma in situ of breast,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22436,139,1.04 [0.83-1.29],0.7438918912260513
Chapter II Neoplasms,Carcinoma in situ of breast,CLASP1,CLIP-associating protein 1,18908,119,0.75 [0.56-1.00],0.0532637494761041
Chapter II Neoplasms,Carcinoma in situ of breast,CLC,Galectin-10,22483,139,1.01 [0.80-1.26],0.9620995910330966
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC10A,C-type lectin domain family 10 member A,22368,139,1.32 [0.87-2.00],0.1989980352802631
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC11A,C-type lectin domain family 11 member A,22476,138,0.94 [0.69-1.29],0.7010744668968248
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC12A,C-type lectin domain family 12 member A,19054,117,1.39 [0.61-3.15],0.4316725373762953
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC14A,C-type lectin domain family 14 member A,22524,138,1.02 [0.63-1.67],0.928281389985305
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC1A,C-type lectin domain family 1 member A,22115,137,1.09 [0.68-1.74],0.733302458629779
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC1B,C-type lectin domain family 1 member B,22715,138,0.83 [0.71-0.97],0.0193529934273922
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC2L,C-type lectin domain family 2 member L,19054,119,0.92 [0.64-1.33],0.6685892916494746
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC3B,Tetranectin,19159,116,1.90 [0.91-3.95],0.0864799622573284
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4A,C-type lectin domain family 4 member A,22477,136,1.35 [0.86-2.12],0.1942916464057497
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4C,C-type lectin domain family 4 member C,22477,136,1.21 [0.87-1.67],0.2520666260458744
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4D,C-type lectin domain family 4 member D,22477,136,0.92 [0.71-1.17],0.4904261049971169
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4G,C-type lectin domain family 4 member G,22477,136,1.21 [0.77-1.91],0.4049262381685005
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4M,C-type lectin domain family 4 member M,19558,123,1.18 [0.82-1.68],0.3731579538679692
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC5A,C-type lectin domain family 5 member A,22451,137,1.66 [0.99-2.78],0.0539961983132471
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC6A,C-type lectin domain family 6 member A,22008,134,1.04 [0.75-1.45],0.8197808169140866
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC7A,C-type lectin domain family 7 member A,22764,139,0.98 [0.76-1.27],0.8921303070026524
Chapter II Neoplasms,Carcinoma in situ of breast,CLGN,Calmegin,19054,119,0.98 [0.66-1.46],0.9272748860618748
Chapter II Neoplasms,Carcinoma in situ of breast,CLIC5,Chloride intracellular channel protein 5,19054,119,0.89 [0.50-1.59],0.7002671286547459
Chapter II Neoplasms,Carcinoma in situ of breast,CLINT1,Clathrin interactor 1,18908,119,1.18 [0.84-1.65],0.3300846591826173
Chapter II Neoplasms,Carcinoma in situ of breast,CLIP2,CAP-Gly domain-containing linker protein 2,22477,136,0.86 [0.75-0.98],0.0212680195770255
Chapter II Neoplasms,Carcinoma in situ of breast,CLMP,CXADR-like membrane protein,22716,137,1.60 [0.76-3.36],0.2191950436597801
Chapter II Neoplasms,Carcinoma in situ of breast,CLNS1A,Methylosome subunit pICln,19054,119,0.67 [0.38-1.17],0.1590387608214288
Chapter II Neoplasms,Carcinoma in situ of breast,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22320,139,0.93 [0.79-1.09],0.3579526517537927
Chapter II Neoplasms,Carcinoma in situ of breast,CLPS,Colipase,22489,137,0.95 [0.76-1.18],0.6334067852589668
Chapter II Neoplasms,Carcinoma in situ of breast,CLSPN,Claspin,21909,134,0.87 [0.54-1.43],0.5918325589553244
Chapter II Neoplasms,Carcinoma in situ of breast,CLSTN1,Calsyntenin-1,21957,134,1.10 [0.84-1.45],0.4704525520718444
Chapter II Neoplasms,Carcinoma in situ of breast,CLSTN2,Calsyntenin-2,22764,139,1.07 [0.73-1.56],0.7244116761225797
Chapter II Neoplasms,Carcinoma in situ of breast,CLSTN3,Calsyntenin-3,19562,122,1.48 [0.89-2.47],0.1319304824664521
Chapter II Neoplasms,Carcinoma in situ of breast,CLTA,Clathrin light chain A,22115,137,1.10 [0.81-1.50],0.5311523337123529
Chapter II Neoplasms,Carcinoma in situ of breast,CLU,Clusterin,19630,119,1.06 [0.65-1.74],0.8183624543201861
Chapter II Neoplasms,Carcinoma in situ of breast,CLUL1,Clusterin-like protein 1,22487,139,1.02 [0.74-1.41],0.9056791811967716
Chapter II Neoplasms,Carcinoma in situ of breast,CMC1,COX assembly mitochondrial protein homolog,19600,119,0.83 [0.68-1.01],0.0690524570304231
Chapter II Neoplasms,Carcinoma in situ of breast,CMIP,C-Maf-inducing protein,19495,120,0.76 [0.61-0.94],0.0122771441887836
Chapter II Neoplasms,Carcinoma in situ of breast,CNDP1,Beta-Ala-His dipeptidase,22579,139,1.35 [0.96-1.91],0.086586956218034
Chapter II Neoplasms,Carcinoma in situ of breast,CNGB3,Cyclic nucleotide-gated cation channel beta-3,18997,118,1.02 [0.75-1.39],0.9047602541666788
Chapter II Neoplasms,Carcinoma in situ of breast,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19069,119,0.81 [0.65-1.01],0.067136825486207
Chapter II Neoplasms,Carcinoma in situ of breast,CNPY2,Protein canopy homolog 2,22115,137,0.98 [0.76-1.27],0.8996819748059353
Chapter II Neoplasms,Carcinoma in situ of breast,CNPY4,Protein canopy homolog 4,22413,140,0.84 [0.69-1.03],0.0878884082477354
Chapter II Neoplasms,Carcinoma in situ of breast,CNST,Consortin,22518,139,0.86 [0.75-0.99],0.0351671486339921
Chapter II Neoplasms,Carcinoma in situ of breast,CNTF,Ciliary neurotrophic factor,18997,118,1.18 [0.72-1.94],0.5097439704765355
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN1,Contactin-1,22786,138,1.50 [0.87-2.59],0.1477578045736512
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN2,Contactin-2,22716,137,1.05 [0.75-1.46],0.7897394733273657
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN3,Contactin-3,22524,138,1.06 [0.69-1.63],0.7783451836286852
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN4,Contactin-4,22524,138,1.24 [0.67-2.33],0.494376798166747
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN5,Contactin-5,22567,137,0.97 [0.64-1.47],0.898524919021476
Chapter II Neoplasms,Carcinoma in situ of breast,CNTNAP2,Contactin-associated protein-like 2,22477,136,1.05 [0.72-1.54],0.803663537331506
Chapter II Neoplasms,Carcinoma in situ of breast,CNTNAP4,Contactin-associated protein-like 4,19054,119,1.00 [0.85-1.19],0.9730301364122504
Chapter II Neoplasms,Carcinoma in situ of breast,COCH,Cochlin,19600,119,0.86 [0.59-1.26],0.4419200572899302
Chapter II Neoplasms,Carcinoma in situ of breast,COL15A1,Collagen alpha-1(XV) chain,19597,123,2.25 [1.18-4.29],0.014272232969277
Chapter II Neoplasms,Carcinoma in situ of breast,COL18A1,Collagen alpha-1(XVIII) chain,22610,136,1.10 [0.57-2.13],0.7718021689946827
Chapter II Neoplasms,Carcinoma in situ of breast,COL1A1,Collagen alpha-1(I) chain,22786,138,1.03 [0.58-1.84],0.911612008831313
Chapter II Neoplasms,Carcinoma in situ of breast,COL24A1,Collagen alpha-1(XXIV) chain,19501,122,1.15 [0.84-1.58],0.3880002243036997
Chapter II Neoplasms,Carcinoma in situ of breast,COL28A1,Collagen alpha-1(XXVIII) chain,19054,119,1.00 [0.78-1.27],0.9922245749587264
Chapter II Neoplasms,Carcinoma in situ of breast,COL2A1,Collagen alpha-1(II) chain,19106,119,0.87 [0.70-1.09],0.2254203505196811
Chapter II Neoplasms,Carcinoma in situ of breast,COL3A1,Collagen alpha-1(III) chain,19597,123,1.31 [0.63-2.73],0.47062695535841
Chapter II Neoplasms,Carcinoma in situ of breast,COL4A1,Collagen alpha-1(IV) chain,22518,139,0.87 [0.59-1.28],0.4811314946211842
Chapter II Neoplasms,Carcinoma in situ of breast,COL4A4,Collagen alpha-4(IV) chain,19192,122,1.00 [0.72-1.39],0.9965446085861236
Chapter II Neoplasms,Carcinoma in situ of breast,COL5A1,Collagen alpha-1(V) chain,19191,120,0.64 [0.40-1.03],0.0672326280426134
Chapter II Neoplasms,Carcinoma in situ of breast,COL6A3,Collagen alpha-3(VI) chain,22786,138,1.33 [0.85-2.08],0.2168261627032781
Chapter II Neoplasms,Carcinoma in situ of breast,COL9A1,Collagen alpha-1(IX) chain,22477,136,1.16 [0.85-1.59],0.3517487487798765
Chapter II Neoplasms,Carcinoma in situ of breast,COL9A2,Collagen alpha-2(IX) chain,19223,122,1.11 [0.80-1.54],0.5425642271169124
Chapter II Neoplasms,Carcinoma in situ of breast,COLEC12,Collectin-12,22510,140,0.89 [0.48-1.64],0.7068244213826045
Chapter II Neoplasms,Carcinoma in situ of breast,COMMD1,COMM domain-containing protein 1,19106,119,0.90 [0.68-1.20],0.4807970231894488
Chapter II Neoplasms,Carcinoma in situ of breast,COMMD9,COMM domain-containing protein 9,19495,120,0.91 [0.58-1.43],0.6813638534425683
Chapter II Neoplasms,Carcinoma in situ of breast,COMP,Cartilage oligomeric matrix protein,22252,135,1.26 [0.80-1.99],0.3220033055340396
Chapter II Neoplasms,Carcinoma in situ of breast,COMT,Catechol O-methyltransferase,21880,134,0.83 [0.69-1.00],0.0514793561403436
Chapter II Neoplasms,Carcinoma in situ of breast,COPB2,Coatomer subunit beta',19003,118,0.71 [0.46-1.09],0.1148517539811489
Chapter II Neoplasms,Carcinoma in situ of breast,COPE,Coatomer subunit epsilon,21957,134,0.72 [0.49-1.07],0.1056408414349534
Chapter II Neoplasms,Carcinoma in situ of breast,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19106,119,1.28 [0.91-1.79],0.1540639039206986
Chapter II Neoplasms,Carcinoma in situ of breast,CORO1A,Coronin-1A,22033,131,0.88 [0.73-1.05],0.1534620691557647
Chapter II Neoplasms,Carcinoma in situ of breast,CORO6,Coronin-6,18997,118,0.89 [0.54-1.47],0.6560637084106562
Chapter II Neoplasms,Carcinoma in situ of breast,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22413,140,0.91 [0.73-1.14],0.41932296106144
Chapter II Neoplasms,Carcinoma in situ of breast,COX6B1,Cytochrome c oxidase subunit 6B1,19600,119,0.59 [0.33-1.05],0.0730667515243244
Chapter II Neoplasms,Carcinoma in situ of breast,CPA1,Carboxypeptidase A1,22786,138,0.81 [0.62-1.05],0.1124772732482643
Chapter II Neoplasms,Carcinoma in situ of breast,CPA2,Carboxypeptidase A2,22629,138,0.78 [0.61-0.99],0.0431434631055535
Chapter II Neoplasms,Carcinoma in situ of breast,CPA4,Carboxypeptidase A4,18802,119,0.89 [0.59-1.33],0.5709655069428787
Chapter II Neoplasms,Carcinoma in situ of breast,CPB1,Carboxypeptidase B,22786,138,0.82 [0.63-1.08],0.161130151304498
Chapter II Neoplasms,Carcinoma in situ of breast,CPB2,Carboxypeptidase B2,19587,118,2.26 [1.08-4.73],0.0304129351890965
Chapter II Neoplasms,Carcinoma in situ of breast,CPE,Carboxypeptidase E,22554,135,0.93 [0.63-1.36],0.7036732796259463
Chapter II Neoplasms,Carcinoma in situ of breast,CPLX2,Complexin-2,18908,119,0.86 [0.47-1.56],0.6158598862639627
Chapter II Neoplasms,Carcinoma in situ of breast,CPM,Carboxypeptidase M,22608,137,0.78 [0.51-1.21],0.2715041961704141
Chapter II Neoplasms,Carcinoma in situ of breast,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19054,117,0.95 [0.50-1.81],0.8845001428931633
Chapter II Neoplasms,Carcinoma in situ of breast,CPPED1,Serine/threonine-protein phosphatase CPPED1,22715,138,1.03 [0.82-1.28],0.8240088596556642
Chapter II Neoplasms,Carcinoma in situ of breast,CPQ,Carboxypeptidase Q,19555,123,0.91 [0.59-1.42],0.6904137352438345
Chapter II Neoplasms,Carcinoma in situ of breast,CPTP,Ceramide-1-phosphate transfer protein,19003,118,1.08 [0.71-1.64],0.7168282945387651
Chapter II Neoplasms,Carcinoma in situ of breast,CPVL,Probable serine carboxypeptidase CPVL,22688,137,0.84 [0.59-1.20],0.335696442838964
Chapter II Neoplasms,Carcinoma in situ of breast,CPXM1,Probable carboxypeptidase X1,22586,140,0.82 [0.66-1.02],0.0747000573603841
Chapter II Neoplasms,Carcinoma in situ of breast,CPXM2,Inactive carboxypeptidase-like protein X2,19600,119,0.88 [0.43-1.80],0.7289884378096625
Chapter II Neoplasms,Carcinoma in situ of breast,CR1,Complement receptor type 1,19524,119,1.30 [0.80-2.14],0.2920434338298142
Chapter II Neoplasms,Carcinoma in situ of breast,CR2,Complement receptor type 2,22579,139,1.19 [0.86-1.65],0.2968367115356404
Chapter II Neoplasms,Carcinoma in situ of breast,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22008,134,0.82 [0.68-1.00],0.0453053416761261
Chapter II Neoplasms,Carcinoma in situ of breast,CRADD,Death domain-containing protein CRADD,22320,139,0.82 [0.68-1.00],0.0484526408331665
Chapter II Neoplasms,Carcinoma in situ of breast,CREB3,Cyclic AMP-responsive element-binding protein 3,18908,119,1.08 [0.80-1.45],0.6195177886824715
Chapter II Neoplasms,Carcinoma in situ of breast,CREBZF,CREB/ATF bZIP transcription factor,18908,119,0.67 [0.33-1.37],0.2758060119497317
Chapter II Neoplasms,Carcinoma in situ of breast,CREG1,Protein CREG1,22220,135,0.87 [0.56-1.33],0.5104204191412682
Chapter II Neoplasms,Carcinoma in situ of breast,CRELD1,Protein disulfide isomerase CRELD1,19191,120,1.33 [0.84-2.11],0.220414978416987
Chapter II Neoplasms,Carcinoma in situ of breast,CRELD2,Protein disulfide isomerase CRELD2,22580,141,0.97 [0.72-1.29],0.8090526867340945
Chapter II Neoplasms,Carcinoma in situ of breast,CRH,Corticoliberin,21967,134,1.01 [0.85-1.21],0.8900718815121681
Chapter II Neoplasms,Carcinoma in situ of breast,CRHBP,Corticotropin-releasing factor-binding protein,22510,140,0.93 [0.55-1.57],0.7819330234342083
Chapter II Neoplasms,Carcinoma in situ of breast,CRHR1,Corticotropin-releasing factor receptor 1,22115,137,1.09 [0.88-1.36],0.4364873189649486
Chapter II Neoplasms,Carcinoma in situ of breast,CRIM1,Cysteine-rich motor neuron 1 protein,22619,141,0.93 [0.44-1.95],0.844002845760756
Chapter II Neoplasms,Carcinoma in situ of breast,CRIP2,Cysteine-rich protein 2,22368,139,0.76 [0.49-1.18],0.2182076187588955
Chapter II Neoplasms,Carcinoma in situ of breast,CRISP2,Cysteine-rich secretory protein 2,22716,137,1.10 [0.86-1.42],0.4423214288384872
Chapter II Neoplasms,Carcinoma in situ of breast,CRISP3,Cysteine-rich secretory protein 3,19427,119,1.25 [0.65-2.39],0.5026086734308214
Chapter II Neoplasms,Carcinoma in situ of breast,CRKL,Crk-like protein,22546,141,0.83 [0.73-0.95],0.0087316342186685
Chapter II Neoplasms,Carcinoma in situ of breast,CRLF1,Cytokine receptor-like factor 1,22619,141,1.40 [0.79-2.49],0.2468240310154947
Chapter II Neoplasms,Carcinoma in situ of breast,CRNN,Cornulin,21874,132,1.00 [0.79-1.26],0.970795405178288
Chapter II Neoplasms,Carcinoma in situ of breast,CRTAC1,Cartilage acidic protein 1,22786,138,1.02 [0.62-1.70],0.927878018581187
Chapter II Neoplasms,Carcinoma in situ of breast,CRTAM,Cytotoxic and regulatory T-cell molecule,22368,139,0.82 [0.61-1.11],0.2066274207891562
Chapter II Neoplasms,Carcinoma in situ of breast,CRTAP,Cartilage-associated protein,19054,119,0.82 [0.55-1.22],0.3286638014327551
Chapter II Neoplasms,Carcinoma in situ of breast,CRX,Cone-rod homeobox protein,22115,137,0.95 [0.82-1.10],0.5068057175695848
Chapter II Neoplasms,Carcinoma in situ of breast,CRYBB1,Beta-crystallin B1,19600,119,0.76 [0.58-1.01],0.0563268661271937
Chapter II Neoplasms,Carcinoma in situ of breast,CRYBB2,Beta-crystallin B2,19562,122,0.91 [0.67-1.23],0.5332714679971227
Chapter II Neoplasms,Carcinoma in situ of breast,CRYGD,Gamma-crystallin D,19562,122,0.84 [0.70-1.00],0.0527942054020176
Chapter II Neoplasms,Carcinoma in situ of breast,CRYM,Ketimine reductase mu-crystallin,18997,118,0.98 [0.77-1.24],0.8592617846878194
Chapter II Neoplasms,Carcinoma in situ of breast,CRYZL1,Quinone oxidoreductase-like protein 1,19106,119,0.86 [0.71-1.04],0.1111993260173049
Chapter II Neoplasms,Carcinoma in situ of breast,CSDE1,Cold shock domain-containing protein E1,19003,118,0.92 [0.78-1.08],0.287813831508881
Chapter II Neoplasms,Carcinoma in situ of breast,CSF1,Macrophage colony-stimulating factor 1,22619,141,0.86 [0.49-1.51],0.5903216365387882
Chapter II Neoplasms,Carcinoma in situ of breast,CSF1R,Macrophage colony-stimulating factor 1 receptor,19605,119,1.09 [0.69-1.71],0.7212193874358499
Chapter II Neoplasms,Carcinoma in situ of breast,CSF2,Granulocyte-macrophage colony-stimulating factor,19003,118,1.55 [1.03-2.31],0.0338026899784811
Chapter II Neoplasms,Carcinoma in situ of breast,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22368,139,1.16 [0.93-1.46],0.1895949351773185
Chapter II Neoplasms,Carcinoma in situ of breast,CSF2RB,Cytokine receptor common subunit beta,19054,117,1.08 [0.72-1.61],0.7164587292280602
Chapter II Neoplasms,Carcinoma in situ of breast,CSF3,Granulocyte colony-stimulating factor,22090,138,0.78 [0.57-1.07],0.1283171031819881
Chapter II Neoplasms,Carcinoma in situ of breast,CSF3R,Granulocyte colony-stimulating factor receptor,19054,117,0.75 [0.41-1.38],0.361028703933413
Chapter II Neoplasms,Carcinoma in situ of breast,CSH1,Chorionic somatomammotropin hormone 1,19605,119,0.97 [0.57-1.65],0.9167161822749592
Chapter II Neoplasms,Carcinoma in situ of breast,CSNK1D,Casein kinase I isoform delta,19054,117,0.70 [0.51-0.96],0.0257155059391826
Chapter II Neoplasms,Carcinoma in situ of breast,CSNK2A1,Casein kinase II subunit alpha,19571,121,0.64 [0.43-0.95],0.0259879649687844
Chapter II Neoplasms,Carcinoma in situ of breast,CSPG4,Chondroitin sulfate proteoglycan 4,19597,123,1.08 [0.64-1.83],0.775879462074585
Chapter II Neoplasms,Carcinoma in situ of breast,CSPG5,Chondroitin sulfate proteoglycan 5,18997,118,1.13 [0.81-1.57],0.4745662018956919
Chapter II Neoplasms,Carcinoma in situ of breast,CSRP3,Cysteine and glycine-rich protein 3,19003,118,1.05 [0.87-1.25],0.62223200928692
Chapter II Neoplasms,Carcinoma in situ of breast,CST1,Cystatin-SN,17008,106,1.05 [0.87-1.27],0.6036776099361341
Chapter II Neoplasms,Carcinoma in situ of breast,CST3,Cystatin-C,22546,139,1.70 [1.00-2.88],0.0513289008122778
Chapter II Neoplasms,Carcinoma in situ of breast,CST5,Cystatin-D,22138,139,1.49 [1.14-1.93],0.002988827726465
Chapter II Neoplasms,Carcinoma in situ of breast,CST6,Cystatin-M,21942,129,1.24 [0.89-1.72],0.210513235432439
Chapter II Neoplasms,Carcinoma in situ of breast,CST7,Cystatin-F,22551,139,0.85 [0.71-1.03],0.0943918920174115
Chapter II Neoplasms,Carcinoma in situ of breast,CSTB,Cystatin-B,22206,134,0.79 [0.55-1.15],0.2192497686106564
Chapter II Neoplasms,Carcinoma in situ of breast,CTAG1A_CTAG1B,Cancer/testis antigen 1,19180,122,1.12 [0.81-1.55],0.5031853596907208
Chapter II Neoplasms,Carcinoma in situ of breast,CTBS,Di-N-acetylchitobiase,19310,114,0.70 [0.39-1.24],0.218214648993385
Chapter II Neoplasms,Carcinoma in situ of breast,CTF1,Cardiotrophin-1,22115,137,0.85 [0.71-1.03],0.0949918383602815
Chapter II Neoplasms,Carcinoma in situ of breast,CTHRC1,Collagen triple helix repeat-containing protein 1,19597,123,1.35 [0.73-2.47],0.3369152960463428
Chapter II Neoplasms,Carcinoma in situ of breast,CTLA4,Cytotoxic T-lymphocyte protein 4,19597,123,0.69 [0.38-1.24],0.2139889254873545
Chapter II Neoplasms,Carcinoma in situ of breast,CTNNA1,Catenin alpha-1,18997,118,0.93 [0.56-1.54],0.7728102982019562
Chapter II Neoplasms,Carcinoma in situ of breast,CTRB1,Chymotrypsinogen B,22524,138,0.91 [0.68-1.21],0.5073813165635621
Chapter II Neoplasms,Carcinoma in situ of breast,CTRC,Chymotrypsin-C,22519,139,0.83 [0.65-1.05],0.1245619855682972
Chapter II Neoplasms,Carcinoma in situ of breast,CTRL,Chymotrypsin-like protease CTRL-1,19562,122,0.82 [0.63-1.06],0.1315282720011789
Chapter II Neoplasms,Carcinoma in situ of breast,CTSB,Cathepsin B,22534,136,1.19 [0.90-1.57],0.2145747514909527
Chapter II Neoplasms,Carcinoma in situ of breast,CTSC,Dipeptidyl peptidase 1,22474,140,0.70 [0.49-1.00],0.0516329847367183
Chapter II Neoplasms,Carcinoma in situ of breast,CTSD,Cathepsin D,20998,125,0.85 [0.55-1.32],0.4740869640156413
Chapter II Neoplasms,Carcinoma in situ of breast,CTSE,Cathepsin E,19191,120,1.04 [0.74-1.45],0.8264394473547664
Chapter II Neoplasms,Carcinoma in situ of breast,CTSF,Cathepsin F,22586,140,0.86 [0.59-1.24],0.415659534160489
Chapter II Neoplasms,Carcinoma in situ of breast,CTSH,Pro-cathepsin H,22053,137,1.01 [0.82-1.24],0.9593979479894056
Chapter II Neoplasms,Carcinoma in situ of breast,CTSL,Cathepsin L1,22518,139,0.69 [0.37-1.32],0.2653513592815762
Chapter II Neoplasms,Carcinoma in situ of breast,CTSO,Cathepsin O,22764,139,0.80 [0.48-1.33],0.3868846620275505
Chapter II Neoplasms,Carcinoma in situ of breast,CTSS,Cathepsin S,17673,113,1.17 [0.55-2.49],0.6776947617151711
Chapter II Neoplasms,Carcinoma in situ of breast,CTSV,Cathepsin L2,22657,136,1.00 [0.70-1.43],0.9840263973127056
Chapter II Neoplasms,Carcinoma in situ of breast,CTSZ,Cathepsin Z,22500,139,1.10 [0.68-1.78],0.7047562552914568
Chapter II Neoplasms,Carcinoma in situ of breast,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19054,119,0.63 [0.35-1.13],0.1216641832555342
Chapter II Neoplasms,Carcinoma in situ of breast,CWC15,Spliceosome-associated protein CWC15 homolog,19383,122,1.06 [0.82-1.39],0.6430489083154733
Chapter II Neoplasms,Carcinoma in situ of breast,CX3CL1,Fractalkine,22368,139,1.38 [0.90-2.12],0.137684814199193
Chapter II Neoplasms,Carcinoma in situ of breast,CXADR,Coxsackievirus and adenovirus receptor,22477,136,0.79 [0.58-1.07],0.1316511816570728
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL1,Growth-regulated alpha protein,22476,139,0.84 [0.71-0.99],0.0359294903405291
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL10,C-X-C motif chemokine 10,22619,141,0.91 [0.73-1.15],0.4465415530638612
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL11,C-X-C motif chemokine 11,22715,138,0.70 [0.57-0.86],0.0007954635608628
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL12,Stromal cell-derived factor 1,22090,138,0.68 [0.46-1.00],0.0509858146537821
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL13,C-X-C motif chemokine 13,22715,138,0.96 [0.75-1.23],0.7768995330056511
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL14,C-X-C motif chemokine 14,22090,138,1.01 [0.80-1.28],0.9461549961361868
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL16,C-X-C motif chemokine 16,22747,136,1.53 [0.81-2.91],0.1908394925058845
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL17,C-X-C motif chemokine 17,22764,139,1.09 [0.75-1.57],0.6555366094760252
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL3,C-X-C motif chemokine 3,22512,139,0.89 [0.76-1.04],0.1445013285272212
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL5,C-X-C motif chemokine 5,22445,138,0.91 [0.80-1.03],0.1484415777835553
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL6,C-X-C motif chemokine 6,22764,139,0.87 [0.72-1.06],0.1701897001924291
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL8,Interleukin-8,22341,135,0.96 [0.77-1.21],0.7349218602449313
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL9,C-X-C motif chemokine 9,22619,141,0.89 [0.71-1.13],0.333708433099823
Chapter II Neoplasms,Carcinoma in situ of breast,CYB5A,Cytochrome b5,18908,119,1.17 [0.96-1.42],0.1126349937030084
Chapter II Neoplasms,Carcinoma in situ of breast,CYB5R2,NADH-cytochrome b5 reductase 2,19259,122,1.01 [0.74-1.37],0.9664597208480836
Chapter II Neoplasms,Carcinoma in situ of breast,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19003,118,0.85 [0.67-1.08],0.1817485564029341
Chapter II Neoplasms,Carcinoma in situ of breast,CYTH3,Cytohesin-3,18908,119,0.93 [0.72-1.19],0.5634009104776667
Chapter II Neoplasms,Carcinoma in situ of breast,CYTL1,Cytokine-like protein 1,19597,123,1.71 [0.82-3.59],0.154645888480451
Chapter II Neoplasms,Carcinoma in situ of breast,DAAM1,Disheveled-associated activator of morphogenesis 1,19191,120,0.75 [0.60-0.93],0.0094785792614926
Chapter II Neoplasms,Carcinoma in situ of breast,DAB2,Disabled homolog 2,22716,137,0.85 [0.74-0.97],0.0164882706589515
Chapter II Neoplasms,Carcinoma in situ of breast,DAG1,Dystroglycan,22619,141,0.71 [0.52-0.98],0.0364954156721637
Chapter II Neoplasms,Carcinoma in situ of breast,DAND5,DAN domain family member 5,19054,117,0.89 [0.63-1.24],0.4785759473486046
Chapter II Neoplasms,Carcinoma in situ of breast,DAPK2,Death-associated protein kinase 2,19054,117,1.37 [1.06-1.76],0.014451375932492
Chapter II Neoplasms,Carcinoma in situ of breast,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22477,136,0.94 [0.83-1.06],0.3339053351423686
Chapter II Neoplasms,Carcinoma in situ of breast,DARS1,"Aspartate--tRNA ligase, cytoplasmic",22320,139,0.88 [0.71-1.07],0.199990259847744
Chapter II Neoplasms,Carcinoma in situ of breast,DBH,Dopamine beta-hydroxylase,19564,119,1.12 [0.93-1.34],0.2213732040633639
Chapter II Neoplasms,Carcinoma in situ of breast,DBI,Acyl-CoA-binding protein,22425,138,0.85 [0.70-1.04],0.1107453225898259
Chapter II Neoplasms,Carcinoma in situ of breast,DBN1,Drebrin,19054,117,0.59 [0.40-0.86],0.0057803016558023
Chapter II Neoplasms,Carcinoma in situ of breast,DBNL,Drebrin-like protein,22619,141,0.82 [0.70-0.96],0.0136102769971405
Chapter II Neoplasms,Carcinoma in situ of breast,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22586,140,1.11 [0.72-1.71],0.6353932401796433
Chapter II Neoplasms,Carcinoma in situ of breast,DCC,Netrin receptor DCC,19054,119,0.87 [0.39-1.95],0.7346610964881388
Chapter II Neoplasms,Carcinoma in situ of breast,DCDC2C,Doublecortin domain-containing protein 2C,18908,119,0.97 [0.73-1.28],0.8054234276708854
Chapter II Neoplasms,Carcinoma in situ of breast,DCLRE1C,Protein artemis,18908,119,0.46 [0.25-0.85],0.0126206585856814
Chapter II Neoplasms,Carcinoma in situ of breast,DCN,Decorin,22115,137,1.17 [0.60-2.29],0.6459354524287929
Chapter II Neoplasms,Carcinoma in situ of breast,DCTD,Deoxycytidylate deaminase,19191,120,0.84 [0.70-1.01],0.0631521214416297
Chapter II Neoplasms,Carcinoma in situ of breast,DCTN1,Dynactin subunit 1,22716,137,0.73 [0.58-0.92],0.0073437933526181
Chapter II Neoplasms,Carcinoma in situ of breast,DCTN2,Dynactin subunit 2,22413,140,0.90 [0.76-1.06],0.1932530000109049
Chapter II Neoplasms,Carcinoma in situ of breast,DCTN6,Dynactin subunit 6,21957,134,0.89 [0.71-1.12],0.3228681129340606
Chapter II Neoplasms,Carcinoma in situ of breast,DCTPP1,dCTP pyrophosphatase 1,22518,139,1.05 [0.65-1.69],0.8563586296916859
Chapter II Neoplasms,Carcinoma in situ of breast,DCUN1D1,DCN1-like protein 1,18997,118,1.06 [0.86-1.32],0.5679983100958392
Chapter II Neoplasms,Carcinoma in situ of breast,DCUN1D2,DCN1-like protein 2,18908,119,1.15 [0.96-1.38],0.1319802199916254
Chapter II Neoplasms,Carcinoma in situ of breast,DCXR,L-xylulose reductase,22586,140,0.83 [0.62-1.12],0.2281497118531908
Chapter II Neoplasms,Carcinoma in situ of breast,DDA1,DET1- and DDB1-associated protein 1,19003,118,0.86 [0.54-1.37],0.5393946469517579
Chapter II Neoplasms,Carcinoma in situ of breast,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22413,140,0.91 [0.64-1.28],0.5843422634313857
Chapter II Neoplasms,Carcinoma in situ of breast,DDC,Aromatic-L-amino-acid decarboxylase,22484,139,0.96 [0.70-1.30],0.7834023443249114
Chapter II Neoplasms,Carcinoma in situ of breast,DDHD2,Phospholipase DDHD2,19571,121,0.74 [0.57-0.97],0.0306388740516774
Chapter II Neoplasms,Carcinoma in situ of breast,DDI2,Protein DDI1 homolog 2,19191,120,0.96 [0.77-1.20],0.7434066885169894
Chapter II Neoplasms,Carcinoma in situ of breast,DDR1,Epithelial discoidin domain-containing receptor 1,22715,138,1.27 [0.66-2.44],0.4795692709695944
Chapter II Neoplasms,Carcinoma in situ of breast,DDT,D-dopachrome decarboxylase,19597,123,0.72 [0.47-1.12],0.1508216095804508
Chapter II Neoplasms,Carcinoma in situ of breast,DDX1,ATP-dependent RNA helicase DDX1,19501,122,1.40 [1.08-1.81],0.0098244443574075
Chapter II Neoplasms,Carcinoma in situ of breast,DDX25,ATP-dependent RNA helicase DDX25,19054,119,1.02 [0.66-1.59],0.9209428145134206
Chapter II Neoplasms,Carcinoma in situ of breast,DDX39A,ATP-dependent RNA helicase DDX39A,19054,117,1.32 [0.63-2.79],0.4596872936986518
Chapter II Neoplasms,Carcinoma in situ of breast,DDX4,Probable ATP-dependent RNA helicase DDX4,19054,117,1.21 [0.92-1.59],0.1760895282093435
Chapter II Neoplasms,Carcinoma in situ of breast,DDX53,Probable ATP-dependent RNA helicase DDX53,19054,119,1.36 [0.85-2.16],0.2015923777406155
Chapter II Neoplasms,Carcinoma in situ of breast,DDX58,Antiviral innate immune response receptor RIG-I,22008,134,0.83 [0.62-1.11],0.2068732967833856
Chapter II Neoplasms,Carcinoma in situ of breast,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22477,136,0.93 [0.80-1.09],0.3837801776552479
Chapter II Neoplasms,Carcinoma in situ of breast,DEFA1_DEFA1B,Neutrophil defensin 1,22037,129,1.42 [1.12-1.81],0.0042534363074672
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB103A_DEFB103B,Beta-defensin 103,18903,117,1.08 [0.72-1.61],0.7237291147165945
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB104A_DEFB104B,Beta-defensin 104,18997,118,1.15 [0.87-1.53],0.3192071004765116
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB116,Beta-defensin 116,18997,118,1.10 [0.90-1.35],0.3322919576040225
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB118,Beta-defensin 118,18997,118,0.94 [0.67-1.30],0.6934738107217516
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB4A_DEFB4B,Beta-defensin 4A,22209,139,0.99 [0.89-1.09],0.7959574338588669
Chapter II Neoplasms,Carcinoma in situ of breast,DENND2B,DENN domain-containing protein 2B,19003,118,0.93 [0.65-1.33],0.6971439978650245
Chapter II Neoplasms,Carcinoma in situ of breast,DENR,Density-regulated protein,19054,117,0.60 [0.42-0.86],0.0049755062524544
Chapter II Neoplasms,Carcinoma in situ of breast,DFFA,DNA fragmentation factor subunit alpha,22764,139,0.79 [0.63-0.99],0.0451669096606
Chapter II Neoplasms,Carcinoma in situ of breast,DGCR6,Protein DGCR6,18997,118,0.77 [0.48-1.22],0.2660673863372012
Chapter II Neoplasms,Carcinoma in situ of breast,DGKA,Diacylglycerol kinase alpha,19054,117,0.70 [0.49-0.99],0.044067740461446
Chapter II Neoplasms,Carcinoma in situ of breast,DGKZ,Diacylglycerol kinase zeta,22090,138,0.83 [0.54-1.29],0.4165636754791607
Chapter II Neoplasms,Carcinoma in situ of breast,DHODH,Dihydroorotate dehydrogenase,19003,118,1.08 [0.77-1.52],0.6376139109476198
Chapter II Neoplasms,Carcinoma in situ of breast,DHPS,Deoxyhypusine synthase,19495,120,1.30 [0.93-1.80],0.1218921364797817
Chapter II Neoplasms,Carcinoma in situ of breast,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19562,122,0.82 [0.55-1.22],0.3231937023034038
Chapter II Neoplasms,Carcinoma in situ of breast,DIABLO,"Diablo homolog, mitochondrial",22451,137,0.85 [0.75-0.98],0.0249941740586626
Chapter II Neoplasms,Carcinoma in situ of breast,DIPK1C,Divergent protein kinase domain 1C,19054,119,0.53 [0.32-0.87],0.0128916868399173
Chapter II Neoplasms,Carcinoma in situ of breast,DIPK2B,Divergent protein kinase domain 2B,19191,120,1.45 [0.77-2.72],0.2479996510272037
Chapter II Neoplasms,Carcinoma in situ of breast,DKK1,Dickkopf-related protein 1,22715,138,0.76 [0.60-0.98],0.0341817971252478
Chapter II Neoplasms,Carcinoma in situ of breast,DKK3,Dickkopf-related protein 3,22786,138,1.04 [0.63-1.74],0.8678287919450755
Chapter II Neoplasms,Carcinoma in situ of breast,DKK4,Dickkopf-related protein 4,22337,139,0.98 [0.70-1.36],0.8885303877479268
Chapter II Neoplasms,Carcinoma in situ of breast,DKKL1,Dickkopf-like protein 1,22413,140,1.18 [0.98-1.42],0.0869506561474641
Chapter II Neoplasms,Carcinoma in situ of breast,DLG4,Disks large homolog 4,19562,122,0.77 [0.59-1.00],0.0474464232563699
Chapter II Neoplasms,Carcinoma in situ of breast,DLGAP5,Disks large-associated protein 5,19571,121,0.81 [0.55-1.21],0.3088772326101138
Chapter II Neoplasms,Carcinoma in situ of breast,DLK1,Protein delta homolog 1,22786,138,1.00 [0.75-1.32],0.9876869315411232
Chapter II Neoplasms,Carcinoma in situ of breast,DLL1,Delta-like protein 1,22586,140,1.47 [0.88-2.46],0.139652960425102
Chapter II Neoplasms,Carcinoma in situ of breast,DLL4,Delta-like protein 4,19106,119,0.93 [0.72-1.19],0.5633581502067784
Chapter II Neoplasms,Carcinoma in situ of breast,DMD,Dystrophin,19106,119,0.68 [0.46-1.02],0.0645957417927941
Chapter II Neoplasms,Carcinoma in situ of breast,DMP1,Dentin matrix acidic phosphoprotein 1,19106,119,0.93 [0.71-1.21],0.5967645112438644
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJA1,DnaJ homolog subfamily A member 1,18908,119,0.91 [0.61-1.36],0.6421575098623975
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJA2,DnaJ homolog subfamily A member 2,22696,137,0.78 [0.65-0.94],0.007557045859884
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJA4,DnaJ homolog subfamily A member 4,19562,122,0.98 [0.77-1.24],0.844953514864291
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB1,DnaJ homolog subfamily B member 1,22413,140,0.83 [0.70-0.99],0.03859865153235
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB14,DnaJ homolog subfamily B member 14,19501,122,0.82 [0.62-1.08],0.1546656030349543
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB2,DnaJ homolog subfamily B member 2,19191,120,0.76 [0.55-1.06],0.1088024925248427
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB6,DnaJ homolog subfamily B member 6,19000,120,0.85 [0.69-1.05],0.1372396764433809
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB8,DnaJ homolog subfamily B member 8,22115,137,1.19 [0.96-1.48],0.110709648790065
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJC21,DnaJ homolog subfamily C member 21,19562,122,0.88 [0.56-1.40],0.5973150972669474
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19106,119,0.77 [0.62-0.96],0.018726726359768
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJC9,DnaJ homolog subfamily C member 9,19501,122,0.85 [0.68-1.06],0.1547946987917829
Chapter II Neoplasms,Carcinoma in situ of breast,DNER,Delta and Notch-like epidermal growth factor-related receptor,22478,139,1.15 [0.63-2.11],0.6476706090603396
Chapter II Neoplasms,Carcinoma in situ of breast,DNLZ,DNL-type zinc finger protein,18997,118,1.06 [0.89-1.26],0.5129126514828288
Chapter II Neoplasms,Carcinoma in situ of breast,DNM1,Dynamin-1,19501,122,0.88 [0.76-1.03],0.1051212432666185
Chapter II Neoplasms,Carcinoma in situ of breast,DNM3,Dynamin-3,19571,121,0.77 [0.54-1.08],0.1294644162127134
Chapter II Neoplasms,Carcinoma in situ of breast,DNMBP,Dynamin-binding protein,22368,139,0.83 [0.64-1.06],0.1402275772731533
Chapter II Neoplasms,Carcinoma in situ of breast,DNPEP,Aspartyl aminopeptidase,19562,122,0.84 [0.63-1.11],0.2142557798245885
Chapter II Neoplasms,Carcinoma in situ of breast,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22585,141,0.82 [0.62-1.09],0.170996608574214
Chapter II Neoplasms,Carcinoma in situ of breast,DOC2B,Double C2-like domain-containing protein beta,19054,119,0.74 [0.42-1.31],0.2990537418046324
Chapter II Neoplasms,Carcinoma in situ of breast,DOCK9,Dedicator of cytokinesis protein 9,18997,118,1.04 [0.90-1.20],0.607053858656869
Chapter II Neoplasms,Carcinoma in situ of breast,DOK1,Docking protein 1,19562,122,0.86 [0.76-0.98],0.0181518169428643
Chapter II Neoplasms,Carcinoma in situ of breast,DOK2,Docking protein 2,22518,139,0.86 [0.76-0.97],0.0149059810772958
Chapter II Neoplasms,Carcinoma in situ of breast,DPEP1,Dipeptidase 1,22320,139,0.88 [0.66-1.17],0.3835664498601999
Chapter II Neoplasms,Carcinoma in situ of breast,DPEP2,Dipeptidase 2,22413,140,0.67 [0.39-1.13],0.13428242091918
Chapter II Neoplasms,Carcinoma in situ of breast,DPP10,Inactive dipeptidyl peptidase 10,22477,136,0.83 [0.52-1.32],0.4266113413519629
Chapter II Neoplasms,Carcinoma in situ of breast,DPP4,Dipeptidyl peptidase 4,22072,134,1.31 [0.78-2.21],0.3038798794314498
Chapter II Neoplasms,Carcinoma in situ of breast,DPP6,Dipeptidyl aminopeptidase-like protein 6,22413,140,0.91 [0.58-1.44],0.7006369550509773
Chapter II Neoplasms,Carcinoma in situ of breast,DPP7,Dipeptidyl peptidase 2,22330,139,0.95 [0.74-1.23],0.6953157656655362
Chapter II Neoplasms,Carcinoma in situ of breast,DPT,Dermatopontin,22786,138,0.85 [0.49-1.48],0.5696934694898457
Chapter II Neoplasms,Carcinoma in situ of breast,DPY30,Protein dpy-30 homolog,22643,137,0.96 [0.74-1.24],0.7633870747697787
Chapter II Neoplasms,Carcinoma in situ of breast,DRAXIN,Draxin,22368,139,1.19 [0.84-1.68],0.3345150979206553
Chapter II Neoplasms,Carcinoma in situ of breast,DRG2,Developmentally-regulated GTP-binding protein 2,22413,140,0.68 [0.51-0.90],0.0067111886469897
Chapter II Neoplasms,Carcinoma in situ of breast,DSC2,Desmocollin-2,22281,136,1.15 [0.72-1.82],0.554919587523999
Chapter II Neoplasms,Carcinoma in situ of breast,DSCAM,Down syndrome cell adhesion molecule,19571,121,0.82 [0.50-1.34],0.4248268899085178
Chapter II Neoplasms,Carcinoma in situ of breast,DSG2,Desmoglein-2,22524,138,1.19 [0.68-2.09],0.5329993621364834
Chapter II Neoplasms,Carcinoma in situ of breast,DSG3,Desmoglein-3,22648,137,1.09 [0.69-1.71],0.722095139611517
Chapter II Neoplasms,Carcinoma in situ of breast,DSG4,Desmoglein-4,22334,140,0.88 [0.66-1.18],0.39190894250053
Chapter II Neoplasms,Carcinoma in situ of breast,DTD1,D-aminoacyl-tRNA deacylase 1,19191,120,0.82 [0.67-1.01],0.0586673846509957
Chapter II Neoplasms,Carcinoma in situ of breast,DTNB,Dystrobrevin beta,19467,120,0.68 [0.44-1.06],0.0881881291084176
Chapter II Neoplasms,Carcinoma in situ of breast,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19054,119,0.70 [0.51-0.97],0.0319842358619109
Chapter II Neoplasms,Carcinoma in situ of breast,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22413,140,0.94 [0.50-1.80],0.8587271495688918
Chapter II Neoplasms,Carcinoma in situ of breast,DTYMK,Thymidylate kinase,19600,119,0.74 [0.57-0.95],0.0193077515657053
Chapter II Neoplasms,Carcinoma in situ of breast,DUOX2,Dual oxidase 2,22115,137,0.96 [0.77-1.19],0.7048186837882499
Chapter II Neoplasms,Carcinoma in situ of breast,DUSP13,Dual specificity protein phosphatase 13 isoform A,19495,120,1.12 [0.75-1.69],0.5718763801810635
Chapter II Neoplasms,Carcinoma in situ of breast,DUSP29,Dual specificity phosphatase 29,19054,119,0.78 [0.57-1.08],0.1306636314204339
Chapter II Neoplasms,Carcinoma in situ of breast,DUSP3,Dual specificity protein phosphatase 3,21957,134,0.82 [0.67-1.01],0.0661920981401115
Chapter II Neoplasms,Carcinoma in situ of breast,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19501,122,0.86 [0.72-1.02],0.0780470047483829
Chapter II Neoplasms,Carcinoma in situ of breast,DXO,Decapping and exoribonuclease protein,19562,122,0.85 [0.58-1.25],0.4107450986700939
Chapter II Neoplasms,Carcinoma in situ of breast,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19495,120,0.72 [0.46-1.12],0.1464128518620866
Chapter II Neoplasms,Carcinoma in situ of breast,DYNLT1,Dynein light chain Tctex-type 1,19054,119,1.10 [0.89-1.34],0.3752595930502527
Chapter II Neoplasms,Carcinoma in situ of breast,DYNLT3,Dynein light chain Tctex-type 3,19495,120,0.80 [0.53-1.20],0.2802838176908088
Chapter II Neoplasms,Carcinoma in situ of breast,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22368,139,0.82 [0.70-0.97],0.0172567570188003
Chapter II Neoplasms,Carcinoma in situ of breast,EBI3_IL27,Interleukin-27,22677,137,1.02 [0.62-1.67],0.9354799333691488
Chapter II Neoplasms,Carcinoma in situ of breast,ECE1,Endothelin-converting enzyme 1,21957,134,0.85 [0.55-1.32],0.4686282066153485
Chapter II Neoplasms,Carcinoma in situ of breast,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19600,119,1.01 [0.80-1.28],0.9185144957058976
Chapter II Neoplasms,Carcinoma in situ of breast,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19106,119,0.88 [0.73-1.05],0.163434287972016
Chapter II Neoplasms,Carcinoma in situ of breast,ECI2,Enoyl-CoA delta isomerase 2,19003,118,0.72 [0.52-1.00],0.0513308018234947
Chapter II Neoplasms,Carcinoma in situ of breast,ECM1,Extracellular matrix protein 1,19069,116,0.94 [0.58-1.51],0.7834539993129899
Chapter II Neoplasms,Carcinoma in situ of breast,ECSCR,Endothelial cell-specific chemotaxis regulator,18997,118,1.05 [0.76-1.45],0.7856254369414359
Chapter II Neoplasms,Carcinoma in situ of breast,EDA2R,Tumor necrosis factor receptor superfamily member 27,22716,137,1.28 [0.83-2.00],0.2652589814300682
Chapter II Neoplasms,Carcinoma in situ of breast,EDAR,Tumor necrosis factor receptor superfamily member EDAR,22477,136,0.91 [0.78-1.08],0.2892464099806906
Chapter II Neoplasms,Carcinoma in situ of breast,EDDM3B,Epididymal secretory protein E3-beta,19495,120,1.34 [0.94-1.90],0.1087175288057154
Chapter II Neoplasms,Carcinoma in situ of breast,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19003,118,0.78 [0.46-1.33],0.3618620254905939
Chapter II Neoplasms,Carcinoma in situ of breast,EDF1,Endothelial differentiation-related factor 1,19571,121,0.77 [0.57-1.02],0.0719650848505166
Chapter II Neoplasms,Carcinoma in situ of breast,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22115,137,1.26 [0.83-1.93],0.2802786515042719
Chapter II Neoplasms,Carcinoma in situ of breast,EDN1,Endothelin-1,19106,119,1.44 [0.79-2.63],0.2329126259902889
Chapter II Neoplasms,Carcinoma in situ of breast,EDNRB,Endothelin receptor type B,19054,117,0.80 [0.51-1.26],0.3372379645319492
Chapter II Neoplasms,Carcinoma in situ of breast,EEF1D,Elongation factor 1-delta,19600,119,0.85 [0.70-1.04],0.1122597821441075
Chapter II Neoplasms,Carcinoma in situ of breast,EFCAB14,EF-hand calcium-binding domain-containing protein 14,19501,122,1.24 [0.69-2.22],0.4720068638629949
Chapter II Neoplasms,Carcinoma in situ of breast,EFCAB2,Dynein regulatory complex protein 8,19223,122,0.71 [0.42-1.20],0.1958934421505059
Chapter II Neoplasms,Carcinoma in situ of breast,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22540,137,1.42 [0.86-2.32],0.170111444468677
Chapter II Neoplasms,Carcinoma in situ of breast,EFHD1,EF-hand domain-containing protein D1,19571,121,0.78 [0.46-1.34],0.3725199578386448
Chapter II Neoplasms,Carcinoma in situ of breast,EFNA1,Ephrin-A1,22490,138,1.00 [0.56-1.78],0.996892341533973
Chapter II Neoplasms,Carcinoma in situ of breast,EFNA4,Ephrin-A4,22333,139,1.06 [0.61-1.83],0.847376248356584
Chapter II Neoplasms,Carcinoma in situ of breast,EFNB2,Ephrin-B2,19054,119,1.00 [0.75-1.35],0.9793381972043408
Chapter II Neoplasms,Carcinoma in situ of breast,EGF,Pro-epidermal growth factor,22480,140,0.84 [0.73-0.97],0.017317369458608
Chapter II Neoplasms,Carcinoma in situ of breast,EGFL7,Epidermal growth factor-like protein 7,22008,134,0.94 [0.64-1.38],0.7540912753532173
Chapter II Neoplasms,Carcinoma in situ of breast,EGFLAM,Pikachurin,19501,122,1.06 [0.61-1.85],0.8414179982307989
Chapter II Neoplasms,Carcinoma in situ of breast,EGFR,Epidermal growth factor receptor,22786,138,1.59 [0.64-3.98],0.3202076776291386
Chapter II Neoplasms,Carcinoma in situ of breast,EGLN1,Egl nine homolog 1,22477,136,0.95 [0.72-1.27],0.7471873815220853
Chapter II Neoplasms,Carcinoma in situ of breast,EHBP1,EH domain-binding protein 1,19600,119,0.77 [0.60-0.98],0.0361525022540754
Chapter II Neoplasms,Carcinoma in situ of breast,EHD3,EH domain-containing protein 3,19106,119,0.92 [0.79-1.07],0.2863698364546648
Chapter II Neoplasms,Carcinoma in situ of breast,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19562,122,0.93 [0.67-1.30],0.6859860367816302
Chapter II Neoplasms,Carcinoma in situ of breast,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19434,120,0.82 [0.70-0.98],0.024279336244699
Chapter II Neoplasms,Carcinoma in situ of breast,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19003,118,0.66 [0.49-0.89],0.0067243196543538
Chapter II Neoplasms,Carcinoma in situ of breast,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19106,119,0.66 [0.41-1.06],0.0862694493882033
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4B,Eukaryotic translation initiation factor 4B,22368,139,0.71 [0.55-0.90],0.0059079424167872
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4E,Eukaryotic translation initiation factor 4E,19054,117,0.81 [0.67-1.00],0.0455694810629111
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22518,139,0.78 [0.61-0.99],0.0420064489811253
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22764,139,0.82 [0.71-0.95],0.0086843286874657
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19571,121,0.80 [0.61-1.06],0.1207695871194512
Chapter II Neoplasms,Carcinoma in situ of breast,EIF5,Eukaryotic translation initiation factor 5,19003,118,0.84 [0.55-1.29],0.4262200744540079
Chapter II Neoplasms,Carcinoma in situ of breast,EIF5A,Eukaryotic translation initiation factor 5A-1,22090,138,0.87 [0.51-1.47],0.5983994829374332
Chapter II Neoplasms,Carcinoma in situ of breast,ELAC1,Zinc phosphodiesterase ELAC protein 1,19571,121,0.82 [0.67-1.00],0.0525427102315096
Chapter II Neoplasms,Carcinoma in situ of breast,ELAVL4,ELAV-like protein 4,18997,118,0.98 [0.80-1.20],0.8440678035699266
Chapter II Neoplasms,Carcinoma in situ of breast,ELN,Elastin,19600,119,0.97 [0.59-1.61],0.9089658662239222
Chapter II Neoplasms,Carcinoma in situ of breast,ELOA,Elongin-A,22413,140,0.98 [0.73-1.30],0.8748920919746502
Chapter II Neoplasms,Carcinoma in situ of breast,ELOB,Elongin-B,19003,118,0.72 [0.43-1.19],0.2035030564741261
Chapter II Neoplasms,Carcinoma in situ of breast,ENAH,Protein enabled homolog,22090,138,0.94 [0.68-1.30],0.7098564707166366
Chapter II Neoplasms,Carcinoma in situ of breast,ENDOU,Poly(U)-specific endoribonuclease,18105,111,1.21 [0.85-1.71],0.2899217342941922
Chapter II Neoplasms,Carcinoma in situ of breast,ENG,Endoglin,22786,138,0.85 [0.35-2.07],0.7272721535271913
Chapter II Neoplasms,Carcinoma in situ of breast,ENO1,Alpha-enolase,22482,138,0.91 [0.75-1.09],0.3021151537490176
Chapter II Neoplasms,Carcinoma in situ of breast,ENO2,Gamma-enolase,22715,138,0.77 [0.61-0.97],0.0268629681548214
Chapter II Neoplasms,Carcinoma in situ of breast,ENO3,Beta-enolase,19106,119,0.74 [0.53-1.05],0.091945199148971
Chapter II Neoplasms,Carcinoma in situ of breast,ENOPH1,Enolase-phosphatase E1,19495,120,0.74 [0.51-1.07],0.1083255393917018
Chapter II Neoplasms,Carcinoma in situ of breast,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19003,118,0.64 [0.33-1.26],0.1985446927823282
Chapter II Neoplasms,Carcinoma in situ of breast,ENPEP,Glutamyl aminopeptidase,19003,118,0.87 [0.56-1.36],0.5391200200150523
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22786,138,0.82 [0.48-1.38],0.447609174537621
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22619,141,1.06 [0.74-1.53],0.7450348773247562
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19106,119,1.47 [0.91-2.38],0.1143781326779083
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21821,137,0.95 [0.80-1.13],0.5826423204628582
Chapter II Neoplasms,Carcinoma in situ of breast,ENSA,Alpha-endosulfine,19495,120,0.88 [0.62-1.24],0.4622771681963569
Chapter II Neoplasms,Carcinoma in situ of breast,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22008,134,0.81 [0.57-1.15],0.2373100741815772
Chapter II Neoplasms,Carcinoma in situ of breast,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22115,137,0.99 [0.48-2.03],0.9679918366326534
Chapter II Neoplasms,Carcinoma in situ of breast,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22115,137,0.93 [0.54-1.61],0.7993827993956296
Chapter II Neoplasms,Carcinoma in situ of breast,ENTR1,Endosome-associated-trafficking regulator 1,19106,119,1.04 [0.77-1.41],0.7960143323369833
Chapter II Neoplasms,Carcinoma in situ of breast,EP300,Histone acetyltransferase p300,19054,117,1.24 [0.73-2.10],0.4230718155736465
Chapter II Neoplasms,Carcinoma in situ of breast,EPB41L5,Band 4.1-like protein 5,19054,119,1.01 [0.77-1.32],0.9551410448673244
Chapter II Neoplasms,Carcinoma in situ of breast,EPCAM,Epithelial cell adhesion molecule,22514,140,0.89 [0.77-1.04],0.1451735626549988
Chapter II Neoplasms,Carcinoma in situ of breast,EPGN,Epigen,19495,120,1.04 [0.74-1.46],0.8371141169577977
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA1,Ephrin type-A receptor 1,22585,141,1.00 [0.65-1.55],0.9876603661207444
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA10,Ephrin type-A receptor 10,21957,134,1.09 [0.87-1.35],0.452443150485896
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA2,Ephrin type-A receptor 2,21713,137,0.85 [0.50-1.46],0.5606877699704805
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA4,Ephrin type-A receptor 4,19191,120,0.79 [0.42-1.48],0.4585659053069224
Chapter II Neoplasms,Carcinoma in situ of breast,EPHB4,Ephrin type-B receptor 4,22786,138,1.04 [0.55-1.96],0.9009187044918344
Chapter II Neoplasms,Carcinoma in situ of breast,EPHB6,Ephrin type-B receptor 6,22320,139,1.09 [0.67-1.79],0.7230842186255153
Chapter II Neoplasms,Carcinoma in situ of breast,EPHX2,Bifunctional epoxide hydrolase 2,22115,137,0.89 [0.69-1.16],0.3964693441965079
Chapter II Neoplasms,Carcinoma in situ of breast,EPN1,Epsin-1,19223,122,0.96 [0.64-1.45],0.8530857276506258
Chapter II Neoplasms,Carcinoma in situ of breast,EPO,Erythropoietin,22477,136,0.94 [0.77-1.15],0.5796181055736345
Chapter II Neoplasms,Carcinoma in situ of breast,EPPK1,Epiplakin,19106,119,0.92 [0.72-1.17],0.4815993036043705
Chapter II Neoplasms,Carcinoma in situ of breast,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22682,137,0.94 [0.56-1.57],0.820902935959652
Chapter II Neoplasms,Carcinoma in situ of breast,ERBB2,Receptor tyrosine-protein kinase erbB-2,22586,140,1.05 [0.57-1.95],0.8724174146489485
Chapter II Neoplasms,Carcinoma in situ of breast,ERBB3,Receptor tyrosine-protein kinase erbB-3,22450,138,1.06 [0.48-2.35],0.8811975539215579
Chapter II Neoplasms,Carcinoma in situ of breast,ERBB4,Receptor tyrosine-protein kinase erbB-4,22586,140,1.73 [0.93-3.23],0.0835671160682364
Chapter II Neoplasms,Carcinoma in situ of breast,ERBIN,Erbin,22413,140,0.80 [0.70-0.93],0.0031205816771078
Chapter II Neoplasms,Carcinoma in situ of breast,ERC2,ERC protein 2,19054,119,0.72 [0.53-0.97],0.0326568993199645
Chapter II Neoplasms,Carcinoma in situ of breast,ERCC1,DNA excision repair protein ERCC-1,18908,119,0.59 [0.32-1.08],0.0880402190249364
Chapter II Neoplasms,Carcinoma in situ of breast,EREG,Proepiregulin,22320,139,0.86 [0.71-1.05],0.1461368670537361
Chapter II Neoplasms,Carcinoma in situ of breast,ERI1,3'-5' exoribonuclease 1,19223,122,1.00 [0.60-1.68],0.9918558440920736
Chapter II Neoplasms,Carcinoma in situ of breast,ERMAP,Erythroid membrane-associated protein,19054,117,0.50 [0.33-0.75],0.0008131337982942
Chapter II Neoplasms,Carcinoma in situ of breast,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19495,120,0.74 [0.46-1.18],0.2039808160914151
Chapter II Neoplasms,Carcinoma in situ of breast,ERP29,Endoplasmic reticulum resident protein 29,19191,120,0.86 [0.74-1.00],0.0542920770391022
Chapter II Neoplasms,Carcinoma in situ of breast,ERP44,Endoplasmic reticulum resident protein 44,22373,139,0.66 [0.37-1.19],0.1657413566695004
Chapter II Neoplasms,Carcinoma in situ of breast,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19003,118,0.91 [0.61-1.35],0.6296602009168051
Chapter II Neoplasms,Carcinoma in situ of breast,ESAM,Endothelial cell-selective adhesion molecule,22786,138,0.67 [0.41-1.11],0.118373492416904
Chapter II Neoplasms,Carcinoma in situ of breast,ESM1,Endothelial cell-specific molecule 1,22510,140,0.84 [0.54-1.31],0.4483353703095706
Chapter II Neoplasms,Carcinoma in situ of breast,ESPL1,Separin,18908,119,0.80 [0.55-1.15],0.2239618603439479
Chapter II Neoplasms,Carcinoma in situ of breast,ESR1,Estrogen receptor,19054,117,0.92 [0.67-1.27],0.6290095208967263
Chapter II Neoplasms,Carcinoma in situ of breast,ESYT2,Extended synaptotagmin-2,19562,122,0.80 [0.64-1.00],0.0496318243669577
Chapter II Neoplasms,Carcinoma in situ of breast,EVI2B,Protein EVI2B,18908,119,0.93 [0.59-1.47],0.760075384542893
Chapter II Neoplasms,Carcinoma in situ of breast,EVI5,Ecotropic viral integration site 5 protein homolog,19054,117,0.84 [0.68-1.02],0.080450120155203
Chapter II Neoplasms,Carcinoma in situ of breast,EVPL,Envoplakin,19223,122,0.75 [0.42-1.32],0.313164863534577
Chapter II Neoplasms,Carcinoma in situ of breast,EXOSC10,Exosome component 10,19003,118,0.87 [0.63-1.21],0.4114843214411936
Chapter II Neoplasms,Carcinoma in situ of breast,EXTL1,Exostosin-like 1,19003,118,0.96 [0.66-1.40],0.8300153652185613
Chapter II Neoplasms,Carcinoma in situ of breast,EZR,Ezrin,22715,138,0.64 [0.34-1.23],0.1837547359669847
Chapter II Neoplasms,Carcinoma in situ of breast,F10,Coagulation factor X,19605,119,1.04 [0.53-2.02],0.9189409132067046
Chapter II Neoplasms,Carcinoma in situ of breast,F11,Coagulation factor XI,19344,117,1.24 [0.77-1.99],0.3729552625448539
Chapter II Neoplasms,Carcinoma in situ of breast,F11R,Junctional adhesion molecule A,22524,138,0.79 [0.60-1.04],0.0953187052185847
Chapter II Neoplasms,Carcinoma in situ of breast,F12,Coagulation factor XII,19630,119,1.10 [0.73-1.67],0.6524752336767441
Chapter II Neoplasms,Carcinoma in situ of breast,F13B,Coagulation factor XIII B chain,19514,118,2.14 [1.07-4.27],0.0315936511745331
Chapter II Neoplasms,Carcinoma in situ of breast,F2,Prothrombin,19630,119,1.27 [0.39-4.10],0.6885001269996553
Chapter II Neoplasms,Carcinoma in situ of breast,F2R,Proteinase-activated receptor 1,22580,141,0.82 [0.64-1.07],0.1456902266459943
Chapter II Neoplasms,Carcinoma in situ of breast,F3,Tissue factor,22581,136,1.04 [0.61-1.79],0.8818954117486663
Chapter II Neoplasms,Carcinoma in situ of breast,F7,Coagulation factor VII,22550,139,1.22 [0.74-2.03],0.4363997690851998
Chapter II Neoplasms,Carcinoma in situ of breast,F9,Coagulation factor IX,22542,139,2.05 [0.91-4.64],0.0838644378040417
Chapter II Neoplasms,Carcinoma in situ of breast,FABP1,"Fatty acid-binding protein, liver",22510,140,0.97 [0.82-1.14],0.7068550286573068
Chapter II Neoplasms,Carcinoma in situ of breast,FABP2,"Fatty acid-binding protein, intestinal",22518,139,0.99 [0.81-1.20],0.8809801893958076
Chapter II Neoplasms,Carcinoma in situ of breast,FABP3,"Fatty acid-binding protein, heart",19600,119,0.75 [0.51-1.10],0.140607806610046
Chapter II Neoplasms,Carcinoma in situ of breast,FABP4,"Fatty acid-binding protein, adipocyte",22786,138,0.90 [0.66-1.23],0.5005124362916482
Chapter II Neoplasms,Carcinoma in situ of breast,FABP5,Fatty acid-binding protein 5,22648,138,0.80 [0.64-1.01],0.056044284031931
Chapter II Neoplasms,Carcinoma in situ of breast,FABP6,Gastrotropin,22082,137,1.17 [0.90-1.53],0.2363463945342016
Chapter II Neoplasms,Carcinoma in situ of breast,FABP9,Fatty acid-binding protein 9,22477,136,0.86 [0.66-1.14],0.2946815753417318
Chapter II Neoplasms,Carcinoma in situ of breast,FADD,FAS-associated death domain protein,22518,139,0.81 [0.66-0.99],0.0362175484016097
Chapter II Neoplasms,Carcinoma in situ of breast,FAM13A,Protein FAM13A,19501,122,0.66 [0.50-0.87],0.0032888771679911
Chapter II Neoplasms,Carcinoma in situ of breast,FAM171A2,Protein FAM171A2,19571,121,1.02 [0.92-1.13],0.7034588533860985
Chapter II Neoplasms,Carcinoma in situ of breast,FAM171B,Protein FAM171B,19495,120,1.27 [0.73-2.20],0.4012843624893958
Chapter II Neoplasms,Carcinoma in situ of breast,FAM172A,Cotranscriptional regulator FAM172A,19106,119,0.94 [0.71-1.25],0.6847676943434242
Chapter II Neoplasms,Carcinoma in situ of breast,FAM20A,Pseudokinase FAM20A,19600,119,1.04 [0.56-1.92],0.9072390409239482
Chapter II Neoplasms,Carcinoma in situ of breast,FAM3B,Protein FAM3B,22413,140,0.66 [0.44-0.97],0.0336469839475132
Chapter II Neoplasms,Carcinoma in situ of breast,FAM3C,Protein FAM3C,22484,139,0.80 [0.47-1.34],0.39454545701226
Chapter II Neoplasms,Carcinoma in situ of breast,FAM3D,Protein FAM3D,19501,122,1.06 [0.86-1.30],0.597638711577718
Chapter II Neoplasms,Carcinoma in situ of breast,FAP,Prolyl endopeptidase FAP,22786,138,1.52 [0.87-2.65],0.142995876136946
Chapter II Neoplasms,Carcinoma in situ of breast,FARSA,Phenylalanine--tRNA ligase alpha subunit,19054,119,0.88 [0.67-1.16],0.361218900789739
Chapter II Neoplasms,Carcinoma in situ of breast,FAS,Tumor necrosis factor receptor superfamily member 6,22718,136,1.24 [0.84-1.83],0.2865991149922425
Chapter II Neoplasms,Carcinoma in situ of breast,FASLG,Tumor necrosis factor ligand superfamily member 6,22764,139,0.88 [0.59-1.33],0.5536015135549479
Chapter II Neoplasms,Carcinoma in situ of breast,FBLN2,Fibulin-2,19597,123,1.22 [0.70-2.12],0.4848126464779545
Chapter II Neoplasms,Carcinoma in situ of breast,FBN2,Fibrillin-2,19054,119,0.84 [0.63-1.13],0.2480772269365397
Chapter II Neoplasms,Carcinoma in situ of breast,FBP1,"Fructose-1,6-bisphosphatase 1",22518,139,0.95 [0.78-1.17],0.6528861893461414
Chapter II Neoplasms,Carcinoma in situ of breast,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19600,119,0.83 [0.65-1.07],0.1464013384758337
Chapter II Neoplasms,Carcinoma in situ of breast,FCAR,Immunoglobulin alpha Fc receptor,22477,136,1.18 [0.86-1.63],0.3019870651268522
Chapter II Neoplasms,Carcinoma in situ of breast,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19571,121,0.62 [0.30-1.25],0.1800581493903435
Chapter II Neoplasms,Carcinoma in situ of breast,FCER2,Low affinity immunoglobulin epsilon Fc receptor,22524,138,1.02 [0.74-1.41],0.9038155969120216
Chapter II Neoplasms,Carcinoma in situ of breast,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22403,137,1.05 [0.81-1.36],0.7092108648034514
Chapter II Neoplasms,Carcinoma in situ of breast,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22008,134,0.94 [0.72-1.22],0.6221839059806646
Chapter II Neoplasms,Carcinoma in situ of breast,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22511,139,1.36 [1.00-1.86],0.0533636609782627
Chapter II Neoplasms,Carcinoma in situ of breast,FCN1,Ficolin-1,19564,119,0.88 [0.66-1.17],0.3823701414384762
Chapter II Neoplasms,Carcinoma in situ of breast,FCN2,Ficolin-2,22390,138,1.44 [0.97-2.14],0.0676439746582828
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL1,Fc receptor-like protein 1,22518,139,1.02 [0.72-1.44],0.9074948193420764
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL2,Fc receptor-like protein 2,22656,138,0.92 [0.67-1.28],0.6228809649546256
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL3,Fc receptor-like protein 3,22090,138,1.00 [0.76-1.33],0.9851809834093646
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL5,Fc receptor-like protein 5,22524,138,1.02 [0.78-1.33],0.904996006123479
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL6,Fc receptor-like protein 6,22477,136,0.89 [0.71-1.11],0.3065678139211174
Chapter II Neoplasms,Carcinoma in situ of breast,FCRLB,Fc receptor-like B,22008,134,0.84 [0.63-1.11],0.2229817050375795
Chapter II Neoplasms,Carcinoma in situ of breast,FDX1,"Adrenodoxin, mitochondrial",19003,118,1.00 [0.75-1.32],0.9841150648513202
Chapter II Neoplasms,Carcinoma in situ of breast,FDX2,"Ferredoxin-2, mitochondrial",19003,118,0.61 [0.42-0.88],0.0084508498690071
Chapter II Neoplasms,Carcinoma in situ of breast,FEN1,Flap endonuclease 1,22008,134,0.98 [0.77-1.25],0.8758683277220257
Chapter II Neoplasms,Carcinoma in situ of breast,FES,Tyrosine-protein kinase Fes/Fps,22008,134,0.66 [0.46-0.95],0.0264850771327354
Chapter II Neoplasms,Carcinoma in situ of breast,FETUB,Fetuin-B,22542,139,0.72 [0.49-1.04],0.0777672716075322
Chapter II Neoplasms,Carcinoma in situ of breast,FGA,Fibrinogen alpha chain,19164,116,1.66 [0.94-2.91],0.0779913723363094
Chapter II Neoplasms,Carcinoma in situ of breast,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19571,121,0.81 [0.65-1.02],0.0711289719668002
Chapter II Neoplasms,Carcinoma in situ of breast,FGF12,Fibroblast growth factor 12,19054,117,1.02 [0.70-1.47],0.9309245100306434
Chapter II Neoplasms,Carcinoma in situ of breast,FGF16,Fibroblast growth factor 16,19054,117,1.03 [0.72-1.47],0.8685096956165395
Chapter II Neoplasms,Carcinoma in situ of breast,FGF19,Fibroblast growth factor 19,22619,141,1.07 [0.88-1.30],0.4809796854843197
Chapter II Neoplasms,Carcinoma in situ of breast,FGF2,Fibroblast growth factor 2,22477,136,0.80 [0.63-1.02],0.0740710732116702
Chapter II Neoplasms,Carcinoma in situ of breast,FGF20,Fibroblast growth factor 20,19054,117,0.75 [0.47-1.21],0.241568662920579
Chapter II Neoplasms,Carcinoma in situ of breast,FGF21,Fibroblast growth factor 21,22677,137,0.91 [0.80-1.04],0.1771322366952023
Chapter II Neoplasms,Carcinoma in situ of breast,FGF23,Fibroblast growth factor 23,22684,137,0.76 [0.57-1.02],0.0677048643111867
Chapter II Neoplasms,Carcinoma in situ of breast,FGF3,Fibroblast growth factor 3,19054,117,1.38 [0.90-2.12],0.1430682049222733
Chapter II Neoplasms,Carcinoma in situ of breast,FGF5,Fibroblast growth factor 5,22090,138,0.88 [0.55-1.41],0.6018931636590881
Chapter II Neoplasms,Carcinoma in situ of breast,FGF6,Fibroblast growth factor 6,19054,117,1.20 [0.85-1.68],0.294524496243436
Chapter II Neoplasms,Carcinoma in situ of breast,FGF7,Fibroblast growth factor 7,18908,119,0.78 [0.59-1.03],0.0748226867433381
Chapter II Neoplasms,Carcinoma in situ of breast,FGF9,Fibroblast growth factor 9,18870,119,1.00 [0.65-1.54],0.9959925529804174
Chapter II Neoplasms,Carcinoma in situ of breast,FGFBP1,Fibroblast growth factor-binding protein 1,22586,140,1.09 [0.68-1.75],0.7256233417031066
Chapter II Neoplasms,Carcinoma in situ of breast,FGFBP2,Fibroblast growth factor-binding protein 2,19597,123,1.38 [0.99-1.92],0.0585114420833127
Chapter II Neoplasms,Carcinoma in situ of breast,FGFBP3,Fibroblast growth factor-binding protein 3,19562,122,0.65 [0.40-1.04],0.0751634223248827
Chapter II Neoplasms,Carcinoma in situ of breast,FGFR2,Fibroblast growth factor receptor 2,22586,140,1.85 [0.94-3.67],0.0759965582929141
Chapter II Neoplasms,Carcinoma in situ of breast,FGFR4,Fibroblast growth factor receptor 4,19191,120,1.17 [0.85-1.62],0.3333406139094063
Chapter II Neoplasms,Carcinoma in situ of breast,FGL1,Fibrinogen-like protein 1,19605,119,0.83 [0.64-1.09],0.1804419224382228
Chapter II Neoplasms,Carcinoma in situ of breast,FGR,Tyrosine-protein kinase Fgr,21957,134,1.16 [0.92-1.46],0.1971315459576522
Chapter II Neoplasms,Carcinoma in situ of breast,FH,"Fumarate hydratase, mitochondrial",18997,118,0.99 [0.81-1.22],0.9522914920833816
Chapter II Neoplasms,Carcinoma in situ of breast,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19003,118,1.28 [0.97-1.69],0.0804649506668469
Chapter II Neoplasms,Carcinoma in situ of breast,FHIT,Bis(5'-adenosyl)-triphosphatase,21957,134,0.82 [0.67-1.00],0.053311623261894
Chapter II Neoplasms,Carcinoma in situ of breast,FIS1,Mitochondrial fission 1 protein,22517,139,0.88 [0.72-1.07],0.2020980919558494
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19571,121,0.84 [0.71-1.00],0.0543493217080536
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22583,138,0.87 [0.76-1.00],0.0490835106259943
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22368,139,0.65 [0.46-0.90],0.0098340490252522
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22368,139,0.87 [0.74-1.02],0.0790082978414546
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,21909,134,0.99 [0.71-1.38],0.9564257963980431
Chapter II Neoplasms,Carcinoma in situ of breast,FKBPL,FK506-binding protein-like,19501,122,0.85 [0.63-1.15],0.2899474298673417
Chapter II Neoplasms,Carcinoma in situ of breast,FLI1,Friend leukemia integration 1 transcription factor,22008,134,0.85 [0.74-0.99],0.0335556606776528
Chapter II Neoplasms,Carcinoma in situ of breast,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22368,139,1.11 [0.65-1.90],0.7013283399134086
Chapter II Neoplasms,Carcinoma in situ of breast,FLT1,Vascular endothelial growth factor receptor 1,22373,140,0.60 [0.28-1.25],0.1724167835960642
Chapter II Neoplasms,Carcinoma in situ of breast,FLT3,Receptor-type tyrosine-protein kinase FLT3,22008,134,1.05 [0.64-1.73],0.8388927740287934
Chapter II Neoplasms,Carcinoma in situ of breast,FLT3LG,Fms-related tyrosine kinase 3 ligand,22764,139,0.92 [0.58-1.47],0.7312426633648825
Chapter II Neoplasms,Carcinoma in situ of breast,FLT4,Vascular endothelial growth factor receptor 3,22586,140,1.35 [0.86-2.13],0.1923388168987642
Chapter II Neoplasms,Carcinoma in situ of breast,FMNL1,Formin-like protein 1,21957,134,1.15 [0.94-1.41],0.1682128689808097
Chapter II Neoplasms,Carcinoma in situ of breast,FMR1,Synaptic functional regulator FMR1,22008,134,0.83 [0.53-1.29],0.3973860245521609
Chapter II Neoplasms,Carcinoma in situ of breast,FN1,Fibronectin,19630,119,1.87 [0.99-3.56],0.0546464323043824
Chapter II Neoplasms,Carcinoma in situ of breast,FNDC1,Fibronectin type III domain-containing protein 1,19562,122,0.76 [0.52-1.10],0.1467595169331625
Chapter II Neoplasms,Carcinoma in situ of breast,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19495,120,0.70 [0.41-1.20],0.1937055886629745
Chapter II Neoplasms,Carcinoma in situ of breast,FOLH1,Glutamate carboxypeptidase 2,19054,117,0.99 [0.84-1.17],0.9001135757119036
Chapter II Neoplasms,Carcinoma in situ of breast,FOLR1,Folate receptor alpha,22479,139,1.29 [0.75-2.22],0.353521743875093
Chapter II Neoplasms,Carcinoma in situ of breast,FOLR2,Folate receptor beta,22715,138,0.89 [0.53-1.49],0.6505031169726374
Chapter II Neoplasms,Carcinoma in situ of breast,FOLR3,Folate receptor gamma,22513,139,0.96 [0.88-1.04],0.3130579002992258
Chapter II Neoplasms,Carcinoma in situ of breast,FOS,Proto-oncogene c-Fos,18870,119,0.81 [0.49-1.33],0.3994919593187113
Chapter II Neoplasms,Carcinoma in situ of breast,FOSB,Protein fosB,21957,134,1.08 [0.75-1.55],0.6824257908169438
Chapter II Neoplasms,Carcinoma in situ of breast,FOXJ3,Forkhead box protein J3,19054,117,0.75 [0.48-1.17],0.2020558258596146
Chapter II Neoplasms,Carcinoma in situ of breast,FOXO1,Forkhead box protein O1,22477,136,0.85 [0.70-1.01],0.0707341125796564
Chapter II Neoplasms,Carcinoma in situ of breast,FOXO3,Forkhead box protein O3,22008,134,0.79 [0.66-0.94],0.0078370613972524
Chapter II Neoplasms,Carcinoma in situ of breast,FRMD4B,FERM domain-containing protein 4B,19003,118,0.64 [0.48-0.85],0.0019080956207749
Chapter II Neoplasms,Carcinoma in situ of breast,FRMD7,FERM domain-containing protein 7,19054,119,0.73 [0.43-1.24],0.2450098311973179
Chapter II Neoplasms,Carcinoma in situ of breast,FRZB,Secreted frizzled-related protein 3,22294,139,1.33 [0.75-2.37],0.3290687714587808
Chapter II Neoplasms,Carcinoma in situ of breast,FSHB,Follitropin subunit beta,19106,119,1.19 [0.92-1.52],0.1869725893397176
Chapter II Neoplasms,Carcinoma in situ of breast,FST,Follistatin,22580,141,1.01 [0.76-1.34],0.9638430719859712
Chapter II Neoplasms,Carcinoma in situ of breast,FSTL1,Follistatin-related protein 1,19106,119,0.81 [0.37-1.79],0.6096521772856798
Chapter II Neoplasms,Carcinoma in situ of breast,FSTL3,Follistatin-related protein 3,22477,140,1.07 [0.65-1.76],0.7866181764583734
Chapter II Neoplasms,Carcinoma in situ of breast,FTCD,Formimidoyltransferase-cyclodeaminase,19534,122,0.93 [0.75-1.14],0.47819444757225
Chapter II Neoplasms,Carcinoma in situ of breast,FUCA1,Tissue alpha-L-fucosidase,22659,137,1.11 [0.91-1.35],0.2976520915781527
Chapter II Neoplasms,Carcinoma in situ of breast,FUOM,Fucose mutarotase,19191,120,0.95 [0.72-1.25],0.7123287959440592
Chapter II Neoplasms,Carcinoma in situ of breast,FURIN,Furin,22586,140,0.83 [0.53-1.29],0.4019260780620831
Chapter II Neoplasms,Carcinoma in situ of breast,FUS,RNA-binding protein FUS,21977,134,0.72 [0.48-1.09],0.1244256242720099
Chapter II Neoplasms,Carcinoma in situ of breast,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19180,122,1.03 [0.80-1.34],0.8136780620430774
Chapter II Neoplasms,Carcinoma in situ of breast,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22715,138,1.02 [0.73-1.43],0.8883389463809597
Chapter II Neoplasms,Carcinoma in situ of breast,FUT8,"Alpha-(1,6)-fucosyltransferase",22368,139,0.91 [0.70-1.17],0.4596416425763371
Chapter II Neoplasms,Carcinoma in situ of breast,FXN,"Frataxin, mitochondrial",22716,137,0.85 [0.69-1.04],0.1154702497017286
Chapter II Neoplasms,Carcinoma in situ of breast,FXYD5,FXYD domain-containing ion transport regulator 5,22090,138,0.94 [0.74-1.19],0.6148476308956394
Chapter II Neoplasms,Carcinoma in situ of breast,FYB1,FYN-binding protein 1,22489,137,0.83 [0.70-0.98],0.0257725768642356
Chapter II Neoplasms,Carcinoma in situ of breast,FZD10,Frizzled-10,19054,119,0.89 [0.64-1.24],0.4984763845042207
Chapter II Neoplasms,Carcinoma in situ of breast,FZD8,Frizzled-8,18997,118,1.05 [0.71-1.56],0.7927747498000441
Chapter II Neoplasms,Carcinoma in situ of breast,GABARAP,Gamma-aminobutyric acid receptor-associated protein,19495,120,0.72 [0.48-1.07],0.0997971807926873
Chapter II Neoplasms,Carcinoma in situ of breast,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19223,122,1.13 [0.90-1.43],0.2864307263328227
Chapter II Neoplasms,Carcinoma in situ of breast,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,18997,118,0.85 [0.62-1.16],0.304187615936759
Chapter II Neoplasms,Carcinoma in situ of breast,GAD1,Glutamate decarboxylase 1,18908,119,0.53 [0.27-1.05],0.0674727078202187
Chapter II Neoplasms,Carcinoma in situ of breast,GAD2,Glutamate decarboxylase 2,19054,117,0.95 [0.64-1.41],0.8061665260261816
Chapter II Neoplasms,Carcinoma in situ of breast,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19223,122,0.94 [0.65-1.36],0.7322172131646556
Chapter II Neoplasms,Carcinoma in situ of breast,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19106,119,0.88 [0.62-1.24],0.4667305120349653
Chapter II Neoplasms,Carcinoma in situ of breast,GAGE2A,G antigen 2A,18908,119,0.93 [0.69-1.25],0.6103087316575442
Chapter II Neoplasms,Carcinoma in situ of breast,GAL,Galanin peptides,22619,141,1.42 [1.13-1.79],0.0030533166979158
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22413,140,0.80 [0.47-1.37],0.4134690931892925
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22716,137,0.79 [0.44-1.42],0.4237870219169645
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22090,138,0.86 [0.60-1.24],0.4193123068379955
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19600,119,0.99 [0.52-1.88],0.9709115976509084
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT7,N-acetylgalactosaminyltransferase 7,22413,140,0.75 [0.37-1.52],0.4270697811028516
Chapter II Neoplasms,Carcinoma in situ of breast,GAMT,Guanidinoacetate N-methyltransferase,19003,118,0.76 [0.44-1.31],0.3166733858020465
Chapter II Neoplasms,Carcinoma in situ of breast,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18770,119,0.89 [0.54-1.48],0.6573048721706369
Chapter II Neoplasms,Carcinoma in situ of breast,GART,Trifunctional purine biosynthetic protein adenosine-3,19571,121,0.77 [0.38-1.57],0.477126996493508
Chapter II Neoplasms,Carcinoma in situ of breast,GAS2,Growth arrest-specific protein 2,19223,122,0.99 [0.72-1.38],0.971313831962107
Chapter II Neoplasms,Carcinoma in situ of breast,GAS6,Growth arrest-specific protein 6,22639,136,1.03 [0.57-1.86],0.927314972721567
Chapter II Neoplasms,Carcinoma in situ of breast,GASK1A,Golgi-associated kinase 1A,19003,118,1.06 [0.70-1.60],0.774873527223592
Chapter II Neoplasms,Carcinoma in situ of breast,GAST,Gastrin,19562,122,1.01 [0.88-1.15],0.9079990587495108
Chapter II Neoplasms,Carcinoma in situ of breast,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,18908,119,0.75 [0.39-1.47],0.4085153068326551
Chapter II Neoplasms,Carcinoma in situ of breast,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19106,119,0.97 [0.77-1.22],0.7802209137433107
Chapter II Neoplasms,Carcinoma in situ of breast,GBA,Lysosomal acid glucosylceramidase,19054,119,1.22 [0.91-1.65],0.1881440310578984
Chapter II Neoplasms,Carcinoma in situ of breast,GBP1,Guanylate-binding protein 1,19525,122,1.18 [0.92-1.53],0.1965010804445652
Chapter II Neoplasms,Carcinoma in situ of breast,GBP2,Guanylate-binding protein 2,22090,138,0.86 [0.66-1.11],0.2382950938682166
Chapter II Neoplasms,Carcinoma in situ of breast,GBP4,Guanylate-binding protein 4,21957,134,0.90 [0.65-1.24],0.5050442600704652
Chapter II Neoplasms,Carcinoma in situ of breast,GBP6,Guanylate-binding protein 6,19003,118,1.10 [0.78-1.57],0.5796426558831909
Chapter II Neoplasms,Carcinoma in situ of breast,GC,Vitamin D-binding protein,19630,119,1.41 [0.73-2.70],0.3077167620626008
Chapter II Neoplasms,Carcinoma in situ of breast,GCC1,GRIP and coiled-coil domain-containing protein 1,19562,122,0.87 [0.74-1.02],0.0886710665273355
Chapter II Neoplasms,Carcinoma in situ of breast,GCG,Pro-glucagon,22008,134,0.97 [0.86-1.10],0.68324716758703
Chapter II Neoplasms,Carcinoma in situ of breast,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18724,120,0.96 [0.67-1.38],0.8417695098989482
Chapter II Neoplasms,Carcinoma in situ of breast,GCLM,Glutamate--cysteine ligase regulatory subunit,19003,118,0.76 [0.50-1.18],0.2233172629019054
Chapter II Neoplasms,Carcinoma in situ of breast,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22413,140,0.99 [0.64-1.52],0.9545151052808006
Chapter II Neoplasms,Carcinoma in situ of breast,GDF15,Growth/differentiation factor 15,22786,138,1.02 [0.71-1.48],0.9041273093753855
Chapter II Neoplasms,Carcinoma in situ of breast,GDF2,Growth/differentiation factor 2,22518,139,1.27 [0.83-1.92],0.2663130892550127
Chapter II Neoplasms,Carcinoma in situ of breast,GDNF,Glial cell line-derived neurotrophic factor,21957,134,0.93 [0.62-1.40],0.7363284183065382
Chapter II Neoplasms,Carcinoma in situ of breast,GET3,ATPase GET3,19600,119,0.79 [0.56-1.12],0.1832049609688933
Chapter II Neoplasms,Carcinoma in situ of breast,GFAP,Glial fibrillary acidic protein,21972,134,1.00 [0.72-1.41],0.9843316794675188
Chapter II Neoplasms,Carcinoma in situ of breast,GFER,FAD-linked sulfhydryl oxidase ALR,22008,134,0.76 [0.59-0.98],0.0322503230174413
Chapter II Neoplasms,Carcinoma in situ of breast,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22008,134,1.04 [0.93-1.16],0.4673786556805617
Chapter II Neoplasms,Carcinoma in situ of breast,GFRA1,GDNF family receptor alpha-1,22677,137,0.94 [0.54-1.65],0.834531290333003
Chapter II Neoplasms,Carcinoma in situ of breast,GFRA2,GDNF family receptor alpha-2,22413,140,0.75 [0.37-1.49],0.4071930732682915
Chapter II Neoplasms,Carcinoma in situ of breast,GFRA3,GDNF family receptor alpha-3,22301,136,1.41 [0.84-2.38],0.1972454358527515
Chapter II Neoplasms,Carcinoma in situ of breast,GFRAL,GDNF family receptor alpha-like,18974,120,1.09 [0.82-1.44],0.5683006573916953
Chapter II Neoplasms,Carcinoma in situ of breast,GGA1,ADP-ribosylation factor-binding protein GGA1,21957,134,1.19 [0.99-1.44],0.0585391634943436
Chapter II Neoplasms,Carcinoma in situ of breast,GGACT,Gamma-glutamylaminecyclotransferase,19600,119,0.80 [0.62-1.03],0.0823511582270077
Chapter II Neoplasms,Carcinoma in situ of breast,GGCT,Gamma-glutamylcyclotransferase,19557,119,0.77 [0.53-1.12],0.166247928629921
Chapter II Neoplasms,Carcinoma in situ of breast,GGH,Gamma-glutamyl hydrolase,22116,133,1.27 [0.82-1.96],0.2803339116676921
Chapter II Neoplasms,Carcinoma in situ of breast,GGT1,Glutathione hydrolase 1 proenzyme,22490,138,0.81 [0.58-1.13],0.2064275252550917
Chapter II Neoplasms,Carcinoma in situ of breast,GGT5,Glutathione hydrolase 5 proenzyme,22368,139,1.14 [0.59-2.21],0.6866202898528911
Chapter II Neoplasms,Carcinoma in situ of breast,GH1,Somatotropin,22484,139,1.03 [0.95-1.12],0.4521588970498709
Chapter II Neoplasms,Carcinoma in situ of breast,GH2,Growth hormone variant,22008,134,0.97 [0.88-1.06],0.5061351444418214
Chapter II Neoplasms,Carcinoma in situ of breast,GHR,Growth hormone receptor,19191,120,1.36 [0.74-2.49],0.327146310808394
Chapter II Neoplasms,Carcinoma in situ of breast,GHRHR,Growth hormone-releasing hormone receptor,21957,134,0.98 [0.74-1.29],0.8725239908928757
Chapter II Neoplasms,Carcinoma in situ of breast,GHRL,Appetite-regulating hormone,22518,139,1.11 [0.91-1.34],0.293504879444764
Chapter II Neoplasms,Carcinoma in situ of breast,GID8,Glucose-induced degradation protein 8 homolog,19571,121,1.23 [0.80-1.91],0.3487099524358104
Chapter II Neoplasms,Carcinoma in situ of breast,GIGYF2,GRB10-interacting GYF protein 2,19571,121,0.82 [0.65-1.03],0.0877459075394001
Chapter II Neoplasms,Carcinoma in situ of breast,GIMAP7,GTPase IMAP family member 7,19191,120,1.31 [0.82-2.09],0.2507539991530069
Chapter II Neoplasms,Carcinoma in situ of breast,GIMAP8,GTPase IMAP family member 8,18908,119,0.91 [0.64-1.30],0.5986169858768063
Chapter II Neoplasms,Carcinoma in situ of breast,GIP,Gastric inhibitory polypeptide,19106,119,1.07 [0.76-1.50],0.7072563648729548
Chapter II Neoplasms,Carcinoma in situ of breast,GIPC2,PDZ domain-containing protein GIPC2,19562,122,0.67 [0.36-1.24],0.2050101273433722
Chapter II Neoplasms,Carcinoma in situ of breast,GIPC3,PDZ domain-containing protein GIPC3,19501,122,0.85 [0.71-1.00],0.0547043618691885
Chapter II Neoplasms,Carcinoma in situ of breast,GIPR,Gastric inhibitory polypeptide receptor,19054,117,0.90 [0.60-1.34],0.6005782721197669
Chapter II Neoplasms,Carcinoma in situ of breast,GIT1,ARF GTPase-activating protein GIT1,19054,117,0.84 [0.69-1.01],0.0640256771621956
Chapter II Neoplasms,Carcinoma in situ of breast,GJA8,Gap junction alpha-8 protein,18908,119,1.00 [0.75-1.32],0.9779811713434828
Chapter II Neoplasms,Carcinoma in situ of breast,GKN1,Gastrokine-1,21533,131,1.76 [1.05-2.96],0.0324846748407251
Chapter II Neoplasms,Carcinoma in situ of breast,GLA,Alpha-galactosidase A,19148,120,0.85 [0.52-1.40],0.5292427507353503
Chapter II Neoplasms,Carcinoma in situ of breast,GLB1,Beta-galactosidase,22368,139,0.77 [0.52-1.12],0.17074800189546
Chapter II Neoplasms,Carcinoma in situ of breast,GLI2,Zinc finger protein GLI2,19054,117,0.85 [0.48-1.50],0.5757930912908418
Chapter II Neoplasms,Carcinoma in situ of breast,GLO1,Lactoylglutathione lyase,22115,137,0.89 [0.69-1.15],0.363011426325692
Chapter II Neoplasms,Carcinoma in situ of breast,GLOD4,Glyoxalase domain-containing protein 4,22478,139,0.67 [0.44-1.01],0.0530424256945051
Chapter II Neoplasms,Carcinoma in situ of breast,GLP1R,Glucagon-like peptide 1 receptor,18997,118,1.02 [0.65-1.60],0.9403863461848748
Chapter II Neoplasms,Carcinoma in situ of breast,GLRX,Glutaredoxin-1,22368,139,0.91 [0.70-1.19],0.4935841538757624
Chapter II Neoplasms,Carcinoma in situ of breast,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19191,120,0.84 [0.69-1.03],0.0902729771678529
Chapter II Neoplasms,Carcinoma in situ of breast,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,21957,134,1.09 [0.82-1.46],0.5501027052864511
Chapter II Neoplasms,Carcinoma in situ of breast,GLYR1,Putative oxidoreductase GLYR1,19495,120,0.98 [0.74-1.32],0.918128978303156
Chapter II Neoplasms,Carcinoma in situ of breast,GM2A,Ganglioside GM2 activator,19124,121,1.06 [0.69-1.64],0.7905391793955238
Chapter II Neoplasms,Carcinoma in situ of breast,GMFG,Glia maturation factor gamma,19600,119,0.80 [0.63-1.02],0.0700214631037283
Chapter II Neoplasms,Carcinoma in situ of breast,GMPR,GMP reductase 1,22764,139,0.73 [0.56-0.97],0.0278877597227336
Chapter II Neoplasms,Carcinoma in situ of breast,GMPR2,GMP reductase 2,19191,120,0.83 [0.64-1.08],0.1606532604335481
Chapter II Neoplasms,Carcinoma in situ of breast,GNAS,Neuroendocrine secretory protein 55,19571,121,0.92 [0.75-1.13],0.4177149056202754
Chapter II Neoplasms,Carcinoma in situ of breast,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22008,134,0.74 [0.57-0.94],0.0161099321195423
Chapter II Neoplasms,Carcinoma in situ of breast,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19054,119,0.81 [0.55-1.21],0.3108815794357484
Chapter II Neoplasms,Carcinoma in situ of breast,GNLY,Granulysin,22524,138,0.85 [0.64-1.14],0.2890716745251641
Chapter II Neoplasms,Carcinoma in situ of breast,GNPDA1,Glucosamine-6-phosphate isomerase 1,19106,119,0.91 [0.52-1.59],0.7474921979113317
Chapter II Neoplasms,Carcinoma in situ of breast,GNPDA2,Glucosamine-6-phosphate isomerase 2,19191,120,0.81 [0.49-1.31],0.3846784113954633
Chapter II Neoplasms,Carcinoma in situ of breast,GOLGA3,Golgin subfamily A member 3,19571,121,0.72 [0.56-0.91],0.007180395742249
Chapter II Neoplasms,Carcinoma in situ of breast,GOLM2,Protein GOLM2,22715,138,0.62 [0.31-1.23],0.169111720876977
Chapter II Neoplasms,Carcinoma in situ of breast,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22477,136,0.88 [0.76-1.02],0.094846324144162
Chapter II Neoplasms,Carcinoma in situ of breast,GORASP2,Golgi reassembly-stacking protein 2,19501,122,0.77 [0.52-1.13],0.1766642954278585
Chapter II Neoplasms,Carcinoma in situ of breast,GOT1,"Aspartate aminotransferase, cytoplasmic",19597,123,0.73 [0.47-1.12],0.1497824581790954
Chapter II Neoplasms,Carcinoma in situ of breast,GP1BA,Platelet glycoprotein Ib alpha chain,22390,137,1.15 [0.72-1.84],0.5638191947888922
Chapter II Neoplasms,Carcinoma in situ of breast,GP1BB,Platelet glycoprotein Ib beta chain,19003,118,0.93 [0.71-1.21],0.5738196430656963
Chapter II Neoplasms,Carcinoma in situ of breast,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21841,135,1.05 [0.88-1.25],0.5797544636093985
Chapter II Neoplasms,Carcinoma in situ of breast,GP5,Platelet glycoprotein V,19191,120,0.68 [0.43-1.08],0.1053984023829281
Chapter II Neoplasms,Carcinoma in situ of breast,GP6,Platelet glycoprotein VI,22489,137,0.85 [0.72-1.01],0.0683348405012136
Chapter II Neoplasms,Carcinoma in situ of breast,GPA33,Cell surface A33 antigen,22413,140,0.93 [0.84-1.04],0.2086356847671815
Chapter II Neoplasms,Carcinoma in situ of breast,GPC1,Glypican-1,22716,137,1.08 [0.64-1.81],0.779648887756741
Chapter II Neoplasms,Carcinoma in situ of breast,GPC5,Glypican-5,22368,139,0.81 [0.62-1.06],0.128367362839039
Chapter II Neoplasms,Carcinoma in situ of breast,GPD1,Glycerol-3-phosphate dehydrogenase,19495,120,0.80 [0.56-1.15],0.2335357601551276
Chapter II Neoplasms,Carcinoma in situ of breast,GPHA2,Glycoprotein hormone alpha-2,19501,122,1.12 [0.82-1.54],0.4751754923576036
Chapter II Neoplasms,Carcinoma in situ of breast,GPI,Glucose-6-phosphate isomerase,19605,119,0.83 [0.57-1.22],0.3520055514017285
Chapter II Neoplasms,Carcinoma in situ of breast,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19501,122,1.04 [0.81-1.33],0.7677881041386142
Chapter II Neoplasms,Carcinoma in situ of breast,GPKOW,G-patch domain and KOW motifs-containing protein,21957,134,1.07 [0.64-1.81],0.7974774765617094
Chapter II Neoplasms,Carcinoma in situ of breast,GPNMB,Transmembrane glycoprotein NMB,21904,135,1.40 [0.81-2.42],0.2274448132701799
Chapter II Neoplasms,Carcinoma in situ of breast,GPR101,Probable G-protein coupled receptor 101,18997,118,1.13 [0.88-1.44],0.3429351762914102
Chapter II Neoplasms,Carcinoma in situ of breast,GPR158,Probable G-protein coupled receptor 158,19571,121,1.02 [0.64-1.63],0.9365325943065076
Chapter II Neoplasms,Carcinoma in situ of breast,GPR15L,Protein GPR15L,19501,122,0.96 [0.72-1.27],0.765634828608943
Chapter II Neoplasms,Carcinoma in situ of breast,GPR37,Prosaposin receptor GPR37,22115,137,0.92 [0.73-1.15],0.4557752231166808
Chapter II Neoplasms,Carcinoma in situ of breast,GPRC5C,G-protein coupled receptor family C group 5 member C,19495,120,0.86 [0.62-1.21],0.4020163632596893
Chapter II Neoplasms,Carcinoma in situ of breast,GRAP2,GRB2-related adapter protein 2,22518,139,0.88 [0.78-0.98],0.0261393901010558
Chapter II Neoplasms,Carcinoma in situ of breast,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19600,119,0.78 [0.60-1.03],0.0780497908926267
Chapter II Neoplasms,Carcinoma in situ of breast,GRIK2,"Glutamate receptor ionotropic, kainate 2",19571,121,0.64 [0.39-1.05],0.07612536683499
Chapter II Neoplasms,Carcinoma in situ of breast,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",18997,118,0.98 [0.72-1.34],0.9038775982745434
Chapter II Neoplasms,Carcinoma in situ of breast,GRK5,G protein-coupled receptor kinase 5,22115,137,0.77 [0.55-1.09],0.1438441460078265
Chapter II Neoplasms,Carcinoma in situ of breast,GRN,Progranulin,22427,138,1.28 [0.69-2.38],0.4421046322133199
Chapter II Neoplasms,Carcinoma in situ of breast,GRP,Gastrin-releasing peptide,19106,119,1.14 [0.82-1.58],0.4382212422850825
Chapter II Neoplasms,Carcinoma in situ of breast,GRPEL1,"GrpE protein homolog 1, mitochondrial",22413,140,0.89 [0.69-1.16],0.3990136155120193
Chapter II Neoplasms,Carcinoma in situ of breast,GRSF1,G-rich sequence factor 1,18802,118,0.79 [0.62-1.01],0.0599383622806672
Chapter II Neoplasms,Carcinoma in situ of breast,GSAP,Gamma-secretase-activating protein,22008,134,1.04 [0.88-1.23],0.6226902163352748
Chapter II Neoplasms,Carcinoma in situ of breast,GSN,Gelsolin,19536,119,2.23 [0.91-5.45],0.0780104325851534
Chapter II Neoplasms,Carcinoma in situ of breast,GSR,"Glutathione reductase, mitochondrial",19487,119,0.86 [0.39-1.90],0.7039216502231646
Chapter II Neoplasms,Carcinoma in situ of breast,GSTA1,Glutathione S-transferase A1,22483,139,0.87 [0.73-1.05],0.1599485934884655
Chapter II Neoplasms,Carcinoma in situ of breast,GSTA3,Glutathione S-transferase A3,22008,134,0.97 [0.79-1.19],0.7552395924926776
Chapter II Neoplasms,Carcinoma in situ of breast,GSTM4,Glutathione S-transferase Mu 4,19003,118,1.13 [0.91-1.40],0.2521624814515616
Chapter II Neoplasms,Carcinoma in situ of breast,GSTP1,Glutathione S-transferase P,21821,133,1.06 [0.85-1.32],0.5970981565056049
Chapter II Neoplasms,Carcinoma in situ of breast,GSTT2B,Glutathione S-transferase theta-2B,19562,122,0.99 [0.92-1.07],0.818808942190125
Chapter II Neoplasms,Carcinoma in situ of breast,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19223,122,1.08 [0.87-1.33],0.5072269385059638
Chapter II Neoplasms,Carcinoma in situ of breast,GTPBP2,GTP-binding protein 2,19054,119,0.81 [0.65-1.02],0.0723915937284994
Chapter II Neoplasms,Carcinoma in situ of breast,GUCA2A,Guanylin,22415,137,1.07 [0.67-1.71],0.7818677933624623
Chapter II Neoplasms,Carcinoma in situ of breast,GUCY2C,Heat-stable enterotoxin receptor,19223,122,1.04 [0.86-1.26],0.697581328360575
Chapter II Neoplasms,Carcinoma in situ of breast,GUK1,Guanylate kinase,19003,118,1.10 [0.74-1.64],0.6420690911408086
Chapter II Neoplasms,Carcinoma in situ of breast,GUSB,Beta-glucuronidase,22624,135,0.93 [0.72-1.20],0.5846950965344051
Chapter II Neoplasms,Carcinoma in situ of breast,GYS1,"Glycogen [starch] synthase, muscle",22115,137,0.85 [0.72-1.00],0.0497329802653673
Chapter II Neoplasms,Carcinoma in situ of breast,GZMA,Granzyme A,22764,139,0.67 [0.43-1.04],0.0731538737941321
Chapter II Neoplasms,Carcinoma in situ of breast,GZMB,Granzyme B,22477,136,0.83 [0.64-1.07],0.1426877728371354
Chapter II Neoplasms,Carcinoma in situ of breast,GZMH,Granzyme H,22115,137,0.88 [0.71-1.10],0.2581401205601634
Chapter II Neoplasms,Carcinoma in situ of breast,H2AP,Huntingtin-interacting protein M,18908,119,0.69 [0.43-1.11],0.1267807068564934
Chapter II Neoplasms,Carcinoma in situ of breast,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19003,118,1.17 [0.95-1.44],0.1310338088448655
Chapter II Neoplasms,Carcinoma in situ of breast,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22644,136,0.96 [0.79-1.18],0.7187565283709527
Chapter II Neoplasms,Carcinoma in situ of breast,HAO1,Hydroxyacid oxidase 1,22716,137,1.02 [0.91-1.15],0.6852394443948824
Chapter II Neoplasms,Carcinoma in situ of breast,HARS1,"Histidine--tRNA ligase, cytoplasmic",22524,138,0.81 [0.67-0.99],0.0379807792067049
Chapter II Neoplasms,Carcinoma in situ of breast,HAVCR1,Hepatitis A virus cellular receptor 1,22683,136,0.98 [0.76-1.27],0.8678636535784849
Chapter II Neoplasms,Carcinoma in situ of breast,HAVCR2,Hepatitis A virus cellular receptor 2,22524,138,0.91 [0.58-1.43],0.6948869768563531
Chapter II Neoplasms,Carcinoma in situ of breast,HBEGF,Proheparin-binding EGF-like growth factor,22644,136,0.78 [0.63-0.96],0.0179833826409955
Chapter II Neoplasms,Carcinoma in situ of breast,HBQ1,Hemoglobin subunit theta-1,22716,137,1.00 [0.78-1.28],0.9843686975815708
Chapter II Neoplasms,Carcinoma in situ of breast,HBZ,Hemoglobin subunit zeta,19600,119,1.11 [0.95-1.30],0.2026380294848647
Chapter II Neoplasms,Carcinoma in situ of breast,HCG22,Protein PBMUCL2,19003,118,0.56 [0.34-0.93],0.0248044501468545
Chapter II Neoplasms,Carcinoma in situ of breast,HCLS1,Hematopoietic lineage cell-specific protein,22764,139,0.73 [0.56-0.95],0.0181497018788372
Chapter II Neoplasms,Carcinoma in situ of breast,HDAC8,Histone deacetylase 8,19054,117,1.07 [0.83-1.39],0.6061701810602595
Chapter II Neoplasms,Carcinoma in situ of breast,HDAC9,Histone deacetylase 9,18997,118,1.02 [0.78-1.33],0.8876313568442311
Chapter II Neoplasms,Carcinoma in situ of breast,HDDC2,5'-deoxynucleotidase HDDC2,19501,122,0.83 [0.55-1.24],0.3583653910496747
Chapter II Neoplasms,Carcinoma in situ of breast,HDGF,Hepatoma-derived growth factor,22687,137,0.95 [0.81-1.11],0.5402937037281683
Chapter II Neoplasms,Carcinoma in situ of breast,HDGFL2,Hepatoma-derived growth factor-related protein 2,19562,122,0.93 [0.70-1.22],0.5900584054685079
Chapter II Neoplasms,Carcinoma in situ of breast,HEBP1,Heme-binding protein 1,22115,137,1.16 [0.92-1.45],0.210235788143398
Chapter II Neoplasms,Carcinoma in situ of breast,HEG1,Protein HEG homolog 1,19191,120,0.74 [0.37-1.45],0.374137594643945
Chapter II Neoplasms,Carcinoma in situ of breast,HEPACAM2,HEPACAM family member 2,19562,122,0.78 [0.51-1.20],0.2618232561672634
Chapter II Neoplasms,Carcinoma in situ of breast,HEPH,Hephaestin,19600,119,1.18 [0.59-2.37],0.6415699420079737
Chapter II Neoplasms,Carcinoma in situ of breast,HEXIM1,Protein HEXIM1,22477,136,0.83 [0.69-1.00],0.0526925053315513
Chapter II Neoplasms,Carcinoma in situ of breast,HGF,Hepatocyte growth factor,22764,139,0.73 [0.47-1.15],0.1769186168125608
Chapter II Neoplasms,Carcinoma in situ of breast,HGFAC,Hepatocyte growth factor activator,19413,118,0.93 [0.52-1.67],0.816278264059223
Chapter II Neoplasms,Carcinoma in situ of breast,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22008,134,0.72 [0.58-0.89],0.0020125615747984
Chapter II Neoplasms,Carcinoma in situ of breast,HHEX,Hematopoietically-expressed homeobox protein HHEX,19562,122,0.86 [0.68-1.08],0.1915669650327138
Chapter II Neoplasms,Carcinoma in situ of breast,HIF1A,Hypoxia-inducible factor 1-alpha,19054,117,1.05 [0.82-1.34],0.7122569524563979
Chapter II Neoplasms,Carcinoma in situ of breast,HIP1,Huntingtin-interacting protein 1,19003,118,1.14 [0.71-1.83],0.5956037154226889
Chapter II Neoplasms,Carcinoma in situ of breast,HIP1R,Huntingtin-interacting protein 1-related protein,19528,122,1.06 [0.72-1.57],0.7650604788662962
Chapter II Neoplasms,Carcinoma in situ of breast,HJV,Hemojuvelin,19571,121,0.86 [0.57-1.29],0.4680341546097379
Chapter II Neoplasms,Carcinoma in situ of breast,HK2,Hexokinase-2,22115,137,1.41 [0.86-2.31],0.169450652146998
Chapter II Neoplasms,Carcinoma in situ of breast,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19571,121,0.85 [0.50-1.45],0.5587392545603216
Chapter II Neoplasms,Carcinoma in situ of breast,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22412,134,1.20 [0.79-1.81],0.3903985235170778
Chapter II Neoplasms,Carcinoma in situ of breast,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22477,136,0.83 [0.48-1.45],0.5161324968055441
Chapter II Neoplasms,Carcinoma in situ of breast,HMBS,Porphobilinogen deaminase,22716,137,1.18 [0.85-1.63],0.3202485429172412
Chapter II Neoplasms,Carcinoma in situ of breast,HMCN2,Hemicentin-2,19155,120,1.35 [0.99-1.85],0.0600293455487532
Chapter II Neoplasms,Carcinoma in situ of breast,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19106,119,0.93 [0.65-1.33],0.6980895104029399
Chapter II Neoplasms,Carcinoma in situ of breast,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19003,118,0.63 [0.40-0.99],0.0439922089864172
Chapter II Neoplasms,Carcinoma in situ of breast,HMMR,Hyaluronan mediated motility receptor,18880,119,0.72 [0.47-1.11],0.138585143640006
Chapter II Neoplasms,Carcinoma in situ of breast,HMOX1,Heme oxygenase 1,22269,137,1.26 [0.92-1.73],0.1499344040207023
Chapter II Neoplasms,Carcinoma in situ of breast,HMOX2,Heme oxygenase 2,21957,134,1.24 [0.92-1.67],0.1573903971594928
Chapter II Neoplasms,Carcinoma in situ of breast,HNF1A,Hepatocyte nuclear factor 1-alpha,19054,119,0.92 [0.70-1.21],0.5415868189153709
Chapter II Neoplasms,Carcinoma in situ of breast,HNMT,Histamine N-methyltransferase,22250,139,1.00 [0.72-1.40],0.9800393118710348
Chapter II Neoplasms,Carcinoma in situ of breast,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22050,137,0.85 [0.69-1.04],0.1170448445359775
Chapter II Neoplasms,Carcinoma in situ of breast,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19571,121,0.90 [0.62-1.31],0.59397563860625
Chapter II Neoplasms,Carcinoma in situ of breast,HPCAL1,Hippocalcin-like protein 1,22764,139,0.85 [0.70-1.03],0.0980007462364397
Chapter II Neoplasms,Carcinoma in situ of breast,HPGDS,Hematopoietic prostaglandin D synthase,22008,134,1.03 [0.68-1.55],0.8981053894558235
Chapter II Neoplasms,Carcinoma in situ of breast,HPSE,Heparanase,19321,123,0.77 [0.64-0.92],0.003760959365491
Chapter II Neoplasms,Carcinoma in situ of breast,HRAS,GTPase Hras,19187,120,1.03 [0.87-1.21],0.7463720341391387
Chapter II Neoplasms,Carcinoma in situ of breast,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19106,119,0.74 [0.43-1.28],0.2807932605750922
Chapter II Neoplasms,Carcinoma in situ of breast,HRG,Histidine-rich glycoprotein,19514,118,0.98 [0.57-1.71],0.9560104646860396
Chapter II Neoplasms,Carcinoma in situ of breast,HS1BP3,HCLS1-binding protein 3,19106,119,0.87 [0.71-1.06],0.1687359600034887
Chapter II Neoplasms,Carcinoma in situ of breast,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22413,140,0.84 [0.57-1.23],0.3690549007285212
Chapter II Neoplasms,Carcinoma in situ of breast,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22716,137,0.74 [0.48-1.16],0.1943879469435527
Chapter II Neoplasms,Carcinoma in situ of breast,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19054,117,0.99 [0.54-1.80],0.969868489211316
Chapter II Neoplasms,Carcinoma in situ of breast,HSBP1,Heat shock factor-binding protein 1,19106,119,0.89 [0.74-1.08],0.2362388496794777
Chapter II Neoplasms,Carcinoma in situ of breast,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22477,136,1.30 [0.88-1.92],0.18299757242486
Chapter II Neoplasms,Carcinoma in situ of breast,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19562,122,1.11 [0.85-1.46],0.4505103989948864
Chapter II Neoplasms,Carcinoma in situ of breast,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19003,118,0.78 [0.52-1.17],0.226754485581121
Chapter II Neoplasms,Carcinoma in situ of breast,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19106,119,0.82 [0.56-1.21],0.3215069858955951
Chapter II Neoplasms,Carcinoma in situ of breast,HSP90B1,Endoplasmin,21856,134,1.05 [0.85-1.29],0.6592617203315784
Chapter II Neoplasms,Carcinoma in situ of breast,HSPA1A,Heat shock 70 kDa protein 1A,22585,141,0.87 [0.70-1.07],0.1831959038276118
Chapter II Neoplasms,Carcinoma in situ of breast,HSPA2,Heat shock-related 70 kDa protein 2,19495,120,0.87 [0.50-1.49],0.6053019427515387
Chapter II Neoplasms,Carcinoma in situ of breast,HSPB1,Heat shock protein beta-1,22151,135,0.71 [0.58-0.87],0.0009988845608543
Chapter II Neoplasms,Carcinoma in situ of breast,HSPB6,Heat shock protein beta-6,22716,137,1.00 [0.65-1.52],0.984410845242208
Chapter II Neoplasms,Carcinoma in situ of breast,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22323,137,1.81 [1.03-3.19],0.0387864307364904
Chapter II Neoplasms,Carcinoma in situ of breast,HTR1A,5-hydroxytryptamine receptor 1A,18997,118,0.81 [0.62-1.06],0.1263782924781571
Chapter II Neoplasms,Carcinoma in situ of breast,HTR1B,5-hydroxytryptamine receptor 1B,18997,118,0.91 [0.59-1.41],0.6825869452294657
Chapter II Neoplasms,Carcinoma in situ of breast,HTRA2,"Serine protease HTRA2, mitochondrial",22586,140,0.82 [0.64-1.05],0.1231640274223516
Chapter II Neoplasms,Carcinoma in situ of breast,HYAL1,Hyaluronidase-1,22352,139,1.61 [0.86-3.01],0.1361997933534037
Chapter II Neoplasms,Carcinoma in situ of breast,HYOU1,Hypoxia up-regulated protein 1,22786,138,1.34 [0.67-2.69],0.4116085349079452
Chapter II Neoplasms,Carcinoma in situ of breast,ICA1,Islet cell autoantigen 1,22090,138,0.82 [0.68-1.00],0.0548396699977824
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM1,Intercellular adhesion molecule 1,22401,136,1.04 [0.60-1.78],0.8994423040710713
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM2,Intercellular adhesion molecule 2,22786,138,0.81 [0.50-1.30],0.3835298406056371
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM3,Intercellular adhesion molecule 3,22786,138,1.21 [0.66-2.20],0.5420931174394473
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM4,Intercellular adhesion molecule 4,22477,136,0.94 [0.71-1.25],0.6888287454976512
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM5,Intercellular adhesion molecule 5,22518,139,0.76 [0.54-1.06],0.1012106638120004
Chapter II Neoplasms,Carcinoma in situ of breast,ICOSLG,ICOS ligand,22413,140,1.81 [0.84-3.90],0.1329598278211689
Chapter II Neoplasms,Carcinoma in situ of breast,ID4,DNA-binding protein inhibitor ID-4,19223,122,1.06 [0.74-1.51],0.7512782613712469
Chapter II Neoplasms,Carcinoma in situ of breast,IDI2,Isopentenyl-diphosphate delta-isomerase 2,21957,134,0.96 [0.69-1.34],0.8091873219696893
Chapter II Neoplasms,Carcinoma in situ of breast,IDO1,"Indoleamine 2,3-dioxygenase 1",19106,119,0.89 [0.67-1.18],0.4081876537739338
Chapter II Neoplasms,Carcinoma in situ of breast,IDS,Iduronate 2-sulfatase,22764,139,0.55 [0.10-2.91],0.4791156937805924
Chapter II Neoplasms,Carcinoma in situ of breast,IDUA,Alpha-L-iduronidase,22716,137,0.78 [0.57-1.07],0.1250022280263794
Chapter II Neoplasms,Carcinoma in situ of breast,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19022,118,0.92 [0.57-1.47],0.7188115255857603
Chapter II Neoplasms,Carcinoma in situ of breast,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19223,122,0.91 [0.65-1.27],0.577574383338548
Chapter II Neoplasms,Carcinoma in situ of breast,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19223,122,0.89 [0.55-1.44],0.6311766555516113
Chapter II Neoplasms,Carcinoma in situ of breast,IFNAR1,Interferon alpha/beta receptor 1,19501,122,1.47 [0.83-2.60],0.1872924693518683
Chapter II Neoplasms,Carcinoma in situ of breast,IFNG,Interferon gamma,22090,138,0.88 [0.78-1.00],0.0442768753944243
Chapter II Neoplasms,Carcinoma in situ of breast,IFNGR1,Interferon gamma receptor 1,22619,141,1.48 [0.71-3.11],0.2949180200742798
Chapter II Neoplasms,Carcinoma in situ of breast,IFNGR2,Interferon gamma receptor 2,22368,139,0.93 [0.69-1.24],0.6138319283623002
Chapter II Neoplasms,Carcinoma in situ of breast,IFNL1,Interferon lambda-1,21957,134,1.04 [0.74-1.46],0.8328532169453197
Chapter II Neoplasms,Carcinoma in situ of breast,IFNL2,Interferon lambda-2,18997,118,1.08 [0.84-1.39],0.529798006657751
Chapter II Neoplasms,Carcinoma in situ of breast,IFNLR1,Interferon lambda receptor 1,22477,136,0.91 [0.60-1.39],0.6778610089517024
Chapter II Neoplasms,Carcinoma in situ of breast,IFNW1,Interferon omega-1,19003,118,0.88 [0.52-1.48],0.6303795896433595
Chapter II Neoplasms,Carcinoma in situ of breast,IFT20,Intraflagellar transport protein 20 homolog,19054,119,0.80 [0.52-1.23],0.3060835008477398
Chapter II Neoplasms,Carcinoma in situ of breast,IGBP1,Immunoglobulin-binding protein 1,19571,121,0.76 [0.57-1.01],0.0582534342042185
Chapter II Neoplasms,Carcinoma in situ of breast,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,18997,118,0.99 [0.69-1.43],0.9519610832877552
Chapter II Neoplasms,Carcinoma in situ of breast,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19597,123,0.99 [0.50-1.94],0.9746516859600528
Chapter II Neoplasms,Carcinoma in situ of breast,IGF1R,Insulin-like growth factor 1 receptor,22413,140,0.52 [0.25-1.09],0.0850077444035687
Chapter II Neoplasms,Carcinoma in situ of breast,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19003,118,0.88 [0.59-1.33],0.5536922860896278
Chapter II Neoplasms,Carcinoma in situ of breast,IGF2R,Cation-independent mannose-6-phosphate receptor,22524,138,1.00 [0.52-1.94],0.9894017901428082
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP1,Insulin-like growth factor-binding protein 1,22747,137,1.05 [0.93-1.20],0.4292483935365974
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP2,Insulin-like growth factor-binding protein 2,22747,138,1.08 [0.85-1.36],0.5438095708741861
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP3,Insulin-like growth factor-binding protein 3,22579,139,1.66 [0.93-2.96],0.084528952389802
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP4,Insulin-like growth factor-binding protein 4,22229,136,1.06 [0.72-1.55],0.7712569150349924
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP6,Insulin-like growth factor-binding protein 6,22397,136,1.66 [1.00-2.77],0.05095403264983
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP7,Insulin-like growth factor-binding protein 7,22786,138,1.30 [0.79-2.13],0.3002635402256484
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22518,139,0.75 [0.47-1.19],0.2258085131127453
Chapter II Neoplasms,Carcinoma in situ of breast,IGFL4,Insulin growth factor-like family member 4,19054,117,1.02 [0.81-1.27],0.8905843948023175
Chapter II Neoplasms,Carcinoma in situ of breast,IGHMBP2,DNA-binding protein SMUBP-2,19003,118,0.81 [0.58-1.15],0.2403466873217731
Chapter II Neoplasms,Carcinoma in situ of breast,IGLC2,Immunoglobulin lambda constant 2,19591,119,0.99 [0.48-2.05],0.9744205950155668
Chapter II Neoplasms,Carcinoma in situ of breast,IGLON5,IgLON family member 5,18908,119,0.69 [0.51-0.93],0.0155473825742
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF21,Immunoglobulin superfamily member 21,19106,119,0.91 [0.57-1.45],0.6929130043500358
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF3,Immunoglobulin superfamily member 3,22413,140,0.63 [0.38-1.03],0.0632604604210197
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF8,Immunoglobulin superfamily member 8,22518,139,0.75 [0.45-1.25],0.2700295743223651
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF9,Protein turtle homolog A,19600,119,0.96 [0.77-1.19],0.6997235788678904
Chapter II Neoplasms,Carcinoma in situ of breast,IKBKG,NF-kappa-B essential modulator,22477,136,0.85 [0.72-1.01],0.0622816250886721
Chapter II Neoplasms,Carcinoma in situ of breast,IKZF2,Zinc finger protein Helios,22008,134,1.01 [0.86-1.18],0.9207375867376132
Chapter II Neoplasms,Carcinoma in situ of breast,IL10,Interleukin-10,22090,138,1.07 [0.90-1.27],0.4532202645950567
Chapter II Neoplasms,Carcinoma in situ of breast,IL10RA,Interleukin-10 receptor subunit alpha,22090,138,1.03 [0.81-1.31],0.7821266780934578
Chapter II Neoplasms,Carcinoma in situ of breast,IL10RB,Interleukin-10 receptor subunit beta,22619,141,1.09 [0.65-1.85],0.7381301392901443
Chapter II Neoplasms,Carcinoma in situ of breast,IL11,Interleukin-11,22090,138,0.96 [0.75-1.23],0.750986090003988
Chapter II Neoplasms,Carcinoma in situ of breast,IL12A_IL12B,Interleukin-12,22413,140,0.86 [0.70-1.04],0.1243904426771343
Chapter II Neoplasms,Carcinoma in situ of breast,IL12B,Interleukin-12 subunit beta,22764,139,0.86 [0.65-1.13],0.2793522462795147
Chapter II Neoplasms,Carcinoma in situ of breast,IL12RB1,Interleukin-12 receptor subunit beta-1,22090,138,0.76 [0.51-1.15],0.1926709792488687
Chapter II Neoplasms,Carcinoma in situ of breast,IL12RB2,Interleukin-12 receptor subunit beta-2,19054,117,0.85 [0.55-1.32],0.4688491236098081
Chapter II Neoplasms,Carcinoma in situ of breast,IL13,Interleukin-13,22090,138,0.96 [0.70-1.32],0.8045346360082062
Chapter II Neoplasms,Carcinoma in situ of breast,IL13RA1,Interleukin-13 receptor subunit alpha-1,22233,138,1.34 [0.65-2.78],0.4260208009186268
Chapter II Neoplasms,Carcinoma in situ of breast,IL13RA2,Interleukin-13 receptor subunit alpha-2,18997,118,0.65 [0.35-1.19],0.1612200548280595
Chapter II Neoplasms,Carcinoma in situ of breast,IL15,Interleukin-15,22477,136,1.00 [0.63-1.60],0.9972384234803436
Chapter II Neoplasms,Carcinoma in situ of breast,IL15RA,Interleukin-15 receptor subunit alpha,22090,138,0.94 [0.61-1.45],0.7701109682965807
Chapter II Neoplasms,Carcinoma in situ of breast,IL16,Pro-interleukin-16,22764,139,1.18 [0.84-1.65],0.3359211880401153
Chapter II Neoplasms,Carcinoma in situ of breast,IL17A,Interleukin-17A,22066,138,1.07 [0.76-1.50],0.71588429714897
Chapter II Neoplasms,Carcinoma in situ of breast,IL17C,Interleukin-17C,22090,138,1.09 [0.88-1.34],0.4398738335549369
Chapter II Neoplasms,Carcinoma in situ of breast,IL17D,Interleukin-17D,22090,138,1.03 [0.66-1.60],0.894229671654239
Chapter II Neoplasms,Carcinoma in situ of breast,IL17F,Interleukin-17F,22090,138,1.10 [0.93-1.30],0.2820796819133994
Chapter II Neoplasms,Carcinoma in situ of breast,IL17RA,Interleukin-17 receptor A,22524,138,0.93 [0.67-1.31],0.6951319816883619
Chapter II Neoplasms,Carcinoma in situ of breast,IL17RB,Interleukin-17 receptor B,22184,133,1.36 [1.02-1.81],0.0370294112751826
Chapter II Neoplasms,Carcinoma in situ of breast,IL18,Interleukin-18,22435,140,0.90 [0.66-1.24],0.5254565746305908
Chapter II Neoplasms,Carcinoma in situ of breast,IL18BP,Interleukin-18-binding protein,22579,139,1.49 [0.93-2.39],0.1013220078209062
Chapter II Neoplasms,Carcinoma in situ of breast,IL18R1,Interleukin-18 receptor 1,22764,139,1.07 [0.68-1.68],0.7776617996046369
Chapter II Neoplasms,Carcinoma in situ of breast,IL18RAP,Interleukin-18 receptor accessory protein,22222,138,0.93 [0.85-1.02],0.1321315341968356
Chapter II Neoplasms,Carcinoma in situ of breast,IL19,Interleukin-19,21954,137,0.95 [0.75-1.19],0.6517973305704956
Chapter II Neoplasms,Carcinoma in situ of breast,IL1A,Interleukin-1 alpha,22090,138,1.04 [0.80-1.36],0.7548930293884131
Chapter II Neoplasms,Carcinoma in situ of breast,IL1B,Interleukin-1 beta,21990,138,0.69 [0.51-0.93],0.0164083580643397
Chapter II Neoplasms,Carcinoma in situ of breast,IL1R1,Interleukin-1 receptor type 1,22490,138,1.19 [0.60-2.35],0.6101972322233091
Chapter II Neoplasms,Carcinoma in situ of breast,IL1R2,Interleukin-1 receptor type 2,22481,140,1.30 [0.60-2.83],0.5048948641104025
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RAP,Interleukin-1 receptor accessory protein,22524,138,1.28 [0.91-1.80],0.1549942262502049
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RL1,Interleukin-1 receptor-like 1,22718,136,0.90 [0.65-1.26],0.5512211385489387
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RL2,Interleukin-1 receptor-like 2,22090,138,1.09 [0.75-1.59],0.6486314884312123
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RN,Interleukin-1 receptor antagonist protein,22476,139,0.99 [0.76-1.29],0.9370027905398054
Chapter II Neoplasms,Carcinoma in situ of breast,IL2,Interleukin-2,22090,138,0.83 [0.51-1.34],0.447873559297905
Chapter II Neoplasms,Carcinoma in situ of breast,IL20,Interleukin-20,22090,138,0.89 [0.65-1.23],0.4976840451260024
Chapter II Neoplasms,Carcinoma in situ of breast,IL20RA,Interleukin-20 receptor subunit alpha,22090,138,1.16 [0.87-1.54],0.3255645265586145
Chapter II Neoplasms,Carcinoma in situ of breast,IL20RB,Interleukin-20 receptor subunit beta,19054,117,1.10 [0.73-1.66],0.6330088768059376
Chapter II Neoplasms,Carcinoma in situ of breast,IL21R,Interleukin-21 receptor,19054,117,0.94 [0.67-1.32],0.7287905438703887
Chapter II Neoplasms,Carcinoma in situ of breast,IL22,Interleukin-22,19495,120,1.11 [0.86-1.43],0.4143226841480119
Chapter II Neoplasms,Carcinoma in situ of breast,IL22RA1,Interleukin-22 receptor subunit alpha-1,22090,138,1.02 [0.73-1.43],0.8939785814920574
Chapter II Neoplasms,Carcinoma in situ of breast,IL24,Interleukin-24,22090,138,1.07 [0.80-1.44],0.6502519156866382
Chapter II Neoplasms,Carcinoma in situ of breast,IL25,Interleukin-25,18838,118,0.78 [0.47-1.30],0.3373691201256967
Chapter II Neoplasms,Carcinoma in situ of breast,IL2RA,Interleukin-2 receptor subunit alpha,22346,132,1.28 [0.87-1.88],0.2035897259581721
Chapter II Neoplasms,Carcinoma in situ of breast,IL2RB,Interleukin-2 receptor subunit beta,22090,138,0.95 [0.64-1.43],0.8196738304983664
Chapter II Neoplasms,Carcinoma in situ of breast,IL2RG,Cytokine receptor common subunit gamma,19495,120,0.84 [0.50-1.39],0.4872463920108876
Chapter II Neoplasms,Carcinoma in situ of breast,IL3,Interleukin-3,18908,119,0.77 [0.61-0.97],0.0283471881904874
Chapter II Neoplasms,Carcinoma in situ of breast,IL31,Interleukin-31,19054,117,0.65 [0.44-0.98],0.0371774487983796
Chapter II Neoplasms,Carcinoma in situ of breast,IL31RA,Interleukin-31 receptor subunit alpha,18980,117,1.03 [0.66-1.60],0.8952678652103496
Chapter II Neoplasms,Carcinoma in situ of breast,IL32,Interleukin-32,22477,136,1.02 [0.71-1.46],0.9094445567567324
Chapter II Neoplasms,Carcinoma in situ of breast,IL33,Interleukin-33,22090,138,0.91 [0.62-1.34],0.630543260913299
Chapter II Neoplasms,Carcinoma in situ of breast,IL34,Interleukin-34,21927,134,0.86 [0.56-1.30],0.4651599129008567
Chapter II Neoplasms,Carcinoma in situ of breast,IL36A,Interleukin-36 alpha,19054,117,0.94 [0.69-1.30],0.7284898861512593
Chapter II Neoplasms,Carcinoma in situ of breast,IL36G,Interleukin-36 gamma,18973,117,1.00 [0.77-1.30],0.990913620519868
Chapter II Neoplasms,Carcinoma in situ of breast,IL3RA,Interleukin-3 receptor subunit alpha,22090,138,1.00 [0.62-1.60],0.9835514041073008
Chapter II Neoplasms,Carcinoma in situ of breast,IL4,Interleukin-4,22090,138,0.96 [0.82-1.13],0.6592633720430261
Chapter II Neoplasms,Carcinoma in situ of breast,IL4R,Interleukin-4 receptor subunit alpha,22477,136,1.15 [0.75-1.75],0.5240201465648467
Chapter II Neoplasms,Carcinoma in situ of breast,IL5,Interleukin-5,22090,138,0.99 [0.90-1.10],0.9154172040452724
Chapter II Neoplasms,Carcinoma in situ of breast,IL5RA,Interleukin-5 receptor subunit alpha,22477,136,1.07 [0.81-1.42],0.6174947676252278
Chapter II Neoplasms,Carcinoma in situ of breast,IL6,Interleukin-6,22413,140,0.81 [0.64-1.03],0.0841704123995552
Chapter II Neoplasms,Carcinoma in situ of breast,IL6R,Interleukin-6 receptor subunit alpha,22357,136,1.17 [0.75-1.84],0.4837233404494532
Chapter II Neoplasms,Carcinoma in situ of breast,IL6ST,Interleukin-6 receptor subunit beta,22518,139,1.26 [0.54-2.95],0.5901205192845391
Chapter II Neoplasms,Carcinoma in situ of breast,IL7,Interleukin-7,22477,136,0.83 [0.65-1.05],0.1245727169134435
Chapter II Neoplasms,Carcinoma in situ of breast,IL7R,Interleukin-7 receptor subunit alpha,22524,138,1.03 [0.77-1.37],0.8516393764928043
Chapter II Neoplasms,Carcinoma in situ of breast,IL9,Interleukin-9,19223,122,0.96 [0.70-1.31],0.7758097313073924
Chapter II Neoplasms,Carcinoma in situ of breast,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,21931,132,0.68 [0.51-0.91],0.0099775282157179
Chapter II Neoplasms,Carcinoma in situ of breast,IMMT,MICOS complex subunit MIC60,19495,120,0.68 [0.44-1.07],0.0963950391303574
Chapter II Neoplasms,Carcinoma in situ of breast,IMPA1,Inositol monophosphatase 1,22368,139,0.79 [0.62-1.02],0.0741351648821295
Chapter II Neoplasms,Carcinoma in situ of breast,IMPACT,Protein IMPACT,19562,122,0.71 [0.53-0.97],0.03288156275035
Chapter II Neoplasms,Carcinoma in situ of breast,IMPG1,Interphotoreceptor matrix proteoglycan 1,18997,118,0.75 [0.39-1.42],0.3731087477496666
Chapter II Neoplasms,Carcinoma in situ of breast,ING1,Inhibitor of growth protein 1,21909,134,0.99 [0.70-1.39],0.933114954875489
Chapter II Neoplasms,Carcinoma in situ of breast,INHBB,Inhibin beta B chain,19191,120,1.25 [0.89-1.74],0.1985327297648935
Chapter II Neoplasms,Carcinoma in situ of breast,INHBC,Inhibin beta C chain,22524,138,0.83 [0.59-1.17],0.2873649187879632
Chapter II Neoplasms,Carcinoma in situ of breast,INPP1,Inositol polyphosphate 1-phosphatase,22413,140,1.01 [0.77-1.33],0.9312294046384052
Chapter II Neoplasms,Carcinoma in situ of breast,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19106,119,0.69 [0.50-0.96],0.0284959112957156
Chapter II Neoplasms,Carcinoma in situ of breast,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19571,121,1.00 [0.68-1.49],0.983419996728869
Chapter II Neoplasms,Carcinoma in situ of breast,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22413,140,0.82 [0.70-0.96],0.0131324410107006
Chapter II Neoplasms,Carcinoma in situ of breast,INSL3,Insulin-like 3,19562,122,0.91 [0.69-1.20],0.4854527851171648
Chapter II Neoplasms,Carcinoma in situ of breast,INSL4,Early placenta insulin-like peptide,19495,120,1.00 [0.72-1.39],0.9937600761876212
Chapter II Neoplasms,Carcinoma in situ of breast,INSL5,Insulin-like peptide INSL5,19501,122,1.10 [0.92-1.32],0.2812291224618614
Chapter II Neoplasms,Carcinoma in situ of breast,INSR,Insulin receptor,19054,117,0.71 [0.24-2.07],0.5293082485235197
Chapter II Neoplasms,Carcinoma in situ of breast,IPCEF1,Interactor protein for cytohesin exchange factors 1,22333,139,0.83 [0.70-0.98],0.0271991581383532
Chapter II Neoplasms,Carcinoma in situ of breast,IQGAP2,Ras GTPase-activating-like protein IQGAP2,22413,140,0.81 [0.61-1.07],0.1350460281317017
Chapter II Neoplasms,Carcinoma in situ of breast,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22115,137,0.92 [0.77-1.10],0.3759290254665253
Chapter II Neoplasms,Carcinoma in situ of breast,IRAK1,Interleukin-1 receptor-associated kinase 1,22090,138,0.75 [0.60-0.95],0.0152422604735437
Chapter II Neoplasms,Carcinoma in situ of breast,IRAK4,Interleukin-1 receptor-associated kinase 4,22477,136,0.89 [0.77-1.02],0.100924016742483
Chapter II Neoplasms,Carcinoma in situ of breast,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21650,131,0.77 [0.50-1.17],0.2211346731488912
Chapter II Neoplasms,Carcinoma in situ of breast,ISM1,Isthmin-1,22477,136,0.81 [0.55-1.19],0.2799697723325908
Chapter II Neoplasms,Carcinoma in situ of breast,ISM2,Isthmin-2,19597,123,0.96 [0.65-1.43],0.8487205541531455
Chapter II Neoplasms,Carcinoma in situ of breast,IST1,IST1 homolog,19361,118,0.82 [0.69-0.98],0.0320159013984753
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA11,Integrin alpha-11,22477,136,1.19 [0.77-1.83],0.4399690864199747
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA2,Integrin alpha-2,19191,120,0.96 [0.57-1.62],0.8825466713483409
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA5,Integrin alpha-5,22524,138,0.75 [0.40-1.38],0.353648579412151
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA6,Integrin alpha-6,22477,136,0.85 [0.64-1.14],0.2910039301278068
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAL,Integrin alpha-L,19054,117,0.88 [0.59-1.30],0.5111869983034745
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAM,Integrin alpha-M,22524,138,1.06 [0.66-1.71],0.7983955709044718
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAV,Integrin alpha-V,22716,137,1.68 [0.66-4.30],0.2759056511980223
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAX,Integrin alpha-X,19223,122,0.96 [0.69-1.32],0.7854433211150219
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB1,Integrin beta-1,22471,137,1.87 [1.01-3.46],0.0464653208062855
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB1BP1,Integrin beta-1-binding protein 1,22008,134,0.79 [0.54-1.14],0.2027759555746707
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB1BP2,Integrin beta-1-binding protein 2,22115,137,0.83 [0.72-0.94],0.0044413279181357
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB2,Integrin beta-2,22368,134,1.03 [0.60-1.76],0.9177710639522164
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB5,Integrin beta-5,22586,140,0.83 [0.55-1.26],0.3863542879115508
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB6,Integrin beta-6,22090,138,1.05 [0.63-1.74],0.861436724510331
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB7,Integrin beta-7,22716,137,1.08 [0.78-1.49],0.6475133978427561
Chapter II Neoplasms,Carcinoma in situ of breast,ITGBL1,Integrin beta-like protein 1,19597,123,0.95 [0.57-1.57],0.8340176081546145
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19630,119,1.41 [0.59-3.38],0.4411227975686338
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22579,139,1.71 [1.13-2.57],0.0107713070539041
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19630,119,1.47 [0.82-2.63],0.2001621151911438
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19495,120,1.17 [0.83-1.64],0.3702526524838482
Chapter II Neoplasms,Carcinoma in situ of breast,ITM2A,Integral membrane protein 2A,22477,136,1.12 [0.87-1.44],0.3842039270222106
Chapter II Neoplasms,Carcinoma in situ of breast,ITPA,Inosine triphosphate pyrophosphatase,19003,118,0.83 [0.64-1.09],0.1764615847865079
Chapter II Neoplasms,Carcinoma in situ of breast,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19106,119,0.79 [0.60-1.05],0.1036186422026907
Chapter II Neoplasms,Carcinoma in situ of breast,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",18997,118,0.96 [0.65-1.41],0.8274241482349732
Chapter II Neoplasms,Carcinoma in situ of breast,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",21957,134,0.99 [0.72-1.35],0.9366944320131524
Chapter II Neoplasms,Carcinoma in situ of breast,IZUMO1,Izumo sperm-egg fusion protein 1,18908,119,0.90 [0.61-1.34],0.6119970707830906
Chapter II Neoplasms,Carcinoma in situ of breast,JAM2,Junctional adhesion molecule B,22715,138,0.77 [0.42-1.42],0.3989002449737052
Chapter II Neoplasms,Carcinoma in situ of breast,JAM3,Junctional adhesion molecule C,19191,120,0.92 [0.65-1.32],0.6622898886896762
Chapter II Neoplasms,Carcinoma in situ of breast,JCHAIN,Immunoglobulin J chain,22090,138,1.07 [0.83-1.37],0.6110572066132163
Chapter II Neoplasms,Carcinoma in situ of breast,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,18908,119,0.87 [0.62-1.22],0.419125657136844
Chapter II Neoplasms,Carcinoma in situ of breast,JPT2,Jupiter microtubule associated homolog 2,19501,122,0.85 [0.69-1.03],0.0987956660600473
Chapter II Neoplasms,Carcinoma in situ of breast,JUN,Transcription factor AP-1,22090,138,0.97 [0.73-1.31],0.8634405560226084
Chapter II Neoplasms,Carcinoma in situ of breast,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22413,140,1.38 [0.97-1.96],0.0760171198335366
Chapter II Neoplasms,Carcinoma in situ of breast,KAZN,Kazrin,19501,122,0.81 [0.69-0.96],0.0145952709254128
Chapter II Neoplasms,Carcinoma in situ of breast,KCNC4,Potassium voltage-gated channel subfamily C member 4,18997,118,0.76 [0.52-1.12],0.1633747525298045
Chapter II Neoplasms,Carcinoma in situ of breast,KCNH2,Potassium voltage-gated channel subfamily H member 2,19054,119,0.93 [0.73-1.19],0.5517369283166704
Chapter II Neoplasms,Carcinoma in situ of breast,KCNIP4,Kv channel-interacting protein 4,21957,134,0.99 [0.73-1.34],0.9437460328646288
Chapter II Neoplasms,Carcinoma in situ of breast,KCTD5,BTB/POZ domain-containing protein KCTD5,19201,121,0.99 [0.66-1.49],0.9724049756070016
Chapter II Neoplasms,Carcinoma in situ of breast,KDM3A,Lysine-specific demethylase 3A,19054,117,1.00 [0.83-1.21],0.9828693548244049
Chapter II Neoplasms,Carcinoma in situ of breast,KDR,Vascular endothelial growth factor receptor 2,22586,140,1.03 [0.57-1.85],0.924024309682341
Chapter II Neoplasms,Carcinoma in situ of breast,KEL,Kell blood group glycoprotein,21957,134,0.74 [0.48-1.13],0.1614836117269865
Chapter II Neoplasms,Carcinoma in situ of breast,KHDC3L,KH domain-containing protein 3,18908,119,0.90 [0.68-1.20],0.4751735062937144
Chapter II Neoplasms,Carcinoma in situ of breast,KHK,Ketohexokinase,19106,119,0.91 [0.70-1.20],0.5169549904311848
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA0319,Dyslexia-associated protein KIAA0319,19562,122,1.34 [0.81-2.21],0.2616851675017434
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA1549,UPF0606 protein KIAA1549,19223,122,0.97 [0.76-1.24],0.8172598308107694
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA1549L,UPF0606 protein KIAA1549L,19223,122,0.81 [0.43-1.52],0.5096604966190011
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA2013,Uncharacterized protein KIAA2013,19495,120,0.98 [0.72-1.33],0.8796070750023075
Chapter II Neoplasms,Carcinoma in situ of breast,KIF1C,Kinesin-like protein KIF1C,19003,118,0.68 [0.37-1.23],0.2006738596793575
Chapter II Neoplasms,Carcinoma in situ of breast,KIF20B,Kinesin-like protein KIF20B,18997,118,1.00 [0.80-1.25],0.978415411573414
Chapter II Neoplasms,Carcinoma in situ of breast,KIF22,Kinesin-like protein KIF22,19003,118,0.82 [0.72-0.95],0.0078255213250442
Chapter II Neoplasms,Carcinoma in situ of breast,KIFBP,KIF-binding protein,22413,140,0.84 [0.70-1.00],0.0476015092077044
Chapter II Neoplasms,Carcinoma in situ of breast,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19495,120,0.91 [0.74-1.11],0.3408424162923963
Chapter II Neoplasms,Carcinoma in situ of breast,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22008,134,0.88 [0.72-1.08],0.2288937774461305
Chapter II Neoplasms,Carcinoma in situ of breast,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19501,122,1.02 [0.93-1.13],0.6570259239688205
Chapter II Neoplasms,Carcinoma in situ of breast,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22008,134,0.89 [0.79-1.02],0.0876196898275236
Chapter II Neoplasms,Carcinoma in situ of breast,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,18908,119,0.99 [0.80-1.22],0.9082043089898326
Chapter II Neoplasms,Carcinoma in situ of breast,KIRREL1,Kin of IRRE-like protein 1,18997,118,0.65 [0.42-1.00],0.0476748981660025
Chapter II Neoplasms,Carcinoma in situ of breast,KIRREL2,Kin of IRRE-like protein 2,21957,134,0.69 [0.47-1.02],0.0639821988464165
Chapter II Neoplasms,Carcinoma in situ of breast,KIT,Mast/stem cell growth factor receptor Kit,22542,139,2.57 [1.58-4.18],0.0001468504439274
Chapter II Neoplasms,Carcinoma in situ of breast,KITLG,Kit ligand,22518,139,1.55 [1.01-2.38],0.0437176584243644
Chapter II Neoplasms,Carcinoma in situ of breast,KLB,Beta-klotho,21957,134,1.06 [0.86-1.31],0.5768626809967651
Chapter II Neoplasms,Carcinoma in situ of breast,KLF4,Krueppel-like factor 4,18997,118,0.81 [0.51-1.29],0.375663529525212
Chapter II Neoplasms,Carcinoma in situ of breast,KLHL41,Kelch-like protein 41,19571,121,0.78 [0.52-1.17],0.2258903002497118
Chapter II Neoplasms,Carcinoma in situ of breast,KLK1,Kallikrein-1,22280,137,0.97 [0.86-1.10],0.641378972004893
Chapter II Neoplasms,Carcinoma in situ of breast,KLK10,Kallikrein-10,22514,140,0.74 [0.50-1.09],0.1226601496373384
Chapter II Neoplasms,Carcinoma in situ of breast,KLK11,Kallikrein-11,22364,140,1.00 [0.60-1.66],0.985271257611364
Chapter II Neoplasms,Carcinoma in situ of breast,KLK12,Kallikrein-12,22008,134,0.91 [0.82-1.02],0.0977526043953198
Chapter II Neoplasms,Carcinoma in situ of breast,KLK13,Kallikrein-13,22018,138,0.91 [0.65-1.30],0.6145050468768496
Chapter II Neoplasms,Carcinoma in situ of breast,KLK14,Kallikrein-14,22716,137,1.00 [0.72-1.38],0.9872167144579884
Chapter II Neoplasms,Carcinoma in situ of breast,KLK15,Kallikrein-15,19470,120,0.79 [0.56-1.11],0.1663140144674487
Chapter II Neoplasms,Carcinoma in situ of breast,KLK3,Prostate-specific antigen,19597,123,1.23 [0.94-1.61],0.1237598533134792
Chapter II Neoplasms,Carcinoma in situ of breast,KLK4,Kallikrein-4,22716,137,1.24 [0.98-1.56],0.0695016184139389
Chapter II Neoplasms,Carcinoma in situ of breast,KLK6,Kallikrein-6,22559,140,1.53 [0.93-2.52],0.0961928786924612
Chapter II Neoplasms,Carcinoma in situ of breast,KLK7,Kallikrein-7,18672,120,1.13 [0.73-1.77],0.5850862452010606
Chapter II Neoplasms,Carcinoma in situ of breast,KLK8,Kallikrein-8,21761,137,1.41 [0.93-2.15],0.1045796994094446
Chapter II Neoplasms,Carcinoma in situ of breast,KLKB1,Plasma kallikrein,19231,116,1.43 [0.71-2.86],0.3123612820704215
Chapter II Neoplasms,Carcinoma in situ of breast,KLRB1,Killer cell lectin-like receptor subfamily B member 1,22764,139,0.92 [0.61-1.38],0.6823650933285418
Chapter II Neoplasms,Carcinoma in situ of breast,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,18997,118,0.69 [0.47-1.00],0.0529054430640802
Chapter II Neoplasms,Carcinoma in situ of breast,KLRD1,Natural killer cells antigen CD94,22764,139,0.81 [0.58-1.12],0.2063225129299633
Chapter II Neoplasms,Carcinoma in situ of breast,KLRF1,Killer cell lectin-like receptor subfamily F member 1,19054,117,1.07 [0.73-1.56],0.7304365607175212
Chapter II Neoplasms,Carcinoma in situ of breast,KLRK1,NKG2-D type II integral membrane protein,19562,122,0.73 [0.51-1.05],0.0871622475266422
Chapter II Neoplasms,Carcinoma in situ of breast,KRT14,"Keratin, type I cytoskeletal 14",21239,126,0.87 [0.48-1.56],0.6403280883847426
Chapter II Neoplasms,Carcinoma in situ of breast,KRT17,"Keratin, type I cytoskeletal 17",19003,118,0.92 [0.57-1.47],0.7174886763723612
Chapter II Neoplasms,Carcinoma in situ of breast,KRT18,"Keratin, type I cytoskeletal 18",22413,140,0.96 [0.79-1.17],0.6711996589487645
Chapter II Neoplasms,Carcinoma in situ of breast,KRT19,"Keratin, type I cytoskeletal 19",22444,136,1.06 [0.84-1.33],0.6351407870627179
Chapter II Neoplasms,Carcinoma in situ of breast,KRT5,"Keratin, type II cytoskeletal 5",21957,134,1.03 [0.75-1.41],0.8615482277431115
Chapter II Neoplasms,Carcinoma in situ of breast,KRT6C,"Keratin, type II cytoskeletal 6C",19003,118,0.98 [0.63-1.54],0.943845135153142
Chapter II Neoplasms,Carcinoma in situ of breast,KRT8,"Keratin, type II cytoskeletal 8",18997,118,0.79 [0.56-1.13],0.2009878592616271
Chapter II Neoplasms,Carcinoma in situ of breast,KYAT1,Kynurenine--oxoglutarate transaminase 1,22479,137,0.78 [0.59-1.02],0.071349197795804
Chapter II Neoplasms,Carcinoma in situ of breast,KYNU,Kynureninase,22764,139,0.75 [0.54-1.06],0.1036287894540501
Chapter II Neoplasms,Carcinoma in situ of breast,L1CAM,Neural cell adhesion molecule L1,22586,140,1.43 [0.85-2.41],0.1808762539286538
Chapter II Neoplasms,Carcinoma in situ of breast,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19600,119,0.91 [0.75-1.10],0.3274819242237334
Chapter II Neoplasms,Carcinoma in situ of breast,LACRT,Extracellular glycoprotein lacritin,19458,119,1.15 [0.85-1.55],0.3717139621752627
Chapter II Neoplasms,Carcinoma in situ of breast,LACTB2,Endoribonuclease LACTB2,22518,139,0.79 [0.62-0.99],0.0443316568395229
Chapter II Neoplasms,Carcinoma in situ of breast,LAG3,Lymphocyte activation gene 3 protein,22413,140,0.96 [0.66-1.39],0.8150886581169474
Chapter II Neoplasms,Carcinoma in situ of breast,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22510,140,1.05 [0.71-1.55],0.8214683236127103
Chapter II Neoplasms,Carcinoma in situ of breast,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22368,139,0.98 [0.85-1.13],0.7974775122715184
Chapter II Neoplasms,Carcinoma in situ of breast,LAMA1,Laminin subunit alpha-1,19003,118,0.87 [0.60-1.25],0.4504574447296593
Chapter II Neoplasms,Carcinoma in situ of breast,LAMA4,Laminin subunit alpha-4,22619,141,0.63 [0.39-1.00],0.048904076355798
Chapter II Neoplasms,Carcinoma in situ of breast,LAMB1,Laminin subunit beta-1,19106,119,0.85 [0.47-1.54],0.6020883886464663
Chapter II Neoplasms,Carcinoma in situ of breast,LAMP1,Lysosome-associated membrane glycoprotein 1,19049,121,1.31 [0.86-2.00],0.2135723427031138
Chapter II Neoplasms,Carcinoma in situ of breast,LAMP2,Lysosome-associated membrane glycoprotein 2,21831,134,0.47 [0.21-1.06],0.0681988194573032
Chapter II Neoplasms,Carcinoma in situ of breast,LAMP3,Lysosome-associated membrane glycoprotein 3,22724,138,1.02 [0.75-1.38],0.9194628619434866
Chapter II Neoplasms,Carcinoma in situ of breast,LAMTOR5,Ragulator complex protein LAMTOR5,19495,120,1.20 [0.82-1.75],0.3574238030000837
Chapter II Neoplasms,Carcinoma in situ of breast,LAP3,Cytosol aminopeptidase,22090,138,0.84 [0.61-1.16],0.2810558930331036
Chapter II Neoplasms,Carcinoma in situ of breast,LARP1,La-related protein 1,19495,120,0.91 [0.68-1.21],0.515090832017953
Chapter II Neoplasms,Carcinoma in situ of breast,LAT,Linker for activation of T-cells family member 1,22764,139,0.80 [0.67-0.97],0.0195847523460501
Chapter II Neoplasms,Carcinoma in situ of breast,LAT2,Linker for activation of T-cells family member 2,22413,140,0.85 [0.75-0.97],0.0123271684874431
Chapter II Neoplasms,Carcinoma in situ of breast,LATS1,Serine/threonine-protein kinase LATS1,19054,117,0.83 [0.67-1.03],0.0886729920351406
Chapter II Neoplasms,Carcinoma in situ of breast,LAYN,Layilin,22320,139,1.19 [0.76-1.88],0.4430715173694274
Chapter II Neoplasms,Carcinoma in situ of breast,LBP,Lipopolysaccharide-binding protein,22579,139,1.11 [0.86-1.43],0.4378507423997768
Chapter II Neoplasms,Carcinoma in situ of breast,LBR,Delta(14)-sterol reductase LBR,22715,138,0.99 [0.79-1.23],0.9039880110478112
Chapter II Neoplasms,Carcinoma in situ of breast,LCAT,Phosphatidylcholine-sterol acyltransferase,19605,119,1.53 [0.68-3.44],0.3022437123214651
Chapter II Neoplasms,Carcinoma in situ of breast,LCN15,Lipocalin-15,19571,121,0.92 [0.68-1.23],0.5549134458469762
Chapter II Neoplasms,Carcinoma in situ of breast,LCN2,Neutrophil gelatinase-associated lipocalin,21816,133,1.40 [0.95-2.06],0.0859316077813458
Chapter II Neoplasms,Carcinoma in situ of breast,LCP1,Plastin-2,19597,123,0.96 [0.67-1.38],0.8235170439758464
Chapter II Neoplasms,Carcinoma in situ of breast,LDLR,Low-density lipoprotein receptor,22577,135,0.97 [0.72-1.29],0.8171560699143687
Chapter II Neoplasms,Carcinoma in situ of breast,LDLRAP1,Low density lipoprotein receptor adapter protein 1,19571,121,0.81 [0.68-0.97],0.0240641944484094
Chapter II Neoplasms,Carcinoma in situ of breast,LECT2,Leukocyte cell-derived chemotaxin-2,19600,119,0.89 [0.68-1.17],0.411300393423916
Chapter II Neoplasms,Carcinoma in situ of breast,LEFTY2,Left-right determination factor 2,22677,137,1.10 [0.83-1.46],0.5130269218260401
Chapter II Neoplasms,Carcinoma in situ of breast,LEG1,Protein LEG1 homolog,18534,115,1.08 [0.83-1.39],0.5648999039393957
Chapter II Neoplasms,Carcinoma in situ of breast,LELP1,Late cornified envelope-like proline-rich protein 1,18997,118,0.99 [0.77-1.26],0.9168035376728924
Chapter II Neoplasms,Carcinoma in situ of breast,LEO1,RNA polymerase-associated protein LEO1,19571,121,0.66 [0.33-1.32],0.2396180755757363
Chapter II Neoplasms,Carcinoma in situ of breast,LEP,Leptin,22518,139,0.93 [0.73-1.17],0.5156713166552598
Chapter II Neoplasms,Carcinoma in situ of breast,LEPR,Leptin receptor,22518,139,0.99 [0.60-1.62],0.9665350703478762
Chapter II Neoplasms,Carcinoma in situ of breast,LETM1,Mitochondrial proton/calcium exchanger protein,19571,121,0.69 [0.48-0.99],0.0453040017021307
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS1,Galectin-1,22518,139,1.06 [0.68-1.66],0.7986005601865604
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS3,Galectin-3,22569,135,1.06 [0.64-1.78],0.8118125920116311
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS3BP,Galectin-3-binding protein,19630,119,0.71 [0.38-1.32],0.2764902782943892
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS4,Galectin-4,22510,140,0.94 [0.71-1.26],0.6999869586805603
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS7_LGALS7B,Galectin-7,22479,135,1.03 [0.70-1.49],0.8959687667086201
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS8,Galectin-8,22715,138,0.74 [0.57-0.96],0.0239048678007716
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS9,Galectin-9,22512,139,0.76 [0.47-1.22],0.2568678693939638
Chapter II Neoplasms,Carcinoma in situ of breast,LGMN,Legumain,22619,141,0.59 [0.38-0.90],0.0141697605140062
Chapter II Neoplasms,Carcinoma in situ of breast,LHB,Lutropin subunit beta,22008,134,0.86 [0.71-1.06],0.1544365545829105
Chapter II Neoplasms,Carcinoma in situ of breast,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22544,141,0.96 [0.75-1.24],0.7769520480369951
Chapter II Neoplasms,Carcinoma in situ of breast,LIF,Leukemia inhibitory factor,21957,134,0.93 [0.68-1.26],0.6264678524204133
Chapter II Neoplasms,Carcinoma in situ of breast,LIFR,Leukemia inhibitory factor receptor,22477,136,1.04 [0.56-1.94],0.8926258322401781
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22524,138,1.02 [0.68-1.54],0.9139687515857198
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19597,123,1.03 [0.90-1.18],0.6224566467256969
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19003,118,0.80 [0.54-1.18],0.2539548919495063
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22484,139,0.84 [0.52-1.35],0.4652464385505503
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19600,119,0.86 [0.68-1.09],0.2107994319669242
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22786,138,1.01 [0.58-1.75],0.9698545634373248
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22679,136,1.24 [0.79-1.94],0.343402624847215
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22090,138,0.88 [0.62-1.26],0.4916800753467237
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22786,138,0.89 [0.73-1.10],0.2817345568828058
Chapter II Neoplasms,Carcinoma in situ of breast,LIPF,Gastric triacylglycerol lipase,19106,119,1.31 [0.99-1.73],0.0567280295440256
Chapter II Neoplasms,Carcinoma in situ of breast,LMNB1,Lamin-B1,19458,122,1.55 [1.28-1.86],4.0716814026616805e-06
Chapter II Neoplasms,Carcinoma in situ of breast,LMNB2,Lamin-B2,19562,122,1.32 [0.72-2.42],0.3723800311956151
Chapter II Neoplasms,Carcinoma in situ of breast,LMOD1,Leiomodin-1,19571,121,0.85 [0.51-1.43],0.5498299253098228
Chapter II Neoplasms,Carcinoma in situ of breast,LMOD2,Leiomodin-2,18997,118,0.79 [0.58-1.08],0.1422702769662003
Chapter II Neoplasms,Carcinoma in situ of breast,LONP1,"Lon protease homolog, mitochondrial",19106,119,0.87 [0.71-1.08],0.2015769103573845
Chapter II Neoplasms,Carcinoma in situ of breast,LPA,Apolipoprotein(a),19139,115,1.03 [0.93-1.14],0.5728364988880521
Chapter II Neoplasms,Carcinoma in situ of breast,LPCAT2,Lysophosphatidylcholine acyltransferase 2,22413,140,1.41 [1.12-1.77],0.0032626977014769
Chapter II Neoplasms,Carcinoma in situ of breast,LPL,Lipoprotein lipase,22518,139,1.15 [0.83-1.60],0.3927359733266602
Chapter II Neoplasms,Carcinoma in situ of breast,LPO,Lactoperoxidase,21819,136,0.96 [0.74-1.24],0.7347500951039535
Chapter II Neoplasms,Carcinoma in situ of breast,LPP,Lipoma-preferred partner,19003,118,0.74 [0.57-0.98],0.0328682241855147
Chapter II Neoplasms,Carcinoma in situ of breast,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19003,118,0.69 [0.52-0.92],0.0117931682383109
Chapter II Neoplasms,Carcinoma in situ of breast,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19054,119,0.88 [0.59-1.30],0.5199808882869199
Chapter II Neoplasms,Carcinoma in situ of breast,LRG1,Leucine-rich alpha-2-glycoprotein,19630,119,1.77 [0.92-3.37],0.0848408744781026
Chapter II Neoplasms,Carcinoma in situ of breast,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22644,136,1.03 [0.67-1.61],0.8798412629129067
Chapter II Neoplasms,Carcinoma in situ of breast,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,18979,115,1.09 [0.61-1.96],0.7683587612289153
Chapter II Neoplasms,Carcinoma in situ of breast,LRP1,Prolow-density lipoprotein receptor-related protein 1,22413,140,0.95 [0.54-1.69],0.867132784590002
Chapter II Neoplasms,Carcinoma in situ of breast,LRP11,Low-density lipoprotein receptor-related protein 11,22518,139,0.91 [0.59-1.40],0.6591197978045149
Chapter II Neoplasms,Carcinoma in situ of breast,LRP2,Low-density lipoprotein receptor-related protein 2,19054,119,0.60 [0.35-1.03],0.0638708893077563
Chapter II Neoplasms,Carcinoma in situ of breast,LRP2BP,LRP2-binding protein,19054,119,0.99 [0.81-1.22],0.9199598781778888
Chapter II Neoplasms,Carcinoma in situ of breast,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22715,138,0.86 [0.64-1.15],0.3018502394233479
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC25,Leucine-rich repeat-containing protein 25,22413,140,1.00 [0.68-1.47],0.9923686609853308
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC37A2,Leucine-rich repeat-containing protein 37A2,19501,122,1.13 [0.75-1.70],0.5682936873840784
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC38,Leucine-rich repeat-containing protein 38,19054,119,1.07 [0.76-1.51],0.6915039162768821
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC59,Leucine-rich repeat-containing protein 59,19600,119,0.61 [0.40-0.93],0.0223340368730921
Chapter II Neoplasms,Carcinoma in situ of breast,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19495,120,0.69 [0.46-1.02],0.0626560484077458
Chapter II Neoplasms,Carcinoma in situ of breast,LRRN1,Leucine-rich repeat neuronal protein 1,22090,138,1.36 [0.91-2.02],0.135492675845592
Chapter II Neoplasms,Carcinoma in situ of breast,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19054,119,0.66 [0.40-1.08],0.0997387238361225
Chapter II Neoplasms,Carcinoma in situ of breast,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19571,121,0.98 [0.52-1.87],0.9566200874811857
Chapter II Neoplasms,Carcinoma in situ of breast,LSM1,U6 snRNA-associated Sm-like protein LSm1,22008,134,0.87 [0.65-1.18],0.373038085974991
Chapter II Neoplasms,Carcinoma in situ of breast,LSM8,U6 snRNA-associated Sm-like protein LSm8,19223,122,1.00 [0.82-1.21],0.9711711749950204
Chapter II Neoplasms,Carcinoma in situ of breast,LSP1,Lymphocyte-specific protein 1,22477,136,1.12 [0.77-1.62],0.5549795949094591
Chapter II Neoplasms,Carcinoma in situ of breast,LTA,Lymphotoxin-alpha,22477,136,0.95 [0.65-1.39],0.7832903175298553
Chapter II Neoplasms,Carcinoma in situ of breast,LTA4H,Leukotriene A-4 hydrolase,22716,137,1.04 [0.80-1.35],0.7709478079072536
Chapter II Neoplasms,Carcinoma in situ of breast,LTB,Lymphotoxin-beta,19495,120,1.01 [0.62-1.66],0.952595244847072
Chapter II Neoplasms,Carcinoma in situ of breast,LTBP2,Latent-transforming growth factor beta-binding protein 2,22786,138,1.12 [0.70-1.81],0.6370981085418339
Chapter II Neoplasms,Carcinoma in situ of breast,LTBP3,Latent-transforming growth factor beta-binding protein 3,22008,134,0.97 [0.73-1.29],0.8251186736224347
Chapter II Neoplasms,Carcinoma in situ of breast,LTBR,Tumor necrosis factor receptor superfamily member 3,22408,138,1.41 [0.82-2.43],0.2179432059819178
Chapter II Neoplasms,Carcinoma in situ of breast,LTO1,Protein LTO1 homolog,22090,138,0.89 [0.61-1.31],0.5527168264038105
Chapter II Neoplasms,Carcinoma in situ of breast,LUZP2,Leucine zipper protein 2,19495,120,0.98 [0.66-1.45],0.9112012486514732
Chapter II Neoplasms,Carcinoma in situ of breast,LXN,Latexin,22265,139,1.06 [0.86-1.32],0.5805479493404931
Chapter II Neoplasms,Carcinoma in situ of breast,LY6D,Lymphocyte antigen 6D,22409,138,1.14 [0.76-1.72],0.5356788448284777
Chapter II Neoplasms,Carcinoma in situ of breast,LY75,Lymphocyte antigen 75,22477,136,1.16 [0.78-1.73],0.4531149738752743
Chapter II Neoplasms,Carcinoma in situ of breast,LY9,T-lymphocyte surface antigen Ly-9,22298,137,0.82 [0.47-1.40],0.4628245294784683
Chapter II Neoplasms,Carcinoma in situ of breast,LY96,Lymphocyte antigen 96,22368,139,0.90 [0.57-1.40],0.6286288655149194
Chapter II Neoplasms,Carcinoma in situ of breast,LYAR,Cell growth-regulating nucleolar protein,22008,134,0.84 [0.60-1.17],0.2958272672615052
Chapter II Neoplasms,Carcinoma in situ of breast,LYN,Tyrosine-protein kinase Lyn,22413,140,0.83 [0.70-0.99],0.0362515100503693
Chapter II Neoplasms,Carcinoma in situ of breast,LYPD1,Ly6/PLAUR domain-containing protein 1,21957,134,0.74 [0.54-1.03],0.0728159737303943
Chapter II Neoplasms,Carcinoma in situ of breast,LYPD3,Ly6/PLAUR domain-containing protein 3,22399,140,1.40 [0.92-2.11],0.1129389115596768
Chapter II Neoplasms,Carcinoma in situ of breast,LYPD8,Ly6/PLAUR domain-containing protein 8,22008,134,0.81 [0.59-1.12],0.2016292544135121
Chapter II Neoplasms,Carcinoma in situ of breast,LYPLA2,Acyl-protein thioesterase 2,18997,118,1.03 [0.88-1.20],0.7282912971519802
Chapter II Neoplasms,Carcinoma in situ of breast,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19054,119,0.83 [0.68-1.01],0.0628649346665095
Chapter II Neoplasms,Carcinoma in situ of breast,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19630,119,0.75 [0.31-1.83],0.5335847340116893
Chapter II Neoplasms,Carcinoma in situ of breast,LYZL2,Lysozyme-like protein 2,18908,119,1.11 [0.70-1.77],0.6604182604484325
Chapter II Neoplasms,Carcinoma in situ of breast,LZTFL1,Leucine zipper transcription factor-like protein 1,19191,120,0.82 [0.64-1.06],0.1252163517654485
Chapter II Neoplasms,Carcinoma in situ of breast,M6PR,Cation-dependent mannose-6-phosphate receptor,19106,119,1.09 [0.73-1.62],0.6694344277941111
Chapter II Neoplasms,Carcinoma in situ of breast,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22284,138,1.06 [0.79-1.43],0.6900001147665304
Chapter II Neoplasms,Carcinoma in situ of breast,MAEA,E3 ubiquitin-protein transferase MAEA,22008,134,0.64 [0.42-0.99],0.0440991057322815
Chapter II Neoplasms,Carcinoma in situ of breast,MAG,Myelin-associated glycoprotein,19054,119,1.05 [0.72-1.52],0.81869318349217
Chapter II Neoplasms,Carcinoma in situ of breast,MAGEA3,Melanoma-associated antigen 3,19223,122,0.94 [0.77-1.14],0.5080692131827882
Chapter II Neoplasms,Carcinoma in situ of breast,MAGED1,Melanoma-associated antigen D1,22008,134,0.77 [0.55-1.08],0.1303835637874322
Chapter II Neoplasms,Carcinoma in situ of breast,MAMDC2,MAM domain-containing protein 2,19600,119,1.19 [0.71-1.99],0.5106242367176219
Chapter II Neoplasms,Carcinoma in situ of breast,MAMDC4,Apical endosomal glycoprotein,19495,120,1.17 [0.85-1.60],0.3317749554515975
Chapter II Neoplasms,Carcinoma in situ of breast,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19106,119,1.58 [0.79-3.13],0.19308547022299
Chapter II Neoplasms,Carcinoma in situ of breast,MAN2B2,Epididymis-specific alpha-mannosidase,19600,119,1.09 [0.81-1.46],0.5840498421322049
Chapter II Neoplasms,Carcinoma in situ of breast,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",18908,119,0.94 [0.66-1.34],0.7394309833312136
Chapter II Neoplasms,Carcinoma in situ of breast,MANF,Mesencephalic astrocyte-derived neurotrophic factor,22619,141,0.86 [0.77-0.97],0.0118170744142551
Chapter II Neoplasms,Carcinoma in situ of breast,MANSC1,MANSC domain-containing protein 1,22586,140,1.50 [0.88-2.58],0.1394850098610395
Chapter II Neoplasms,Carcinoma in situ of breast,MANSC4,MANSC domain-containing protein 4,19003,118,0.78 [0.58-1.04],0.0887017400837784
Chapter II Neoplasms,Carcinoma in situ of breast,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,18997,118,0.96 [0.55-1.67],0.8788509575581546
Chapter II Neoplasms,Carcinoma in situ of breast,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19003,118,1.05 [0.82-1.35],0.6736203551909665
Chapter II Neoplasms,Carcinoma in situ of breast,MAP2,Microtubule-associated protein 2,19562,122,0.56 [0.36-0.87],0.0102311209965139
Chapter II Neoplasms,Carcinoma in situ of breast,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19501,122,0.76 [0.58-1.00],0.0525165381237098
Chapter II Neoplasms,Carcinoma in situ of breast,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22477,136,0.88 [0.76-1.02],0.0890655480518484
Chapter II Neoplasms,Carcinoma in situ of breast,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22008,134,0.76 [0.64-0.91],0.0020128587951681
Chapter II Neoplasms,Carcinoma in situ of breast,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22320,139,0.86 [0.75-0.98],0.0249945845613826
Chapter II Neoplasms,Carcinoma in situ of breast,MAPK13,Mitogen-activated protein kinase 13,18908,119,1.16 [0.80-1.67],0.4352810211609532
Chapter II Neoplasms,Carcinoma in situ of breast,MAPK9,Mitogen-activated protein kinase 9,22477,136,0.86 [0.60-1.22],0.3898834124989913
Chapter II Neoplasms,Carcinoma in situ of breast,MAPKAPK2,MAP kinase-activated protein kinase 2,19223,122,0.81 [0.63-1.03],0.0815372344221127
Chapter II Neoplasms,Carcinoma in situ of breast,MAPRE3,Microtubule-associated protein RP/EB family member 3,18908,119,0.93 [0.81-1.07],0.2958850100073841
Chapter II Neoplasms,Carcinoma in situ of breast,MAPT,Microtubule-associated protein tau,21957,134,1.01 [0.75-1.35],0.9511422730806508
Chapter II Neoplasms,Carcinoma in situ of breast,MARCO,Macrophage receptor MARCO,22518,139,1.06 [0.60-1.87],0.8453625374233009
Chapter II Neoplasms,Carcinoma in situ of breast,MARS1,"Methionine--tRNA ligase, cytoplasmic",19148,120,0.87 [0.70-1.07],0.1775042230497485
Chapter II Neoplasms,Carcinoma in situ of breast,MASP1,Mannan-binding lectin serine protease 1,22320,139,1.26 [0.66-2.37],0.4837990355648858
Chapter II Neoplasms,Carcinoma in situ of breast,MATN2,Matrilin-2,22552,140,1.16 [0.70-1.92],0.5629122527567678
Chapter II Neoplasms,Carcinoma in situ of breast,MATN3,Matrilin-3,22333,139,1.36 [0.84-2.18],0.2071731766512453
Chapter II Neoplasms,Carcinoma in situ of breast,MAVS,Mitochondrial antiviral-signaling protein,22008,134,0.80 [0.67-0.95],0.0111333763958432
Chapter II Neoplasms,Carcinoma in situ of breast,MAX,Protein max,21957,134,0.85 [0.73-0.99],0.0316110049017185
Chapter II Neoplasms,Carcinoma in situ of breast,MB,Myoglobin,22786,138,1.04 [0.77-1.41],0.8062183064787013
Chapter II Neoplasms,Carcinoma in situ of breast,MBL2,Mannose-binding protein C,19344,117,1.05 [0.89-1.23],0.6002810173499975
Chapter II Neoplasms,Carcinoma in situ of breast,MCAM,Cell surface glycoprotein MUC18,22579,139,1.84 [1.23-2.74],0.0030523412593273
Chapter II Neoplasms,Carcinoma in situ of breast,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19571,121,0.82 [0.53-1.28],0.3778106124702248
Chapter II Neoplasms,Carcinoma in situ of breast,MCEMP1,Mast cell-expressed membrane protein 1,19054,117,0.87 [0.71-1.06],0.1772958775115559
Chapter II Neoplasms,Carcinoma in situ of breast,MCFD2,Multiple coagulation factor deficiency protein 2,22421,139,0.83 [0.59-1.18],0.2963246922906192
Chapter II Neoplasms,Carcinoma in situ of breast,MCTS1,Malignant T-cell-amplified sequence 1,19501,122,0.81 [0.40-1.66],0.5706405217548403
Chapter II Neoplasms,Carcinoma in situ of breast,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22368,139,0.94 [0.76-1.16],0.5581241411420602
Chapter II Neoplasms,Carcinoma in situ of breast,MDH1,"Malate dehydrogenase, cytoplasmic",19484,119,0.62 [0.40-0.99],0.0438190645490581
Chapter II Neoplasms,Carcinoma in situ of breast,MDK,Midkine,22527,139,0.80 [0.59-1.09],0.1569032940230662
Chapter II Neoplasms,Carcinoma in situ of breast,MDM1,Nuclear protein MDM1,19054,119,0.45 [0.25-0.82],0.00850307649449
Chapter II Neoplasms,Carcinoma in situ of breast,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19106,119,0.89 [0.73-1.09],0.252241947409124
Chapter II Neoplasms,Carcinoma in situ of breast,MED18,Mediator of RNA polymerase II transcription subunit 18,22008,134,0.81 [0.66-0.99],0.0364143006542405
Chapter II Neoplasms,Carcinoma in situ of breast,MED21,Mediator of RNA polymerase II transcription subunit 21,19003,118,1.05 [0.75-1.47],0.7719675592919352
Chapter II Neoplasms,Carcinoma in situ of breast,MEGF10,Multiple epidermal growth factor-like domains protein 10,22510,140,0.99 [0.67-1.46],0.960456914915686
Chapter II Neoplasms,Carcinoma in situ of breast,MEGF11,Multiple epidermal growth factor-like domains protein 11,19003,118,0.65 [0.35-1.22],0.1825784310277469
Chapter II Neoplasms,Carcinoma in situ of breast,MEGF9,Multiple epidermal growth factor-like domains protein 9,22718,136,1.30 [0.64-2.62],0.4715463557810471
Chapter II Neoplasms,Carcinoma in situ of breast,MELTF,Melanotransferrin,19600,119,0.53 [0.29-0.95],0.032266403344469
Chapter II Neoplasms,Carcinoma in situ of breast,MENT,Protein MENT,19191,120,1.74 [0.77-3.92],0.1825844497881414
Chapter II Neoplasms,Carcinoma in situ of breast,MEP1A,Meprin A subunit alpha,19501,122,0.99 [0.77-1.27],0.9431784385591644
Chapter II Neoplasms,Carcinoma in situ of breast,MEP1B,Meprin A subunit beta,22518,139,1.00 [0.89-1.14],0.9403720935147916
Chapter II Neoplasms,Carcinoma in situ of breast,MEPE,Matrix extracellular phosphoglycoprotein,22510,140,0.79 [0.46-1.36],0.3971626955639403
Chapter II Neoplasms,Carcinoma in situ of breast,MERTK,Tyrosine-protein kinase Mer,22764,139,0.97 [0.55-1.72],0.9197810978746728
Chapter II Neoplasms,Carcinoma in situ of breast,MESD,LRP chaperone MESD,22524,138,0.87 [0.77-0.99],0.0318923609189174
Chapter II Neoplasms,Carcinoma in situ of breast,MET,Hepatocyte growth factor receptor,22573,135,1.00 [0.47-2.12],0.99462755236945
Chapter II Neoplasms,Carcinoma in situ of breast,METAP1,Methionine aminopeptidase 1,21957,134,1.00 [0.60-1.65],0.9873967208226188
Chapter II Neoplasms,Carcinoma in situ of breast,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22477,136,0.95 [0.79-1.14],0.587852616636904
Chapter II Neoplasms,Carcinoma in situ of breast,METAP2,Methionine aminopeptidase 2,22677,137,0.73 [0.57-0.94],0.0133536183262664
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP3,Microfibril-associated glycoprotein 3,22115,137,1.16 [0.88-1.51],0.2858534232649393
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP3L,Microfibrillar-associated protein 3-like,19054,119,0.90 [0.67-1.20],0.4700388698630523
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP4,Microfibril-associated glycoprotein 4,19191,120,1.13 [0.65-1.98],0.6685738093697108
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP5,Microfibrillar-associated protein 5,22786,138,1.09 [0.76-1.58],0.630833687941168
Chapter II Neoplasms,Carcinoma in situ of breast,MFGE8,Lactadherin,22524,138,0.84 [0.58-1.21],0.3518241290541962
Chapter II Neoplasms,Carcinoma in situ of breast,MGLL,Monoglyceride lipase,22580,141,0.85 [0.72-1.01],0.0615856612863934
Chapter II Neoplasms,Carcinoma in situ of breast,MGMT,Methylated-DNA--protein-cysteine methyltransferase,22477,136,0.92 [0.82-1.04],0.1727194848910576
Chapter II Neoplasms,Carcinoma in situ of breast,MIA,Melanoma-derived growth regulatory protein,22586,140,1.15 [0.77-1.71],0.5090808394994613
Chapter II Neoplasms,Carcinoma in situ of breast,MICALL2,MICAL-like protein 2,19054,119,0.57 [0.42-0.79],0.0005587921219136
Chapter II Neoplasms,Carcinoma in situ of breast,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22477,136,0.96 [0.87-1.05],0.3440756841367448
Chapter II Neoplasms,Carcinoma in situ of breast,MIF,Macrophage migration inhibitory factor,22494,138,0.80 [0.65-0.99],0.0442690233837224
Chapter II Neoplasms,Carcinoma in situ of breast,MILR1,Allergin-1,22090,138,0.88 [0.65-1.21],0.4376584252856693
Chapter II Neoplasms,Carcinoma in situ of breast,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19495,120,0.79 [0.68-0.93],0.0043793978057676
Chapter II Neoplasms,Carcinoma in situ of breast,MINK1,Misshapen-like kinase 1,19562,122,0.80 [0.66-0.96],0.015817897325442
Chapter II Neoplasms,Carcinoma in situ of breast,MITD1,MIT domain-containing protein 1,22368,139,0.84 [0.72-0.98],0.0234958431494902
Chapter II Neoplasms,Carcinoma in situ of breast,MKI67,Proliferation marker protein Ki-67,19054,117,1.19 [0.81-1.76],0.3736933789187058
Chapter II Neoplasms,Carcinoma in situ of breast,MLLT1,Protein ENL,18908,119,1.13 [0.90-1.41],0.2933800493916113
Chapter II Neoplasms,Carcinoma in situ of breast,MLN,Promotilin,22477,136,1.01 [0.85-1.20],0.8992504524101674
Chapter II Neoplasms,Carcinoma in situ of breast,MME,Neprilysin,22413,140,1.01 [0.85-1.22],0.8751556153695399
Chapter II Neoplasms,Carcinoma in situ of breast,MMP1,Interstitial collagenase,21651,134,0.80 [0.68-0.94],0.0058900994114211
Chapter II Neoplasms,Carcinoma in situ of breast,MMP10,Stromelysin-2,22478,139,0.94 [0.73-1.21],0.6448564511692154
Chapter II Neoplasms,Carcinoma in situ of breast,MMP12,Macrophage metalloelastase,22536,136,0.90 [0.67-1.22],0.5095101026657534
Chapter II Neoplasms,Carcinoma in situ of breast,MMP13,Collagenase 3,21957,134,1.31 [0.82-2.10],0.2548249919717691
Chapter II Neoplasms,Carcinoma in situ of breast,MMP15,Matrix metalloproteinase-15,19600,119,1.04 [0.75-1.45],0.7936627967709848
Chapter II Neoplasms,Carcinoma in situ of breast,MMP3,Stromelysin-1,22524,138,1.38 [1.02-1.85],0.035609139563686
Chapter II Neoplasms,Carcinoma in situ of breast,MMP7,Matrilysin,22074,137,0.93 [0.68-1.28],0.6751070910578518
Chapter II Neoplasms,Carcinoma in situ of breast,MMP8,Neutrophil collagenase,22675,138,1.10 [0.90-1.34],0.3399534892283242
Chapter II Neoplasms,Carcinoma in situ of breast,MMP9,Matrix metalloproteinase-9,22483,138,1.09 [0.85-1.39],0.4970764090523999
Chapter II Neoplasms,Carcinoma in situ of breast,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19003,118,0.90 [0.62-1.30],0.5762763063699028
Chapter II Neoplasms,Carcinoma in situ of breast,MN1,Transcriptional activator MN1,19054,119,0.75 [0.53-1.08],0.119837624775119
Chapter II Neoplasms,Carcinoma in situ of breast,MNAT1,CDK-activating kinase assembly factor MAT1,19223,122,1.24 [0.88-1.76],0.2236230951499614
Chapter II Neoplasms,Carcinoma in situ of breast,MNDA,Myeloid cell nuclear differentiation antigen,22483,139,1.07 [0.93-1.23],0.3651842737791306
Chapter II Neoplasms,Carcinoma in situ of breast,MOCS2,Molybdopterin synthase catalytic subunit,19191,120,0.71 [0.54-0.94],0.0164201710023543
Chapter II Neoplasms,Carcinoma in situ of breast,MOG,Myelin-oligodendrocyte glycoprotein,22716,137,1.07 [0.67-1.73],0.7667445257246154
Chapter II Neoplasms,Carcinoma in situ of breast,MORC3,MORC family CW-type zinc finger protein 3,19562,122,1.26 [0.74-2.15],0.3992715070632116
Chapter II Neoplasms,Carcinoma in situ of breast,MORF4L1,Mortality factor 4-like protein 1,19223,122,0.86 [0.54-1.36],0.5110246063745046
Chapter II Neoplasms,Carcinoma in situ of breast,MORF4L2,Mortality factor 4-like protein 2,18908,119,0.92 [0.56-1.50],0.7265478388196642
Chapter II Neoplasms,Carcinoma in situ of breast,MORN4,MORN repeat-containing protein 4,18908,119,0.79 [0.60-1.05],0.1016103228669137
Chapter II Neoplasms,Carcinoma in situ of breast,MPHOSPH8,M-phase phosphoprotein 8,22115,137,0.87 [0.70-1.07],0.1843632328934735
Chapter II Neoplasms,Carcinoma in situ of breast,MPI,Mannose-6-phosphate isomerase,22413,140,0.84 [0.70-1.00],0.0484971340748043
Chapter II Neoplasms,Carcinoma in situ of breast,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22580,141,0.81 [0.68-0.97],0.0214393708560965
Chapter II Neoplasms,Carcinoma in situ of breast,MPO,Myeloperoxidase,22524,138,1.07 [0.79-1.47],0.6526123618457809
Chapter II Neoplasms,Carcinoma in situ of breast,MPRIP,Myosin phosphatase Rho-interacting protein,19452,120,0.76 [0.50-1.14],0.1776441767814648
Chapter II Neoplasms,Carcinoma in situ of breast,MRC1,Macrophage mannose receptor 1,19605,119,0.98 [0.53-1.83],0.9495131928565432
Chapter II Neoplasms,Carcinoma in situ of breast,MRI1,Methylthioribose-1-phosphate isomerase,19054,119,0.90 [0.70-1.16],0.4186294090320713
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL24,"39S ribosomal protein L24, mitochondrial",19003,118,1.13 [0.76-1.70],0.537837050454602
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL28,"39S ribosomal protein L28, mitochondrial",19571,121,1.09 [0.72-1.66],0.6917697339305713
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL46,"39S ribosomal protein L46, mitochondrial",21957,134,1.29 [0.77-2.16],0.3334221799956724
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL52,"39S ribosomal protein L52, mitochondrial",18880,119,1.08 [0.55-2.14],0.8271675714715236
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19571,121,0.62 [0.45-0.86],0.0040889467722745
Chapter II Neoplasms,Carcinoma in situ of breast,MRPS16,"28S ribosomal protein S16, mitochondrial",19054,117,1.64 [1.09-2.48],0.0185864398790965
Chapter II Neoplasms,Carcinoma in situ of breast,MSLN,Mesothelin,22382,140,0.99 [0.74-1.32],0.9325446704888026
Chapter II Neoplasms,Carcinoma in situ of breast,MSLNL,Mesothelin-like protein,19054,119,0.64 [0.39-1.07],0.0903264193413717
Chapter II Neoplasms,Carcinoma in situ of breast,MSMB,Beta-microseminoprotein,22431,137,1.13 [0.90-1.41],0.2894209996989265
Chapter II Neoplasms,Carcinoma in situ of breast,MSR1,Macrophage scavenger receptor types I and II,22715,138,1.07 [0.77-1.50],0.6829830091957394
Chapter II Neoplasms,Carcinoma in situ of breast,MSRA,Mitochondrial peptide methionine sulfoxide reductase,22586,140,0.86 [0.70-1.05],0.1403969231085086
Chapter II Neoplasms,Carcinoma in situ of breast,MST1,Hepatocyte growth factor-like protein,19292,116,0.99 [0.75-1.32],0.9682649367354852
Chapter II Neoplasms,Carcinoma in situ of breast,MSTN,Growth/differentiation factor 8,22115,137,0.96 [0.71-1.29],0.7855811002332737
Chapter II Neoplasms,Carcinoma in situ of breast,MTDH,Protein LYRIC,19054,117,0.87 [0.71-1.06],0.1769819955981183
Chapter II Neoplasms,Carcinoma in situ of breast,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19562,122,0.66 [0.31-1.40],0.2741612106620882
Chapter II Neoplasms,Carcinoma in situ of breast,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19223,122,0.92 [0.78-1.07],0.2719396843276991
Chapter II Neoplasms,Carcinoma in situ of breast,MTIF3,"Translation initiation factor IF-3, mitochondrial",19501,122,0.89 [0.73-1.09],0.2678940452360078
Chapter II Neoplasms,Carcinoma in situ of breast,MTPN,Myotrophin,22115,137,0.95 [0.59-1.52],0.8287056514408909
Chapter II Neoplasms,Carcinoma in situ of breast,MTR,Methionine synthase,19003,118,0.86 [0.64-1.17],0.3489815781941424
Chapter II Neoplasms,Carcinoma in situ of breast,MTSS1,Protein MTSS 1,19501,122,0.77 [0.66-0.91],0.0015388787276213
Chapter II Neoplasms,Carcinoma in situ of breast,MTSS2,Protein MTSS 2,19495,120,0.90 [0.75-1.08],0.2563331704849637
Chapter II Neoplasms,Carcinoma in situ of breast,MTUS1,Microtubule-associated tumor suppressor 1,19223,122,0.94 [0.69-1.29],0.7099289360295785
Chapter II Neoplasms,Carcinoma in situ of breast,MUC13,Mucin-13,21957,134,0.89 [0.65-1.22],0.4606334418505262
Chapter II Neoplasms,Carcinoma in situ of breast,MUC16,Mucin-16,22413,140,1.02 [0.95-1.11],0.5519361210374079
Chapter II Neoplasms,Carcinoma in situ of breast,MUC2,Mucin-2,19597,123,0.98 [0.81-1.18],0.7985271018091675
Chapter II Neoplasms,Carcinoma in situ of breast,MUCL3,Mucin-like protein 3,18908,119,0.97 [0.65-1.44],0.8769465941707312
Chapter II Neoplasms,Carcinoma in situ of breast,MVK,Mevalonate kinase,22090,138,0.84 [0.68-1.03],0.0941740971418248
Chapter II Neoplasms,Carcinoma in situ of breast,MXRA8,Matrix remodeling-associated protein 8,19191,120,1.20 [0.67-2.13],0.5359921980225943
Chapter II Neoplasms,Carcinoma in situ of breast,MYBPC1,"Myosin-binding protein C, slow-type",19600,119,0.88 [0.66-1.17],0.3659941838546906
Chapter II Neoplasms,Carcinoma in situ of breast,MYBPC2,"Myosin-binding protein C, fast-type",19106,119,0.93 [0.74-1.17],0.5228240437544531
Chapter II Neoplasms,Carcinoma in situ of breast,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19571,121,0.83 [0.63-1.10],0.1940047369126412
Chapter II Neoplasms,Carcinoma in situ of breast,MYDGF,Myeloid-derived growth factor,19600,119,0.86 [0.72-1.02],0.0905784853342344
Chapter II Neoplasms,Carcinoma in situ of breast,MYH4,Myosin-4,19003,118,0.95 [0.64-1.41],0.7967249227839377
Chapter II Neoplasms,Carcinoma in situ of breast,MYH7B,Myosin-7B,18908,119,1.07 [0.74-1.56],0.7202120049816871
Chapter II Neoplasms,Carcinoma in situ of breast,MYH9,Myosin-9,19597,123,0.92 [0.79-1.07],0.2908933724706771
Chapter II Neoplasms,Carcinoma in situ of breast,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19003,118,1.12 [0.76-1.66],0.5572887135655455
Chapter II Neoplasms,Carcinoma in situ of breast,MYL3,Myosin light chain 3,19106,119,0.93 [0.71-1.20],0.5617237410196805
Chapter II Neoplasms,Carcinoma in situ of breast,MYL4,Myosin light chain 4,19106,119,1.03 [0.75-1.42],0.8458170559237947
Chapter II Neoplasms,Carcinoma in situ of breast,MYL6B,Myosin light chain 6B,19054,119,0.98 [0.81-1.19],0.823343474380784
Chapter II Neoplasms,Carcinoma in situ of breast,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19054,119,0.64 [0.38-1.08],0.0963040185042531
Chapter II Neoplasms,Carcinoma in situ of breast,MYO6,Unconventional myosin-VI,19571,121,0.60 [0.34-1.05],0.0748229113468442
Chapter II Neoplasms,Carcinoma in situ of breast,MYO9B,Unconventional myosin-IXb,22090,138,0.80 [0.63-1.03],0.0781127426898972
Chapter II Neoplasms,Carcinoma in situ of breast,MYOC,Myocilin,22524,138,0.92 [0.66-1.28],0.626667479716459
Chapter II Neoplasms,Carcinoma in situ of breast,MYOM1,Myomesin-1,18997,118,1.04 [0.73-1.49],0.830204512754438
Chapter II Neoplasms,Carcinoma in situ of breast,MYOM2,Myomesin-2,19003,118,0.77 [0.50-1.16],0.2120066629894541
Chapter II Neoplasms,Carcinoma in situ of breast,MYOM3,Myomesin-3,19191,120,1.03 [0.85-1.25],0.7346321085372025
Chapter II Neoplasms,Carcinoma in situ of breast,MZB1,Marginal zone B- and B1-cell-specific protein,22591,140,0.83 [0.61-1.13],0.2384352640739434
Chapter II Neoplasms,Carcinoma in situ of breast,MZT1,Mitotic-spindle organizing protein 1,22008,134,0.77 [0.56-1.07],0.1161353099159118
Chapter II Neoplasms,Carcinoma in situ of breast,NAA10,N-alpha-acetyltransferase 10,19003,118,0.66 [0.47-0.93],0.0168914683042855
Chapter II Neoplasms,Carcinoma in situ of breast,NAA80,N-alpha-acetyltransferase 80,19054,119,0.85 [0.73-0.99],0.0323822087401629
Chapter II Neoplasms,Carcinoma in situ of breast,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22263,138,0.85 [0.65-1.10],0.2209374072479192
Chapter II Neoplasms,Carcinoma in situ of breast,NACC1,Nucleus accumbens-associated protein 1,19495,120,0.77 [0.54-1.08],0.1259678194814429
Chapter II Neoplasms,Carcinoma in situ of breast,NADK,NAD kinase,22518,139,1.13 [0.88-1.45],0.3309900318511605
Chapter II Neoplasms,Carcinoma in situ of breast,NAGA,Alpha-N-acetylgalactosaminidase,19015,117,0.86 [0.62-1.21],0.3931725301239879
Chapter II Neoplasms,Carcinoma in situ of breast,NAGK,N-acetyl-D-glucosamine kinase,19069,119,1.00 [0.73-1.36],0.9817257708816184
Chapter II Neoplasms,Carcinoma in situ of breast,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19191,120,1.24 [0.54-2.83],0.6114297587885127
Chapter II Neoplasms,Carcinoma in situ of breast,NAMPT,Nicotinamide phosphoribosyltransferase,22008,134,0.90 [0.66-1.22],0.488368841744987
Chapter II Neoplasms,Carcinoma in situ of breast,NAP1L4,Nucleosome assembly protein 1-like 4,19473,122,0.75 [0.51-1.12],0.1614839658766096
Chapter II Neoplasms,Carcinoma in situ of breast,NAPRT,Nicotinate phosphoribosyltransferase,19562,122,0.87 [0.51-1.49],0.6136166867655133
Chapter II Neoplasms,Carcinoma in situ of breast,NARS1,"Asparagine--tRNA ligase, cytoplasmic",19571,121,0.77 [0.54-1.10],0.1489319758388827
Chapter II Neoplasms,Carcinoma in situ of breast,NBL1,Neuroblastoma suppressor of tumorigenicity 1,22586,140,1.28 [0.72-2.28],0.4059947062321513
Chapter II Neoplasms,Carcinoma in situ of breast,NBN,Nibrin,22090,138,0.88 [0.64-1.21],0.4355389671567815
Chapter II Neoplasms,Carcinoma in situ of breast,NCAM1,Neural cell adhesion molecule 1,22579,139,2.07 [1.27-3.39],0.003765715459711
Chapter II Neoplasms,Carcinoma in situ of breast,NCAM2,Neural cell adhesion molecule 2,22524,138,1.47 [0.84-2.55],0.1735627875880748
Chapter II Neoplasms,Carcinoma in situ of breast,NCAN,Neurocan core protein,22715,138,0.85 [0.57-1.27],0.433173154034653
Chapter II Neoplasms,Carcinoma in situ of breast,NCF2,Neutrophil cytosol factor 2,22449,135,1.07 [0.91-1.27],0.4108385235661321
Chapter II Neoplasms,Carcinoma in situ of breast,NCK2,Cytoplasmic protein NCK2,22619,141,0.85 [0.74-0.98],0.0216660056998741
Chapter II Neoplasms,Carcinoma in situ of breast,NCLN,Nicalin,22090,138,0.93 [0.69-1.25],0.6273151553477101
Chapter II Neoplasms,Carcinoma in situ of breast,NCR1,Natural cytotoxicity triggering receptor 1,22444,136,1.13 [0.74-1.73],0.5654702484845908
Chapter II Neoplasms,Carcinoma in situ of breast,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19501,122,1.29 [0.76-2.18],0.3453821973535802
Chapter II Neoplasms,Carcinoma in situ of breast,NCS1,Neuronal calcium sensor 1,22716,137,0.81 [0.48-1.39],0.4473015639243622
Chapter II Neoplasms,Carcinoma in situ of breast,NDRG1,Protein NDRG1,21957,134,0.89 [0.70-1.14],0.3532274945739172
Chapter II Neoplasms,Carcinoma in situ of breast,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19495,120,1.11 [0.87-1.41],0.4049963988728389
Chapter II Neoplasms,Carcinoma in situ of breast,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19020,117,0.91 [0.54-1.51],0.7026572249045068
Chapter II Neoplasms,Carcinoma in situ of breast,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19501,122,0.84 [0.69-1.02],0.0789367912267967
Chapter II Neoplasms,Carcinoma in situ of breast,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22008,134,0.91 [0.74-1.13],0.3985871812121689
Chapter II Neoplasms,Carcinoma in situ of breast,NEB,Nebulin,19003,118,0.54 [0.30-0.98],0.042857630316555
Chapter II Neoplasms,Carcinoma in situ of breast,NECAP2,Adaptin ear-binding coat-associated protein 2,19003,118,0.77 [0.57-1.03],0.0742518079150527
Chapter II Neoplasms,Carcinoma in situ of breast,NECTIN1,Nectin-1,19054,117,1.27 [0.76-2.14],0.365697788168555
Chapter II Neoplasms,Carcinoma in situ of breast,NECTIN2,Nectin-2,22484,139,0.71 [0.41-1.23],0.2188777186330583
Chapter II Neoplasms,Carcinoma in situ of breast,NECTIN4,Nectin-4,22586,140,1.64 [1.03-2.61],0.0374049496015306
Chapter II Neoplasms,Carcinoma in situ of breast,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19054,117,0.89 [0.62-1.28],0.5288580690938854
Chapter II Neoplasms,Carcinoma in situ of breast,NEDD9,Enhancer of filamentation 1,19054,117,1.39 [0.90-2.14],0.1359632579321266
Chapter II Neoplasms,Carcinoma in situ of breast,NEFL,Neurofilament light polypeptide,21879,134,1.34 [0.94-1.93],0.1101092715891855
Chapter II Neoplasms,Carcinoma in situ of breast,NEK7,Serine/threonine-protein kinase Nek7,19223,122,0.93 [0.73-1.19],0.583839336373393
Chapter II Neoplasms,Carcinoma in situ of breast,NELL1,Protein kinase C-binding protein NELL1,22586,140,0.98 [0.68-1.40],0.9129740776214048
Chapter II Neoplasms,Carcinoma in situ of breast,NELL2,Protein kinase C-binding protein NELL2,22619,141,0.43 [0.25-0.73],0.002072676680211
Chapter II Neoplasms,Carcinoma in situ of breast,NENF,Neudesin,19495,120,0.97 [0.83-1.14],0.7493736092983578
Chapter II Neoplasms,Carcinoma in situ of breast,NEO1,Neogenin,19571,121,1.82 [0.94-3.55],0.0760750156032527
Chapter II Neoplasms,Carcinoma in situ of breast,NEXN,Nexilin,19605,119,0.88 [0.67-1.14],0.3275514984472293
Chapter II Neoplasms,Carcinoma in situ of breast,NFASC,Neurofascin,22764,139,0.66 [0.38-1.17],0.1559042247341205
Chapter II Neoplasms,Carcinoma in situ of breast,NFAT5,Nuclear factor of activated T-cells 5,19054,117,0.83 [0.67-1.04],0.1078879995849224
Chapter II Neoplasms,Carcinoma in situ of breast,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22477,136,0.84 [0.71-0.99],0.0336656627008086
Chapter II Neoplasms,Carcinoma in situ of breast,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22090,138,0.81 [0.61-1.07],0.1350324443567166
Chapter II Neoplasms,Carcinoma in situ of breast,NFE2,Transcription factor NF-E2 45 kDa subunit,19106,119,0.78 [0.61-1.00],0.0456173327268218
Chapter II Neoplasms,Carcinoma in situ of breast,NFIC,Nuclear factor 1 C-type,19571,121,0.88 [0.56-1.38],0.5780352119485381
Chapter II Neoplasms,Carcinoma in situ of breast,NFKB1,Nuclear factor NF-kappa-B p105 subunit,19003,118,0.76 [0.60-0.98],0.0343704259493019
Chapter II Neoplasms,Carcinoma in situ of breast,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19223,122,0.85 [0.59-1.22],0.3782951288107351
Chapter II Neoplasms,Carcinoma in situ of breast,NFKBIE,NF-kappa-B inhibitor epsilon,22008,134,0.58 [0.41-0.81],0.0017696883721028
Chapter II Neoplasms,Carcinoma in situ of breast,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19501,122,0.89 [0.75-1.05],0.1676686731448499
Chapter II Neoplasms,Carcinoma in situ of breast,NFX1,Transcriptional repressor NF-X1,19003,118,0.85 [0.65-1.13],0.2616318628104057
Chapter II Neoplasms,Carcinoma in situ of breast,NFYA,Nuclear transcription factor Y subunit alpha,19003,118,1.40 [0.99-1.97],0.05465565522268
Chapter II Neoplasms,Carcinoma in situ of breast,NGF,Beta-nerve growth factor,22368,139,0.78 [0.23-2.69],0.6938052451893706
Chapter II Neoplasms,Carcinoma in situ of breast,NGFR,Tumor necrosis factor receptor superfamily member 16,19600,119,0.73 [0.38-1.40],0.3461767813411862
Chapter II Neoplasms,Carcinoma in situ of breast,NGRN,Neugrin,19562,122,0.70 [0.30-1.63],0.4071774328683156
Chapter II Neoplasms,Carcinoma in situ of breast,NHLRC3,NHL repeat-containing protein 3,18712,119,1.02 [0.58-1.77],0.9530400956980808
Chapter II Neoplasms,Carcinoma in situ of breast,NID1,Nidogen-1,22502,139,1.04 [0.72-1.52],0.8249682769492458
Chapter II Neoplasms,Carcinoma in situ of breast,NID2,Nidogen-2,22524,138,0.89 [0.72-1.09],0.2528613507228816
Chapter II Neoplasms,Carcinoma in situ of breast,NINJ1,Ninjurin-1,22008,134,0.82 [0.59-1.12],0.2145142734516938
Chapter II Neoplasms,Carcinoma in situ of breast,NIT1,Deaminated glutathione amidase,19106,119,0.81 [0.57-1.15],0.2384830251718629
Chapter II Neoplasms,Carcinoma in situ of breast,NIT2,Omega-amidase NIT2,19531,119,0.84 [0.67-1.06],0.1448775945308636
Chapter II Neoplasms,Carcinoma in situ of breast,NLGN1,Neuroligin-1,19054,119,1.04 [0.82-1.32],0.7324185069127838
Chapter II Neoplasms,Carcinoma in situ of breast,NLGN2,Neuroligin-2,18997,118,1.11 [0.80-1.54],0.5345866888093374
Chapter II Neoplasms,Carcinoma in situ of breast,NME1,Nucleoside diphosphate kinase A,19054,117,1.15 [0.52-2.56],0.7338165687580938
Chapter II Neoplasms,Carcinoma in situ of breast,NME3,Nucleoside diphosphate kinase 3,22552,140,0.97 [0.51-1.83],0.9154739543231544
Chapter II Neoplasms,Carcinoma in situ of breast,NMI,N-myc-interactor,19424,119,0.84 [0.65-1.08],0.1697830297083755
Chapter II Neoplasms,Carcinoma in situ of breast,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22368,139,1.10 [0.91-1.33],0.318748668175939
Chapter II Neoplasms,Carcinoma in situ of breast,NMRK2,Nicotinamide riboside kinase 2,18908,119,0.75 [0.45-1.24],0.2658882771657563
Chapter II Neoplasms,Carcinoma in situ of breast,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19571,121,0.85 [0.64-1.14],0.2808034874087363
Chapter II Neoplasms,Carcinoma in situ of breast,NOMO1,Nodal modulator 1,22524,138,1.17 [0.63-2.19],0.6139721568775908
Chapter II Neoplasms,Carcinoma in situ of breast,NOP56,Nucleolar protein 56,19003,118,0.97 [0.82-1.14],0.7035521250786294
Chapter II Neoplasms,Carcinoma in situ of breast,NOS1,"Nitric oxide synthase, brain",21957,134,1.24 [0.92-1.68],0.154094694741865
Chapter II Neoplasms,Carcinoma in situ of breast,NOS2,"Nitric oxide synthase, inducible",19003,118,1.13 [0.74-1.74],0.5701691940168896
Chapter II Neoplasms,Carcinoma in situ of breast,NOS3,"Nitric oxide synthase, endothelial",21957,134,0.93 [0.69-1.25],0.6220388918193018
Chapter II Neoplasms,Carcinoma in situ of breast,NOTCH1,Neurogenic locus notch homolog protein 1,22786,138,0.93 [0.35-2.47],0.8893863522656266
Chapter II Neoplasms,Carcinoma in situ of breast,NOTCH2,Neurogenic locus notch homolog protein 2,19597,123,2.22 [1.07-4.61],0.0314471147212027
Chapter II Neoplasms,Carcinoma in situ of breast,NOTCH3,Neurogenic locus notch homolog protein 3,22786,138,1.06 [0.69-1.64],0.778568211378183
Chapter II Neoplasms,Carcinoma in situ of breast,NPC2,NPC intracellular cholesterol transporter 2,19263,122,0.83 [0.46-1.49],0.5247577826778922
Chapter II Neoplasms,Carcinoma in situ of breast,NPDC1,Neural proliferation differentiation and control protein 1,22518,139,1.23 [0.75-2.03],0.4080028558661571
Chapter II Neoplasms,Carcinoma in situ of breast,NPHS1,Nephrin,19054,117,0.80 [0.47-1.39],0.4305106796224128
Chapter II Neoplasms,Carcinoma in situ of breast,NPHS2,Podocin,19054,117,1.00 [0.85-1.19],0.9854434782239604
Chapter II Neoplasms,Carcinoma in situ of breast,NPL,N-acetylneuraminate lyase,19600,119,0.93 [0.62-1.40],0.7419729559167982
Chapter II Neoplasms,Carcinoma in situ of breast,NPPB,Natriuretic peptides B,22115,137,1.02 [0.90-1.14],0.8004962016585708
Chapter II Neoplasms,Carcinoma in situ of breast,NPPC,C-type natriuretic peptide,22477,136,0.91 [0.63-1.30],0.5930621091078447
Chapter II Neoplasms,Carcinoma in situ of breast,NPR1,Atrial natriuretic peptide receptor 1,19003,118,0.82 [0.51-1.33],0.4247619748073058
Chapter II Neoplasms,Carcinoma in situ of breast,NPTN,Neuroplastin,22008,134,1.07 [0.91-1.26],0.4360592503899242
Chapter II Neoplasms,Carcinoma in situ of breast,NPTX1,Neuronal pentraxin-1,22524,138,0.84 [0.57-1.24],0.380807845945732
Chapter II Neoplasms,Carcinoma in situ of breast,NPTX2,Neuronal pentraxin-2,19597,123,1.11 [0.66-1.88],0.691207818079513
Chapter II Neoplasms,Carcinoma in situ of breast,NPTXR,Neuronal pentraxin receptor,22518,139,1.25 [0.82-1.90],0.2950379174408082
Chapter II Neoplasms,Carcinoma in situ of breast,NPY,Pro-neuropeptide Y,22716,137,1.08 [0.86-1.36],0.4902047001745209
Chapter II Neoplasms,Carcinoma in situ of breast,NRCAM,Neuronal cell adhesion molecule,22518,139,0.87 [0.51-1.50],0.6171987238154323
Chapter II Neoplasms,Carcinoma in situ of breast,NRGN,Neurogranin,19605,119,0.85 [0.70-1.04],0.1110498159484194
Chapter II Neoplasms,Carcinoma in situ of breast,NRN1,Neuritin,19571,121,0.63 [0.34-1.17],0.143749457360609
Chapter II Neoplasms,Carcinoma in situ of breast,NRP1,Neuropilin-1,22621,139,1.75 [1.04-2.95],0.0344848813318855
Chapter II Neoplasms,Carcinoma in situ of breast,NRP2,Neuropilin-2,22524,138,1.24 [0.75-2.06],0.3977241003067979
Chapter II Neoplasms,Carcinoma in situ of breast,NRTN,Neurturin,22090,138,1.08 [0.81-1.44],0.5944984984350601
Chapter II Neoplasms,Carcinoma in situ of breast,NRXN3,Neurexin-3,19054,119,1.02 [0.63-1.66],0.9415932848728954
Chapter II Neoplasms,Carcinoma in situ of breast,NSFL1C,NSFL1 cofactor p47,22715,138,0.77 [0.61-0.97],0.0242495274706126
Chapter II Neoplasms,Carcinoma in situ of breast,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19600,119,0.83 [0.66-1.05],0.124369280975991
Chapter II Neoplasms,Carcinoma in situ of breast,NT5C1A,Cytosolic 5'-nucleotidase 1A,19562,122,0.77 [0.42-1.38],0.3728158178687033
Chapter II Neoplasms,Carcinoma in situ of breast,NT5C3A,Cytosolic 5'-nucleotidase 3A,22448,136,0.86 [0.73-1.02],0.0800809809967944
Chapter II Neoplasms,Carcinoma in situ of breast,NT5E,5'-nucleotidase,22586,140,1.01 [0.78-1.31],0.9228342495520668
Chapter II Neoplasms,Carcinoma in situ of breast,NTF3,Neurotrophin-3,22477,136,0.67 [0.43-1.04],0.070937912458877
Chapter II Neoplasms,Carcinoma in situ of breast,NTF4,Neurotrophin-4,22008,134,1.00 [0.68-1.47],0.9817926713626344
Chapter II Neoplasms,Carcinoma in situ of breast,NTRK2,BDNF/NT-3 growth factors receptor,22518,139,0.91 [0.51-1.63],0.7431651370829432
Chapter II Neoplasms,Carcinoma in situ of breast,NTRK3,NT-3 growth factor receptor,22715,138,1.39 [0.70-2.77],0.3462535587654284
Chapter II Neoplasms,Carcinoma in situ of breast,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22518,139,1.01 [0.86-1.18],0.930353457553316
Chapter II Neoplasms,Carcinoma in situ of breast,NUB1,NEDD8 ultimate buster 1,22477,136,0.87 [0.72-1.05],0.1430261107795599
Chapter II Neoplasms,Carcinoma in situ of breast,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19495,120,0.92 [0.76-1.11],0.3919985357978232
Chapter II Neoplasms,Carcinoma in situ of breast,NUCB2,Nucleobindin-2,22675,137,0.74 [0.49-1.12],0.1511180210059943
Chapter II Neoplasms,Carcinoma in situ of breast,NUDC,Nuclear migration protein nudC,22764,139,0.83 [0.66-1.04],0.1050279898589238
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19106,119,1.38 [0.81-2.35],0.2383717032664861
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19003,118,0.70 [0.46-1.06],0.0936458511828441
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT16,U8 snoRNA-decapping enzyme,19465,121,0.85 [0.69-1.03],0.1033435868549929
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22413,140,0.97 [0.74-1.26],0.8119777305193194
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT5,ADP-sugar pyrophosphatase,22524,138,0.81 [0.60-1.09],0.1696573311396574
Chapter II Neoplasms,Carcinoma in situ of breast,NUMB,Protein numb homolog,19054,117,0.80 [0.65-0.99],0.0429101510254316
Chapter II Neoplasms,Carcinoma in situ of breast,NUP50,Nuclear pore complex protein Nup50,19003,118,0.86 [0.48-1.53],0.6039169619036798
Chapter II Neoplasms,Carcinoma in situ of breast,NXPE4,NXPE family member 4,19003,118,1.11 [0.71-1.75],0.6421765071714504
Chapter II Neoplasms,Carcinoma in situ of breast,NXPH1,Neurexophilin-1,21957,134,0.96 [0.64-1.46],0.8628019302688781
Chapter II Neoplasms,Carcinoma in situ of breast,NXPH3,Neurexophilin-3,19054,117,0.86 [0.48-1.56],0.6273140154518051
Chapter II Neoplasms,Carcinoma in situ of breast,OBP2B,Odorant-binding protein 2b,22297,139,0.98 [0.78-1.23],0.852375311895859
Chapter II Neoplasms,Carcinoma in situ of breast,OCLN,Occludin,19571,121,1.01 [0.67-1.52],0.9600092869983552
Chapter II Neoplasms,Carcinoma in situ of breast,ODAM,Odontogenic ameloblast-associated protein,21927,134,1.13 [0.87-1.47],0.3447697199366906
Chapter II Neoplasms,Carcinoma in situ of breast,OFD1,Oral-facial-digital syndrome 1 protein,19223,122,0.88 [0.66-1.18],0.3961482874878421
Chapter II Neoplasms,Carcinoma in situ of breast,OGA,Protein O-GlcNAcase,19501,122,0.79 [0.62-1.02],0.0740379736968805
Chapter II Neoplasms,Carcinoma in situ of breast,OGFR,Opioid growth factor receptor,22413,140,0.76 [0.48-1.21],0.2508763345465172
Chapter II Neoplasms,Carcinoma in situ of breast,OGN,Mimecan,22524,138,1.13 [0.77-1.65],0.5280692567104257
Chapter II Neoplasms,Carcinoma in situ of breast,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19223,122,0.81 [0.59-1.12],0.1998578725691003
Chapter II Neoplasms,Carcinoma in situ of breast,OLFM4,Olfactomedin-4,18466,116,1.03 [0.89-1.19],0.7309105893078256
Chapter II Neoplasms,Carcinoma in situ of breast,OLR1,Oxidized low-density lipoprotein receptor 1,22300,136,1.22 [0.96-1.53],0.0988099054724222
Chapter II Neoplasms,Carcinoma in situ of breast,OMD,Osteomodulin,22619,141,0.91 [0.65-1.26],0.5589426379139422
Chapter II Neoplasms,Carcinoma in situ of breast,OMG,Oligodendrocyte-myelin glycoprotein,22413,140,0.97 [0.76-1.23],0.7927773235398179
Chapter II Neoplasms,Carcinoma in situ of breast,OMP,Olfactory marker protein,18997,118,1.02 [0.72-1.43],0.9231966831829128
Chapter II Neoplasms,Carcinoma in situ of breast,OPHN1,Oligophrenin-1,19562,122,0.83 [0.70-0.97],0.0229860338765576
Chapter II Neoplasms,Carcinoma in situ of breast,OPLAH,5-oxoprolinase,19106,119,0.88 [0.68-1.15],0.3614647125564536
Chapter II Neoplasms,Carcinoma in situ of breast,OPTC,Opticin,22413,140,0.92 [0.66-1.30],0.6527111133495759
Chapter II Neoplasms,Carcinoma in situ of breast,ORM1,Alpha-1-acid glycoprotein 1,19562,118,1.35 [0.57-3.21],0.4993500852710051
Chapter II Neoplasms,Carcinoma in situ of breast,OSBPL2,Oxysterol-binding protein-related protein 2,19562,122,1.44 [1.09-1.92],0.0112527822286781
Chapter II Neoplasms,Carcinoma in situ of breast,OSCAR,Osteoclast-associated immunoglobulin-like receptor,22552,140,1.08 [0.68-1.69],0.752330927640454
Chapter II Neoplasms,Carcinoma in situ of breast,OSM,Oncostatin-M,22374,134,0.97 [0.79-1.19],0.7610065831321632
Chapter II Neoplasms,Carcinoma in situ of breast,OSMR,Oncostatin-M-specific receptor subunit beta,22621,139,2.02 [1.01-4.05],0.0469690420476686
Chapter II Neoplasms,Carcinoma in situ of breast,OSTN,Osteocrin,19054,119,0.43 [0.24-0.76],0.0040889441150094
Chapter II Neoplasms,Carcinoma in situ of breast,OTOA,Otoancorin,18997,118,0.68 [0.45-1.04],0.0726956251662446
Chapter II Neoplasms,Carcinoma in situ of breast,OTUD6B,Deubiquitinase OTUD6B,19501,122,0.68 [0.50-0.93],0.0146457128051571
Chapter II Neoplasms,Carcinoma in situ of breast,OTUD7B,OTU domain-containing protein 7B,19571,121,0.71 [0.54-0.94],0.0179807715154493
Chapter II Neoplasms,Carcinoma in situ of breast,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19106,119,0.89 [0.69-1.16],0.3978544935783549
Chapter II Neoplasms,Carcinoma in situ of breast,OXT,Oxytocin-neurophysin 1,22715,138,0.93 [0.83-1.05],0.2412292491712216
Chapter II Neoplasms,Carcinoma in situ of breast,P4HB,Protein disulfide-isomerase,22402,139,0.87 [0.59-1.29],0.486577404196528
Chapter II Neoplasms,Carcinoma in situ of breast,PACS2,Phosphofurin acidic cluster sorting protein 2,19003,118,0.64 [0.47-0.87],0.0043991967231243
Chapter II Neoplasms,Carcinoma in situ of breast,PADI2,Protein-arginine deiminase type-2,22090,138,0.87 [0.64-1.17],0.3629165786314544
Chapter II Neoplasms,Carcinoma in situ of breast,PADI4,Protein-arginine deiminase type-4,21927,134,1.13 [0.94-1.36],0.1945468272706526
Chapter II Neoplasms,Carcinoma in situ of breast,PAEP,Glycodelin,22368,139,1.01 [0.90-1.12],0.9259615336809044
Chapter II Neoplasms,Carcinoma in situ of breast,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19571,121,0.97 [0.84-1.13],0.7386728549224378
Chapter II Neoplasms,Carcinoma in situ of breast,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19223,122,0.73 [0.50-1.06],0.098115656838087
Chapter II Neoplasms,Carcinoma in situ of breast,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22115,137,0.89 [0.67-1.18],0.4107602197807719
Chapter II Neoplasms,Carcinoma in situ of breast,PAGR1,PAXIP1-associated glutamate-rich protein 1,19106,119,0.92 [0.62-1.39],0.703692505870962
Chapter II Neoplasms,Carcinoma in situ of breast,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18870,119,1.03 [0.74-1.44],0.838716991590976
Chapter II Neoplasms,Carcinoma in situ of breast,PAK4,Serine/threonine-protein kinase PAK 4,21957,134,0.82 [0.62-1.07],0.1482444991288195
Chapter II Neoplasms,Carcinoma in situ of breast,PALLD,Palladin,19054,117,0.85 [0.53-1.37],0.5063875432330118
Chapter II Neoplasms,Carcinoma in situ of breast,PALM,Paralemmin-1,19398,121,1.42 [0.79-2.53],0.2414386024493257
Chapter II Neoplasms,Carcinoma in situ of breast,PALM2,Paralemmin-2,19562,122,0.81 [0.50-1.32],0.3998286886923103
Chapter II Neoplasms,Carcinoma in situ of breast,PALM3,Paralemmin-3,19003,118,0.99 [0.78-1.26],0.93198704539872
Chapter II Neoplasms,Carcinoma in situ of breast,PAM,Peptidyl-glycine alpha-amidating monooxygenase,22657,138,0.98 [0.57-1.69],0.9523174553521446
Chapter II Neoplasms,Carcinoma in situ of breast,PAMR1,Inactive serine protease PAMR1,22524,138,1.39 [0.81-2.40],0.2308048115515253
Chapter II Neoplasms,Carcinoma in situ of breast,PAPPA,Pappalysin-1,22090,138,1.01 [0.73-1.39],0.9675955365145088
Chapter II Neoplasms,Carcinoma in situ of breast,PARD3,Partitioning defective 3 homolog,19223,122,0.83 [0.63-1.08],0.1565998471995682
Chapter II Neoplasms,Carcinoma in situ of breast,PARK7,Parkinson disease protein 7,22524,138,0.77 [0.58-1.03],0.0739058990410157
Chapter II Neoplasms,Carcinoma in situ of breast,PARP1,Poly [ADP-ribose] polymerase 1,22477,136,0.79 [0.56-1.09],0.1541220810337375
Chapter II Neoplasms,Carcinoma in situ of breast,PAXX,Protein PAXX,19191,120,0.78 [0.53-1.15],0.202069503016259
Chapter II Neoplasms,Carcinoma in situ of breast,PBK,Lymphokine-activated killer T-cell-originated protein kinase,18908,119,0.80 [0.45-1.44],0.4616398277466593
Chapter II Neoplasms,Carcinoma in situ of breast,PBLD,Phenazine biosynthesis-like domain-containing protein,21957,134,0.84 [0.61-1.15],0.2657335284354053
Chapter II Neoplasms,Carcinoma in situ of breast,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19501,122,0.87 [0.48-1.59],0.6593690334941009
Chapter II Neoplasms,Carcinoma in situ of breast,PCARE,Photoreceptor cilium actin regulator,18997,118,0.85 [0.67-1.09],0.1990277650404567
Chapter II Neoplasms,Carcinoma in situ of breast,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19152,120,0.89 [0.60-1.32],0.5604162559047211
Chapter II Neoplasms,Carcinoma in situ of breast,PCBP2,Poly(rC)-binding protein 2,19571,121,0.76 [0.59-0.97],0.0291344958254673
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH1,Protocadherin-1,22694,138,1.41 [0.76-2.63],0.2747302872480849
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH12,Protocadherin-12,19571,121,1.02 [0.52-2.00],0.963554594821994
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH17,Protocadherin-17,22518,139,1.03 [0.67-1.60],0.8915359556078862
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH7,Protocadherin-7,19501,122,1.10 [0.69-1.78],0.6817198907638158
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH9,Protocadherin-9,19501,122,0.90 [0.54-1.49],0.6766512756961932
Chapter II Neoplasms,Carcinoma in situ of breast,PCDHB15,Protocadherin beta-15,19495,120,1.13 [0.74-1.72],0.5754727555864014
Chapter II Neoplasms,Carcinoma in situ of breast,PCNA,Proliferating cell nuclear antigen,18908,119,0.91 [0.67-1.24],0.5523652970334509
Chapter II Neoplasms,Carcinoma in situ of breast,PCSK7,Proprotein convertase subtilisin/kexin type 7,19495,120,1.10 [0.77-1.58],0.5971313298736178
Chapter II Neoplasms,Carcinoma in situ of breast,PCSK9,Proprotein convertase subtilisin/kexin type 9,22786,138,1.17 [0.80-1.72],0.4155879965897155
Chapter II Neoplasms,Carcinoma in situ of breast,PCYT2,Ethanolamine-phosphate cytidylyltransferase,19501,122,0.84 [0.67-1.05],0.1344353665492486
Chapter II Neoplasms,Carcinoma in situ of breast,PDAP1,28 kDa heat- and acid-stable phosphoprotein,19600,119,0.86 [0.72-1.03],0.0987630258037216
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD1,Programmed cell death protein 1,22684,137,0.92 [0.64-1.32],0.6537029391964682
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD1LG2,Programmed cell death 1 ligand 2,22413,140,1.15 [0.71-1.85],0.5668521533283521
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD5,Programmed cell death protein 5,22715,138,0.81 [0.63-1.05],0.1183773069514725
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD6,Programmed cell death protein 6,22518,139,1.06 [0.84-1.33],0.6221393993571528
Chapter II Neoplasms,Carcinoma in situ of breast,PDCL2,Phosducin-like protein 2,18908,119,0.85 [0.59-1.22],0.3730910679145143
Chapter II Neoplasms,Carcinoma in situ of breast,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",18908,119,0.84 [0.58-1.21],0.339415797971726
Chapter II Neoplasms,Carcinoma in situ of breast,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19003,118,1.00 [0.75-1.32],0.981502158641966
Chapter II Neoplasms,Carcinoma in situ of breast,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19191,120,0.82 [0.70-0.97],0.0188924750883643
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFA,Platelet-derived growth factor subunit A,22786,138,0.88 [0.71-1.07],0.2026404195697855
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFB,Platelet-derived growth factor subunit B,22619,141,0.85 [0.71-1.00],0.049906758084746
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFC,Platelet-derived growth factor C,22008,134,0.63 [0.37-1.08],0.0905744598877622
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFRA,Platelet-derived growth factor receptor alpha,22518,139,1.29 [0.77-2.16],0.3334384965708411
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFRB,Platelet-derived growth factor receptor beta,22786,138,0.85 [0.56-1.29],0.4470700220719623
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA2,Protein disulfide-isomerase A2,18908,119,0.82 [0.51-1.32],0.4232918969147689
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA3,Protein disulfide-isomerase A3,19191,120,0.81 [0.39-1.68],0.5799689591644915
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA4,Protein disulfide-isomerase A4,19597,123,0.85 [0.63-1.13],0.2642001633677042
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA5,Protein disulfide-isomerase A5,18908,119,0.70 [0.50-0.98],0.0368108407577039
Chapter II Neoplasms,Carcinoma in situ of breast,PDLIM5,PDZ and LIM domain protein 5,19571,121,0.84 [0.73-0.96],0.0131057319170882
Chapter II Neoplasms,Carcinoma in situ of breast,PDLIM7,PDZ and LIM domain protein 7,22619,141,0.84 [0.75-0.95],0.0045270513702192
Chapter II Neoplasms,Carcinoma in situ of breast,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22008,134,0.92 [0.67-1.26],0.607353406466985
Chapter II Neoplasms,Carcinoma in situ of breast,PDRG1,p53 and DNA damage-regulated protein 1,19054,119,0.82 [0.56-1.18],0.2831995927790208
Chapter II Neoplasms,Carcinoma in situ of breast,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,18908,119,0.53 [0.31-0.90],0.018567961482977
Chapter II Neoplasms,Carcinoma in situ of breast,PDZD2,PDZ domain-containing protein 2,19003,118,0.74 [0.53-1.02],0.0695730566934083
Chapter II Neoplasms,Carcinoma in situ of breast,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19054,117,0.90 [0.58-1.38],0.6154490434760982
Chapter II Neoplasms,Carcinoma in situ of breast,PEAR1,Platelet endothelial aggregation receptor 1,22786,138,0.59 [0.31-1.12],0.1048892145646202
Chapter II Neoplasms,Carcinoma in situ of breast,PEBP1,Phosphatidylethanolamine-binding protein 1,22524,138,0.77 [0.59-1.00],0.051296766723307
Chapter II Neoplasms,Carcinoma in situ of breast,PECAM1,Platelet endothelial cell adhesion molecule,22524,138,0.71 [0.43-1.18],0.1866219789574062
Chapter II Neoplasms,Carcinoma in situ of breast,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19106,119,0.57 [0.28-1.14],0.1111038868491424
Chapter II Neoplasms,Carcinoma in situ of breast,PENK,Proenkephalin-A,19191,120,0.72 [0.40-1.32],0.2887200829799381
Chapter II Neoplasms,Carcinoma in situ of breast,PEPD,Xaa-Pro dipeptidase,19605,119,0.86 [0.44-1.68],0.65436190070546
Chapter II Neoplasms,Carcinoma in situ of breast,PER3,Period circadian protein homolog 3,19054,117,0.86 [0.74-1.01],0.0739861437872026
Chapter II Neoplasms,Carcinoma in situ of breast,PF4,Platelet factor 4,19489,116,0.82 [0.69-0.98],0.0327902258483304
Chapter II Neoplasms,Carcinoma in situ of breast,PFDN2,Prefoldin subunit 2,21957,134,1.10 [0.85-1.44],0.4724834966539252
Chapter II Neoplasms,Carcinoma in situ of breast,PFDN4,Prefoldin subunit 4,18908,119,0.68 [0.46-1.00],0.0508382793591207
Chapter II Neoplasms,Carcinoma in situ of breast,PFDN6,Prefoldin subunit 6,19054,119,0.80 [0.58-1.10],0.1663776941773658
Chapter II Neoplasms,Carcinoma in situ of breast,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22373,139,0.84 [0.69-1.03],0.0871668714825495
Chapter II Neoplasms,Carcinoma in situ of breast,PGA4,Pepsin A-4,19605,119,1.41 [1.09-1.83],0.0090389148222622
Chapter II Neoplasms,Carcinoma in situ of breast,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19600,119,0.83 [0.59-1.15],0.2515646336321183
Chapter II Neoplasms,Carcinoma in situ of breast,PGF,Placenta growth factor,22764,139,0.98 [0.53-1.81],0.9558813555789366
Chapter II Neoplasms,Carcinoma in situ of breast,PGLYRP1,Peptidoglycan recognition protein 1,22679,136,1.00 [0.70-1.43],0.9868309474887728
Chapter II Neoplasms,Carcinoma in situ of breast,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19373,117,1.68 [0.94-2.98],0.0776838655977748
Chapter II Neoplasms,Carcinoma in situ of breast,PGLYRP4,Peptidoglycan recognition protein 4,19003,118,1.01 [0.77-1.34],0.9292007418839596
Chapter II Neoplasms,Carcinoma in situ of breast,PGM2,Phosphoglucomutase-2,19054,119,0.78 [0.54-1.12],0.1771144582529581
Chapter II Neoplasms,Carcinoma in situ of breast,PGR,Progesterone receptor,19054,117,0.99 [0.83-1.17],0.899967902821042
Chapter II Neoplasms,Carcinoma in situ of breast,PHACTR2,Phosphatase and actin regulator 2,19571,121,0.84 [0.72-0.98],0.0300184924666756
Chapter II Neoplasms,Carcinoma in situ of breast,PHLDB1,Pleckstrin homology-like domain family B member 1,19501,122,0.89 [0.64-1.23],0.4680539681617176
Chapter II Neoplasms,Carcinoma in situ of breast,PHLDB2,Pleckstrin homology-like domain family B member 2,18908,119,1.01 [0.84-1.22],0.9121591563043951
Chapter II Neoplasms,Carcinoma in situ of breast,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22368,139,1.48 [0.88-2.48],0.1409947282172712
Chapter II Neoplasms,Carcinoma in situ of breast,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19191,120,0.84 [0.55-1.27],0.4099183233028749
Chapter II Neoplasms,Carcinoma in situ of breast,PI16,Peptidase inhibitor 16,19605,119,1.08 [0.53-2.19],0.8384282878745408
Chapter II Neoplasms,Carcinoma in situ of breast,PI3,Elafin,22218,132,1.00 [0.74-1.34],0.9841703597866412
Chapter II Neoplasms,Carcinoma in situ of breast,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19571,121,0.81 [0.64-1.02],0.0727406331491551
Chapter II Neoplasms,Carcinoma in situ of breast,PIGR,Polymeric immunoglobulin receptor,22237,138,1.06 [0.68-1.64],0.8056054524792027
Chapter II Neoplasms,Carcinoma in situ of breast,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22477,136,0.97 [0.76-1.24],0.8158540420682091
Chapter II Neoplasms,Carcinoma in situ of breast,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22524,138,1.27 [0.71-2.29],0.4199446720194357
Chapter II Neoplasms,Carcinoma in situ of breast,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19054,117,0.72 [0.50-1.04],0.0791892621149556
Chapter II Neoplasms,Carcinoma in situ of breast,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22524,138,1.01 [0.70-1.46],0.9421791360157976
Chapter II Neoplasms,Carcinoma in situ of breast,PILRB,Paired immunoglobulin-like type 2 receptor beta,22518,139,0.96 [0.74-1.24],0.7328584808469345
Chapter II Neoplasms,Carcinoma in situ of breast,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19191,120,0.93 [0.72-1.20],0.5589049768134895
Chapter II Neoplasms,Carcinoma in situ of breast,PITHD1,PITH domain-containing protein 1,18870,119,0.92 [0.73-1.16],0.481254319727273
Chapter II Neoplasms,Carcinoma in situ of breast,PKD1,Polycystin-1,19600,119,0.81 [0.41-1.58],0.5343672959589725
Chapter II Neoplasms,Carcinoma in situ of breast,PKD2,Polycystin-2,19003,118,0.81 [0.59-1.12],0.2056656229548561
Chapter II Neoplasms,Carcinoma in situ of breast,PKLR,Pyruvate kinase PKLR,22546,141,1.02 [0.83-1.27],0.830680279003706
Chapter II Neoplasms,Carcinoma in situ of breast,PKN3,Serine/threonine-protein kinase N3,19223,122,0.84 [0.66-1.06],0.1473488105575216
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G10,Group 10 secretory phospholipase A2,22368,139,1.03 [0.80-1.32],0.8272199623927009
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G15,Phospholipase A2 group XV,22586,140,0.80 [0.44-1.43],0.4452425681638167
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G1B,Phospholipase A2,22748,137,0.98 [0.68-1.41],0.9245181065697122
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G2A,"Phospholipase A2, membrane associated",22444,136,1.05 [0.82-1.35],0.6963014372709986
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G4A,Cytosolic phospholipase A2,22619,141,0.83 [0.70-0.99],0.0354397532943245
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G7,Platelet-activating factor acetylhydrolase,22524,138,1.10 [0.68-1.79],0.6912457308879757
Chapter II Neoplasms,Carcinoma in situ of breast,PLAT,Tissue-type plasminogen activator,22718,136,1.07 [0.79-1.46],0.6649135169907008
Chapter II Neoplasms,Carcinoma in situ of breast,PLAU,Urokinase-type plasminogen activator,22524,138,0.92 [0.54-1.54],0.7403886462110226
Chapter II Neoplasms,Carcinoma in situ of breast,PLAUR,Urokinase plasminogen activator surface receptor,22368,138,0.91 [0.50-1.63],0.7425366291796736
Chapter II Neoplasms,Carcinoma in situ of breast,PLB1,"Phospholipase B1, membrane-associated",19562,122,0.94 [0.71-1.25],0.6946249657691778
Chapter II Neoplasms,Carcinoma in situ of breast,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19054,117,1.12 [0.80-1.59],0.5086072268808617
Chapter II Neoplasms,Carcinoma in situ of breast,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19562,122,0.83 [0.69-0.99],0.0335481689870596
Chapter II Neoplasms,Carcinoma in situ of breast,PLEKHO1,Pleckstrin homology domain-containing family O member 1,19562,122,0.74 [0.57-0.97],0.027670952085242
Chapter II Neoplasms,Carcinoma in situ of breast,PLG,Plasminogen,19115,114,1.33 [0.63-2.82],0.4578625276451215
Chapter II Neoplasms,Carcinoma in situ of breast,PLIN1,Perilipin-1,21957,134,0.86 [0.54-1.36],0.517641742365397
Chapter II Neoplasms,Carcinoma in situ of breast,PLIN3,Perilipin-3,22518,139,0.83 [0.58-1.19],0.3134248876303552
Chapter II Neoplasms,Carcinoma in situ of breast,PLPBP,Pyridoxal phosphate homeostasis protein,22518,139,0.78 [0.62-0.97],0.0262538037010212
Chapter II Neoplasms,Carcinoma in situ of breast,PLSCR3,Phospholipid scramblase 3,19533,122,0.70 [0.52-0.95],0.0200888070150427
Chapter II Neoplasms,Carcinoma in situ of breast,PLTP,Phospholipid transfer protein,22699,138,1.46 [0.93-2.29],0.100200698225399
Chapter II Neoplasms,Carcinoma in situ of breast,PLXDC1,Plexin domain-containing protein 1,22008,134,0.81 [0.50-1.34],0.4152549856913201
Chapter II Neoplasms,Carcinoma in situ of breast,PLXDC2,Plexin domain-containing protein 2,19562,122,0.97 [0.52-1.84],0.935060556675914
Chapter II Neoplasms,Carcinoma in situ of breast,PLXNA4,Plexin-A4,22477,136,0.93 [0.78-1.12],0.4715663344290945
Chapter II Neoplasms,Carcinoma in situ of breast,PLXNB2,Plexin-B2,22685,136,1.09 [0.57-2.08],0.8007542477461935
Chapter II Neoplasms,Carcinoma in situ of breast,PLXNB3,Plexin-B3,22453,139,0.81 [0.59-1.12],0.2086159058755688
Chapter II Neoplasms,Carcinoma in situ of breast,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22414,139,1.02 [0.94-1.11],0.6428048868088094
Chapter II Neoplasms,Carcinoma in situ of breast,PMCH,Pro-MCH,19003,118,0.99 [0.80-1.22],0.9293968371953916
Chapter II Neoplasms,Carcinoma in situ of breast,PMM2,Phosphomannomutase 2,19003,118,0.72 [0.53-0.97],0.032522761872367
Chapter II Neoplasms,Carcinoma in situ of breast,PMS1,PMS1 protein homolog 1,19054,119,0.63 [0.42-0.93],0.0205234516954961
Chapter II Neoplasms,Carcinoma in situ of breast,PMVK,Phosphomevalonate kinase,21918,134,0.86 [0.76-0.98],0.0196770189678212
Chapter II Neoplasms,Carcinoma in situ of breast,PNLIP,Pancreatic triacylglycerol lipase,19605,119,0.85 [0.63-1.14],0.2860983947043921
Chapter II Neoplasms,Carcinoma in situ of breast,PNLIPRP1,Inactive pancreatic lipase-related protein 1,19562,122,0.93 [0.74-1.17],0.5219372573662808
Chapter II Neoplasms,Carcinoma in situ of breast,PNLIPRP2,Pancreatic lipase-related protein 2,22510,140,0.98 [0.94-1.03],0.5470652397490048
Chapter II Neoplasms,Carcinoma in situ of breast,PNMA1,Paraneoplastic antigen Ma1,19106,119,0.80 [0.57-1.11],0.1811641556997588
Chapter II Neoplasms,Carcinoma in situ of breast,PNMA2,Paraneoplastic antigen Ma2,18997,118,0.77 [0.50-1.18],0.2248144426148889
Chapter II Neoplasms,Carcinoma in situ of breast,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22090,138,1.01 [0.90-1.14],0.842881032372064
Chapter II Neoplasms,Carcinoma in situ of breast,PODXL,Podocalyxin,22413,140,0.38 [0.15-1.01],0.0523706483357365
Chapter II Neoplasms,Carcinoma in situ of breast,PODXL2,Podocalyxin-like protein 2,22586,140,1.20 [0.69-2.07],0.5156573840707159
Chapter II Neoplasms,Carcinoma in situ of breast,POF1B,Protein POF1B,19054,117,1.03 [0.70-1.51],0.8804252556864567
Chapter II Neoplasms,Carcinoma in situ of breast,POLR2A,DNA-directed RNA polymerase II subunit RPB1,19054,117,0.91 [0.50-1.68],0.7744146557937819
Chapter II Neoplasms,Carcinoma in situ of breast,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22413,140,1.28 [0.88-1.86],0.2032779470016815
Chapter II Neoplasms,Carcinoma in situ of breast,POMC,Pro-opiomelanocortin,19106,119,1.12 [0.87-1.46],0.3819781605554957
Chapter II Neoplasms,Carcinoma in situ of breast,PON1,Serum paraoxonase/arylesterase 1,19605,119,0.91 [0.48-1.75],0.7844710631045352
Chapter II Neoplasms,Carcinoma in situ of breast,PON2,Serum paraoxonase/arylesterase 2,22115,137,0.67 [0.43-1.04],0.0718845716629534
Chapter II Neoplasms,Carcinoma in situ of breast,PON3,Serum paraoxonase/lactonase 3,22619,141,1.11 [0.64-1.92],0.7054842820028482
Chapter II Neoplasms,Carcinoma in situ of breast,POSTN,Periostin,19597,123,1.51 [0.98-2.33],0.0613422701217972
Chapter II Neoplasms,Carcinoma in situ of breast,PPBP,Platelet basic protein,19486,115,0.83 [0.68-1.03],0.0842904864993541
Chapter II Neoplasms,Carcinoma in situ of breast,PPCDC,Phosphopantothenoylcysteine decarboxylase,22715,138,0.76 [0.55-1.05],0.0974893336442095
Chapter II Neoplasms,Carcinoma in situ of breast,PPIB,Peptidyl-prolyl cis-trans isomerase B,22525,135,0.81 [0.70-0.95],0.0097581364817104
Chapter II Neoplasms,Carcinoma in situ of breast,PPIE,Peptidyl-prolyl cis-trans isomerase E,19223,122,1.11 [0.87-1.41],0.4020695467698819
Chapter II Neoplasms,Carcinoma in situ of breast,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19597,123,0.89 [0.67-1.19],0.4336172201267076
Chapter II Neoplasms,Carcinoma in situ of breast,PPL,Periplakin,19054,117,0.90 [0.52-1.56],0.7101201665659038
Chapter II Neoplasms,Carcinoma in situ of breast,PPM1A,Protein phosphatase 1A,22008,134,0.86 [0.52-1.44],0.5718333510997275
Chapter II Neoplasms,Carcinoma in situ of breast,PPM1B,Protein phosphatase 1B,19054,117,1.01 [0.77-1.33],0.9149131251917594
Chapter II Neoplasms,Carcinoma in situ of breast,PPM1F,Protein phosphatase 1F,19600,119,0.75 [0.53-1.05],0.0967233437417657
Chapter II Neoplasms,Carcinoma in situ of breast,PPME1,Protein phosphatase methylesterase 1,22413,140,0.74 [0.58-0.94],0.0150533093674567
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19495,120,0.74 [0.59-0.92],0.0070473128633622
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22586,140,0.83 [0.71-0.98],0.0235675850258523
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19223,122,0.71 [0.53-0.97],0.0291830815074168
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19571,121,0.88 [0.70-1.11],0.2734116251992528
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19571,121,0.71 [0.43-1.19],0.1965928573572449
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R2,Protein phosphatase inhibitor 2,22518,139,0.82 [0.68-0.99],0.0420745125030138
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R9B,Neurabin-2,22764,139,0.80 [0.68-0.94],0.0055855625402978
Chapter II Neoplasms,Carcinoma in situ of breast,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19501,122,0.90 [0.78-1.05],0.1955942228477966
Chapter II Neoplasms,Carcinoma in situ of breast,PPP3R1,Calcineurin subunit B type 1,22368,139,0.96 [0.67-1.38],0.83185463091852
Chapter II Neoplasms,Carcinoma in situ of breast,PPT1,Palmitoyl-protein thioesterase 1,19054,119,0.73 [0.53-1.00],0.0511800807052461
Chapter II Neoplasms,Carcinoma in situ of breast,PPY,Pancreatic prohormone,22504,140,0.99 [0.86-1.15],0.9406738782005656
Chapter II Neoplasms,Carcinoma in situ of breast,PQBP1,Polyglutamine-binding protein 1,22008,134,1.04 [0.80-1.36],0.7502595969543742
Chapter II Neoplasms,Carcinoma in situ of breast,PRAME,Melanoma antigen preferentially expressed in tumors,18908,119,0.49 [0.24-0.99],0.0478483911340021
Chapter II Neoplasms,Carcinoma in situ of breast,PRAP1,Proline-rich acidic protein 1,19597,123,0.76 [0.51-1.13],0.1728839999743738
Chapter II Neoplasms,Carcinoma in situ of breast,PRC1,Protein regulator of cytokinesis 1,19495,120,1.45 [1.22-1.73],3.55496909728854e-05
Chapter II Neoplasms,Carcinoma in situ of breast,PRCP,Lysosomal Pro-X carboxypeptidase,22654,136,0.85 [0.52-1.40],0.52641071708175
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX1,Peroxiredoxin-1,21904,137,0.94 [0.79-1.12],0.4794635044860406
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX2,Peroxiredoxin-2,19264,117,0.97 [0.74-1.29],0.8574730008019005
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22090,138,0.82 [0.66-1.02],0.072611024997757
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX5,"Peroxiredoxin-5, mitochondrial",22764,139,0.81 [0.66-0.99],0.0428473517196459
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX6,Peroxiredoxin-6,22716,137,0.89 [0.69-1.15],0.379082877638205
Chapter II Neoplasms,Carcinoma in situ of breast,PREB,Prolactin regulatory element-binding protein,22090,138,1.18 [0.75-1.87],0.4789043679656453
Chapter II Neoplasms,Carcinoma in situ of breast,PRELP,Prolargin,22510,140,0.83 [0.44-1.54],0.5504688674345924
Chapter II Neoplasms,Carcinoma in situ of breast,PRG2,Bone marrow proteoglycan,19597,123,1.06 [0.77-1.46],0.7262381940171629
Chapter II Neoplasms,Carcinoma in situ of breast,PRG3,Proteoglycan 3,19597,123,0.91 [0.65-1.27],0.575511089245145
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22090,138,0.72 [0.53-0.98],0.0383916713578676
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19054,119,0.79 [0.44-1.42],0.4309263430763621
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22518,139,0.88 [0.74-1.05],0.1616401311210081
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19527,121,0.83 [0.67-1.02],0.0719577444709131
Chapter II Neoplasms,Carcinoma in situ of breast,PRKCQ,Protein kinase C theta type,22090,138,0.77 [0.53-1.13],0.1852201203181073
Chapter II Neoplasms,Carcinoma in situ of breast,PRKD2,Serine/threonine-protein kinase D2,19003,118,0.89 [0.60-1.34],0.5817982906870764
Chapter II Neoplasms,Carcinoma in situ of breast,PRKG1,cGMP-dependent protein kinase 1,19191,120,0.87 [0.76-1.00],0.044224479519
Chapter II Neoplasms,Carcinoma in situ of breast,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22008,134,0.92 [0.73-1.17],0.5005350327821813
Chapter II Neoplasms,Carcinoma in situ of breast,PRL,Prolactin,22715,138,1.17 [0.97-1.41],0.0941043660738464
Chapter II Neoplasms,Carcinoma in situ of breast,PRND,Prion-like protein doppel,19562,122,0.87 [0.62-1.21],0.4059856764334534
Chapter II Neoplasms,Carcinoma in situ of breast,PROC,Vitamin K-dependent protein C,22542,139,1.83 [1.01-3.32],0.0459790349740015
Chapter II Neoplasms,Carcinoma in situ of breast,PROCR,Endothelial protein C receptor,19003,118,0.81 [0.47-1.39],0.4424157914343471
Chapter II Neoplasms,Carcinoma in situ of breast,PROK1,Prokineticin-1,22477,136,1.09 [0.88-1.34],0.4334805975298579
Chapter II Neoplasms,Carcinoma in situ of breast,PROS1,Vitamin K-dependent protein S,19630,119,1.46 [0.75-2.84],0.261471688279745
Chapter II Neoplasms,Carcinoma in situ of breast,PRR4,Proline-rich protein 4,19053,119,0.91 [0.71-1.18],0.4950208223521787
Chapter II Neoplasms,Carcinoma in situ of breast,PRR5,Proline-rich protein 5,19054,117,1.05 [0.74-1.51],0.7737563216204155
Chapter II Neoplasms,Carcinoma in situ of breast,PRRT3,Proline-rich transmembrane protein 3,19106,119,1.15 [0.72-1.85],0.5492298858995246
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS2,Trypsin-2,22579,139,0.96 [0.71-1.30],0.79073487407956
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS22,Brain-specific serine protease 4,19054,117,0.73 [0.42-1.29],0.2843492063679302
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS27,Serine protease 27,22451,137,0.94 [0.65-1.36],0.7264666340216452
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS53,Serine protease 53,19562,122,0.81 [0.51-1.28],0.3622988498213155
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS8,Prostasin,22435,139,0.96 [0.66-1.40],0.8326555200242353
Chapter II Neoplasms,Carcinoma in situ of breast,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,21957,134,0.88 [0.77-1.00],0.0493468202762508
Chapter II Neoplasms,Carcinoma in situ of breast,PRTG,Protogenin,22716,137,1.05 [0.58-1.92],0.871818091835874
Chapter II Neoplasms,Carcinoma in situ of breast,PRTN3,Myeloblastin,21933,133,0.94 [0.68-1.31],0.7242516864997386
Chapter II Neoplasms,Carcinoma in situ of breast,PRUNE2,Protein prune homolog 2,19223,122,1.19 [0.70-2.04],0.5146143189711245
Chapter II Neoplasms,Carcinoma in situ of breast,PSAP,Prosaposin,19408,123,0.92 [0.50-1.70],0.7824926832090858
Chapter II Neoplasms,Carcinoma in situ of breast,PSAPL1,Proactivator polypeptide-like 1,19501,122,1.55 [1.12-2.16],0.0091924391244334
Chapter II Neoplasms,Carcinoma in situ of breast,PSCA,Prostate stem cell antigen,19501,122,0.96 [0.90-1.03],0.2373984416817239
Chapter II Neoplasms,Carcinoma in situ of breast,PSG1,Pregnancy-specific beta-1-glycoprotein 1,22368,139,0.94 [0.83-1.07],0.3630727338983288
Chapter II Neoplasms,Carcinoma in situ of breast,PSIP1,PC4 and SFRS1-interacting protein,22477,136,0.90 [0.70-1.17],0.4328685655950537
Chapter II Neoplasms,Carcinoma in situ of breast,PSMA1,Proteasome subunit alpha type-1,22008,134,0.77 [0.54-1.11],0.1645984027462499
Chapter II Neoplasms,Carcinoma in situ of breast,PSMC3,26S proteasome regulatory subunit 6A,18908,119,0.92 [0.52-1.65],0.7864061449802816
Chapter II Neoplasms,Carcinoma in situ of breast,PSMD1,26S proteasome non-ATPase regulatory subunit 1,19571,121,0.97 [0.68-1.38],0.8528371680541639
Chapter II Neoplasms,Carcinoma in situ of breast,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19054,119,0.72 [0.49-1.06],0.0999202909252195
Chapter II Neoplasms,Carcinoma in situ of breast,PSMD9,26S proteasome non-ATPase regulatory subunit 9,22413,140,0.90 [0.69-1.18],0.449323426979672
Chapter II Neoplasms,Carcinoma in situ of breast,PSME1,Proteasome activator complex subunit 1,22338,139,0.72 [0.48-1.08],0.1127259109245071
Chapter II Neoplasms,Carcinoma in situ of breast,PSME2,Proteasome activator complex subunit 2,22256,137,0.81 [0.54-1.22],0.3056925977490256
Chapter II Neoplasms,Carcinoma in situ of breast,PSMG3,Proteasome assembly chaperone 3,22477,136,0.84 [0.62-1.13],0.2421230722010683
Chapter II Neoplasms,Carcinoma in situ of breast,PSMG4,Proteasome assembly chaperone 4,19054,117,0.83 [0.60-1.14],0.2524186878045663
Chapter II Neoplasms,Carcinoma in situ of breast,PSPN,Persephin,22477,136,1.08 [0.93-1.26],0.2859861221672262
Chapter II Neoplasms,Carcinoma in situ of breast,PSRC1,Proline/serine-rich coiled-coil protein 1,22008,134,0.85 [0.64-1.13],0.2621144797864607
Chapter II Neoplasms,Carcinoma in situ of breast,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18504,114,0.84 [0.71-0.98],0.0308487779540784
Chapter II Neoplasms,Carcinoma in situ of breast,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",21957,134,0.78 [0.47-1.30],0.3450053780844598
Chapter II Neoplasms,Carcinoma in situ of breast,PTGDS,Prostaglandin-H2 D-isomerase,22320,136,1.69 [1.05-2.72],0.0307051669979118
Chapter II Neoplasms,Carcinoma in situ of breast,PTGES2,Prostaglandin E synthase 2,18905,117,0.87 [0.62-1.21],0.4094302958338131
Chapter II Neoplasms,Carcinoma in situ of breast,PTGR1,Prostaglandin reductase 1,19600,119,1.04 [0.84-1.30],0.701419012027445
Chapter II Neoplasms,Carcinoma in situ of breast,PTH,Parathyroid hormone,19054,119,0.79 [0.63-0.99],0.0451678198544539
Chapter II Neoplasms,Carcinoma in situ of breast,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22477,136,0.83 [0.53-1.30],0.4116950078745361
Chapter II Neoplasms,Carcinoma in situ of breast,PTK7,Inactive tyrosine-protein kinase 7,21957,134,1.05 [0.70-1.58],0.8000190234550195
Chapter II Neoplasms,Carcinoma in situ of breast,PTN,Pleiotrophin,22115,137,0.76 [0.56-1.03],0.0780714503773399
Chapter II Neoplasms,Carcinoma in situ of breast,PTP4A3,Protein tyrosine phosphatase type IVA 3,19054,117,0.79 [0.55-1.15],0.2268185021619521
Chapter II Neoplasms,Carcinoma in situ of breast,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22368,139,0.85 [0.69-1.03],0.096185507846523
Chapter II Neoplasms,Carcinoma in situ of breast,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22580,141,0.85 [0.73-1.00],0.0454893225796755
Chapter II Neoplasms,Carcinoma in situ of breast,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19016,117,1.05 [0.67-1.65],0.8419712996710481
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19600,119,1.25 [0.68-2.28],0.4685060034835904
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRC,Receptor-type tyrosine-protein phosphatase C,19597,123,0.83 [0.38-1.78],0.6252022516023825
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRF,Receptor-type tyrosine-protein phosphatase F,22786,138,1.42 [0.84-2.40],0.1866345517201049
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRH,Receptor-type tyrosine-protein phosphatase H,19501,122,1.08 [0.76-1.56],0.6577709221018183
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19501,122,1.48 [0.78-2.80],0.2290508318292098
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRM,Receptor-type tyrosine-protein phosphatase mu,22440,136,0.60 [0.32-1.12],0.1083138792674473
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22289,139,1.10 [0.68-1.79],0.6916830639304095
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRR,Receptor-type tyrosine-protein phosphatase R,19562,122,1.13 [0.69-1.83],0.625011181869058
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRS,Receptor-type tyrosine-protein phosphatase S,22786,138,1.90 [1.02-3.52],0.0431279878808092
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19600,119,0.84 [0.49-1.44],0.5356313619140531
Chapter II Neoplasms,Carcinoma in situ of breast,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19191,120,0.75 [0.56-1.01],0.0561973498114254
Chapter II Neoplasms,Carcinoma in situ of breast,PTS,6-pyruvoyl tetrahydrobiopterin synthase,21868,132,0.89 [0.66-1.19],0.4323214836747782
Chapter II Neoplasms,Carcinoma in situ of breast,PTTG1,Securin,19223,122,1.07 [0.72-1.60],0.7302456709704308
Chapter II Neoplasms,Carcinoma in situ of breast,PTX3,Pentraxin-related protein PTX3,22477,136,1.26 [0.91-1.75],0.1700763832239222
Chapter II Neoplasms,Carcinoma in situ of breast,PVALB,Parvalbumin alpha,22605,136,0.89 [0.79-1.01],0.0830236165369922
Chapter II Neoplasms,Carcinoma in situ of breast,PVR,Poliovirus receptor,22715,138,0.97 [0.64-1.46],0.8811563291745648
Chapter II Neoplasms,Carcinoma in situ of breast,PXDNL,Peroxidasin-like protein,19495,120,1.15 [0.90-1.48],0.2673016112142606
Chapter II Neoplasms,Carcinoma in situ of breast,PXN,Paxillin,21957,134,1.00 [0.75-1.34],0.9872163791148048
Chapter II Neoplasms,Carcinoma in situ of breast,PYDC1,Pyrin domain-containing protein 1,19106,119,1.54 [1.16-2.03],0.0027820468918904
Chapter II Neoplasms,Carcinoma in situ of breast,PYY,Peptide YY,19003,118,0.97 [0.80-1.17],0.7215315819557134
Chapter II Neoplasms,Carcinoma in situ of breast,PZP,Pregnancy zone protein,19630,119,0.85 [0.65-1.12],0.2539471715165479
Chapter II Neoplasms,Carcinoma in situ of breast,QDPR,Dihydropteridine reductase,22419,139,0.85 [0.60-1.21],0.3683746588975012
Chapter II Neoplasms,Carcinoma in situ of breast,QPCT,Glutaminyl-peptide cyclotransferase,22557,134,0.80 [0.45-1.40],0.4291487921060796
Chapter II Neoplasms,Carcinoma in situ of breast,QSOX1,Sulfhydryl oxidase 1,19227,117,0.74 [0.42-1.31],0.3066058008529099
Chapter II Neoplasms,Carcinoma in situ of breast,RAB10,Ras-related protein Rab-10,19600,119,0.72 [0.51-1.01],0.0599444101878139
Chapter II Neoplasms,Carcinoma in situ of breast,RAB11FIP3,Rab11 family-interacting protein 3,19600,119,0.84 [0.72-0.99],0.0392804323153984
Chapter II Neoplasms,Carcinoma in situ of breast,RAB27B,Ras-related protein Rab-27B,19600,119,0.79 [0.64-0.96],0.0183408384830637
Chapter II Neoplasms,Carcinoma in situ of breast,RAB2B,Ras-related protein Rab-2B,19495,120,0.67 [0.50-0.91],0.0089074557472454
Chapter II Neoplasms,Carcinoma in situ of breast,RAB33A,Ras-related protein Rab-33A,19003,118,0.78 [0.59-1.02],0.0739406967003579
Chapter II Neoplasms,Carcinoma in situ of breast,RAB37,Ras-related protein Rab-37,22090,138,0.91 [0.75-1.11],0.3600591693233775
Chapter II Neoplasms,Carcinoma in situ of breast,RAB39B,Ras-related protein Rab-39B,19003,118,0.98 [0.79-1.20],0.8128950981423242
Chapter II Neoplasms,Carcinoma in situ of breast,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,18997,118,1.04 [0.78-1.40],0.7708680010976489
Chapter II Neoplasms,Carcinoma in situ of breast,RAB44,Ras-related protein Rab-44,19495,120,1.47 [1.15-1.88],0.0020929767506378
Chapter II Neoplasms,Carcinoma in situ of breast,RAB6A,Ras-related protein Rab-6A,22477,136,1.19 [0.89-1.60],0.2354112118012283
Chapter II Neoplasms,Carcinoma in situ of breast,RAB6B,Ras-related protein Rab-6B,21957,134,0.98 [0.71-1.34],0.8784865191173684
Chapter II Neoplasms,Carcinoma in situ of breast,RABEP1,Rab GTPase-binding effector protein 1,19191,120,0.79 [0.62-0.99],0.0449087257653956
Chapter II Neoplasms,Carcinoma in situ of breast,RABEPK,Rab9 effector protein with kelch motifs,22008,134,0.98 [0.76-1.27],0.8948644470257775
Chapter II Neoplasms,Carcinoma in situ of breast,RABGAP1L,Rab GTPase-activating protein 1-like,22090,138,0.81 [0.63-1.06],0.1233914855068597
Chapter II Neoplasms,Carcinoma in situ of breast,RAC3,Ras-related C3 botulinum toxin substrate 3,19054,119,0.63 [0.43-0.91],0.0149916100453221
Chapter II Neoplasms,Carcinoma in situ of breast,RAD23B,UV excision repair protein RAD23 homolog B,22008,134,0.85 [0.60-1.19],0.3325101562924277
Chapter II Neoplasms,Carcinoma in situ of breast,RAD51,DNA repair protein RAD51 homolog 1,19223,122,1.09 [0.82-1.44],0.5551846351745764
Chapter II Neoplasms,Carcinoma in situ of breast,RALB,Ras-related protein Ral-B,19054,117,1.62 [0.96-2.73],0.0707519951079358
Chapter II Neoplasms,Carcinoma in situ of breast,RALY,RNA-binding protein Raly,19495,120,1.22 [0.90-1.64],0.1948556828807936
Chapter II Neoplasms,Carcinoma in situ of breast,RANBP1,Ran-specific GTPase-activating protein,19106,119,0.79 [0.57-1.11],0.1714973865062122
Chapter II Neoplasms,Carcinoma in situ of breast,RANBP2,E3 SUMO-protein ligase RanBP2,18997,118,1.18 [0.71-1.96],0.5314551185467258
Chapter II Neoplasms,Carcinoma in situ of breast,RANGAP1,Ran GTPase-activating protein 1,22008,134,0.80 [0.56-1.13],0.2036075178586286
Chapter II Neoplasms,Carcinoma in situ of breast,RAP1A,Ras-related protein Rap-1A,19054,117,0.97 [0.75-1.25],0.811599783162643
Chapter II Neoplasms,Carcinoma in situ of breast,RAPGEF2,Rap guanine nucleotide exchange factor 2,19223,122,0.76 [0.53-1.08],0.1240555572834793
Chapter II Neoplasms,Carcinoma in situ of breast,RARRES1,Retinoic acid receptor responder protein 1,22008,134,1.06 [0.69-1.62],0.8010489532205285
Chapter II Neoplasms,Carcinoma in situ of breast,RARRES2,Retinoic acid receptor responder protein 2,22621,139,0.79 [0.57-1.10],0.1597833031996517
Chapter II Neoplasms,Carcinoma in situ of breast,RASA1,Ras GTPase-activating protein 1,21957,134,0.65 [0.40-1.05],0.0805382002416913
Chapter II Neoplasms,Carcinoma in situ of breast,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,18908,119,0.87 [0.57-1.31],0.4940328279743065
Chapter II Neoplasms,Carcinoma in situ of breast,RASSF2,Ras association domain-containing protein 2,22008,134,0.93 [0.70-1.24],0.641490699332951
Chapter II Neoplasms,Carcinoma in situ of breast,RBFOX3,RNA binding protein fox-1 homolog 3,19571,121,0.73 [0.44-1.23],0.2393966274052817
Chapter II Neoplasms,Carcinoma in situ of breast,RBKS,Ribokinase,21979,138,1.06 [0.79-1.41],0.719395686130119
Chapter II Neoplasms,Carcinoma in situ of breast,RBM17,Splicing factor 45,19571,121,0.75 [0.59-0.95],0.0174344199489571
Chapter II Neoplasms,Carcinoma in situ of breast,RBM19,Probable RNA-binding protein 19,19003,118,1.18 [0.86-1.63],0.2932676666058698
Chapter II Neoplasms,Carcinoma in situ of breast,RBM25,RNA-binding protein 25,18908,119,0.85 [0.58-1.26],0.4312012415426226
Chapter II Neoplasms,Carcinoma in situ of breast,RBP1,Retinol-binding protein 1,19054,119,0.86 [0.64-1.15],0.3136538368562018
Chapter II Neoplasms,Carcinoma in situ of breast,RBP2,Retinol-binding protein 2,22413,140,1.09 [0.90-1.33],0.3841490756823921
Chapter II Neoplasms,Carcinoma in situ of breast,RBP5,Retinol-binding protein 5,22413,140,0.81 [0.61-1.07],0.1420161964664338
Chapter II Neoplasms,Carcinoma in situ of breast,RBP7,Retinoid-binding protein 7,19501,122,1.18 [0.91-1.53],0.2074424684933014
Chapter II Neoplasms,Carcinoma in situ of breast,RBPMS,RNA-binding protein with multiple splicing,19054,117,1.00 [0.77-1.30],0.9794699037570512
Chapter II Neoplasms,Carcinoma in situ of breast,RBPMS2,RNA-binding protein with multiple splicing 2,19106,119,0.82 [0.69-0.98],0.0285189570908819
Chapter II Neoplasms,Carcinoma in situ of breast,RCC1,Regulator of chromosome condensation,19495,120,1.25 [0.95-1.63],0.1047098166885624
Chapter II Neoplasms,Carcinoma in situ of breast,RCOR1,REST corepressor 1,22115,137,0.98 [0.70-1.38],0.9245651049199936
Chapter II Neoplasms,Carcinoma in situ of breast,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19106,119,0.76 [0.32-1.84],0.5475613614641106
Chapter II Neoplasms,Carcinoma in situ of breast,REEP4,Receptor expression-enhancing protein 4,19571,121,0.74 [0.55-1.01],0.058831499656003
Chapter II Neoplasms,Carcinoma in situ of breast,REG1A,Lithostathine-1-alpha,22359,137,1.39 [1.06-1.82],0.0184608335285773
Chapter II Neoplasms,Carcinoma in situ of breast,REG1B,Lithostathine-1-beta,22786,138,1.17 [0.91-1.50],0.218668393368352
Chapter II Neoplasms,Carcinoma in situ of breast,REG3A,Regenerating islet-derived protein 3-alpha,22786,138,1.01 [0.79-1.30],0.9128150766184844
Chapter II Neoplasms,Carcinoma in situ of breast,REG3G,Regenerating islet-derived protein 3-gamma,19495,120,0.88 [0.56-1.37],0.5692815506203357
Chapter II Neoplasms,Carcinoma in situ of breast,REG4,Regenerating islet-derived protein 4,22552,140,1.09 [0.79-1.49],0.607483588299697
Chapter II Neoplasms,Carcinoma in situ of breast,RELB,Transcription factor RelB,19054,117,0.86 [0.59-1.25],0.4265831833613347
Chapter II Neoplasms,Carcinoma in situ of breast,RELT,Tumor necrosis factor receptor superfamily member 19L,22524,138,0.87 [0.49-1.57],0.6454707891193319
Chapter II Neoplasms,Carcinoma in situ of breast,REN,Renin,22518,139,0.90 [0.72-1.13],0.3531505766790654
Chapter II Neoplasms,Carcinoma in situ of breast,REPS1,RalBP1-associated Eps domain-containing protein 1,19054,117,0.83 [0.51-1.34],0.4379127975824296
Chapter II Neoplasms,Carcinoma in situ of breast,REST,RE1-silencing transcription factor,18908,119,0.52 [0.29-0.92],0.0238024243819396
Chapter II Neoplasms,Carcinoma in situ of breast,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22413,140,0.85 [0.59-1.22],0.3714136516324954
Chapter II Neoplasms,Carcinoma in situ of breast,RETN,Resistin,22449,135,1.16 [0.81-1.66],0.4221592659942609
Chapter II Neoplasms,Carcinoma in situ of breast,REXO2,"Oligoribonuclease, mitochondrial",19003,118,0.75 [0.48-1.15],0.1844153733336825
Chapter II Neoplasms,Carcinoma in situ of breast,RFC4,Replication factor C subunit 4,19495,120,1.33 [0.60-2.95],0.4764038548936267
Chapter II Neoplasms,Carcinoma in situ of breast,RGCC,Regulator of cell cycle RGCC,19571,121,0.84 [0.66-1.05],0.1300462613851905
Chapter II Neoplasms,Carcinoma in situ of breast,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19223,122,1.00 [0.77-1.30],0.99274453639993
Chapter II Neoplasms,Carcinoma in situ of breast,RGMA,Repulsive guidance molecule A,22715,138,0.73 [0.45-1.19],0.2071811736842745
Chapter II Neoplasms,Carcinoma in situ of breast,RGMB,RGM domain family member B,22715,138,1.19 [0.66-2.15],0.5632730251703009
Chapter II Neoplasms,Carcinoma in situ of breast,RGS10,Regulator of G-protein signaling 10,19571,121,0.73 [0.54-0.99],0.0436789265612626
Chapter II Neoplasms,Carcinoma in situ of breast,RGS8,Regulator of G-protein signaling 8,22090,138,1.01 [0.81-1.27],0.930298702157166
Chapter II Neoplasms,Carcinoma in situ of breast,RHOC,Rho-related GTP-binding protein RhoC,22212,139,0.87 [0.77-0.99],0.0295652542210628
Chapter II Neoplasms,Carcinoma in situ of breast,RICTOR,Rapamycin-insensitive companion of mTOR,19054,117,0.88 [0.59-1.31],0.5259094923447272
Chapter II Neoplasms,Carcinoma in situ of breast,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19191,120,0.86 [0.60-1.25],0.4362052365507726
Chapter II Neoplasms,Carcinoma in situ of breast,RILP,Rab-interacting lysosomal protein,22644,136,0.75 [0.58-0.96],0.0243874456486047
Chapter II Neoplasms,Carcinoma in situ of breast,RILPL2,RILP-like protein 2,19600,119,0.86 [0.72-1.02],0.0865434197504475
Chapter II Neoplasms,Carcinoma in situ of breast,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19003,118,0.92 [0.70-1.22],0.5775650125219849
Chapter II Neoplasms,Carcinoma in situ of breast,RLN1,Prorelaxin H1,19571,121,0.95 [0.77-1.18],0.670373734156817
Chapter II Neoplasms,Carcinoma in situ of breast,RLN2,Prorelaxin H2,19155,120,0.97 [0.86-1.10],0.668554455798654
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE1,Ribonuclease pancreatic,19605,119,0.95 [0.46-1.99],0.895804894857754
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE10,Inactive ribonuclease-like protein 10,19106,119,0.96 [0.67-1.39],0.8390224649962142
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE3,Eosinophil cationic protein,22416,137,1.06 [0.93-1.20],0.3883113876831101
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE4,Ribonuclease 4,18940,115,1.05 [0.54-2.04],0.8971291175561896
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE6,Ribonuclease K6,19450,118,0.69 [0.35-1.35],0.2764218970016195
Chapter II Neoplasms,Carcinoma in situ of breast,RNASEH2A,Ribonuclease H2 subunit A,19571,121,1.01 [0.72-1.42],0.9639998623921108
Chapter II Neoplasms,Carcinoma in situ of breast,RNASET2,Ribonuclease T2,22686,136,0.58 [0.32-1.06],0.0784292970885473
Chapter II Neoplasms,Carcinoma in situ of breast,RNF149,E3 ubiquitin-protein ligase RNF149,19106,119,1.39 [0.79-2.44],0.247440390301715
Chapter II Neoplasms,Carcinoma in situ of breast,RNF168,E3 ubiquitin-protein ligase RNF168,19054,117,0.78 [0.48-1.26],0.3016228820580198
Chapter II Neoplasms,Carcinoma in situ of breast,RNF31,E3 ubiquitin-protein ligase RNF31,19054,117,0.91 [0.55-1.51],0.7097209870532903
Chapter II Neoplasms,Carcinoma in situ of breast,RNF4,E3 ubiquitin-protein ligase RNF4,19223,122,1.09 [0.86-1.39],0.4773789932275946
Chapter II Neoplasms,Carcinoma in situ of breast,RNF41,E3 ubiquitin-protein ligase NRDP1,22008,134,0.74 [0.58-0.94],0.0147634811340669
Chapter II Neoplasms,Carcinoma in situ of breast,RNF43,E3 ubiquitin-protein ligase RNF43,19223,122,0.89 [0.64-1.24],0.4791515640507783
Chapter II Neoplasms,Carcinoma in situ of breast,RNF5,E3 ubiquitin-protein ligase RNF5,19106,119,0.89 [0.70-1.12],0.3200784374963536
Chapter II Neoplasms,Carcinoma in situ of breast,ROBO1,Roundabout homolog 1,22552,140,0.91 [0.49-1.72],0.775055298035816
Chapter II Neoplasms,Carcinoma in situ of breast,ROBO2,Roundabout homolog 2,22715,138,1.19 [0.62-2.28],0.5933573430537771
Chapter II Neoplasms,Carcinoma in situ of breast,ROBO4,Roundabout homolog 4,19106,119,1.16 [0.43-3.13],0.7729118660680973
Chapter II Neoplasms,Carcinoma in situ of breast,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22518,139,1.52 [0.94-2.46],0.0877539048031008
Chapter II Neoplasms,Carcinoma in situ of breast,RP2,Protein XRP2,22413,140,0.75 [0.51-1.09],0.1277285330215592
Chapter II Neoplasms,Carcinoma in situ of breast,RPA2,Replication protein A 32 kDa subunit,19054,117,1.26 [0.76-2.09],0.3636399887350899
Chapter II Neoplasms,Carcinoma in situ of breast,RPE,Ribulose-phosphate 3-epimerase,19223,122,0.80 [0.61-1.04],0.0958198560253407
Chapter II Neoplasms,Carcinoma in situ of breast,RPGR,X-linked retinitis pigmentosa GTPase regulator,19054,119,0.51 [0.31-0.84],0.0087978231964037
Chapter II Neoplasms,Carcinoma in situ of breast,RPL14,60S ribosomal protein L14,19106,119,0.98 [0.64-1.51],0.9392961883324072
Chapter II Neoplasms,Carcinoma in situ of breast,RPS10,40S ribosomal protein S10,19003,118,0.76 [0.47-1.23],0.2601656959855489
Chapter II Neoplasms,Carcinoma in situ of breast,RRAS,Ras-related protein R-Ras,19054,119,0.88 [0.76-1.01],0.071572105471317
Chapter II Neoplasms,Carcinoma in situ of breast,RRM2,Ribonucleoside-diphosphate reductase subunit M2,22008,134,0.81 [0.57-1.15],0.2425532574865784
Chapter II Neoplasms,Carcinoma in situ of breast,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22008,134,0.88 [0.70-1.10],0.2571035671915876
Chapter II Neoplasms,Carcinoma in situ of breast,RRP15,RRP15-like protein,18997,118,1.07 [0.89-1.29],0.4621033623955242
Chapter II Neoplasms,Carcinoma in situ of breast,RSPO1,R-spondin-1,22368,139,0.86 [0.56-1.32],0.4876998942533
Chapter II Neoplasms,Carcinoma in situ of breast,RSPO3,R-spondin-3,22716,137,0.71 [0.41-1.23],0.2229384292798968
Chapter II Neoplasms,Carcinoma in situ of breast,RTBDN,Retbindin,22413,140,0.63 [0.37-1.08],0.0917629415162921
Chapter II Neoplasms,Carcinoma in situ of breast,RTKN2,Rhotekin-2,19003,118,0.80 [0.54-1.19],0.2749810905740528
Chapter II Neoplasms,Carcinoma in situ of breast,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19571,121,0.84 [0.69-1.02],0.0792764813633184
Chapter II Neoplasms,Carcinoma in situ of breast,RTN4R,Reticulon-4 receptor,22716,137,0.87 [0.55-1.37],0.5515353654508663
Chapter II Neoplasms,Carcinoma in situ of breast,RUVBL1,RuvB-like 1,22008,134,1.11 [0.98-1.27],0.1041129493116241
Chapter II Neoplasms,Carcinoma in situ of breast,RWDD1,RWD domain-containing protein 1,22715,138,0.75 [0.59-0.95],0.017033889698988
Chapter II Neoplasms,Carcinoma in situ of breast,RYR1,Ryanodine receptor 1,19003,118,0.69 [0.38-1.26],0.2238029081159061
Chapter II Neoplasms,Carcinoma in situ of breast,S100A11,Protein S100-A11,22337,138,1.11 [0.83-1.49],0.4677377978264998
Chapter II Neoplasms,Carcinoma in situ of breast,S100A12,Protein S100-A12,22211,140,1.13 [0.93-1.37],0.2126187973797269
Chapter II Neoplasms,Carcinoma in situ of breast,S100A13,Protein S100-A13,19054,117,1.00 [0.60-1.66],0.9881694138813254
Chapter II Neoplasms,Carcinoma in situ of breast,S100A14,Protein S100-A14,19571,121,0.89 [0.64-1.24],0.4805746051988616
Chapter II Neoplasms,Carcinoma in situ of breast,S100A16,Protein S100-A16,21927,134,0.91 [0.70-1.17],0.4556278643527841
Chapter II Neoplasms,Carcinoma in situ of breast,S100A3,Protein S100-A3,19495,120,0.85 [0.54-1.32],0.4618209050017784
Chapter II Neoplasms,Carcinoma in situ of breast,S100A4,Protein S100-A4,22586,140,0.82 [0.64-1.07],0.1434668541804665
Chapter II Neoplasms,Carcinoma in situ of breast,S100G,Protein S100-G,19571,121,0.92 [0.61-1.37],0.6775253781130328
Chapter II Neoplasms,Carcinoma in situ of breast,S100P,Protein S100-P,22115,137,1.19 [0.93-1.52],0.1747462145154047
Chapter II Neoplasms,Carcinoma in situ of breast,SAA4,Serum amyloid A-4 protein,19630,119,0.73 [0.33-1.65],0.4550066252431611
Chapter II Neoplasms,Carcinoma in situ of breast,SAFB2,Scaffold attachment factor B2,19571,121,0.77 [0.40-1.50],0.4422755702554869
Chapter II Neoplasms,Carcinoma in situ of breast,SAG,S-arrestin,18997,118,1.03 [0.75-1.43],0.845828827625875
Chapter II Neoplasms,Carcinoma in situ of breast,SAMD9L,Sterile alpha motif domain-containing protein 9-like,22477,136,0.89 [0.72-1.10],0.2873887801478175
Chapter II Neoplasms,Carcinoma in situ of breast,SAP18,Histone deacetylase complex subunit SAP18,19223,122,1.13 [0.92-1.38],0.2619305260725534
Chapter II Neoplasms,Carcinoma in situ of breast,SARG,Specifically androgen-regulated gene protein,19525,119,0.86 [0.73-1.00],0.0548355778476542
Chapter II Neoplasms,Carcinoma in situ of breast,SART1,U4/U6.U5 tri-snRNP-associated protein 1,19003,118,0.93 [0.56-1.54],0.7825187124074104
Chapter II Neoplasms,Carcinoma in situ of breast,SAT1,Diamine acetyltransferase 1,19003,118,1.19 [0.88-1.60],0.2504361506786503
Chapter II Neoplasms,Carcinoma in situ of breast,SAT2,Thialysine N-epsilon-acetyltransferase,19223,122,1.03 [0.81-1.31],0.8137766392805226
Chapter II Neoplasms,Carcinoma in situ of breast,SATB1,DNA-binding protein SATB1,19571,121,1.16 [0.70-1.93],0.5541322451616612
Chapter II Neoplasms,Carcinoma in situ of breast,SBSN,Suprabasin,19559,123,1.06 [0.64-1.77],0.8114071087190317
Chapter II Neoplasms,Carcinoma in situ of breast,SCAMP3,Secretory carrier-associated membrane protein 3,22413,140,0.78 [0.65-0.93],0.0062856786661966
Chapter II Neoplasms,Carcinoma in situ of breast,SCARA5,Scavenger receptor class A member 5,22715,138,0.96 [0.57-1.62],0.8802098849476062
Chapter II Neoplasms,Carcinoma in situ of breast,SCARB1,Scavenger receptor class B member 1,21957,134,1.22 [1.00-1.49],0.0449480774724786
Chapter II Neoplasms,Carcinoma in situ of breast,SCARB2,Lysosome membrane protein 2,21947,137,0.95 [0.56-1.63],0.861596157643813
Chapter II Neoplasms,Carcinoma in situ of breast,SCARF1,Scavenger receptor class F member 1,22786,138,0.79 [0.55-1.13],0.202800627835451
Chapter II Neoplasms,Carcinoma in situ of breast,SCARF2,Scavenger receptor class F member 2,22715,138,1.22 [0.72-2.05],0.4548865425396554
Chapter II Neoplasms,Carcinoma in situ of breast,SCG2,Secretogranin-2,22603,136,1.16 [0.72-1.88],0.5457180126515349
Chapter II Neoplasms,Carcinoma in situ of breast,SCG3,Secretogranin-3,22552,140,0.96 [0.61-1.51],0.867807328539644
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB1A1,Uteroglobin,22545,140,1.10 [0.84-1.45],0.4789179355744188
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB2A2,Mammaglobin-A,19003,118,0.84 [0.46-1.54],0.5665451964775983
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB3A1,Secretoglobin family 3A member 1,19191,120,2.75 [1.37-5.53],0.0045256326735836
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB3A2,Secretoglobin family 3A member 2,22580,141,1.08 [0.92-1.27],0.334777251693206
Chapter II Neoplasms,Carcinoma in situ of breast,SCGN,Secretagogin,22090,138,1.27 [0.91-1.77],0.1611961332998627
Chapter II Neoplasms,Carcinoma in situ of breast,SCIN,Adseverin,18997,118,0.97 [0.76-1.23],0.781788270023926
Chapter II Neoplasms,Carcinoma in situ of breast,SCLY,Selenocysteine lyase,22644,136,0.86 [0.62-1.19],0.3530718877967538
Chapter II Neoplasms,Carcinoma in situ of breast,SCN2A,Sodium channel protein type 2 subunit alpha,18997,118,0.92 [0.63-1.36],0.6791888052851849
Chapter II Neoplasms,Carcinoma in situ of breast,SCN2B,Sodium channel subunit beta-2,19054,119,0.66 [0.34-1.28],0.2153473084454155
Chapter II Neoplasms,Carcinoma in situ of breast,SCN3A,Sodium channel protein type 3 subunit alpha,19054,119,1.19 [0.80-1.78],0.392993250207948
Chapter II Neoplasms,Carcinoma in situ of breast,SCN3B,Sodium channel subunit beta-3,18997,118,1.15 [0.82-1.62],0.4143366520739736
Chapter II Neoplasms,Carcinoma in situ of breast,SCN4B,Sodium channel subunit beta-4,19106,119,1.16 [0.76-1.77],0.4775798937742485
Chapter II Neoplasms,Carcinoma in situ of breast,SCP2,Non-specific lipid-transfer protein,22008,134,0.94 [0.77-1.16],0.5781996419227105
Chapter II Neoplasms,Carcinoma in situ of breast,SCPEP1,Retinoid-inducible serine carboxypeptidase,19031,119,0.91 [0.63-1.31],0.6135112881426523
Chapter II Neoplasms,Carcinoma in situ of breast,SCRG1,Scrapie-responsive protein 1,19600,119,0.66 [0.34-1.29],0.2269467738650144
Chapter II Neoplasms,Carcinoma in situ of breast,SCRIB,Protein scribble homolog,19106,119,0.97 [0.80-1.17],0.720745534940416
Chapter II Neoplasms,Carcinoma in situ of breast,SCRN1,Secernin-1,22477,136,0.86 [0.65-1.13],0.278403522739051
Chapter II Neoplasms,Carcinoma in situ of breast,SCT,Secretin,19054,119,1.32 [0.91-1.91],0.1466178480473014
Chapter II Neoplasms,Carcinoma in situ of breast,SDC1,Syndecan-1,22518,139,0.91 [0.62-1.36],0.6566425161008684
Chapter II Neoplasms,Carcinoma in situ of breast,SDC4,Syndecan-4,22518,139,0.93 [0.67-1.30],0.6791710079019311
Chapter II Neoplasms,Carcinoma in situ of breast,SDCCAG8,Serologically defined colon cancer antigen 8,19495,120,0.82 [0.70-0.96],0.013667739796684
Chapter II Neoplasms,Carcinoma in situ of breast,SDHB,Succinate dehydrogenase,19501,122,1.04 [0.82-1.33],0.7515449605470278
Chapter II Neoplasms,Carcinoma in situ of breast,SDK2,Protein sidekick-2,19191,120,0.99 [0.62-1.57],0.9533227055796722
Chapter II Neoplasms,Carcinoma in situ of breast,SEC31A,Protein transport protein Sec31A,19106,119,0.89 [0.71-1.12],0.332084214807505
Chapter II Neoplasms,Carcinoma in situ of breast,SEL1L,Protein sel-1 homolog 1,19106,119,0.83 [0.45-1.53],0.5452625926794932
Chapter II Neoplasms,Carcinoma in situ of breast,SELE,E-selectin,22786,138,0.78 [0.58-1.05],0.100660136764289
Chapter II Neoplasms,Carcinoma in situ of breast,SELENOP,Selenoprotein P,19630,119,1.41 [0.67-2.94],0.3647803590503251
Chapter II Neoplasms,Carcinoma in situ of breast,SELL,L-selectin,19630,119,0.83 [0.39-1.78],0.6306577571096221
Chapter II Neoplasms,Carcinoma in situ of breast,SELP,P-selectin,22579,139,0.89 [0.69-1.16],0.3839623248714957
Chapter II Neoplasms,Carcinoma in situ of breast,SELPLG,P-selectin glycoprotein ligand 1,22477,136,0.64 [0.39-1.02],0.0620659578639851
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA3F,Semaphorin-3F,22518,139,0.90 [0.50-1.62],0.7208472150185627
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA3G,Semaphorin-3G,19191,120,0.87 [0.57-1.31],0.4906016531589595
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA4C,Semaphorin-4C,22413,140,0.83 [0.47-1.47],0.5216175079738498
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA4D,Semaphorin-4D,22715,138,0.54 [0.33-0.88],0.0133173235972027
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA6C,Semaphorin-6C,19054,117,0.89 [0.45-1.77],0.7425232547831122
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA7A,Semaphorin-7A,22718,136,0.83 [0.46-1.49],0.5246832016253516
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN3,Neuronal-specific septin-3,19571,121,0.90 [0.71-1.16],0.4218742869532901
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN7,Septin-7,19223,122,0.90 [0.63-1.28],0.558308214522808
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN8,Septin-8,19521,122,0.61 [0.34-1.09],0.0942701005939023
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN9,Septin-9,22413,140,1.09 [0.65-1.83],0.7294486609699777
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA1,Alpha-1-antitrypsin,19242,115,3.41 [0.40-29.28],0.2634472992991041
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA11,Serpin A11,22786,138,0.90 [0.62-1.30],0.5649735848006765
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA12,Serpin A12,21876,138,1.02 [0.90-1.16],0.7873996272650129
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA3,Alpha-1-antichymotrypsin,19550,119,1.77 [0.56-5.63],0.3315734174263866
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA4,Kallistatin,19255,116,1.41 [0.67-2.98],0.3610246187591698
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA5,Plasma serine protease inhibitor,19327,117,1.42 [0.89-2.26],0.1428160279781448
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA6,Corticosteroid-binding globulin,19630,119,1.63 [0.66-4.01],0.2860707797871879
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA7,Thyroxine-binding globulin,19630,119,2.10 [0.84-5.23],0.1119151997069032
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA9,Serpin A9,22283,140,0.94 [0.77-1.16],0.5923644390145647
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB1,Leukocyte elastase inhibitor,22453,138,0.94 [0.80-1.12],0.5046681558012612
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB5,Serpin B5,22115,137,0.95 [0.70-1.29],0.7446594297728601
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB6,Serpin B6,22644,138,0.83 [0.65-1.07],0.1581935930735328
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB8,Serpin B8,22764,139,1.29 [1.06-1.58],0.0125102369814335
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB9,Serpin B9,22368,139,0.90 [0.58-1.41],0.6473170893853665
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINC1,Antithrombin-III,19587,118,3.66 [1.13-11.86],0.0303304972542337
Chapter II Neoplasms,Carcinoma in situ of breast,SERPIND1,Heparin cofactor 2,19587,118,1.41 [0.74-2.67],0.297366906481987
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINE1,Plasminogen activator inhibitor 1,22786,138,0.87 [0.70-1.08],0.2156200778533856
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINE2,Glia-derived nexin,19600,119,0.75 [0.57-0.99],0.0448848408945557
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINF1,Pigment epithelium-derived factor,19327,116,1.32 [0.67-2.59],0.4230125555345343
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINF2,Alpha-2-antiplasmin,19251,116,2.31 [0.66-8.07],0.1905419095825051
Chapter II Neoplasms,Carcinoma in situ of breast,SERPING1,Plasma protease C1 inhibitor,19587,118,3.03 [1.20-7.64],0.0188703886404107
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINH1,Serpin H1,19223,122,0.83 [0.72-0.95],0.0072145797489465
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINI1,Neuroserpin,19148,120,1.60 [0.98-2.61],0.0624530568715773
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINI2,Serpin I2,19501,122,0.88 [0.64-1.21],0.4250127736470525
Chapter II Neoplasms,Carcinoma in situ of breast,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,21957,134,0.76 [0.59-0.97],0.0308682764904398
Chapter II Neoplasms,Carcinoma in situ of breast,SETMAR,Histone-lysine N-methyltransferase SETMAR,22305,137,1.48 [0.93-2.34],0.0975450908408526
Chapter II Neoplasms,Carcinoma in situ of breast,SEZ6,Seizure protein 6 homolog,19054,119,0.68 [0.37-1.26],0.2214115122586686
Chapter II Neoplasms,Carcinoma in situ of breast,SEZ6L,Seizure 6-like protein,22586,140,1.36 [0.79-2.36],0.2659296330473834
Chapter II Neoplasms,Carcinoma in situ of breast,SEZ6L2,Seizure 6-like protein 2,22413,140,0.99 [0.53-1.86],0.9790018620184894
Chapter II Neoplasms,Carcinoma in situ of breast,SF3B4,Splicing factor 3B subunit 4,22413,140,0.79 [0.64-0.98],0.0297051952101793
Chapter II Neoplasms,Carcinoma in situ of breast,SFRP1,Secreted frizzled-related protein 1,22302,139,0.85 [0.59-1.21],0.3612795915213026
Chapter II Neoplasms,Carcinoma in situ of breast,SFRP4,Secreted frizzled-related protein 4,19191,120,0.80 [0.53-1.20],0.2784034681969424
Chapter II Neoplasms,Carcinoma in situ of breast,SFTPA1,Pulmonary surfactant-associated protein A1,22008,134,0.84 [0.62-1.14],0.2682177683505715
Chapter II Neoplasms,Carcinoma in situ of breast,SFTPA2,Pulmonary surfactant-associated protein A2,22008,134,1.03 [0.75-1.40],0.8682378714029048
Chapter II Neoplasms,Carcinoma in situ of breast,SFTPD,Pulmonary surfactant-associated protein D,22518,139,1.30 [1.04-1.63],0.0222329520400952
Chapter II Neoplasms,Carcinoma in situ of breast,SGSH,N-sulphoglucosamine sulphohydrolase,19247,116,1.03 [0.75-1.41],0.8695119508756145
Chapter II Neoplasms,Carcinoma in situ of breast,SH2B3,SH2B adapter protein 3,22008,134,0.83 [0.71-0.97],0.0177576287826454
Chapter II Neoplasms,Carcinoma in situ of breast,SH2D1A,SH2 domain-containing protein 1A,22477,136,0.77 [0.56-1.05],0.1013189170013795
Chapter II Neoplasms,Carcinoma in situ of breast,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,18997,118,0.96 [0.72-1.29],0.797212423521173
Chapter II Neoplasms,Carcinoma in situ of breast,SH3BP1,SH3 domain-binding protein 1,19501,122,1.30 [0.97-1.75],0.0791362804026653
Chapter II Neoplasms,Carcinoma in situ of breast,SH3GL3,Endophilin-A3,19118,121,0.90 [0.74-1.11],0.3285627283846532
Chapter II Neoplasms,Carcinoma in situ of breast,SH3GLB2,Endophilin-B2,19562,122,0.74 [0.57-0.96],0.0235826766750646
Chapter II Neoplasms,Carcinoma in situ of breast,SHBG,Sex hormone-binding globulin,19605,119,0.83 [0.60-1.13],0.2386520489634498
Chapter II Neoplasms,Carcinoma in situ of breast,SHC1,SHC-transforming protein 1,18908,119,0.93 [0.79-1.09],0.3813206433226693
Chapter II Neoplasms,Carcinoma in situ of breast,SHD,SH2 domain-containing adapter protein D,18964,118,0.94 [0.76-1.17],0.5900367017564679
Chapter II Neoplasms,Carcinoma in situ of breast,SHH,Sonic hedgehog protein,19054,117,1.23 [0.86-1.75],0.2668895307093661
Chapter II Neoplasms,Carcinoma in situ of breast,SHISA5,Protein shisa-5,19597,123,1.23 [0.64-2.40],0.5344644267946348
Chapter II Neoplasms,Carcinoma in situ of breast,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22580,141,0.75 [0.63-0.89],0.0011912936812094
Chapter II Neoplasms,Carcinoma in situ of breast,SHPK,Sedoheptulokinase,19223,122,0.88 [0.57-1.36],0.567920949094409
Chapter II Neoplasms,Carcinoma in situ of breast,SIAE,Sialate O-acetylesterase,22550,139,0.72 [0.52-1.00],0.0480560059738255
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC1,Sialoadhesin,22619,141,1.00 [0.71-1.40],0.9779135570467836
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22477,136,1.11 [0.69-1.77],0.6666417662543855
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC15,Sialic acid-binding Ig-like lectin 15,21957,134,0.92 [0.75-1.13],0.4220432097382575
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC5,Sialic acid-binding Ig-like lectin 5,22524,138,0.98 [0.86-1.10],0.7029150239738097
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC6,Sialic acid-binding Ig-like lectin 6,22716,137,0.75 [0.47-1.19],0.2189671198504061
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22518,139,1.14 [0.67-1.95],0.6314856729810581
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19106,119,0.82 [0.56-1.22],0.3334516573472811
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC9,Sialic acid-binding Ig-like lectin 9,22683,136,0.96 [0.58-1.60],0.8778063627848881
Chapter II Neoplasms,Carcinoma in situ of breast,SIL1,Nucleotide exchange factor SIL1,19106,119,0.97 [0.55-1.68],0.9007729096117394
Chapter II Neoplasms,Carcinoma in situ of breast,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22567,136,1.18 [0.89-1.56],0.2459700912336687
Chapter II Neoplasms,Carcinoma in situ of breast,SIRPB1,Signal-regulatory protein beta-1,22476,140,1.07 [0.77-1.50],0.6859641604670709
Chapter II Neoplasms,Carcinoma in situ of breast,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19054,117,0.96 [0.77-1.18],0.6775505954830879
Chapter II Neoplasms,Carcinoma in situ of breast,SIRT2,NAD-dependent protein deacetylase sirtuin-2,22413,140,0.80 [0.68-0.95],0.0097013263202823
Chapter II Neoplasms,Carcinoma in situ of breast,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",21957,134,0.95 [0.72-1.26],0.7278754823409361
Chapter II Neoplasms,Carcinoma in situ of breast,SIT1,Signaling threshold-regulating transmembrane adapter 1,22090,138,1.08 [0.82-1.41],0.5879436705270189
Chapter II Neoplasms,Carcinoma in situ of breast,SKAP1,Src kinase-associated phosphoprotein 1,22320,139,0.94 [0.76-1.15],0.5248344242616632
Chapter II Neoplasms,Carcinoma in situ of breast,SKAP2,Src kinase-associated phosphoprotein 2,22619,141,0.81 [0.71-0.94],0.0046271451048047
Chapter II Neoplasms,Carcinoma in situ of breast,SKIV2L,Helicase SKI2W,19003,118,0.92 [0.58-1.44],0.7005761872873808
Chapter II Neoplasms,Carcinoma in situ of breast,SLA2,Src-like-adapter 2,19571,121,0.85 [0.72-1.01],0.0586806100203789
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF1,Signaling lymphocytic activation molecule,22090,138,0.92 [0.72-1.19],0.5414425727133408
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF6,SLAM family member 6,22008,134,0.90 [0.59-1.36],0.6198375415880233
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF7,SLAM family member 7,22477,136,1.02 [0.78-1.32],0.9121392476074413
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF8,SLAM family member 8,22008,134,0.81 [0.61-1.07],0.1347478052901164
Chapter II Neoplasms,Carcinoma in situ of breast,SLC12A2,Solute carrier family 12 member 2,19003,118,0.56 [0.27-1.15],0.1167324729787913
Chapter II Neoplasms,Carcinoma in situ of breast,SLC13A1,Solute carrier family 13 member 1,19495,120,0.79 [0.55-1.14],0.2113498293460378
Chapter II Neoplasms,Carcinoma in situ of breast,SLC16A1,Monocarboxylate transporter 1,21957,134,0.78 [0.58-1.06],0.1102378059270902
Chapter II Neoplasms,Carcinoma in situ of breast,SLC1A4,Neutral amino acid transporter A,19054,119,0.87 [0.61-1.25],0.4499638154046945
Chapter II Neoplasms,Carcinoma in situ of breast,SLC27A4,Long-chain fatty acid transport protein 4,21957,134,0.87 [0.68-1.12],0.2764216040492299
Chapter II Neoplasms,Carcinoma in situ of breast,SLC28A1,Sodium/nucleoside cotransporter 1,18908,119,0.80 [0.57-1.13],0.2092901885758263
Chapter II Neoplasms,Carcinoma in situ of breast,SLC34A3,Sodium-dependent phosphate transport protein 2C,18908,119,0.98 [0.68-1.41],0.921630826874922
Chapter II Neoplasms,Carcinoma in situ of breast,SLC39A14,Zinc transporter ZIP14,21957,134,1.65 [1.18-2.30],0.0034126955903474
Chapter II Neoplasms,Carcinoma in situ of breast,SLC39A5,Zinc transporter ZIP5,22477,136,1.09 [0.83-1.41],0.538475690930861
Chapter II Neoplasms,Carcinoma in situ of breast,SLC44A4,Choline transporter-like protein 4,19054,119,0.72 [0.52-1.01],0.0588221091026427
Chapter II Neoplasms,Carcinoma in situ of breast,SLC4A1,Band 3 anion transport protein,19597,123,1.04 [0.73-1.49],0.8174276607275852
Chapter II Neoplasms,Carcinoma in situ of breast,SLC51B,Organic solute transporter subunit beta,19003,118,1.00 [0.80-1.25],0.9817554954701116
Chapter II Neoplasms,Carcinoma in situ of breast,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19191,120,0.85 [0.68-1.05],0.12238707149146
Chapter II Neoplasms,Carcinoma in situ of breast,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19501,122,0.95 [0.67-1.35],0.7885928544711495
Chapter II Neoplasms,Carcinoma in situ of breast,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",18908,119,0.78 [0.54-1.12],0.1776995138557451
Chapter II Neoplasms,Carcinoma in situ of breast,SLIT2,Slit homolog 2 protein,21957,134,0.86 [0.63-1.17],0.3382149226902906
Chapter II Neoplasms,Carcinoma in situ of breast,SLITRK1,SLIT and NTRK-like protein 1,19054,117,0.84 [0.48-1.47],0.5431518833811142
Chapter II Neoplasms,Carcinoma in situ of breast,SLITRK2,SLIT and NTRK-like protein 2,22716,137,1.06 [0.71-1.57],0.7829799926237173
Chapter II Neoplasms,Carcinoma in situ of breast,SLITRK6,SLIT and NTRK-like protein 6,22115,137,1.08 [0.70-1.68],0.7255029258529654
Chapter II Neoplasms,Carcinoma in situ of breast,SLK,STE20-like serine/threonine-protein kinase,19223,122,0.97 [0.78-1.22],0.8103109222310992
Chapter II Neoplasms,Carcinoma in situ of breast,SLMAP,Sarcolemmal membrane-associated protein,19501,122,0.79 [0.64-0.99],0.0374506026199887
Chapter II Neoplasms,Carcinoma in situ of breast,SLURP1,Secreted Ly-6/uPAR-related protein 1,19443,122,1.08 [0.70-1.66],0.742572549109408
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD1,Mothers against decapentaplegic homolog 1,22008,134,0.78 [0.63-0.95],0.0127426988449837
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD2,Mothers against decapentaplegic homolog 2,19495,120,0.71 [0.54-0.94],0.0167528126051375
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD3,Mothers against decapentaplegic homolog 3,19495,120,0.69 [0.48-0.99],0.0426329558788403
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD5,Mothers against decapentaplegic homolog 5,22413,140,0.64 [0.32-1.29],0.2120095200761167
Chapter II Neoplasms,Carcinoma in situ of breast,SMARCA2,Probable global transcription activator SNF2L2,21957,134,0.94 [0.76-1.17],0.5810834849086144
Chapter II Neoplasms,Carcinoma in situ of breast,SMC3,Structural maintenance of chromosomes protein 3,18908,119,0.95 [0.68-1.32],0.7574476199036262
Chapter II Neoplasms,Carcinoma in situ of breast,SMNDC1,Survival of motor neuron-related-splicing factor 30,19501,122,1.05 [0.80-1.37],0.7502772983966872
Chapter II Neoplasms,Carcinoma in situ of breast,SMOC1,SPARC-related modular calcium-binding protein 1,22716,137,0.84 [0.53-1.32],0.4512892594752683
Chapter II Neoplasms,Carcinoma in situ of breast,SMOC2,SPARC-related modular calcium-binding protein 2,22619,141,0.74 [0.50-1.11],0.1474539378589455
Chapter II Neoplasms,Carcinoma in situ of breast,SMPD1,Sphingomyelin phosphodiesterase,22602,138,0.77 [0.56-1.07],0.1182986760386768
Chapter II Neoplasms,Carcinoma in situ of breast,SMPD3,Sphingomyelin phosphodiesterase 3,19054,117,0.81 [0.56-1.17],0.2556875231557693
Chapter II Neoplasms,Carcinoma in situ of breast,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22585,141,0.88 [0.70-1.10],0.2466829282287171
Chapter II Neoplasms,Carcinoma in situ of breast,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19495,120,0.87 [0.67-1.13],0.3006511872983282
Chapter II Neoplasms,Carcinoma in situ of breast,SMS,Spermine synthase,18997,118,0.99 [0.75-1.30],0.9181265266761977
Chapter II Neoplasms,Carcinoma in situ of breast,SMTN,Smoothelin,19530,122,0.81 [0.66-0.98],0.0281831569620272
Chapter II Neoplasms,Carcinoma in situ of breast,SNAP23,Synaptosomal-associated protein 23,22518,139,0.85 [0.72-1.00],0.0463795251236379
Chapter II Neoplasms,Carcinoma in situ of breast,SNAP25,Synaptosomal-associated protein 25,18997,118,0.76 [0.52-1.12],0.1655606633769785
Chapter II Neoplasms,Carcinoma in situ of breast,SNAP29,Synaptosomal-associated protein 29,22586,140,0.82 [0.70-0.96],0.0154505921205701
Chapter II Neoplasms,Carcinoma in situ of breast,SNAPIN,SNARE-associated protein Snapin,19571,121,0.80 [0.59-1.10],0.1659380826445921
Chapter II Neoplasms,Carcinoma in situ of breast,SNCA,Alpha-synuclein,19191,120,0.87 [0.75-1.02],0.085778845572075
Chapter II Neoplasms,Carcinoma in situ of breast,SNCG,Gamma-synuclein,22368,139,1.01 [0.80-1.26],0.9525013657653666
Chapter II Neoplasms,Carcinoma in situ of breast,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19106,119,0.94 [0.55-1.60],0.8240875148991272
Chapter II Neoplasms,Carcinoma in situ of breast,SNRPB2,U2 small nuclear ribonucleoprotein B'',19562,122,1.25 [0.94-1.66],0.1300275031489665
Chapter II Neoplasms,Carcinoma in situ of breast,SNU13,NHP2-like protein 1,19003,118,1.12 [0.87-1.43],0.3819711751052217
Chapter II Neoplasms,Carcinoma in situ of breast,SNX15,Sorting nexin-15,19191,120,0.75 [0.54-1.04],0.0810674261621582
Chapter II Neoplasms,Carcinoma in situ of breast,SNX18,Sorting nexin-18,19501,122,0.96 [0.65-1.42],0.8448538276713609
Chapter II Neoplasms,Carcinoma in situ of breast,SNX2,Sorting nexin-2,19495,120,0.84 [0.66-1.06],0.1475042615297509
Chapter II Neoplasms,Carcinoma in situ of breast,SNX5,Sorting nexin-5,19106,119,1.16 [0.66-2.04],0.5948422829998263
Chapter II Neoplasms,Carcinoma in situ of breast,SNX9,Sorting nexin-9,22518,139,0.79 [0.63-0.99],0.0392460051769265
Chapter II Neoplasms,Carcinoma in situ of breast,SOD1,Superoxide dismutase [Cu-Zn],22035,138,0.78 [0.57-1.07],0.1290630123729067
Chapter II Neoplasms,Carcinoma in situ of breast,SOD2,"Superoxide dismutase [Mn], mitochondrial",22524,138,0.84 [0.55-1.28],0.4146969470239904
Chapter II Neoplasms,Carcinoma in situ of breast,SOD3,Extracellular superoxide dismutase,19605,119,0.99 [0.74-1.33],0.9526344545459372
Chapter II Neoplasms,Carcinoma in situ of breast,SORBS1,Sorbin and SH3 domain-containing protein 1,19571,121,0.76 [0.45-1.27],0.292924616093468
Chapter II Neoplasms,Carcinoma in situ of breast,SORCS2,VPS10 domain-containing receptor SorCS2,22008,134,0.74 [0.48-1.14],0.1750374103034831
Chapter II Neoplasms,Carcinoma in situ of breast,SORD,Sorbitol dehydrogenase,22607,136,0.78 [0.63-0.97],0.0229951708984063
Chapter II Neoplasms,Carcinoma in situ of breast,SORT1,Sortilin,22484,139,0.73 [0.48-1.11],0.1418801185142626
Chapter II Neoplasms,Carcinoma in situ of breast,SOST,Sclerostin,22484,139,0.94 [0.64-1.37],0.733992385635033
Chapter II Neoplasms,Carcinoma in situ of breast,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19054,119,0.71 [0.46-1.11],0.130940747390803
Chapter II Neoplasms,Carcinoma in situ of breast,SOX2,Transcription factor SOX-2,19544,121,0.87 [0.41-1.85],0.7178782311510188
Chapter II Neoplasms,Carcinoma in situ of breast,SOX9,Transcription factor SOX-9,19054,119,0.54 [0.28-1.03],0.0631087828133092
Chapter II Neoplasms,Carcinoma in situ of breast,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19571,121,0.52 [0.26-1.03],0.0590677228405757
Chapter II Neoplasms,Carcinoma in situ of breast,SPAG1,Sperm-associated antigen 1,19571,121,0.96 [0.71-1.30],0.811854514908793
Chapter II Neoplasms,Carcinoma in situ of breast,SPARC,SPARC,22586,140,0.86 [0.71-1.05],0.1474940328171562
Chapter II Neoplasms,Carcinoma in situ of breast,SPARCL1,SPARC-like protein 1,22507,138,1.98 [1.31-3.00],0.0012210600628086
Chapter II Neoplasms,Carcinoma in situ of breast,SPART,Spartin,19191,120,0.80 [0.63-1.01],0.0645444378798453
Chapter II Neoplasms,Carcinoma in situ of breast,SPESP1,Sperm equatorial segment protein 1,19600,119,1.18 [0.64-2.20],0.5923886276380027
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK1,Serine protease inhibitor Kazal-type 1,22524,138,0.96 [0.67-1.39],0.8379533577832133
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK2,Serine protease inhibitor Kazal-type 2,19191,120,1.29 [0.83-1.99],0.257428578539232
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK4,Serine protease inhibitor Kazal-type 4,22477,136,1.05 [0.83-1.33],0.6740979142147503
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK5,Serine protease inhibitor Kazal-type 5,22524,138,1.36 [0.86-2.15],0.1929911640301791
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK6,Serine protease inhibitor Kazal-type 6,22716,137,0.98 [0.75-1.29],0.8983632662772025
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK8,Serine protease inhibitor Kazal-type 8,19003,118,1.13 [0.76-1.67],0.5596765186611896
Chapter II Neoplasms,Carcinoma in situ of breast,SPINT1,Kunitz-type protease inhibitor 1,22460,138,1.07 [0.58-1.99],0.8328901073121848
Chapter II Neoplasms,Carcinoma in situ of breast,SPINT2,Kunitz-type protease inhibitor 2,22619,141,0.73 [0.52-1.01],0.0600500390465373
Chapter II Neoplasms,Carcinoma in situ of breast,SPINT3,Kunitz-type protease inhibitor 3,19501,122,1.00 [0.88-1.15],0.9651095869447576
Chapter II Neoplasms,Carcinoma in situ of breast,SPOCK1,Testican-1,22368,139,0.90 [0.49-1.64],0.7264549450966568
Chapter II Neoplasms,Carcinoma in situ of breast,SPON1,Spondin-1,22552,140,0.87 [0.55-1.40],0.5735868552921229
Chapter II Neoplasms,Carcinoma in situ of breast,SPON2,Spondin-2,22418,138,1.19 [0.76-1.85],0.4463103908216257
Chapter II Neoplasms,Carcinoma in situ of breast,SPP1,Osteopontin,22747,138,0.85 [0.62-1.17],0.3240538607444945
Chapter II Neoplasms,Carcinoma in situ of breast,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19054,117,0.65 [0.41-1.03],0.0652229320080594
Chapter II Neoplasms,Carcinoma in situ of breast,SPRING1,SREBP regulating gene protein,18908,119,0.97 [0.71-1.31],0.8378475858076341
Chapter II Neoplasms,Carcinoma in situ of breast,SPRR1B,Cornifin-B,19223,122,0.89 [0.70-1.12],0.3077000853858692
Chapter II Neoplasms,Carcinoma in situ of breast,SPRR3,Small proline-rich protein 3,19562,122,1.07 [0.85-1.37],0.5577344528750843
Chapter II Neoplasms,Carcinoma in situ of breast,SPRY2,Protein sprouty homolog 2,22090,138,0.87 [0.74-1.03],0.1153226740351035
Chapter II Neoplasms,Carcinoma in situ of breast,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",18997,118,0.96 [0.55-1.66],0.8722401867977537
Chapter II Neoplasms,Carcinoma in situ of breast,SPTLC1,Serine palmitoyltransferase 1,19562,122,1.15 [0.76-1.76],0.5099069716565837
Chapter II Neoplasms,Carcinoma in situ of breast,SRC,Proto-oncogene tyrosine-protein kinase Src,22547,139,0.86 [0.77-0.98],0.0183872508359702
Chapter II Neoplasms,Carcinoma in situ of breast,SRP14,Signal recognition particle 14 kDa protein,22413,140,0.96 [0.75-1.23],0.7749601423163518
Chapter II Neoplasms,Carcinoma in situ of breast,SRPK2,SRSF protein kinase 2,22477,136,0.84 [0.69-1.02],0.078364357812878
Chapter II Neoplasms,Carcinoma in situ of breast,SRPX,Sushi repeat-containing protein SRPX,19600,119,1.14 [0.66-1.96],0.6345650336075681
Chapter II Neoplasms,Carcinoma in situ of breast,SSB,Lupus La protein,21957,134,1.08 [0.85-1.37],0.5271820238030513
Chapter II Neoplasms,Carcinoma in situ of breast,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19054,117,1.21 [0.78-1.87],0.40473710702886
Chapter II Neoplasms,Carcinoma in situ of breast,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22484,139,0.89 [0.76-1.03],0.1162082532923014
Chapter II Neoplasms,Carcinoma in situ of breast,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22579,139,1.16 [0.81-1.66],0.4078992583598372
Chapter II Neoplasms,Carcinoma in situ of breast,SSH3,Protein phosphatase Slingshot homolog 3,18908,119,0.66 [0.34-1.25],0.1994664875807599
Chapter II Neoplasms,Carcinoma in situ of breast,SSNA1,Sjoegren syndrome nuclear autoantigen 1,19501,122,0.70 [0.49-1.00],0.0469075938024428
Chapter II Neoplasms,Carcinoma in situ of breast,ST13,Hsc70-interacting protein,19191,120,0.74 [0.54-1.01],0.056913733063519
Chapter II Neoplasms,Carcinoma in situ of breast,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22413,140,1.00 [0.70-1.43],0.9947008970168713
Chapter II Neoplasms,Carcinoma in situ of breast,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22786,138,0.95 [0.56-1.61],0.8445517276905782
Chapter II Neoplasms,Carcinoma in situ of breast,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19054,117,0.80 [0.51-1.25],0.3252776762188142
Chapter II Neoplasms,Carcinoma in situ of breast,STAB2,Stabilin-2,19597,123,0.88 [0.48-1.59],0.6634889371350826
Chapter II Neoplasms,Carcinoma in situ of breast,STAM,Signal transducing adapter molecule 1,19495,120,0.60 [0.36-1.02],0.0578865263465706
Chapter II Neoplasms,Carcinoma in situ of breast,STAMBP,STAM-binding protein,22320,139,0.80 [0.63-1.02],0.0676399806452387
Chapter II Neoplasms,Carcinoma in situ of breast,STAT2,Signal transducer and activator of transcription 2,19054,117,0.77 [0.60-0.98],0.0317458765184152
Chapter II Neoplasms,Carcinoma in situ of breast,STAT5B,Signal transducer and activator of transcription 5B,22413,140,0.86 [0.77-0.96],0.0067244558737775
Chapter II Neoplasms,Carcinoma in situ of breast,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,18908,119,0.86 [0.64-1.15],0.3043250174033985
Chapter II Neoplasms,Carcinoma in situ of breast,STC1,Stanniocalcin-1,22715,138,0.75 [0.51-1.10],0.1377306066703739
Chapter II Neoplasms,Carcinoma in situ of breast,STC2,Stanniocalcin-2,22491,136,1.59 [0.88-2.85],0.1229845342970659
Chapter II Neoplasms,Carcinoma in situ of breast,STEAP4,Metalloreductase STEAP4,18997,118,1.04 [0.83-1.30],0.7248846492217635
Chapter II Neoplasms,Carcinoma in situ of breast,STIP1,Stress-induced-phosphoprotein 1,22494,138,0.75 [0.60-0.96],0.0199898823727949
Chapter II Neoplasms,Carcinoma in situ of breast,STK11,Serine/threonine-protein kinase STK11,22115,137,0.81 [0.65-1.00],0.0479780713691931
Chapter II Neoplasms,Carcinoma in situ of breast,STK24,Serine/threonine-protein kinase 24,21957,134,0.75 [0.58-0.96],0.0244270836152968
Chapter II Neoplasms,Carcinoma in situ of breast,STK4,Serine/threonine-protein kinase 4,22518,139,0.83 [0.70-0.99],0.0337978224593597
Chapter II Neoplasms,Carcinoma in situ of breast,STOML2,"Stomatin-like protein 2, mitochondrial",18908,119,0.98 [0.80-1.19],0.8274364003792308
Chapter II Neoplasms,Carcinoma in situ of breast,STX16,Syntaxin-16,22008,134,0.73 [0.54-0.99],0.0425066219925094
Chapter II Neoplasms,Carcinoma in situ of breast,STX1B,Syntaxin-1B,19054,119,1.15 [0.81-1.64],0.441666239813013
Chapter II Neoplasms,Carcinoma in situ of breast,STX3,Syntaxin-3,19562,122,1.10 [0.73-1.65],0.6567014903794681
Chapter II Neoplasms,Carcinoma in situ of breast,STX4,Syntaxin-4,22413,140,0.86 [0.65-1.12],0.257027195997776
Chapter II Neoplasms,Carcinoma in situ of breast,STX5,Syntaxin-5,19054,117,0.80 [0.49-1.30],0.3706641193652968
Chapter II Neoplasms,Carcinoma in situ of breast,STX6,Syntaxin-6,22008,134,0.81 [0.63-1.05],0.1074276708632183
Chapter II Neoplasms,Carcinoma in situ of breast,STX7,Syntaxin-7,19054,117,0.79 [0.56-1.13],0.1950385257143182
Chapter II Neoplasms,Carcinoma in situ of breast,STX8,Syntaxin-8,22477,136,0.75 [0.54-1.04],0.0845812317159262
Chapter II Neoplasms,Carcinoma in situ of breast,STXBP1,Syntaxin-binding protein 1,19571,121,0.84 [0.67-1.04],0.1155541684342076
Chapter II Neoplasms,Carcinoma in situ of breast,STXBP3,Syntaxin-binding protein 3,22008,134,0.64 [0.43-0.96],0.0302963401812558
Chapter II Neoplasms,Carcinoma in situ of breast,SUGP1,SURP and G-patch domain-containing protein 1,19501,122,0.88 [0.57-1.37],0.5794825153907937
Chapter II Neoplasms,Carcinoma in situ of breast,SUGT1,Protein SGT1 homolog,22008,134,0.78 [0.65-0.94],0.0105260124032943
Chapter II Neoplasms,Carcinoma in situ of breast,SULT1A1,Sulfotransferase 1A1,22715,138,0.91 [0.81-1.02],0.0912985275333963
Chapter II Neoplasms,Carcinoma in situ of breast,SULT2A1,Bile salt sulfotransferase,22477,136,1.07 [0.82-1.40],0.6151889697545452
Chapter II Neoplasms,Carcinoma in situ of breast,SUMF1,Formylglycine-generating enzyme,19054,117,0.98 [0.76-1.27],0.8977807072898587
Chapter II Neoplasms,Carcinoma in situ of breast,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22715,138,0.90 [0.68-1.18],0.4461309612507539
Chapter II Neoplasms,Carcinoma in situ of breast,SUOX,"Sulfite oxidase, mitochondrial",19571,121,0.97 [0.74-1.29],0.8480547323929378
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD1,Sushi domain-containing protein 1,22115,137,0.73 [0.54-0.99],0.0427059201337377
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD2,Sushi domain-containing protein 2,22524,138,1.52 [0.93-2.48],0.0960404318727975
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD4,Sushi domain-containing protein 4,19495,120,0.74 [0.49-1.14],0.1700209338583765
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD5,Sushi domain-containing protein 5,19076,119,1.89 [1.13-3.19],0.0162078770477382
Chapter II Neoplasms,Carcinoma in situ of breast,SV2A,Synaptic vesicle glycoprotein 2A,19054,119,0.60 [0.43-0.84],0.0028161456460399
Chapter II Neoplasms,Carcinoma in situ of breast,SWAP70,Switch-associated protein 70,19501,122,1.15 [0.73-1.80],0.5415499683178251
Chapter II Neoplasms,Carcinoma in situ of breast,SYAP1,Synapse-associated protein 1,19191,120,0.79 [0.57-1.10],0.1676419819095874
Chapter II Neoplasms,Carcinoma in situ of breast,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,18997,118,0.90 [0.64-1.24],0.5091307295665981
Chapter II Neoplasms,Carcinoma in situ of breast,SYT1,Synaptotagmin-1,19562,122,1.09 [0.73-1.65],0.6687327718093844
Chapter II Neoplasms,Carcinoma in situ of breast,SYTL4,Synaptotagmin-like protein 4,19600,119,0.76 [0.59-0.98],0.0368783353104088
Chapter II Neoplasms,Carcinoma in situ of breast,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19223,122,0.83 [0.71-0.98],0.0301116094570559
Chapter II Neoplasms,Carcinoma in situ of breast,TACC3,Transforming acidic coiled-coil-containing protein 3,22413,140,0.86 [0.76-0.98],0.0219935421342338
Chapter II Neoplasms,Carcinoma in situ of breast,TACSTD2,Tumor-associated calcium signal transducer 2,19994,121,1.50 [0.86-2.60],0.1519932096331875
Chapter II Neoplasms,Carcinoma in situ of breast,TADA3,Transcriptional adapter 3,19495,120,0.80 [0.51-1.27],0.3455926755388501
Chapter II Neoplasms,Carcinoma in situ of breast,TAFA5,Chemokine-like protein TAFA-5,22413,140,0.87 [0.56-1.35],0.5324092459654908
Chapter II Neoplasms,Carcinoma in situ of breast,TAGLN3,Transgelin-3,18908,119,1.00 [0.75-1.33],0.9859796796476116
Chapter II Neoplasms,Carcinoma in situ of breast,TALDO1,Transaldolase,19514,123,0.92 [0.63-1.35],0.6802299677957084
Chapter II Neoplasms,Carcinoma in situ of breast,TANK,TRAF family member-associated NF-kappa-B activator,22090,138,0.76 [0.60-0.95],0.015538579793168
Chapter II Neoplasms,Carcinoma in situ of breast,TAP1,Antigen peptide transporter 1,19223,122,0.88 [0.63-1.21],0.42168017938718
Chapter II Neoplasms,Carcinoma in situ of breast,TARBP2,RISC-loading complex subunit TARBP2,21957,134,0.74 [0.61-0.91],0.0039583732439496
Chapter II Neoplasms,Carcinoma in situ of breast,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19054,119,0.88 [0.68-1.13],0.3099424677325281
Chapter II Neoplasms,Carcinoma in situ of breast,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19495,120,0.83 [0.51-1.34],0.444307475991526
Chapter II Neoplasms,Carcinoma in situ of breast,TAX1BP1,Tax1-binding protein 1,19562,122,0.76 [0.57-1.02],0.0691303053612499
Chapter II Neoplasms,Carcinoma in situ of breast,TBC1D17,TBC1 domain family member 17,21957,134,0.73 [0.50-1.05],0.0921293628134529
Chapter II Neoplasms,Carcinoma in situ of breast,TBC1D23,TBC1 domain family member 23,22413,140,0.76 [0.64-0.90],0.0015917705975423
Chapter II Neoplasms,Carcinoma in situ of breast,TBC1D5,TBC1 domain family member 5,22477,136,0.91 [0.75-1.11],0.352927361425573
Chapter II Neoplasms,Carcinoma in situ of breast,TBCA,Tubulin-specific chaperone A,19191,120,0.79 [0.65-0.98],0.0293502759230728
Chapter II Neoplasms,Carcinoma in situ of breast,TBCB,Tubulin-folding cofactor B,22368,139,0.84 [0.73-0.97],0.0206206922436809
Chapter II Neoplasms,Carcinoma in situ of breast,TBCC,Tubulin-specific chaperone C,22368,139,0.82 [0.68-0.99],0.0393610683821221
Chapter II Neoplasms,Carcinoma in situ of breast,TBL1X,F-box-like/WD repeat-containing protein TBL1X,22008,134,0.80 [0.67-0.96],0.0146933519082498
Chapter II Neoplasms,Carcinoma in situ of breast,TBR1,T-box brain protein 1,19054,119,0.63 [0.39-1.04],0.0701622622838422
Chapter II Neoplasms,Carcinoma in situ of breast,TCL1A,T-cell leukemia/lymphoma protein 1A,22329,138,1.01 [0.86-1.18],0.9279525919184144
Chapter II Neoplasms,Carcinoma in situ of breast,TCL1B,T-cell leukemia/lymphoma protein 1B,22115,137,1.08 [0.91-1.27],0.3778082322868519
Chapter II Neoplasms,Carcinoma in situ of breast,TCN1,Transcobalamin-1,19197,114,0.84 [0.49-1.44],0.5275035155986236
Chapter II Neoplasms,Carcinoma in situ of breast,TCN2,Transcobalamin-2,22747,138,0.97 [0.59-1.61],0.9090146866178102
Chapter II Neoplasms,Carcinoma in situ of breast,TCOF1,Treacle protein,19600,119,1.16 [0.67-2.00],0.593794496663121
Chapter II Neoplasms,Carcinoma in situ of breast,TCP11,T-complex protein 11 homolog,19223,122,1.04 [0.79-1.37],0.7788726911372579
Chapter II Neoplasms,Carcinoma in situ of breast,TCTN3,Tectonic-3,19600,119,0.93 [0.51-1.70],0.824220397624695
Chapter II Neoplasms,Carcinoma in situ of breast,TDGF1,Teratocarcinoma-derived growth factor 1,21957,134,0.99 [0.89-1.11],0.9108215525552446
Chapter II Neoplasms,Carcinoma in situ of breast,TDO2,"Tryptophan 2,3-dioxygenase",19054,119,0.88 [0.54-1.43],0.5938826943960804
Chapter II Neoplasms,Carcinoma in situ of breast,TDP1,Tyrosyl-DNA phosphodiesterase 1,19495,120,1.12 [0.90-1.40],0.3221815892987089
Chapter II Neoplasms,Carcinoma in situ of breast,TDRKH,Tudor and KH domain-containing protein,21957,134,0.80 [0.66-0.97],0.0225776429718929
Chapter II Neoplasms,Carcinoma in situ of breast,TEF,Thyrotroph embryonic factor,19003,118,1.03 [0.69-1.54],0.8858009235524769
Chapter II Neoplasms,Carcinoma in situ of breast,TEK,Angiopoietin-1 receptor,22586,140,0.95 [0.47-1.91],0.8878525603975157
Chapter II Neoplasms,Carcinoma in situ of breast,TERF1,Telomeric repeat-binding factor 1,19054,117,1.63 [0.99-2.70],0.0568422704449858
Chapter II Neoplasms,Carcinoma in situ of breast,TET2,Methylcytosine dioxygenase TET2,19187,120,1.08 [0.92-1.26],0.3572139949181707
Chapter II Neoplasms,Carcinoma in situ of breast,TEX101,Testis-expressed protein 101,19054,119,0.81 [0.51-1.27],0.3520990858071442
Chapter II Neoplasms,Carcinoma in situ of breast,TEX33,Testis-expressed protein 33,19223,122,1.23 [0.87-1.72],0.2376050871956142
Chapter II Neoplasms,Carcinoma in situ of breast,TF,Serotransferrin,19630,119,0.86 [0.39-1.88],0.6988968947296519
Chapter II Neoplasms,Carcinoma in situ of breast,TFAP2A,Transcription factor AP-2-alpha,18997,118,1.21 [0.95-1.54],0.1255563569343154
Chapter II Neoplasms,Carcinoma in situ of breast,TFF1,Trefoil factor 1,22414,138,0.95 [0.77-1.16],0.5934493232877701
Chapter II Neoplasms,Carcinoma in situ of breast,TFF2,Trefoil factor 2,22580,141,0.84 [0.64-1.11],0.2313053900748192
Chapter II Neoplasms,Carcinoma in situ of breast,TFF3,Trefoil factor 3,22475,138,1.12 [0.87-1.44],0.3830268509883495
Chapter II Neoplasms,Carcinoma in situ of breast,TFPI,Tissue factor pathway inhibitor,22434,137,1.69 [1.14-2.52],0.0096415558334296
Chapter II Neoplasms,Carcinoma in situ of breast,TFPI2,Tissue factor pathway inhibitor 2,22514,138,1.02 [0.69-1.52],0.9124272859692476
Chapter II Neoplasms,Carcinoma in situ of breast,TFRC,Transferrin receptor protein 1,22590,139,0.91 [0.62-1.32],0.6125982770771579
Chapter II Neoplasms,Carcinoma in situ of breast,TG,Thyroglobulin,19495,120,0.96 [0.83-1.12],0.6091062609539566
Chapter II Neoplasms,Carcinoma in situ of breast,TGFA,Protransforming growth factor alpha,22477,136,0.85 [0.61-1.19],0.3376203905107003
Chapter II Neoplasms,Carcinoma in situ of breast,TGFB1,Transforming growth factor beta-1 proprotein,22724,138,0.66 [0.44-0.99],0.0440168987437731
Chapter II Neoplasms,Carcinoma in situ of breast,TGFB2,Transforming growth factor beta-2 proprotein,19495,120,1.42 [1.12-1.81],0.004536719913816
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBI,Transforming growth factor-beta-induced protein ig-h3,22357,136,1.29 [0.74-2.25],0.3726044615493719
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBR1,TGF-beta receptor type-1,19054,117,1.22 [0.57-2.61],0.6002744887248446
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBR2,TGF-beta receptor type-2,22586,140,1.47 [0.92-2.36],0.1053966443408722
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBR3,Transforming growth factor beta receptor type 3,22786,138,1.16 [0.73-1.84],0.5273816556829147
Chapter II Neoplasms,Carcinoma in situ of breast,TGM2,Protein-glutamine gamma-glutamyltransferase 2,22488,139,1.03 [0.85-1.26],0.7462769934471861
Chapter II Neoplasms,Carcinoma in situ of breast,TGOLN2,Trans-Golgi network integral membrane protein 2,19605,119,1.22 [0.61-2.42],0.5761078321281969
Chapter II Neoplasms,Carcinoma in situ of breast,THAP12,52 kDa repressor of the inhibitor of the protein kinase,18870,119,1.02 [0.84-1.23],0.8551266766010955
Chapter II Neoplasms,Carcinoma in situ of breast,THBD,Thrombomodulin,22518,139,1.37 [0.79-2.36],0.2614786936612031
Chapter II Neoplasms,Carcinoma in situ of breast,THBS2,Thrombospondin-2,22524,138,1.03 [0.67-1.57],0.9000862937893053
Chapter II Neoplasms,Carcinoma in situ of breast,THBS4,Thrombospondin-4,22502,139,1.07 [0.77-1.50],0.6847171501363507
Chapter II Neoplasms,Carcinoma in situ of breast,THOP1,Thimet oligopeptidase,22415,138,0.86 [0.52-1.41],0.5401105700090051
Chapter II Neoplasms,Carcinoma in situ of breast,THPO,Thrombopoietin,22115,137,1.03 [0.69-1.53],0.9024237844446332
Chapter II Neoplasms,Carcinoma in situ of breast,THRAP3,Thyroid hormone receptor-associated protein 3,19003,118,0.97 [0.83-1.14],0.7450148346247587
Chapter II Neoplasms,Carcinoma in situ of breast,THSD1,Thrombospondin type-1 domain-containing protein 1,18911,117,1.24 [0.77-2.01],0.3801912073781995
Chapter II Neoplasms,Carcinoma in situ of breast,THTPA,Thiamine-triphosphatase,19468,119,0.80 [0.65-0.98],0.0282094841519301
Chapter II Neoplasms,Carcinoma in situ of breast,THY1,Thy-1 membrane glycoprotein,22715,138,1.19 [0.69-2.06],0.5402033514056592
Chapter II Neoplasms,Carcinoma in situ of breast,TIA1,Nucleolysin TIA-1 isoform p40,21874,135,0.86 [0.75-0.98],0.0258202682061108
Chapter II Neoplasms,Carcinoma in situ of breast,TIE1,Tyrosine-protein kinase receptor Tie-1,22786,138,0.93 [0.66-1.31],0.6619486070570166
Chapter II Neoplasms,Carcinoma in situ of breast,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",21909,134,1.04 [0.75-1.43],0.8118528794713136
Chapter II Neoplasms,Carcinoma in situ of breast,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19223,122,0.63 [0.37-1.08],0.0942951484065519
Chapter II Neoplasms,Carcinoma in situ of breast,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22579,139,1.39 [1.00-1.94],0.05257693409056
Chapter II Neoplasms,Carcinoma in situ of breast,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19600,119,0.67 [0.42-1.07],0.0969817956618376
Chapter II Neoplasms,Carcinoma in situ of breast,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19562,122,0.84 [0.68-1.03],0.0902026059940904
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP1,Metalloproteinase inhibitor 1,22245,135,1.29 [0.75-2.21],0.3582483312338901
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP2,Metalloproteinase inhibitor 2,19600,119,0.47 [0.20-1.09],0.0791710389332575
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP3,Metalloproteinase inhibitor 3,22619,141,0.93 [0.83-1.04],0.1983221960080831
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP4,Metalloproteinase inhibitor 4,22524,138,1.15 [0.80-1.66],0.4514243261921021
Chapter II Neoplasms,Carcinoma in situ of breast,TINAGL1,Tubulointerstitial nephritis antigen-like,22443,139,1.03 [0.52-2.04],0.9247701803357185
Chapter II Neoplasms,Carcinoma in situ of breast,TJAP1,Tight junction-associated protein 1,22586,140,0.82 [0.68-0.99],0.0362864714369735
Chapter II Neoplasms,Carcinoma in situ of breast,TJP3,Tight junction protein ZO-3,18997,118,0.55 [0.33-0.91],0.0193720882199756
Chapter II Neoplasms,Carcinoma in situ of breast,TK1,"Thymidine kinase, cytosolic",19223,122,1.14 [0.80-1.62],0.4705197314639325
Chapter II Neoplasms,Carcinoma in situ of breast,TLR1,Toll-like receptor 1,19054,117,0.81 [0.40-1.61],0.5408455224987789
Chapter II Neoplasms,Carcinoma in situ of breast,TLR2,Toll-like receptor 2,19223,122,1.63 [0.78-3.37],0.19078644849251
Chapter II Neoplasms,Carcinoma in situ of breast,TLR3,Toll-like receptor 3,22764,139,0.94 [0.74-1.19],0.6002548801220103
Chapter II Neoplasms,Carcinoma in situ of breast,TLR4,Toll-like receptor 4,19054,117,0.47 [0.24-0.90],0.0229250420094404
Chapter II Neoplasms,Carcinoma in situ of breast,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19054,119,0.90 [0.64-1.27],0.5510047194947436
Chapter II Neoplasms,Carcinoma in situ of breast,TMED1,Transmembrane emp24 domain-containing protein 1,19223,122,1.12 [0.83-1.50],0.4546135375271322
Chapter II Neoplasms,Carcinoma in situ of breast,TMED10,Transmembrane emp24 domain-containing protein 10,19003,118,0.86 [0.57-1.30],0.4720887894544292
Chapter II Neoplasms,Carcinoma in situ of breast,TMED4,Transmembrane emp24 domain-containing protein 4,19003,118,1.24 [0.97-1.59],0.0795379123319956
Chapter II Neoplasms,Carcinoma in situ of breast,TMED8,Protein TMED8,19501,122,0.84 [0.71-0.99],0.0378884086115395
Chapter II Neoplasms,Carcinoma in situ of breast,TMEM106A,Transmembrane protein 106A,19495,120,0.81 [0.62-1.05],0.1039914702253277
Chapter II Neoplasms,Carcinoma in situ of breast,TMEM132A,Transmembrane protein 132A,19106,119,1.39 [1.09-1.77],0.008540200763091
Chapter II Neoplasms,Carcinoma in situ of breast,TMEM25,Transmembrane protein 25,19571,121,1.07 [0.74-1.55],0.7301520625423179
Chapter II Neoplasms,Carcinoma in situ of breast,TMOD4,Tropomodulin-4,18908,119,0.89 [0.57-1.38],0.6023330842682781
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS11B,Transmembrane protease serine 11B,18997,118,1.16 [0.96-1.40],0.1351886917315446
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS11D,Transmembrane protease serine 11D,19521,122,1.00 [0.63-1.58],0.9964013403845644
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS15,Enteropeptidase,22413,140,0.97 [0.83-1.14],0.7420953169330307
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS5,Transmembrane protease serine 5,22260,138,1.20 [0.80-1.79],0.3736574750174803
Chapter II Neoplasms,Carcinoma in situ of breast,TMSB10,Thymosin beta-10,22524,138,0.93 [0.76-1.13],0.4488829217259655
Chapter II Neoplasms,Carcinoma in situ of breast,TNC,Tenascin,22579,139,1.31 [0.96-1.79],0.0842910962011805
Chapter II Neoplasms,Carcinoma in situ of breast,TNF,Tumor necrosis factor,22074,137,0.95 [0.63-1.42],0.7935863896038475
Chapter II Neoplasms,Carcinoma in situ of breast,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19501,122,1.07 [0.75-1.53],0.7196989138396355
Chapter II Neoplasms,Carcinoma in situ of breast,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22090,138,1.06 [0.70-1.59],0.7971053124294367
Chapter II Neoplasms,Carcinoma in situ of breast,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19191,120,0.86 [0.65-1.15],0.3054446077525332
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22368,139,0.86 [0.53-1.39],0.5295544450074625
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22368,139,0.66 [0.39-1.14],0.1403435305051045
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22549,136,0.94 [0.70-1.28],0.7086136171592674
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22764,139,0.94 [0.62-1.42],0.7632201483088714
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22510,140,1.08 [0.65-1.80],0.7642499802349884
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22586,140,1.61 [1.06-2.45],0.0257227570579955
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22552,140,0.93 [0.57-1.52],0.7766001277686101
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22090,138,0.97 [0.66-1.42],0.873220980104763
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22552,140,0.79 [0.47-1.34],0.3800437842408767
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19191,120,0.99 [0.64-1.55],0.9729922479918008
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22716,137,1.13 [0.68-1.88],0.6351738820302726
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22524,138,1.16 [0.68-2.01],0.5818549696201869
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22524,138,1.02 [0.67-1.56],0.9309601366892032
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22715,138,1.67 [0.96-2.89],0.0677523891853009
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22724,138,0.85 [0.56-1.30],0.4589313219576519
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22368,139,0.94 [0.71-1.25],0.6780996825226419
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22715,138,1.09 [0.79-1.51],0.6006281946273243
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22368,139,0.90 [0.60-1.35],0.6092105673016519
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF10,Tumor necrosis factor ligand superfamily member 10,22764,139,1.72 [0.97-3.05],0.0637707842914056
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22477,136,0.89 [0.69-1.14],0.3416562092467551
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF12,Tumor necrosis factor ligand superfamily member 12,22764,139,0.70 [0.42-1.18],0.1797438787460758
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22619,141,0.79 [0.45-1.40],0.4250857131767234
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22747,136,0.90 [0.50-1.60],0.7101747690824252
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22368,139,0.91 [0.70-1.18],0.4711743683222453
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF8,Tumor necrosis factor ligand superfamily member 8,19597,123,1.09 [0.67-1.76],0.7251456508797001
Chapter II Neoplasms,Carcinoma in situ of breast,TNIP1,TNFAIP3-interacting protein 1,19562,122,0.87 [0.71-1.06],0.1555596320754397
Chapter II Neoplasms,Carcinoma in situ of breast,TNN,Tenascin-N,19597,123,1.00 [0.68-1.47],0.9978038285442152
Chapter II Neoplasms,Carcinoma in situ of breast,TNNI3,"Troponin I, cardiac muscle",22115,137,1.07 [0.88-1.29],0.5007398697712759
Chapter II Neoplasms,Carcinoma in situ of breast,TNPO1,Transportin-1,19223,122,1.04 [0.64-1.67],0.8766041475848501
Chapter II Neoplasms,Carcinoma in situ of breast,TNR,Tenascin-R,22368,139,1.19 [0.83-1.69],0.3383687465474055
Chapter II Neoplasms,Carcinoma in situ of breast,TNXB,Tenascin-X,22524,138,1.24 [0.69-2.23],0.4637560881530094
Chapter II Neoplasms,Carcinoma in situ of breast,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19600,119,0.82 [0.65-1.04],0.1004353329277705
Chapter II Neoplasms,Carcinoma in situ of breast,TOP1,DNA topoisomerase 1,19501,122,1.04 [0.88-1.22],0.6681207068310054
Chapter II Neoplasms,Carcinoma in situ of breast,TOP1MT,"DNA topoisomerase I, mitochondrial",18908,119,0.73 [0.48-1.11],0.1380544329121388
Chapter II Neoplasms,Carcinoma in situ of breast,TOP2B,DNA topoisomerase 2-beta,19054,117,0.86 [0.68-1.09],0.2241550358677793
Chapter II Neoplasms,Carcinoma in situ of breast,TOR1AIP1,Torsin-1A-interacting protein 1,19106,119,1.21 [0.90-1.63],0.197592014674244
Chapter II Neoplasms,Carcinoma in situ of breast,TP53,Cellular tumor antigen p53,22008,134,0.71 [0.49-1.02],0.0657582851159745
Chapter II Neoplasms,Carcinoma in situ of breast,TP53BP1,TP53-binding protein 1,19054,117,0.91 [0.74-1.11],0.3567895049671817
Chapter II Neoplasms,Carcinoma in situ of breast,TP53I3,Quinone oxidoreductase PIG3,18770,120,0.73 [0.52-1.03],0.0703990864642242
Chapter II Neoplasms,Carcinoma in situ of breast,TP53INP1,Tumor protein p53-inducible nuclear protein 1,22115,137,0.85 [0.51-1.42],0.5346982991948164
Chapter II Neoplasms,Carcinoma in situ of breast,TP73,Tumor protein p73,19054,119,0.89 [0.53-1.48],0.6399726458016403
Chapter II Neoplasms,Carcinoma in situ of breast,TPBGL,Trophoblast glycoprotein-like,19054,119,0.80 [0.51-1.26],0.3388226625321648
Chapter II Neoplasms,Carcinoma in situ of breast,TPD52L2,Tumor protein D54,19191,120,0.84 [0.72-0.99],0.0353208448223971
Chapter II Neoplasms,Carcinoma in situ of breast,TPK1,Thiamin pyrophosphokinase 1,19600,119,1.03 [0.54-1.96],0.924788417026039
Chapter II Neoplasms,Carcinoma in situ of breast,TPM3,Tropomyosin alpha-3 chain,19003,118,0.82 [0.52-1.28],0.3758512109951333
Chapter II Neoplasms,Carcinoma in situ of breast,TPMT,Thiopurine S-methyltransferase,22008,134,0.70 [0.56-0.87],0.0017163836355829
Chapter II Neoplasms,Carcinoma in situ of breast,TPP1,Tripeptidyl-peptidase 1,22366,139,0.83 [0.58-1.19],0.3147457239249711
Chapter II Neoplasms,Carcinoma in situ of breast,TPPP2,Tubulin polymerization-promoting protein family member 2,19223,122,1.09 [0.90-1.33],0.3610076060301614
Chapter II Neoplasms,Carcinoma in situ of breast,TPPP3,Tubulin polymerization-promoting protein family member 3,21957,134,1.13 [0.80-1.59],0.492276358436107
Chapter II Neoplasms,Carcinoma in situ of breast,TPR,Nucleoprotein TPR,19003,118,1.08 [0.77-1.50],0.6587564177770511
Chapter II Neoplasms,Carcinoma in situ of breast,TPRKB,EKC/KEOPS complex subunit TPRKB,18908,119,0.72 [0.51-1.02],0.0624545315087247
Chapter II Neoplasms,Carcinoma in situ of breast,TPSAB1,Tryptase alpha/beta-1,22726,138,0.98 [0.74-1.30],0.8971651685949948
Chapter II Neoplasms,Carcinoma in situ of breast,TPSD1,Tryptase delta,19571,121,1.01 [0.64-1.59],0.9673961161823366
Chapter II Neoplasms,Carcinoma in situ of breast,TPSG1,Tryptase gamma,19054,117,0.92 [0.47-1.79],0.7974696955976702
Chapter II Neoplasms,Carcinoma in situ of breast,TPT1,Translationally-controlled tumor protein,22090,138,1.06 [0.86-1.31],0.5929115616506022
Chapter II Neoplasms,Carcinoma in situ of breast,TRAF2,TNF receptor-associated factor 2,22477,136,0.91 [0.74-1.13],0.4162870998723044
Chapter II Neoplasms,Carcinoma in situ of breast,TRAF3,"TNF receptor-associated factor 3, Isoform 2",19054,117,1.07 [0.67-1.70],0.7856763099821232
Chapter II Neoplasms,Carcinoma in situ of breast,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19003,118,0.74 [0.48-1.16],0.191608091933356
Chapter II Neoplasms,Carcinoma in situ of breast,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19223,122,0.96 [0.78-1.19],0.7389297356429311
Chapter II Neoplasms,Carcinoma in situ of breast,TREH,Trehalase,19597,123,1.02 [0.81-1.28],0.886618070339
Chapter II Neoplasms,Carcinoma in situ of breast,TREM2,Triggering receptor expressed on myeloid cells 2,22510,140,1.03 [0.77-1.38],0.844857248696709
Chapter II Neoplasms,Carcinoma in situ of breast,TREML1,Trem-like transcript 1 protein,19605,119,0.74 [0.53-1.04],0.0857654802416507
Chapter II Neoplasms,Carcinoma in situ of breast,TREML2,Trem-like transcript 2 protein,22524,138,0.88 [0.55-1.40],0.5832668462180164
Chapter II Neoplasms,Carcinoma in situ of breast,TRIAP1,TP53-regulated inhibitor of apoptosis 1,22716,137,0.80 [0.63-1.03],0.0797369816877842
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM21,E3 ubiquitin-protein ligase TRIM21,22477,136,0.91 [0.76-1.10],0.3326044723033942
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM24,Transcription intermediary factor 1-alpha,19180,122,0.92 [0.70-1.21],0.5515396884810556
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19501,122,0.83 [0.71-0.98],0.0249483318773334
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM26,Tripartite motif-containing protein 26,18908,119,1.04 [0.77-1.40],0.81496130716938
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM40,E3 ubiquitin ligase TRIM40,19054,119,0.85 [0.66-1.10],0.2235862198795201
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM5,Tripartite motif-containing protein 5,22477,136,0.92 [0.77-1.10],0.3749334002905666
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM58,E3 ubiquitin-protein ligase TRIM58,19495,120,0.81 [0.66-1.00],0.0455937350680269
Chapter II Neoplasms,Carcinoma in situ of breast,TRPV3,Transient receptor potential cation channel subfamily V member 3,19003,118,0.69 [0.45-1.06],0.0894668935336661
Chapter II Neoplasms,Carcinoma in situ of breast,TSC1,Hamartin,19054,117,0.87 [0.66-1.14],0.3181292521691529
Chapter II Neoplasms,Carcinoma in situ of breast,TSC22D1,TSC22 domain family protein 1,19571,121,0.75 [0.57-0.99],0.0446316299732242
Chapter II Neoplasms,Carcinoma in situ of breast,TSHB,Thyrotropin subunit beta,22518,139,0.90 [0.75-1.07],0.2262754540489941
Chapter II Neoplasms,Carcinoma in situ of breast,TSLP,Thymic stromal lymphopoietin,22115,137,1.00 [0.78-1.28],0.9996771948795016
Chapter II Neoplasms,Carcinoma in situ of breast,TSNAX,Translin-associated protein X,19003,118,0.70 [0.44-1.11],0.1249501196249114
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN1,Tetraspanin-1,22115,137,0.67 [0.38-1.18],0.167169410293982
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN15,Tetraspanin-15,19003,118,1.04 [0.75-1.45],0.8081422688967943
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN7,Tetraspanin-7,18997,118,0.92 [0.75-1.13],0.4417339030086912
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN8,Tetraspanin-8,19501,122,0.94 [0.80-1.11],0.4870420146725446
Chapter II Neoplasms,Carcinoma in situ of breast,TSPYL1,Testis-specific Y-encoded-like protein 1,19054,117,0.71 [0.45-1.13],0.1469651781995103
Chapter II Neoplasms,Carcinoma in situ of breast,TST,Thiosulfate sulfurtransferase,21919,131,0.80 [0.65-0.99],0.0423436674699512
Chapter II Neoplasms,Carcinoma in situ of breast,TTF2,Transcription termination factor 2,19054,119,0.61 [0.41-0.90],0.0118581857024933
Chapter II Neoplasms,Carcinoma in situ of breast,TTN,Titin,19003,118,0.98 [0.75-1.28],0.8740514803319628
Chapter II Neoplasms,Carcinoma in situ of breast,TTR,Transthyretin,19406,116,1.10 [0.55-2.22],0.7882456807559113
Chapter II Neoplasms,Carcinoma in situ of breast,TUBB3,Tubulin beta-3 chain,18997,118,0.73 [0.38-1.39],0.343091767278732
Chapter II Neoplasms,Carcinoma in situ of breast,TWF2,Twinfilin-2,19597,123,0.83 [0.67-1.03],0.0845496859908834
Chapter II Neoplasms,Carcinoma in situ of breast,TXK,Tyrosine-protein kinase TXK,19223,122,0.78 [0.59-1.04],0.0905139013141211
Chapter II Neoplasms,Carcinoma in situ of breast,TXLNA,Alpha-taxilin,22368,139,0.83 [0.70-0.99],0.0376012209943014
Chapter II Neoplasms,Carcinoma in situ of breast,TXN,Thioredoxin,19263,117,0.71 [0.46-1.11],0.1311096183192043
Chapter II Neoplasms,Carcinoma in situ of breast,TXNDC15,Thioredoxin domain-containing protein 15,22586,140,1.26 [0.74-2.17],0.3927709334122892
Chapter II Neoplasms,Carcinoma in situ of breast,TXNDC5,Thioredoxin domain-containing protein 5,22715,138,0.77 [0.61-0.97],0.0288955005723108
Chapter II Neoplasms,Carcinoma in situ of breast,TXNDC9,Thioredoxin domain-containing protein 9,19562,122,0.78 [0.55-1.11],0.1660849608253931
Chapter II Neoplasms,Carcinoma in situ of breast,TXNL1,Thioredoxin-like protein 1,18961,118,1.02 [0.86-1.22],0.8169832487599558
Chapter II Neoplasms,Carcinoma in situ of breast,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22524,138,0.71 [0.51-0.99],0.0461390374679608
Chapter II Neoplasms,Carcinoma in situ of breast,TYMP,Thymidine phosphorylase,22370,136,0.81 [0.64-1.02],0.070003819299855
Chapter II Neoplasms,Carcinoma in situ of breast,TYRO3,Tyrosine-protein kinase receptor TYRO3,22518,139,1.26 [0.74-2.13],0.3998823087088965
Chapter II Neoplasms,Carcinoma in situ of breast,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19054,117,1.11 [0.83-1.49],0.4736192221728386
Chapter II Neoplasms,Carcinoma in situ of breast,UBAC1,Ubiquitin-associated domain-containing protein 1,22413,140,0.87 [0.57-1.32],0.5213905753535735
Chapter II Neoplasms,Carcinoma in situ of breast,UBE2B,Ubiquitin-conjugating enzyme E2 B,19495,120,0.54 [0.29-1.04],0.0641693000169221
Chapter II Neoplasms,Carcinoma in situ of breast,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19600,119,0.71 [0.53-0.96],0.0250794193331558
Chapter II Neoplasms,Carcinoma in situ of breast,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19054,117,0.76 [0.54-1.07],0.1188830021717083
Chapter II Neoplasms,Carcinoma in situ of breast,UBQLN3,Ubiquilin-3,19003,118,1.04 [0.71-1.52],0.850710179425544
Chapter II Neoplasms,Carcinoma in situ of breast,UBXN1,UBX domain-containing protein 1,19191,120,0.72 [0.55-0.94],0.0158778270727429
Chapter II Neoplasms,Carcinoma in situ of breast,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19501,122,0.90 [0.79-1.02],0.0906873898165967
Chapter II Neoplasms,Carcinoma in situ of breast,UGDH,UDP-glucose 6-dehydrogenase,19003,118,1.00 [0.84-1.20],0.9572763697475272
Chapter II Neoplasms,Carcinoma in situ of breast,UHRF2,E3 ubiquitin-protein ligase UHRF2,19003,118,0.80 [0.46-1.39],0.4308299668877021
Chapter II Neoplasms,Carcinoma in situ of breast,ULBP2,UL16-binding protein 2,22368,139,0.99 [0.66-1.50],0.9734260028471972
Chapter II Neoplasms,Carcinoma in situ of breast,UMOD,Uromodulin,22722,138,1.21 [0.90-1.62],0.2040229205609973
Chapter II Neoplasms,Carcinoma in situ of breast,UNC5D,Netrin receptor UNC5D,19054,117,0.94 [0.48-1.84],0.845780559414802
Chapter II Neoplasms,Carcinoma in situ of breast,UNC79,Protein unc-79 homolog,18908,119,0.77 [0.55-1.08],0.1356650848412442
Chapter II Neoplasms,Carcinoma in situ of breast,UNG,Uracil-DNA glycosylase,19495,120,0.88 [0.52-1.49],0.6304549394492385
Chapter II Neoplasms,Carcinoma in situ of breast,UPB1,Beta-ureidopropionase,19600,119,0.97 [0.80-1.17],0.7513420837052436
Chapter II Neoplasms,Carcinoma in situ of breast,UPK3A,Uroplakin-3a,18997,118,1.04 [0.73-1.48],0.825272175196428
Chapter II Neoplasms,Carcinoma in situ of breast,UPK3BL1,Uroplakin-3b-like protein 1,19195,122,1.01 [0.74-1.37],0.963471117282607
Chapter II Neoplasms,Carcinoma in situ of breast,UROD,Uroporphyrinogen decarboxylase,19191,120,0.77 [0.60-0.99],0.0395740627115518
Chapter II Neoplasms,Carcinoma in situ of breast,UROS,Uroporphyrinogen-III synthase,19054,119,0.91 [0.70-1.18],0.4779264728120314
Chapter II Neoplasms,Carcinoma in situ of breast,USO1,General vesicular transport factor p115,22413,140,0.81 [0.69-0.95],0.0116223773568599
Chapter II Neoplasms,Carcinoma in situ of breast,USP25,Ubiquitin carboxyl-terminal hydrolase 25,19495,120,0.72 [0.56-0.92],0.0092311487570187
Chapter II Neoplasms,Carcinoma in situ of breast,USP28,Ubiquitin carboxyl-terminal hydrolase 28,19562,122,1.06 [0.69-1.62],0.79558826170184
Chapter II Neoplasms,Carcinoma in situ of breast,USP47,Ubiquitin carboxyl-terminal hydrolase 47,19003,118,0.90 [0.72-1.12],0.3418450098840776
Chapter II Neoplasms,Carcinoma in situ of breast,USP8,Ubiquitin carboxyl-terminal hydrolase 8,22115,137,0.82 [0.70-0.97],0.0218518013572883
Chapter II Neoplasms,Carcinoma in situ of breast,UXS1,UDP-glucuronic acid decarboxylase 1,22008,134,0.79 [0.59-1.06],0.1191256163972363
Chapter II Neoplasms,Carcinoma in situ of breast,VAMP5,Vesicle-associated membrane protein 5,22115,137,1.01 [0.77-1.32],0.9619855787482744
Chapter II Neoplasms,Carcinoma in situ of breast,VAMP8,Vesicle-associated membrane protein 8,19054,117,0.87 [0.71-1.06],0.1743871977932125
Chapter II Neoplasms,Carcinoma in situ of breast,VASH1,Tubulinyl-Tyr carboxypeptidase 1,22477,136,0.89 [0.74-1.08],0.2416338599594544
Chapter II Neoplasms,Carcinoma in situ of breast,VASN,Vasorin,22131,135,2.47 [1.52-3.99],0.0002386785545895
Chapter II Neoplasms,Carcinoma in situ of breast,VASP,Vasodilator-stimulated phosphoprotein,19605,119,0.80 [0.62-1.03],0.0794884900470566
Chapter II Neoplasms,Carcinoma in situ of breast,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22413,140,1.63 [0.79-3.37],0.1850756846703237
Chapter II Neoplasms,Carcinoma in situ of breast,VAV3,Guanine nucleotide exchange factor VAV3,18997,118,0.82 [0.68-0.98],0.0298181757715903
Chapter II Neoplasms,Carcinoma in situ of breast,VCAM1,Vascular cell adhesion protein 1,22542,139,1.34 [0.77-2.33],0.3015616582697531
Chapter II Neoplasms,Carcinoma in situ of breast,VCAN,Versican core protein,22715,138,0.99 [0.60-1.64],0.9710407704826916
Chapter II Neoplasms,Carcinoma in situ of breast,VCPKMT,Protein-lysine methyltransferase METTL21D,18908,119,1.02 [0.84-1.24],0.8277533321266205
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFA,Vascular endothelial growth factor A,22695,139,0.84 [0.65-1.10],0.2067669858968921
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFB,Vascular endothelial growth factor B,19054,117,0.69 [0.37-1.28],0.2387962254598963
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFC,Vascular endothelial growth factor C,22586,140,0.76 [0.58-0.99],0.0412883554024462
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFD,Vascular endothelial growth factor D,22724,139,1.80 [1.16-2.79],0.0089351364711221
Chapter II Neoplasms,Carcinoma in situ of breast,VGF,Neurosecretory protein VGF,19571,121,1.19 [0.67-2.12],0.5440194419608538
Chapter II Neoplasms,Carcinoma in situ of breast,VIM,Vimentin,22115,137,1.22 [1.06-1.41],0.0060700900949786
Chapter II Neoplasms,Carcinoma in situ of breast,VIPR1,Vasoactive intestinal polypeptide receptor 1,19106,119,1.20 [0.64-2.25],0.5789387757000495
Chapter II Neoplasms,Carcinoma in situ of breast,VIT,Vitrin,19600,119,0.85 [0.53-1.36],0.4856550520645939
Chapter II Neoplasms,Carcinoma in situ of breast,VMO1,Vitelline membrane outer layer protein 1 homolog,22413,140,0.97 [0.78-1.21],0.8064054860210357
Chapter II Neoplasms,Carcinoma in situ of breast,VNN1,Pantetheinase,19605,119,1.08 [0.85-1.38],0.5250107847706348
Chapter II Neoplasms,Carcinoma in situ of breast,VNN2,Vascular non-inflammatory molecule 2,22413,140,0.93 [0.68-1.29],0.6734537776990703
Chapter II Neoplasms,Carcinoma in situ of breast,VPS28,Vacuolar protein sorting-associated protein 28 homolog,19223,122,0.82 [0.62-1.09],0.1723405590592048
Chapter II Neoplasms,Carcinoma in situ of breast,VPS37A,Vacuolar protein sorting-associated protein 37A,22413,140,0.80 [0.66-0.98],0.0269287696250991
Chapter II Neoplasms,Carcinoma in situ of breast,VPS4B,Vacuolar protein sorting-associated protein 4B,19495,120,0.89 [0.74-1.07],0.2282300827116678
Chapter II Neoplasms,Carcinoma in situ of breast,VPS53,Vacuolar protein sorting-associated protein 53 homolog,22413,140,0.74 [0.60-0.91],0.0049222889269011
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG10,V-set and immunoglobulin domain-containing protein 10,19495,120,1.07 [0.68-1.69],0.7737628314295232
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19003,118,1.09 [0.65-1.82],0.753649493626793
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG2,V-set and immunoglobulin domain-containing protein 2,19495,120,0.96 [0.70-1.31],0.7874290592526358
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG4,V-set and immunoglobulin domain-containing protein 4,22491,136,1.08 [0.72-1.61],0.7133160838979717
Chapter II Neoplasms,Carcinoma in situ of breast,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22483,139,0.79 [0.61-1.02],0.0697721603247655
Chapter II Neoplasms,Carcinoma in situ of breast,VSNL1,Visinin-like protein 1,19562,122,1.05 [0.66-1.67],0.8359078228441768
Chapter II Neoplasms,Carcinoma in situ of breast,VSTM1,V-set and transmembrane domain-containing protein 1,21957,134,1.03 [0.75-1.41],0.8632470598999222
Chapter II Neoplasms,Carcinoma in situ of breast,VSTM2B,V-set and transmembrane domain-containing protein 2B,19223,122,1.06 [0.72-1.55],0.7667066178039156
Chapter II Neoplasms,Carcinoma in situ of breast,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22115,137,0.98 [0.75-1.28],0.8792087410875677
Chapter II Neoplasms,Carcinoma in situ of breast,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22715,138,0.82 [0.66-1.01],0.0578261334158102
Chapter II Neoplasms,Carcinoma in situ of breast,VTCN1,V-set domain-containing T-cell activation inhibitor 1,22008,134,0.58 [0.35-0.95],0.0315712659856566
Chapter II Neoplasms,Carcinoma in situ of breast,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19191,120,0.90 [0.66-1.22],0.4800210793275866
Chapter II Neoplasms,Carcinoma in situ of breast,VWA1,von Willebrand factor A domain-containing protein 1,22677,137,0.95 [0.67-1.36],0.7955058184487797
Chapter II Neoplasms,Carcinoma in situ of breast,VWA5A,von Willebrand factor A domain-containing protein 5A,18908,119,0.95 [0.75-1.19],0.6560543386088846
Chapter II Neoplasms,Carcinoma in situ of breast,VWC2,Brorin,22285,139,0.98 [0.66-1.46],0.9304620968314952
Chapter II Neoplasms,Carcinoma in situ of breast,VWC2L,von Willebrand factor C domain-containing protein 2-like,19571,121,1.04 [0.73-1.46],0.8384205548535038
Chapter II Neoplasms,Carcinoma in situ of breast,VWF,von Willebrand factor,22786,138,1.11 [0.91-1.37],0.2989173431745406
Chapter II Neoplasms,Carcinoma in situ of breast,WARS,"Tryptophan--tRNA ligase, cytoplasmic",22524,138,0.87 [0.58-1.29],0.4817085360295111
Chapter II Neoplasms,Carcinoma in situ of breast,WAS,Wiskott-Aldrich syndrome protein,22090,138,0.85 [0.68-1.07],0.1681232777192283
Chapter II Neoplasms,Carcinoma in situ of breast,WASF1,Wiskott-Aldrich syndrome protein family member 1,22115,137,0.80 [0.67-0.95],0.0111555782401391
Chapter II Neoplasms,Carcinoma in situ of breast,WASF3,Wiskott-Aldrich syndrome protein family member 3,21957,134,0.78 [0.66-0.93],0.0048157218489586
Chapter II Neoplasms,Carcinoma in situ of breast,WASHC3,WASH complex subunit 3,19562,122,0.89 [0.70-1.12],0.324415887322507
Chapter II Neoplasms,Carcinoma in situ of breast,WASL,Neural Wiskott-Aldrich syndrome protein,19054,117,1.08 [0.82-1.41],0.5927121063685681
Chapter II Neoplasms,Carcinoma in situ of breast,WDR46,WD repeat-containing protein 46,19495,120,0.58 [0.33-1.01],0.0546159314442679
Chapter II Neoplasms,Carcinoma in situ of breast,WFDC1,WAP four-disulfide core domain protein 1,19111,117,1.06 [0.79-1.43],0.6980181530743048
Chapter II Neoplasms,Carcinoma in situ of breast,WFDC12,WAP four-disulfide core domain protein 12,22688,137,1.18 [0.94-1.49],0.1480163507753668
Chapter II Neoplasms,Carcinoma in situ of breast,WFDC2,WAP four-disulfide core domain protein 2,21355,130,1.08 [0.69-1.70],0.7260686011476489
Chapter II Neoplasms,Carcinoma in situ of breast,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22305,137,1.01 [0.69-1.47],0.9538518220348038
Chapter II Neoplasms,Carcinoma in situ of breast,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22552,140,1.02 [0.66-1.57],0.940004177597247
Chapter II Neoplasms,Carcinoma in situ of breast,WIF1,Wnt inhibitory factor 1,22716,137,0.68 [0.44-1.05],0.0843288164882077
Chapter II Neoplasms,Carcinoma in situ of breast,WNT9A,Protein Wnt-9a,22090,138,0.78 [0.45-1.36],0.3809343162798889
Chapter II Neoplasms,Carcinoma in situ of breast,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22368,139,0.82 [0.62-1.09],0.1646336915704122
Chapter II Neoplasms,Carcinoma in situ of breast,XCL1,Lymphotactin,22716,137,0.93 [0.70-1.23],0.60773341460465
Chapter II Neoplasms,Carcinoma in situ of breast,XG,Glycoprotein Xg,22672,134,1.08 [0.64-1.83],0.7815162660909964
Chapter II Neoplasms,Carcinoma in situ of breast,XIAP,E3 ubiquitin-protein ligase XIAP,19054,117,0.74 [0.54-1.03],0.0742024544305105
Chapter II Neoplasms,Carcinoma in situ of breast,XPNPEP2,Xaa-Pro aminopeptidase 2,22586,140,1.09 [0.92-1.29],0.3191468166358713
Chapter II Neoplasms,Carcinoma in situ of breast,XRCC4,DNA repair protein XRCC4,21957,134,0.81 [0.52-1.25],0.3385045220947834
Chapter II Neoplasms,Carcinoma in situ of breast,YAP1,Transcriptional coactivator YAP1,19562,122,1.24 [0.64-2.38],0.5244106384313234
Chapter II Neoplasms,Carcinoma in situ of breast,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19501,122,0.91 [0.81-1.02],0.1060604767052914
Chapter II Neoplasms,Carcinoma in situ of breast,YES1,Tyrosine-protein kinase Yes,22413,140,0.81 [0.71-0.93],0.0022011391482006
Chapter II Neoplasms,Carcinoma in situ of breast,YJU2,Splicing factor YJU2,19495,120,0.64 [0.36-1.14],0.127908679507921
Chapter II Neoplasms,Carcinoma in situ of breast,YOD1,Ubiquitin thioesterase OTU1,19003,118,0.79 [0.60-1.05],0.1068443158240974
Chapter II Neoplasms,Carcinoma in situ of breast,YTHDF3,YTH domain-containing family protein 3,22090,138,0.88 [0.73-1.05],0.1620713666806096
Chapter II Neoplasms,Carcinoma in situ of breast,YWHAQ,14-3-3 protein theta,19191,120,0.78 [0.61-1.00],0.0539395292260143
Chapter II Neoplasms,Carcinoma in situ of breast,YY1,Transcriptional repressor protein YY1,19054,117,1.00 [0.53-1.87],0.9879500430370588
Chapter II Neoplasms,Carcinoma in situ of breast,ZBP1,Z-DNA-binding protein 1,19054,117,0.90 [0.56-1.43],0.6490498722051539
Chapter II Neoplasms,Carcinoma in situ of breast,ZBTB16,Zinc finger and BTB domain-containing protein 16,22008,134,0.76 [0.60-0.97],0.0262914268821153
Chapter II Neoplasms,Carcinoma in situ of breast,ZBTB17,Zinc finger and BTB domain-containing protein 17,22115,137,0.98 [0.68-1.42],0.9271342432614958
Chapter II Neoplasms,Carcinoma in situ of breast,ZCCHC8,Zinc finger CCHC domain-containing protein 8,19003,118,1.10 [0.85-1.42],0.4884006496163494
Chapter II Neoplasms,Carcinoma in situ of breast,ZFYVE19,Abscission/NoCut checkpoint regulator,19501,122,0.84 [0.69-1.01],0.0691832826678967
Chapter II Neoplasms,Carcinoma in situ of breast,ZHX2,Zinc fingers and homeoboxes protein 2,19562,122,1.33 [0.90-1.98],0.151420924625269
Chapter II Neoplasms,Carcinoma in situ of breast,ZNF174,Zinc finger protein 174,19054,117,0.99 [0.62-1.57],0.9495915555320068
Chapter II Neoplasms,Carcinoma in situ of breast,ZNF75D,Zinc finger protein 75D,19223,122,0.88 [0.65-1.20],0.422980659833549
Chapter II Neoplasms,Carcinoma in situ of breast,ZNF830,Zinc finger protein 830,19495,120,1.07 [0.87-1.31],0.514335523306755
Chapter II Neoplasms,Carcinoma in situ of breast,ZNRD2,Protein ZNRD2,19501,122,0.86 [0.66-1.11],0.2480045965511323
Chapter II Neoplasms,Carcinoma in situ of breast,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19495,120,0.76 [0.54-1.07],0.1181944057548184
Chapter II Neoplasms,Carcinoma in situ of breast,ZP3,Zona pellucida sperm-binding protein 3,19106,119,1.02 [0.96-1.10],0.5015739291755905
Chapter II Neoplasms,Carcinoma in situ of breast,ZP4,Zona pellucida sperm-binding protein 4,18908,119,0.63 [0.32-1.22],0.1692104017278694
Chapter II Neoplasms,Carcinoma in situ of breast,ZPR1,Zinc finger protein ZPR1,18997,118,1.01 [0.84-1.21],0.9192115411804166
